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Neutrophil	   clearance	   is	   an	   essential	   prerequisite	   for	   the	   successful	   resolution	   of	  
inflammation.	  Dysregulation	  of	  the	  mechanisms	  that	  regulate	  inflammation	  resolution	  
may	   lead	   to	   persistent	   neutrophilic	   inflammation	   and	   extensive	   host	   tissue	   damage,	  
which	   contributes	   to	   the	   pathogenesis	   of	   chronic	   inflammatory	   diseases.	   Many	   of	  
these	  respond	  poorly	  to	  current	  treatments	  and	  uncovering	  new	  mechanisms	  by	  which	  
inflammation	  resolution	  can	  be	  accelerated	  is	  key	  for	  the	  development	  of	  novel,	  more	  
effective	  therapies,	  which	  specifically	  target	  neutrophil	  clearance.	  
	  
Using	  a	  zebrafish	  model	  of	  neutrophilic	  inflammation,	  I	  have	  designed	  and	  optimised	  a	  
partially	   automated	   compound	   screening	   assay,	  with	   the	   hypothesis	   that	   this	  would	  
lead	   to	   the	   discovery	   of	   novel	   or	   previously	   unsuspected	   anti-­‐inflammatory	  
compounds	  that	  accelerate	  the	  resolution	  of	  inflammation.	  This	  approach	  enabled	  the	  
identification	  of	  multiple	  active	  compounds,	  acting	  via	  distinct	  anti-­‐inflammatory	  and	  
pro-­‐resolution	  mechanisms.	   By	   hierarchical	   cluster	   analysis,	   I	   was	   able	   to	   accurately	  
predict	  the	  mechanism	  of	  action	  of	  one	  of	  these	  compounds,	  isopimpinellin,	  which	  led	  
to	   the	   development	   of	   a	   model	   for	   analysing	   PI-­‐3K	   activity	   during	   neutrophil	  
recruitment	  in	  vivo.	  Chemical	  structure	  comparison	  also	  revealed	  a	  potential	  structure-­‐
activity	  relationship	  within	  a	  subset	  of	  the	  assay	  positive	  compounds.	  
	  
The	   most	   interesting	   compound	   identified,	   tanshinone	   IIA,	   was	   found	   to	   induce	  
apoptosis	  of	  human	  neutrophils	   in	  vitro,	  even	   in	  the	  presence	  of	  survival	  signals,	  but	  
also	   drive	   inflammation	   resolution	   in	   vivo	   via	   an	   additional,	   novel	   mechanism.	  
Tanshinone	  IIA	  promotes	  neutrophil	  clearance	  from	  the	  wound	  by	  reverse	  migration,	  
without	  increasing	  neutrophil	  speed,	  and	  dynamic	  modelling	  reveals	  that	  this	  occurs	  as	  
a	  passive	  redistribution	  process	  rather	  than	  active	  fugetaxis.	  Importantly,	  this	  effect	  is	  
maintained	   in	   the	   presence	   of	   survival	   signalling.	   This	   is	   the	   first	   evidence	   to	  
demonstrate	  that	   it	   is	  possible	  to	  pharmacologically	  drive	   inflammation	  resolution	  by	  
promoting	  neutrophil	  reverse	  migration.	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Chapter	  1:	  Introduction	  
	  
	  
1.1	  Overview	  of	  inflammation	  
	  
The	   inflammatory	   response	   is	   a	   multistep	   process	   initiated	   by	   the	   innate	   immune	  
system	  in	  the	  event	  of	  tissue	  injury	  or	  infection.	  It	  is	  a	  rapid	  and	  highly	  controlled	  host-­‐
defence	   mechanism,	   which	   functions	   to	   detect	   and	   destroy	   invading	   pathogens	  
(Medzhitov,	   2007).	   The	   response	   is	   triggered	   by	   recognition	   of	   an	   inflammatory	  
stimulus	  by	  immune	  cell	  receptors,	  which	  leads	  to	  activation	  of	  multiple	  inflammatory	  
signalling	  cascades	  and	  the	  production	  of	  pro-­‐inflammatory	  mediators.	  These	  promote	  
the	   rapid	   recruitment	   and	   activation	   of	   innate	   immune	   cells	   such	   as	   neutrophil	  
granulocytes,	  which	  function	  to	  eliminate	  infectious	  agents.	  	  
	  
It	   is	   critical	   that	   the	   inflammatory	   response	   resolves	   effectively	   to	   allow	   successful	  
tissue	   repair	   and	   the	   return	   to	   normal	   homeostasis.	   Host	   tissue	   damage	   may	   be	  
required	  in	  order	  to	  contain	  an	  infection,	  but	  this	  must	  be	  selective	  and	  controlled	  to	  
avoid	  extensive	  tissue	  destruction.	  Without	  adequate	  control,	  detrimental	  damage	  to	  
healthy	   tissue	  may	  ensue	  and	   failure	  of	   the	   acute	   inflammatory	   response	   to	   resolve	  
may	   result	   in	   chronic	   inflammation	   (Medzhitov,	   2010).	   Persistent	   inflammation	   and	  
dysregulation	  of	  the	  mechanisms	  governing	  resolution	  of	  inflammation	  are	  associated	  
with	   the	   progression	   of	   chronic	   inflammatory	   diseases,	   such	   as	   rheumatoid	   arthritis	  
(RA)	  and	  chronic	  obstructive	  pulmonary	  disease	  (COPD)	  (Serhan	  et	  al.,	  2007).	  	  
1.1.1	  Evolution	  of	  inflammation	  
The	  innate	  immune	  response	  is	  the	  first	  line	  of	  host	  defence,	  designed	  to	  identify	  and	  
destroy	   foreign	   invaders.	   It	   is	  an	  evolutionarily	  ancient	  system,	  many	  components	  of	  
which	   are	   highly	   conserved	   and	   exist	   in	   all	  metazoan	   organisms	   (Barton,	   2008).	   The	  
concept	  of	  cellular	  immunity	  was	  first	  documented	  by	  Elie	  Metchnikoff	  in	  1892,	  when	  
he	  observed	  the	  accumulation	  of	  phagocytes	  at	  a	  site	  of	  injury	  induced	  by	  a	  rose	  thorn	  
in	   starfish	   larvae.	   He	   recognised	   the	   beneficial	   function	   of	   phagocytosis	   for	   host	  





Inflammation	  was	  initially	  defined	  in	  the	  first	  century	  AD	  by	  the	  Roman	  encyclopaedist	  
Cornelius	   Celsus,	   who	   described	   the	   four	   principal	   signs	   as	   rubor	   (redness),	   tumor	  
(swelling),	   calore	   (heat)	   and	   dolore	   (pain)	   (Medzhitov,	   2010).	   These	   simple	  
observations	   are	   an	   accurate	   portrayal	   of	   inflammation	   as	   we	   understand	   it	   today.	  
Vasodilation	   and	   extravasation	   of	   red	   blood	   cells	   results	   in	   heat	   and	   redness,	  whilst	  
swelling	   is	   caused	   by	   fluid	   accumulation	   and	   pain	  may	   ensue	   via	   the	   stimulation	   of	  
sensory	  nerve	  endings	  by	  chemical	  mediators	  such	  as	  bradykinin.	  A	  fifth	  cardinal	  sign	  
of	  inflammation,	  functio	  laesa	  (disturbance	  of	  function),	  was	  defined	  centuries	  later	  in	  
1858,	  by	  the	  German	  physician	  Rudolph	  Virchow	  (Medzhitov,	  2010).	  	  	  
1.1.2	  Initiation	  of	  the	  inflammatory	  response	  
Inflammation	   can	  be	   initiated	  by	  either	   endogenous	  or	   exogenous	   stimuli.	   The	  most	  
well	   characterised	   inflammatory	   response	   is	   that	   induced	   by	   microbial	   infection	  
(Medzhitov,	  2008).	  Tissue	  resident	  macrophages,	  dendritic	  cells	  and	  mast	  cells	  detect	  
the	   presence	   of	   foreign	   microorganisms	   via	   the	   recognition	   of	   pathogen-­‐associated	  
molecular	   patterns	   (PAMPs).	   These	   are	   conserved	   microbial	   components	   such	   as	  
lipopolysaccharides	  (LPS),	  flagellin	  and	  double-­‐	  or	  single-­‐stranded	  RNA,	  which	  bind	  to	  
Pattern	  Recognition	  Receptors	   (PRRs),	   such	  as	   the	   family	  of	   transmembrane	  Toll-­‐like	  
receptors	   (TLRs)	   (Medzhitov,	   2001).	   Binding	   causes	   phagocytosis	   of	   the	   foreign	  
microbe	  and	  initiates	  an	  intracellular,	  pro-­‐inflammatory	  signalling	  cascade,	  resulting	  in	  
the	  activation	  of	  transcription	  factors	  such	  as	  nuclear	  factor-­‐κB	  (NF-­‐κB)	  and	  interferon-­‐
regulatory	  factors	  (IRFs)	  (Medzhitov,	  2007;	  Barton,	  2008).	  These	  important	  regulators	  
drive	   the	   expression	   of	   pro-­‐inflammatory	   genes	   including	   Tumor	   Necrosis	   Factor-­‐α	  
(TNF-­‐α)	  and	  interleukin-­‐1	  (IL-­‐1),	  resulting	  in	  immune	  cell	  activation	  and	  the	  subsequent	  
release	  of	  multiple	  pro-­‐inflammatory	  mediators	  (Nathan,	  2002).	  
	  
Alternatively,	  the	  inflammatory	  response	  can	  be	  initiated	  via	  the	  activation	  of	  cytosolic	  
receptors,	   amongst	   which	   are	   the	   family	   of	   NACHT-­‐leucine-­‐rich	   repeat	   containing	  
receptors	  (NLRs)	  (Pétrilli	  et	  al.,	  2007).	  The	  Nod1	  and	  Nod2	  proteins	  form	  a	  subfamily	  of	  
NLRs,	  which	   function	   in	  a	  comparable	  manner	   to	  TLRs,	  by	  binding	  bacterial	  products	  
such	   as	   peptidoglycan	   to	   activate	   NF-­‐κB	   and	   enhance	   pro-­‐inflammatory	   gene	  
expression	  (Strober	  et	  al.,	  2006).	  Nod2	  mutations	  have	  been	  associated	  with	  Crohn’s	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disease,	   emphasising	   the	   significance	   of	   these	   proteins	   in	   coordination	   of	   the	  
inflammatory	  response	  (Strober	  et	  al.,	  2006).	  	  	  
	  
Other	   intracellular	   NLRs	   function	   in	   a	   different	   manner,	   including	   the	   NLR	   family	  
apoptosis	   inhibitory	  proteins	   (NAIPs)	  and	  NACHT-­‐,	  LRR-­‐,	  and	  pyrin	  domain-­‐containing	  
proteins	   (NALPs),	   which	   target	   internalised	   exogenous	   ligands	   such	   as	   bacterial	  
flagellin	   and	   RNA,	   and	   the	   endogenous	   uric	   acid	   crystals	   characteristic	   of	   gout	  
(Mariathasan	   et	   al.,	   2007).	   Binding	   triggers	   activation	   of	   a	   multi-­‐protein	   complex	  
known	  as	  the	  inflammasome,	  which	  sequentially	  activates	  caspase-­‐1	  to	  allow	  cleavage	  
and	  processing	  of	  the	  IL-­‐1	  cytokine	  family,	  members	  of	  which	  include	  IL-­‐1β,	  IL-­‐18	  and	  
IL-­‐33	   (Mariathasan	   &	   Monack,	   2007;	   Medzhitov,	   2007).	   It	   is	   likely	   that	   crosstalk	  
between	   the	  TLR	  and	  NLR	  pathways	  exists,	  as	  both	   lead	   to	   inflammasome	  activation	  
and	  subsequent	  IL-­‐1	  secretion	  (Barton,	  2008).	  
	  
In	  terms	  of	  sterile	  tissue	  injury	  in	  which	  there	  is	  an	  absence	  of	  microbial	  infection,	  it	  is	  
likely	   that	   TLRs	   are	   responsible	   for	   induction	   of	   the	   inflammatory	   response	   via	   the	  
recognition	   of	   endogenous,	   intracellular	   ligands	   that	   are	   released	   by	   necrotic	   cells,	  
such	  as	  heat	  shock	  proteins	  and	  β-­‐defensin	  (Ohashi	  et	  al.,	  2000;	  Biragyn	  et	  al.,	  2002).	  
For	   example,	   knockout	   mice	   studies	   have	   revealed	   that	   TLR2	   and	   TLR4,	   along	   with	  
MyD88,	  are	  necessary	   for	   the	  detection	  of	  hyaluronan,	  an	  extracellular	  matrix	   (ECM)	  
glycosaminoglycan	   that	   is	   present	   in	   the	   serum	   of	   acute	   lung	   injury	   patients	   and	   is	  
responsible	   for	   stimulating	   inflammation	   via	   activation	   of	   NF-­‐κB	   (Jiang	   et	   al.,	   2005).	  
These	  endogenous	  stimuli	  are	  collectively	  referred	  to	  as	  damage-­‐associated	  molecular	  
patterns	  (DAMPs)	  and	  also	  include	  adenosine	  triphosphate	  (ATP),	  high-­‐mobility	  group	  
box	   1	   protein	   (HMGB1)	   and	   various	   members	   of	   the	   S100	   calcium-­‐binding	   protein	  
family	   (Bianchi,	   2007).	   ATP	   binding	   to	   purinoceptors	   such	   as	   P2X7	   on	  macrophages	  
decreases	   intracellular	   K+	   levels	   and	   contributes	   to	   activation	   of	   the	   inflammasome	  
(Mariathasan	  et	  al.,	  2006).	  In	  addition	  to	  the	  inflammatory	  response	  induced	  by	  innate	  
receptor	   signalling,	   activation	   of	   afferent	   neurons	   in	   response	   to	   pain	   from	   tissue	  
injury	   results	   in	   the	   release	   of	   bioactive	   peptides	   such	   as	   calcitonin	   gene-­‐related	  




1.1.3	  Inflammatory	  mediators	  
Following	   initiation	   of	   the	   inflammatory	   response,	   pro-­‐inflammatory	   mediators	  
released	   by	   macrophages	   and	   other	   tissue-­‐resident	   inflammatory	   cells	   amplify	   the	  
response	  and	  have	  various	  effects	  on	  the	   local	  environment	  (Table	  1.1).	  This	  cascade	  
of	  inflammatory	  ‘go’	  signals	  (Nathan,	  2002)	  results	  in	  a	  combination	  of	  systemic	  effects	  
and	   local	   morphological	   and	   biochemical	   changes.	   The	   release	   of	   cytokines	   such	   as	  
TNF-­‐α,	   IL-­‐1	   and	   IL-­‐6	   causes	   priming	   and	   activation	   of	   the	   endothelium	   and	   other	  
leukocytes,	   to	   promote	   their	   transmigration	   and	   recruitment	   (Medzhitov,	   2008).	  
Vasodilation	   is	   triggered	   by	   the	   release	   of	   histamine,	   eicosanoids	   and	   tryptases,	  
particularly	   from	   mast	   cells,	   and	   increased	   vascular	   permeability	   results	   in	  
extravasation	  of	   fluid	   into	   the	  surrounding	   tissue,	   forming	   the	   inflammatory	  exudate	  
(Nathan,	  2002).	  	  
	  
Platelet-­‐activating	   factors	   (PAFs),	   produced	   via	   the	   acetylation	   of	   lysophosphatidic	  
acid,	  are	  released	  from	  leukocytes	  and	  also	  function	  to	  promote	  vascular	  changes	  and	  
increase	  the	  adhesive	  properties	  of	  the	  endothelium	  (Nathan,	  2002;	  Medzhitov,	  2008).	  
Other	  lipid	  mediators,	  the	  eicosanoids,	  are	  generated	  from	  either	  the	  cyclooxygenase	  
(COX)-­‐	  or	  lipoxygenase	  (LO)-­‐mediated	  metabolism	  of	  arachidonic	  acid	  (AA),	  to	  produce	  
prostaglandins	   (PGs)	   and	   thromboxanes,	   or	   leukotrienes	   and	   lipoxins,	   respectively	  
(Medzhitov,	  2008).	  Prostaglandins	  can	  induce	  fever	  and	  vasodilation	  and	  leukotrienes	  
promote	   leukocyte	   recruitment.	   Lipoxins	   play	   a	   role	   in	   the	   resolution	   phase	   of	  
inflammation	   and	   will	   be	   discussed	   later.	   Another	   important	   class	   of	   inflammatory	  
mediators	  is	  the	  chemokine	  family,	  a	  group	  of	  approximately	  50	  secreted	  proteins	  that	  
mediate	   extravasation	   and	   directed	   migration	   (Moser	   et	   al.,	   2004).	   Other	  
inflammatory	  mediators	  are	  indicated	  in	  Table	  1.1.	  	  
	  
The	   combined	   and	   co-­‐ordinated	   effect	   of	   these	   inflammatory	   mediators	   is	   the	  
recruitment	   of	   circulating	   leukocytes,	   the	   first	   of	   which	   to	   arrive	   at	   the	   site	   of	  
inflammation	  is	  the	  neutrophil	  (Barton,	  2008).	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Inflammatory	  mediator	   Examples	   Effects	  
Vasoactive	  amines	   Histamine	  
Serotonin	  
Vasodilation,	  ↑	  vascular	  
permeability	  (may	  cause	  
vasoconstriction	  in	  some	  
circumstances)	   	  
Vasoactive	  peptides	   Substance	  P	  
Fibrinopeptides	  
Kinins	  
Mast	  cell	  degranulation,	  
vasodilation,	  ↑	  vascular	  
permeability,	  pro-­‐algesic	  
Complement	  fragments	   C3a,	  C3b	  
C4a	  
C5a	  
Mast	  cell	  degranulation,	  	  
↑	  leukocyte	  recruitment,	  
opsonisation	  of	  pathogens,	  
formation	  of	  membrane	  attack	  
complex	  




















↑	  Recruitment	  of	  leukocytes,	  
vasodilation/constriction,	  platelet	  
activation	  
Cytokines	   TNF-­‐α	  
IL-­‐1	  
IL-­‐6	  	  
Activate	  endothelium	  and	  
leukocytes,	  induce	  acute-­‐phase	  
systemic	  response	  (↑	  fever,	  ↑	  
metabolism)	  




Affect	  leukocyte	  extravasation	  and	  
chemotaxis	  




Degrade	  extracellular	  matrix	  and	  
basement	  membrane	  proteins,	  
affect	  leukocyte	  migration	  
	  
Table	  1.1:	  Inflammatory	  mediators	  and	  their	  effects.	  
Following	   initiation,	   the	   inflammatory	   response	   is	   amplified	   by	   pro-­‐inflammatory	   mediators,	   which	  
trigger	  a	  combination	  of	  systemic	  effects	  and	   local	  morphological	  and	  biochemical	  changes.	  There	  are	  
seven	   groups	   of	   inflammatory	   mediators,	   classified	   by	   their	   biochemical	   attributes.	   Adapted	   from	  
(Medzhitov,	  2008).	  




1.2	  The	  neutrophil	  in	  inflammation	  
	  
1.2.1	  The	  neutrophil	  lifespan	  
Neutrophils	   have	   evolved	   as	   key	   components	   of	   the	   inflammatory	   response	   and	   are	  
critical	   for	   the	   first	   line	   of	   host	   defence.	   They	   are	   polymorphonuclear	   leukocytes	  
(PMNs),	  characterised	  by	  a	  multi-­‐lobed	  nucleus	  connected	  by	   thin	  bridges	  of	  nuclear	  
material	   and	  a	  plethora	  of	   cytoplasmic	  granules.	  Neutrophils	  are	   the	  most	  abundant	  
human	   leukocyte	   and,	   along	  with	   other	   granulocytes	   and	  macrophages,	   are	   derived	  
from	   common	   myeloid	   progenitors,	   which	   arise	   from	   haematopoietic	   stem	   cells	  
(Akashi	  et	  al.,	  2000).	  	  
	  
In	   the	   adult	   vertebrate,	   haematopoiesis	   takes	  place	   in	   the	  bone	  marrow,	  where	   key	  
cytokines	   such	   as	   Granulocyte	   Colony	   Stimulating	   Factor	   (G-­‐CSF),	   Granulocyte-­‐
Macrophage	   Colony	   Stimulating	   Factor	   (GM-­‐CSF)	   and	   IL-­‐3,	   drive	   the	  maturation	   and	  
functional	  activation	  of	  neutrophils	   (Berliner,	  2008;	  Dale	  et	  al.,	  2008).	   It	   is	  estimated	  
that	  under	  basal	  conditions,	  between	  5	  x	  1010	  and	  10	  x	  1010	  neutrophils	  are	  produced	  
in	  the	  bone	  marrow	  every	  day	  (Summers	  et	  al.,	  2010).	  The	  majority	  of	  differentiated	  
neutrophils	   reside	  here	   to	   form	  a	   reserve	  population	  up	   to	   ten-­‐fold	   higher	   than	   the	  
circulating	   population	   (Berliner,	   2008).	   In	   addition	   to	   these	   populations,	   there	   also	  
exist	   a	   number	   of	   marginated	   neutrophil	   pools	   within	   the	   capillary	   beds	   of	   specific	  
organs	  such	  as	  the	  spleen,	  liver	  and	  lung	  (Summers	  et	  al.,	  2010).	  
	  
For	   homeostasis	   to	   be	   maintained,	   a	   tightly	   regulated	   balance	   must	   exist	   between	  
granulopoiesis,	  the	  release	  of	  neutrophils	  from	  the	  bone	  marrow	  and	  their	  elimination	  
from	  the	  circulation.	  G-­‐CSF	  is	  a	  particularly	  important	  regulator	  of	  granulopoiesis	  and	  
the	   loss	  of	   functional	  G-­‐CSF	   receptors	  has	  been	  shown	  to	  cause	  neutropenia	   in	  both	  
mice	   and	   humans	   (Lieschke	   et	   al.,	   1994;	   Druhan	   et	   al.,	   2005).	   Mature	   neutrophils	  
express	   low	   levels	  of	   the	  chemokine	  receptor	  CXCR4,	  which	  binds	  to	  stromal-­‐derived	  
factor-­‐1	   (SDF-­‐1),	   a	   chemokine	   that	   is	   constitutively	   produced	   in	   the	   bone	   marrow	  
(Sugiyama	   et	   al.,	   2006).	   The	   CXCR4-­‐SDF-­‐1	   axis	   mediates	   neutrophil	   retention	   and	  
disruption	  of	  this	  interaction	  induces	  neutrophil	  release	  (Ma	  et	  al.,	  1999;	  Devine	  et	  al.,	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2008).	  Failure	  of	  neutrophil	  mobilisation	  can	  result	  in	  neutropenia,	  as	  demonstrated	  in	  
WHIM	   syndrome	   (warts,	   hypogammaglobulinaemia,	   infection	   and	   myelokathesis),	   a	  
rare	   disorder	   in	   which	   neutrophils	   have	   increased	   sensitivity	   to	   SDF-­‐1	   due	   to	   a	  
mutation	   in	   CXCR4	   (Hernandez	   et	   al.,	   2003).	   There	   is	   evidence	   to	   suggest	   that	  
signalling	   via	   another	   chemokine	   receptor,	   CXCR2,	   also	   plays	   a	   role	   in	   neutrophil	  
trafficking	  and	  acts	   in	  an	  antagonist	  manner	  to	  CXCR4,	  as	  neutrophils	   in	  Cxcr2-­‐/-­‐	  mice	  
are	  retained	  in	  the	  bone	  marrow	  (Eash	  et	  al.,	  2010).	  	  
	  
Despite	   their	   abundance,	   neutrophils	   possess	   a	   relatively	   short	   half-­‐life	   due	   to	   their	  
predisposition	  to	  undergo	  spontaneous	  apoptosis.	  Circulating	  neutrophils	  are	  generally	  
accepted	   to	   have	   a	   half-­‐life	   of	   approximately	   8	   hours	   (Dancey	   et	   al.,	   1976).	   More	  
recent	  evidence	  obtained	  by	  in	  vivo	  2H2O	  labelling	  of	  human	  neutrophils	  proposed	  that	  
circulating	  neutrophils	  have	  a	  mean	  lifespan	  of	  5.4	  days	  (Pillay	  et	  al.,	  2010),	  although	  
this	  has	  been	  met	  with	  some	  criticism	   (Pillay	  et	  al.,	  2011;	  Tofts	  et	  al.,	  2011).	  Studies	  
performed	  in	  mice	  suggest	  that	  under	  physiological	  conditions,	  senescent	  neutrophils	  
return	  to	  the	  bone	  marrow	  where	  they	  undergo	  apoptosis,	   followed	  by	  phagocytosis	  
by	  stromal	  macrophages,	  which	  then	  stimulates	  G-­‐CSF	  production	  (Furze	  et	  al.,	  2008).	  
This	  homing	  behaviour	   is	  believed	   to	  be	  CXCR4-­‐dependent,	  as	   senescent	  neutrophils	  
have	  up-­‐regulated	  expression	  of	   the	  chemokine	  receptor	  and	   increased	  sensitivity	   to	  
SDF-­‐1α	  (Martin	  et	  al.,	  2003).	  This	  process	  has	  not	  yet	  been	  fully	  defined,	  particularly	  in	  
humans,	  and	  it	  is	  likely	  that	  other	  mechanisms	  may	  also	  be	  important	  in	  the	  regulation	  
of	  neutrophil	  clearance	  from	  the	  circulation.	  
	  
During	   inflammation,	   neutrophil	   release	   from	   the	  bone	  marrow	   is	   increased	  by	   pro-­‐
inflammatory	   mediators	   such	   as	   IL-­‐8,	   TNF-­‐α,	   complement	   component	   C5a	   and	  
leukotriene	  B4	   (LTB4)	   (Terashima	  et	   al.,	   1998;	   Summers	   et	   al.,	   2010).	  G-­‐CSF	   and	  CXC	  
chemokines	   can	   also	   mediate	   neutrophil	   release	   under	   inflammatory	   conditions	  
(Semerad	  et	  al.,	  2002;	  Burdon	  et	  al.,	  2008),	  and	  it	  is	  likely	  that	  this	  involves	  disruption	  
of	   the	   CXCR4-­‐SDF-­‐1	   axis	   (Wengner	   et	   al.,	   2008).	   Activated	   neutrophils	   that	   have	  
migrated	   into	   inflamed	   tissue	  may	   have	   a	   lifespan	   of	   up	   to	   4	   days	   (Edwards	   et	   al.,	  




CSF,	   IL-­‐1β,	   TNF-­‐α	   and	   interferon-­‐γ	   (IFN-­‐γ),	   which	   interfere	   with	   apoptotic	   pathways	  
(Colotta	  et	  al.,	  1992),	  as	  will	  be	  discussed	  later.	  	  
1.2.2	  Neutrophil	  priming	  and	  recruitment	  
Neutrophils	   must	   respond	   rapidly	   in	   the	   event	   of	   tissue	   injury	   or	   infection.	   Upon	  
exposure	   to	   pro-­‐inflammatory	   mediators	   including	   cytokines,	   chemokines	   and	  
bacterial	   products,	   neutrophils	   become	   partially	   activated,	   or	   ‘primed’,	   and	   are	  
recruited	  towards	  the	  inflamed	  area	  (Hallett	  &	  Lloyds,	  1995).	  This	  initial	  activation	  step	  
is	   required	   to	   prevent	   inappropriate	   degranulation	   before	   the	   neutrophils	   have	  
reached	   their	   destination.	   It	   is	   also	   essential	   for	  maximising	   the	   neutrophil	   effector	  
functions,	  such	  as	  the	  activation	  of	  NADPH	  oxidase,	  once	  they	  arrive	  (Summers	  et	  al.,	  
2010).	  Priming	  by	  agents	  such	  as	  LPS	  and	  GM-­‐CSF	  also	  extends	  neutrophil	  lifespan,	  to	  
maximise	  the	  duration	  of	  the	  response	  and	  facilitate	  efficient	  elimination	  of	  pathogens	  
(Condliffe	  et	  al.,	  1998).	  
	  
Recruitment	  of	  circulating	  neutrophils	  to	  sites	  of	   inflammation	  or	   infection	  involves	  a	  
complex	  process	  of	  rolling	  and	  adhesion	  on	  endothelial	  cells,	  directed	  by	  a	  chemotactic	  
gradient.	  Once	  firmed	  adhered	  to	  the	  endothelium,	  neutrophils	  transmigrate	  into	  the	  
tissues,	   a	   process	   known	   as	   extravasation.	   From	   here,	   neutrophils	   migrate	   to	   the	  
required	  tissue	  site	  by	  chemotaxis.	  
1.2.3	  Extravasation	  
Changes	   in	   hemodynamic	   flow	   as	   blood	   enters	   the	   post-­‐capillary	   venules	   results	   in	  
leukocytes	  passing	  through	  in	  close	  proximity	  to	  the	  vessel	  wall	  (Simon	  et	  al.,	  2002).	  In	  
areas	  of	  inflammation,	  cytokines	  such	  as	  TNF-­‐α	  and	  IL-­‐1	  promote	  the	  expression	  of	  an	  
array	  of	  adhesion	  molecules	  on	  vascular	  endothelial	  cells	  (Spertini	  et	  al.,	  1991;	  Kansas,	  
1996).	   These	   bind	   their	   corresponding	   ligands,	   including	   E-­‐,	   P-­‐,	   and	   L-­‐selectin,	   to	  
facilitate	  a	  weak	  interaction	  between	  neutrophils	  and	  the	  endothelial	  cells,	  known	  as	  
tethering.	   Transient	   and	   sequential	   selectin-­‐binding	   also	  mediates	   neutrophil	   rolling	  
along	   the	   vessel	  wall,	  which	   is	   a	   prerequisite	   for	   neutrophil	   arrest	   (Ley	   et	   al.,	   1995;	  
Kansas,	   1996).	   Immobilised	   chemokines	   are	   presented	   on	   the	   luminal	   surface	   of	  
endothelial	   cells	   by	   interacting	   with	   glycosaminoglycans,	   and	   these	   also	   promote	  
neutrophil	   tethering	   and	   activation	   via	   G-­‐protein	   coupled	   receptor	   (GPCR)	   binding	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(Grabovsky	   et	   al.,	   2000;	  Middleton	   et	   al.,	   2002).	   The	   reduction	   of	   neutrophil	   rolling	  
speed	   and	   their	   firm	   adhesion	   to	   the	   endothelial	   surface	   is	   achieved	   via	   ‘inside-­‐out’	  
signalling,	  which	  alters	  the	  conformation	  of	  β2-­‐integrins	  including	  lymphocyte	  function	  
antigen	  (LFA-­‐1)	  and	  macrophage	  antigen-­‐1	  (Mac-­‐1)	  on	  the	  neutrophil	  surface,	  enabling	  
them	  to	  bind	  ligands	  such	  as	  intracellular	  adhesion	  molecule-­‐1	  (ICAM-­‐1;	  also	  known	  as	  
CD54)	   (Zimmerman	  et	  al.,	  1992;	  Dunne	  et	  al.,	  2002;	  Zarbock	  et	  al.,	  2008).	  Additional	  
priming	   of	   neutrophils	   by	   TNF-­‐α,	   C5a	   and	   other	   inflammatory	   mediators	   causes	  
release	   of	   PAF	   and	   elastase,	   resulting	   in	   cleavage	   of	   CD43,	   an	   anti-­‐adhesive	  
sialoprotein,	   from	   the	   cell	   surface	   (Nathan	   et	   al.,	   1993).	   This	   enables	   neutrophil	  
spreading	  and	  firm	  adhesion	  to	  the	  ECM	  through	  β2-­‐integrin	  interactions.	  
	  
Following	   neutrophil	   arrest,	   ‘outside-­‐in’	   signalling	   triggers	   neutrophil	   diapedesis	   and	  
transmigration	  through	  the	  endothelium	  (Zarbock	  et	  al.,	  2008).	  It	  is	  believed	  that	  this	  
emigration	   may	   occur	   either	   paracellularly,	   between	   the	   junction	   of	   two	   tightly	  
apposed	   endothelial	   cells,	   or	   transcellularly,	   across	   one	   epithelial	   cell	   (Petri	   et	   al.,	  
2013).	   The	   latter	   phenomenon	   has	   been	   investigated	   by	   electron	   microscopy	   of	  
sections	   of	   inflamed	   venular	   epithelium	   from	   guinea	   pigs,	   in	   which	   in	   most	   cases	  
neutrophils	   were	   observed	   to	   emigrate	   through	   trans-­‐endothelial	   cell	   pores,	   rather	  
than	   inter-­‐endothelial	   cell	   gaps	   (Feng	   et	   al.,	   1998).	   This	   form	   of	   transmigration	   is	  
believed	  to	  be	  highly	  dependent	  on	  the	  interaction	  between	  ICAM-­‐1	  and	  LFA-­‐1,	  which	  
may	  trigger	  the	  extension	  of	  neutrophil	  pseudopodia	  into	  the	  endothelial	  cells,	  at	  sites	  
away	   from	  cell-­‐cell	   junctions	   (Yang	  et	   al.,	   2005).	   Emigration	   is	   also	   facilitated	  by	   the	  
redistribution	   and	   recycling	   of	   many	   other	   adhesion	   molecules	   on	   the	   surface	   of	  
endothelial	  cells,	  including	  members	  of	  the	  junctional	  adhesion	  molecule	  (JAM)	  family,	  
platelet	  endothelial	  cell	  adhesion	  molecule-­‐1	  (PECAM-­‐1)	  and	  the	  vascular	  endothelial	  
cadherin	  complex	  (Williams	  et	  al.,	  2011).	  	  
1.2.4	  Neutrophil	  chemotaxis	  
Following	   extravasation,	   neutrophils	   continue	   their	   migration	   through	   the	   tissue	  
microenvironment	   towards	   the	   site	   of	   inflammation	   by	   a	   process	   known	   as	  
chemotaxis.	   They	   are	   directed	   by	   gradients	   of	   soluble	   chemoattractants,	   including	  




More	  than	  40	  chemokines	  and	  19	  different	  chemokine	  receptors	  have	  been	  identified,	  
which	  enables	  specificity	  between	  leukocyte	  subtypes	  (Kim,	  2004).	  Selective	  trafficking	  
is	   achieved	   via	   the	   differential	   expression	   of	   chemokine	   receptors	   and	   adhesion	  
molecules	  on	  immune	  cells	  and	  within	  different	  tissues.	  	  
	  
The	  predominant	  receptors	  that	  regulate	  neutrophil	  trafficking	  are	  the	  CXC	  chemokine	  
receptors,	  CXCR1	  and	  CXCR2	  (Holmes	  et	  al.,	  1991;	  Murphy	  &	  Tiffany,	  1991).	  These	  are	  
GPCRs,	   which	   are	   activated	   by	   glutamic	   acid-­‐leucine-­‐arginine	   containing	   (ELR+)	  
chemokines.	   The	   receptors	   are	  highly	   homologous,	   sharing	   77%	  amino	   acid	   identity,	  
but	   have	  different	   binding	   affinities	   for	   IL-­‐8	   (Holmes	   et	   al.,	   1991;	  Murphy	  &	   Tiffany,	  
1991).	   CXCR1	   binds	   IL-­‐8	   with	   high	   affinity	   and	   also	   binds	   CXCL6	   (granulocyte	  
chemotactic	   protein-­‐2)	   (Wolf	   et	   al.,	   1998).	   CXCR2	  binds	   both	  of	   these	   ligands,	   along	  
with	   other	   ELR+	   chemokines	   including	   CXCL7	   (neutrophil-­‐activating	   protein	   2)	   and	  
CXCL5	   (epithelial	   cell-­‐derived	   neutrophil-­‐activating	   peptide-­‐78)	   (Ahuja	   et	   al.,	   1996).	  
CXCR1	   and	   CXCR2	   activate	   a	   number	   of	   intracellular	   signalling	   pathways	   to	   regulate	  
neutrophil	   polarisation	   and	   motility	   in	   response	   to	   chemotactic	   stimuli,	   which	   are	  
described	  below	  (Stillie	  et	  al.,	  2009).	  	  
	  
A	   complex	   spatial	   and	   temporal	   array	  of	  different	   chemoattractant	   signals	  may	  exist	  
within	  the	  tissue	  environment	  and	  neutrophils	  must	  be	  able	  to	  respond	  appropriately.	  
In	   some	   circumstances,	   neutrophils	   can	   migrate	   against	   a	   chemokine	   gradient	   in	  
response	  to	  a	  different,	  opposing	  chemotactic	  signal	  (Foxman	  et	  al.,	  1997).	  It	  has	  been	  
proposed	   that	   during	   inflammation,	   neutrophils	   first	   respond	   to	   ‘intermediary’	  
chemoattractants	   such	  as	   IL-­‐8	  and	  LTB4,	  which	  activate	  phosphatidylinositol-­‐3	  kinase	  
(PI-­‐3K)	  signalling	  (Hirsch,	  2000;	  Heit	  et	  al.,	  2002).	  A	  signalling	  hierarchy	  exists	  and	  once	  
neutrophils	   encounter	   ‘end-­‐target’	   chemoattractants	   such	   as	   C5a	   and	   bacterial	   N-­‐
formyl	  peptides	  (fMLPs),	  these	  signals	  take	  precedence,	  leading	  to	  inactivation	  of	  PI-­‐3K	  
signalling	   and	   activation	   of	   p38	   mitogen-­‐activated	   protein	   kinase	   (MAPK)	   signalling	  
(Nick	  et	  al.,	  1997;	  Heit	  et	  al.,	  2002).	  Chemoattractant	  receptor	  cross-­‐desensitisation	  is	  
also	  believed	  to	  regulate	  the	  responsiveness	  of	  neutrophils	  to	  competing	  chemotactic	  
signals	  (Ali	  et	  al.,	  1999).	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1.2.5	  Intracellular	  pathways	  involved	  in	  neutrophil	  recruitment	  
The	  activation	  of	  chemoattractant	  GPCRs	  triggers	  an	   increase	   in	  cAMP	  levels	  and	  the	  
mobilisation	  of	   intracellular	  calcium,	  which	  can	  regulate	  chemotaxis	   (Partida-­‐Sánchez	  
et	  al.,	   2001;	  Partida-­‐Sánchez	  et	  al.,	   2004).	   This,	   along	  with	   the	  activation	  of	  multiple	  
intracellular	  signalling	  cascades,	  is	  responsible	  for	  the	  cytoskeletal	  rearrangements	  and	  
F-­‐actin	  polymerisation	  required	  for	  directed	  neutrophil	  migration.	  Much	  of	  our	  current	  
understanding	  of	  chemotaxis	  has	  been	  established	  from	  study	  of	  the	  simple	  eukaryotic	  
organism	  Dictyostelium	   discoideum	   (Bagorda	   et	   al.,	   2006).	   It	   was	   originally	   believed	  
that	   cells	   possess	   an	   internal	   ‘compass’	   and	   once	   they	   encounter	   a	   chemokine	  
gradient,	   actin	   polymerisation	   and	   pseudopod	   formation	   ensue	   to	   direct	   the	   cell	  
towards	   the	   appropriate	   location	   (Bourne	   et	   al.,	   2002).	   However,	   it	   has	   since	   been	  
proposed	   that	   during	   chemotaxis,	   pseudopods	   are	   formed	   independently	   of	  
chemoattractant	   signalling,	   are	   usually	   generated	   by	   the	   bifurcation	   of	   existing	  
pseudopods,	  and	  only	   those	  which	  detect	   the	  chemokine	  gradient	  are	  maintained	   in	  
order	  to	  direct	  migration	  (Andrew	  et	  al.,	  2007;	  Insall,	  2010).	  Neutrophil	  chemotaxis	  is	  
highly	   complex,	   context-­‐dependent	   and	   involves	   cross-­‐talk	   between	   a	   number	   of	  
intracellular	  signalling	  pathways	  in	  order	  to	  co-­‐ordinate	  effective	  gradient	  sensing	  and	  
create	  a	  functional	  response.	  	  
	  	  
The	  PI-­‐3K	  pathway	  
	  
The	   PI-­‐3K	   pathway	   plays	   an	   integral	   role	   in	   the	   amplification	   of	   chemoattractant	  
gradients	  and	  neutrophil	  polarisation.	  Following	  PI-­‐3K	  activation,	  phosphatidylinositol	  
(3,4,5)-­‐triphosphate	   (PIP3)	   accumulates	   at	   the	   leading	   edge	   of	   the	   neutrophil	   and	  
recruits	   various	   Pleckstrin	   Homology	   (PH)	   domain	   proteins,	   such	   as	   AKT,	   to	   the	  
membrane,	  where	  they	  activate	  the	  downstream	  components	  required	  for	  migration	  
(Stephens	   et	   al.,	   2002)	   (Figure	   1.1).	   This	   process	   is	   believed	   to	   be	  mediated	   by	   the	  
small	  GTPase	  Ras,	  as	   its	   loss	  or	  mutation	   is	  associated	  with	  defects	   in	  directional	  cell	  
movement	  (Sasaki	  et	  al.,	  2004).	  
	  
Studies	  indicate	  that	  PI-­‐3Kγ	  is	  the	  principal	  class	  I	  PI-­‐3K	  isoform	  involved	  in	  leukocyte	  
migration.	   In	  PI-­‐3Kγ-­‐/-­‐	  mice,	  neutrophils	  are	  unable	   to	  produce	  PIP3	  or	  phosphorylate	  




an	  impaired	  motility	  and	  also	  reduced	  respiratory	  burst	  (Hirsch,	  2000).	  Additionally,	  in	  
PI-­‐3Kγ-­‐/-­‐	   neutrophils,	   the	   correct	   spatial	   and	   temporal	   accumulation	  of	  PIP3,	  AKT	  and	  
polymerised	   F-­‐actin	   at	   the	   leading	   edge	   are	   impaired,	   leading	   to	   defects	   in	   cell	  
movement	  (Hannigan	  et	  al.,	  2002;	  Ferguson	  et	  al.,	  2007).	  A	  class	  Ia	  PI-­‐3K	  isoform,	  PI-­‐
3Kδ,	   may	   also	   facilitate	   directional	   neutrophil	   migration,	   as	   its	   specific	   blockade	  
inhibits	  PIP3	  production	  and	  polarisation	  and	  reduces	  recruitment	  of	  neutrophils	  to	  the	  







Figure	  1.1:	  Schematic	  representation	  of	  PI-­‐3Kγ	  signalling.	  
Activation	   of	   GPCRs	   such	   as	   CXCR2	   by	   IL-­‐8	   binding	   causes	   activation	   of	   the	   heterotrimeric	   G-­‐protein	  
complex,	  via	  dissociation	  of	  GDP	  and	  binding	  of	  GTP.	  The	  Gβγ	  subunit	  recruits	  PI-­‐3Kγ,	  the	  activation	  of	  
which	  results	  in	  accumulation	  of	  PIP3	  at	  the	  plasma	  membrane.	  This	  causes	  subsequent	  recruitment	  of	  
PH	   domain	   containing	   proteins	   such	   as	   AKT	   and	   also	   activates	   GTPases	   such	   as	   Ras	   (not	   shown)	   to	  
promote	  neutrophil	  migration.	  AKT	  is	  activated	  by	  phosphorylation	  by	  mTORC2	  at	  serine	  473	  and	  PDK1	  
at	   threonine	   308,	   which	   leads	   to	   activation	   of	   its	   downstream	   targets	   such	   as	   NF-­‐κB,	   BCL-­‐2	   family	  
members	   and	   FOXO	   transcription	   factors.	   Endogenous	   regulators	   of	   this	   pathway	   include	   the	  
phosphatase	  PTEN,	  which	  dephosphorylates	  PIP3	  back	  to	  PIP2.	  Adapted	  from	  (Rommel	  et	  al.,	  2007;	  Stillie	  
et	  al.,	  2009).	  





















The	  MAPK	  pathway	  
	  
In	  response	  to	  certain	  stimuli,	  neutrophil	  chemotaxis	  can	  occur	  independently	  of	  PI-­‐3K	  
signalling.	  For	  example,	  PI-­‐3K	  is	  not	  required	  for	  signal	  transduction	  of	  the	  end-­‐target	  
chemoattractant	  fMLP,	  although	  it	  does	  appear	  to	  accelerate	  the	  response	  (Heit	  et	  al.,	  
2008).	   Instead,	   fMLP	   and	   other	   end-­‐target	   chemotactic	   signals	   can	   activate	   the	   p38	  
MAPK	  pathway	  to	   induce	  neutrophil	  polarisation	  and	  migration	   (Heit	  et	  al.,	  2002).	  F-­‐
actin	   polymerisation	   at	   the	   leading	   edge	   is	   disrupted	   in	   the	   presence	   of	   p38	  MAPK	  
inhibitors	   and	   in	   neutrophils	   that	   are	   deficient	   in	   MK2,	   a	   downstream	   signalling	  
component	   of	   the	   p38	   MAPK	   pathway	   (Wu	   et	   al.,	   2004;	   Heit	   et	   al.,	   2008).	   MAPK	  
inhibition	   has	   also	   been	   shown	   to	   reduce	   neutrophil	   expression	   of	   the	   β2-­‐integrin	  
Mac-­‐1,	   suggesting	   that	   this	   pathway	   may	   regulate	   multiple	   stages	   of	   neutrophil	  
recruitment	  (Xu	  et	  al.,	  2013).	  	  
	  
Other	   MAP	   kinases,	   c-­‐Jun	   amino-­‐terminal	   kinase	   (JNK)	   and	   extracellular	   signal-­‐
regulated	   kinase	   (ERK)	  may	   also	   be	   involved	   in	   neutrophil	  migration	   (Johnson	   et	   al.,	  
2002).	   Interestingly,	   it	   has	   recently	   been	   reported	   that	   the	   p38	   and	   ERK	   MAPKs	  
differentially	   regulate	   neutrophil	   chemotaxis,	   with	   p38	   mediating	   neutrophil	   ‘go’	  
signals	   whilst	   ERK	   may	   control	   the	   ‘stop’	   signals	   that	   take	   precedence	   once	   the	  
neutrophil	   has	   reached	   its	   destination	   (Liu	   et	   al.,	   2012).	   The	   role	   of	   JNK	   is	   less	  well	  
defined,	   although	   pharmacological	   inhibition	   of	   this	   kinase	   reduces	   neutrophil	  
recruitment	  to	  the	  lung	  in	  a	  murine	  model	  of	  acute	  lung	  inflammation	  and	  is	  likely	  to	  
alleviate	  the	  symptoms	  of	  RA	  (Han	  et	  al.,	  2001;	  Arndt,	  Young,	  Lieber,	  et	  al.,	  2005).	  	  
1.2.6	  The	  role	  of	  the	  neutrophil	  at	  the	  site	  of	  inflammation	  
Under	  physiological	  conditions,	  neutrophils	  are	  recruited	  until	  approximately	  6	  hours	  
after	  initiation	  of	  the	  inflammatory	  response	  (Serhan	  and	  Savill,	  2005).	  Neutrophils	  are	  
highly	   specialised	   for	  host	  defence	  and	  once	   they	  arrive	  at	   the	   site	  of	   inflammation,	  
they	  perform	  a	  myriad	  of	   functions	   in	   order	   to	   eliminate	   invading	  pathogens.	   These	  
include	  phagocytosis,	  degranulation	  and	  the	  formation	  of	  reactive	  oxygen	  species	  and	  






Neutrophil	  phagocytosis	  and	  degranulation	  
	  
The	   binding	   of	   microbial	   products	   to	   specific	   cell	   surface	   receptors	   activates	  
neutrophils,	  triggering	  reorganisation	  of	  the	  actin	  cytoskeleton	  to	  allow	  endocytosis	  of	  
foreign	  material	  into	  phagosomes	  (Dale	  et	  al.,	  2008).	  These	  include	  TLRs,	  which	  detect	  
conserved	  PAMPs,	  and	  Fc-­‐γ	   receptors,	  which	   interact	  with	  pathogens	  that	  have	  been	  
targeted	   for	   destruction	   via	   opsonisation.	   This	   process	   involves	   the	   coating	   of	  
phagocytic	  targets	  with	  immunoglobulin	  G	  (IgG).	  Pathogens	  can	  also	  be	  opsonised	  by	  
C3	   complement	   fragments	   and	   these	   bind	   to	   complement	   receptors	   on	   neutrophils,	  
triggering	  a	  different	  form	  of	  phagocytosis	  that	  does	  not	  promote	  neutrophil	  effector	  
functions,	   in	   contrast	   to	   Fc-­‐γ-­‐dependent	   phagocytosis	   (Caron	   et	   al.,	   1998).	   During	  
phagocytosis,	   there	   is	   a	   rapid	   rise	   in	   intracellular	   calcium	   levels	   and	   this	   mediates	  
fusion	   of	   the	   phagosome	   with	   neutrophil	   granules,	   exposing	   microbes	   to	   a	   lethal	  
microenvironment	  containing	  proteases,	  defensins	  and	  other	  toxic	  products	  (Jaconi	  et	  
al.,	  1990).	  
	  
Various	  types	  of	  cytoplasmic	  granules	  exist,	  dependent	  on	  their	  contents	  and	  time	  of	  
formation	   (Borregaard	  et	  al.,	  1997).	  Primary,	  or	  azurophil,	   granules	   stain	  positive	   for	  
myeloperoxidase	   (MPO)	   and	   are	   formed	   during	   the	   early	   stages	   of	   granulopoiesis.	  
These	   granules	   are	   highly	   antimicrobial	   and,	   along	   with	   MPO,	   contain	   α-­‐defensins,	  
elastase,	   cathepsin	   G	   and	   proteinase-­‐3.	   Granules	   formed	   later	   in	   neutrophil	  
development,	  after	  promyelocytes	  differentiate	  into	  myelocytes,	  do	  not	  contain	  MPO	  
(Borregaard	  et	  al.,	  1997).	  These	  include	  secondary	  (specific)	  granules,	  which	  contain	  an	  
abundance	   of	   the	   antibacterial	   glycoprotein	   lactoferrin,	   and	   tertiary	   (gelatinase)	  
granules.	   These	   contain	   high	   levels	   of	   elastase,	   gelatinase	   and	   metalloproteinase	  
enzymes,	   which	   are	   required	   for	   degradation	   of	   the	   ECM	   during	   neutrophil	  
extravasation	  (Delclaux	  et	  al.,	  1996).	  Therefore,	  at	  times	  it	  is	  necessary	  for	  neutrophils	  
to	   degranulate,	   releasing	   their	   toxic	   granule	   contents	   into	   the	   extracellular	  
environment.	   Degranulation	   can	   also	   help	   to	   destroy	   pathogens	   at	   sites	   of	  
inflammation,	   however	   this	   process	  must	   be	   tightly	   controlled	   in	   order	   to	   limit	   host	  




The	  respiratory	  burst	  
	  
Neutrophil	   phagocytosis	   also	   triggers	   a	   prolonged	   ‘respiratory	   burst’,	   in	   which	   the	  
NADPH	   oxidase	   complex	   catalyses	   the	   formation	   of	   hydrogen	   peroxide	   and	   reactive	  
oxygen	  species	  (ROS)	  (Babior	  et	  al.,	  1976).	  	  Within	  the	  phagosome,	  MPO	  from	  primary	  
granules	   catalyses	   the	   reaction	   between	   hydrogen	   peroxide	   and	   chloride	   to	   form	  
hypochlorous	   acid,	   a	   potent	   oxidant	   that	   is	   responsible	   for	   microbe	   destruction	  
(Klebanoff,	   2005).	   Activation	   of	   TLRs,	   for	   example	   by	   bacterial	   LPS,	   also	   induces	  
generation	   of	   ROS,	   along	   with	   shedding	   of	   L-­‐selectin	   and	   down-­‐regulation	   of	   the	  
chemokine	  receptor,	  CXCR2	  (Sabroe	  et	  al.,	  2005).	  The	  NADPH	  oxidase	  complex	  can	  also	  
be	  recruited	  to	  the	  neutrophil	  plasma	  membrane,	  resulting	  in	  the	  release	  of	  ROS	  into	  
the	  extracellular	  environment	  and	  rapid	  elimination	  of	  invading	  pathogens,	  but	  at	  the	  
expense	   of	   host	   tissue	   damage	   (El-­‐Benna	   et	   al.,	   2008).	   Mutations	   in	   the	   NADPH	  
oxidase	   complex	   can	   cause	   chronic	   granulomatous	   disease	   (CGD),	   in	   which	   the	  
respiratory	  burst	  is	  impaired	  and	  patients	  suffer	  from	  recurrent	  infections,	  due	  to	  their	  
inability	  to	  destroy	  pathogens	  (Gallin	  et	  al.,	  1992).	  
	  
Neutrophil	  extracellular	  traps	  (NETs)	  
	  
Another	   putative	   neutrophil	   defence	   strategy	   is	   the	   formation	   of	   neutrophil	  
extracellular	   traps	   (NETs),	  which	  can	  be	   triggered	  by	  a	   range	  of	   stimuli	   including	   IL-­‐8	  
and	   LPS	   (Brinkmann	   et	   al.,	   2004).	   These	   are	   web-­‐like	   structures	   composed	   of	   DNA,	  
histones,	   antimicrobial	   peptides	   and	   proteases,	   which	   capture	   invading	   pathogens	  
within	   a	   highly	   concentrated	   anti-­‐microbial	   milieu,	   destroying	   them	   extracellularly.	  
NETs	   can	  be	   visualised	   in	   vitro	  by	   confocal	  microscopy	   techniques,	   using	   fluorescent	  
probes	   to	   label	   nucleic	   acids	   in	   stimulated	   neutrophils	   (Yousefi	   et	   al.,	   2009).	   Early	  
studies	  indicate	  that	  NET	  production	  is	  an	  alternative	  mechanism	  of	  cell	  death,	  termed	  
NETosis,	   as	   it	   involves	   nuclear	   and	   membrane	   disintegration	   (Fuchs	   et	   al.,	   2007;	  
Steinberg	  et	  al.,	  2007).	   In	  neutrophils,	   this	  was	  evidenced	  by	   the	   loss	  of	  a	  viable	  cell	  
marker,	   calcein	   blue,	   and	   the	   simultaneous	   detection	   of	   Annexin	   V,	   a	   marker	   of	  
apoptosis,	   along	   with	   fluorescent	   antibodies	   against	   various	   histone	   components	  
(Fuchs	  et	  al.,	  2007).	  The	  precise	  mechanisms	  that	  control	  NET	  formation	  are	  not	  fully	  




production	  is	   impaired	  in	  neutrophils	   isolated	  from	  CGD	  patients	  (Fuchs	  et	  al.,	  2007).	  
More	   recent	  evidence,	  obtained	  using	  a	   fluorescent	  probe	   specific	   for	  mitochondrial	  
DNA	   and	   that	   can	   enter	   living	   cells,	   suggests	   that	   NETs	   consisting	   of	   mitochondrial	  
rather	   than	   nuclear	   DNA	   may	   also	   be	   released	   from	   viable	   neutrophils	   in	   a	   ROS-­‐
dependent	  manner	  (Yousefi	  et	  al.,	  2009).	  
1.2.7	  Neutrophil	  survival	  factors	  
At	   the	   site	   of	   inflammation,	   neutrophil	   half-­‐life	   is	   significantly	   extended	   to	   allow	  
successful	  elimination	  of	  pathogens	  and	  control	  of	  the	  infection.	  There	  are	  a	  number	  
of	  survival	  factors	  that	  can	  prolong	  neutrophil	   longevity	  and	  these	  include	  both	  host-­‐	  
and	   pathogen-­‐derived	   signals,	   as	   well	   as	   physical	   conditions	   of	   the	   inflammatory	  
environment.	  Multiple	  pro-­‐inflammatory	  cytokines	  have	  been	  shown	  to	  act	  as	  potent	  
neutrophil	  survival	  factors	  in	  vitro,	  including	  GM-­‐CSF,	  G-­‐CSF,	  IL-­‐2	  and	  IFN-­‐γ	  (Klebanoff	  
et	   al.,	   1992;	   Lee	   et	   al.,	   1993;	   Pericle	   et	   al.,	   1994).	   Macrophages	   are	   a	   source	   of	  
neutrophil	  survival	  cytokines	  at	  the	  site	  of	  inflammation	  where,	  along	  with	  G-­‐CSF	  and	  
GM-­‐CSF,	  they	  also	  release	  IL-­‐1β	  and	  TNF-­‐α	  (Kumar	  &	  Sharma,	  2010).	  The	  latter	  plays	  a	  
complex	   role	   in	   the	   regulation	   of	   neutrophil	   lifespan;	   high	   levels	   of	   TNF-­‐α	   induce	  
apoptosis,	   but	   at	   low	   doses,	   transcription	   of	   pro-­‐survival	   proteins	   such	   as	   BFL-­‐1	   is	  
increased	  (van	  den	  Berg	  et	  al.,	  2001;	  Cross	  et	  al.,	  2008).	  
	  
On	  binding	  to	  their	  receptors,	  cytokines	  activate	  intracellular	  signalling,	  predominantly	  
via	   the	  PI-­‐3K,	  MAPK,	  NF-­‐κB	  and	   JAK/STAT	  pathways,	  which	   regulate	  members	  of	   the	  
BCL-­‐2	  family	  of	  proteins	  and	  the	  production	  of	  cytokines	  (Epling-­‐Burnette	  et	  al.,	  2001;	  
Luo	  et	  al.,	  2008).	  For	  example,	  GM-­‐CSF	  induces	  phosphorylation	  and	  inactivation	  of	  the	  
pro-­‐apoptotic	   protein	   BAD	   and	   a	   reduction	   in	   Bad	   mRNA	   (Cowburn	   et	   al.,	   2002).	  
Bacterial	   products	   such	   as	   LPS	   and	   lipoteichoic	   acid	   (LTA)	   can	   promote	   neutrophil	  
survival	  via	  TLR	  binding	  and	  these,	  along	  with	  GM-­‐CSF	  and	  IL-­‐1β,	  have	  been	  shown	  to	  
increase	  levels	  of	  the	  anti-­‐apoptotic	  proteins	  Mcl-­‐1	  and	  Bcl-­‐x(L)	  (Moulding	  et	  al.,	  1998;	  
François	  et	  al.,	  2005;	  Ocaña	  et	  al.,	  2008).	  The	  release	  of	  MPO	  has	  also	  been	  reported	  to	  
prolong	  neutrophil	  lifespan	  in	  a	  paracrine	  manner,	  via	  binding	  to	  the	  β2-­‐integrin	  Mac-­‐1	  
(El	  Kebir	  et	  al.,	  2008).	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Typically,	   sites	  of	   inflammation	  are	  oxygen-­‐depleted	  and	  neutrophils	   are	   required	   to	  
function	  within	  hypoxic	  conditions	  (Hunt	  et	  al.,	  1967).	  Neutrophil	  survival	  is	  prolonged	  
in	  hypoxia	  and	  this	  effect	   is	  mediated	  via	  the	  hypoxia-­‐inducible	  factor	  (HIF)	  signalling	  
pathway,	  which	  activates	  NF-­‐κB	  (Hannah	  et	  al.,	  1995;	  Walmsley	  et	  al.,	  2005).	  Studies	  
also	  indicate	  that	  hypoxic	  neutrophil	  survival	  is	  associated	  with	  up-­‐regulation	  of	  Mcl-­‐1,	  
which	   occurs	   in	   a	   MAPK	   dependent	   manner	   (Leuenroth	   et	   al.,	   2000).	   It	   has	   been	  
suggested	  that	  hypoxic	  conditions	  promote	  the	  activity	  of	  anti-­‐apoptotic	  signals	  at	  the	  
site	   of	   inflammation,	   in	   preference	   to	   pro-­‐apoptotic	   signalling	   (Cross	   et	   al.,	   2006).	  
Additionally,	   activation	   of	   hypoxia	   signalling	   has	   been	   shown	   to	   delay	   neutrophil	  
apoptosis	  in	  a	  zebrafish	  model	  of	  inflammation	  (Elks	  et	  al.,	  2011).	  	  
	  
	  
1.3	  The	  resolution	  of	  inflammation	  	  
	  
Once	   any	   infection	   or	   injury	   has	   been	   controlled,	   it	   is	   critical	   that	   inflammation	  
resolves	  effectively	  in	  order	  to	  restore	  homeostasis	  and	  enable	  tissue	  repair.	  There	  is	  a	  
switch	  from	  the	  local	  production	  of	  pro-­‐inflammatory	  mediators	  to	  anti-­‐inflammatory	  
ones,	   including	   lipoxins,	   resolvins	  and	  protectins,	  which	   trigger	  pro-­‐resolution	  events	  
and	  promote	  healing	  (Serhan	  &	  Savill,	  2005).	  This	  is	  an	  active	  process	  that	  is	  inherent	  
to	   inflammatory	   cells,	   such	   that	   as	   soon	   as	   inflammation	   is	   initiated,	   resolution	   is	  
programmed	  to	  occur	  in	  a	  timely	  and	  controlled	  manner	  (Serhan	  &	  Savill,	  2005).	  	  
	  
For	   successful	   resolution,	   there	   are	   a	   number	   of	   necessary	   pre-­‐requisites,	   including	  
removal	   of	   the	   inciting	   stimulus,	   catabolism	   of	   pro-­‐inflammatory	  mediators	   and	   the	  
inhibition	  of	  further	  neutrophil	  recruitment.	  Another	  essential	  step	  is	  the	  clearance	  of	  
extravasated	   neutrophils,	   a	   process	   that	   was	   originally	   believed	   to	   be	   primarily	  
dependent	   on	   the	   apoptosis	   of	   neutrophils	   and	   their	   clearance	   by	   phagocytic	  
macrophages	  (Savill	  et	  al.,	  1989).	  More	  recently,	  evidence	  from	  various	  model	  systems	  
has	   indicated	   that	  an	  alternative	  mechanism	  may	  also	  be	   involved.	  Potentially	  viable	  
neutrophils	   have	  been	  observed	   to	   leave	   sites	   of	   inflammation	  by	   reverse	  migration	  




1.3.1	  Neutrophil	  apoptosis	  and	  macrophage	  clearance	  
Neutrophils	   are	   unique	   among	   cell	   types	   in	   that	   they	   can	   undergo	   spontaneous	  
apoptosis	  in	  the	  absence	  of	  external	  signals,	  a	  feature	  that	  may	  be	  attributed	  to	  their	  
constitutive	   expression	   of	   pro-­‐apoptotic	   BCL-­‐2	   family	   proteins	   (Akgul	   et	   al.,	   2001).	  
These	  proteins	  have	  a	  relatively	  long	  half-­‐life	  in	  comparison	  to	  anti-­‐apoptotic	  members	  
such	  as	  Mcl-­‐1,	  which	  is	  estimated	  to	  be	  between	  2	  and	  3	  hours	  (Akgul	  et	  al.,	  2001).	  As	  
described	  above,	  neutrophil	  survival	  can	  be	  extended,	  for	  example	  by	  the	  modulation	  
of	   apoptotic	   pathways	   by	   cytokines.	   Likewise,	   apoptosis	   can	   also	   be	   accelerated,	   by	  
both	   intracellular	   and	   extracellular	   signals,	   and	   is	   regulated	   by	   survival	   signalling	  
pathways	  such	  as	  PI-­‐3K	  and	  MAPK	  (Akgul	  et	  al.,	  2001).	  The	  apoptosis	  of	  inflammatory	  
neutrophils	   represents	   a	   key	   step	   towards	   successful	   inflammation	   resolution,	   along	  
with	  their	  subsequent	  recognition	  and	  clearance	  by	  phagocytic	  macrophages	  (Savill	  et	  
al.,	   1989).	   It	   is	   critical	   that	   neutrophil	   cell	   membrane	   integrity	   is	   preserved	   during	  
apoptosis,	   to	   avoid	   leakage	   of	   cytotoxic	   granule	   products	   that	   have	   the	   potential	   to	  
damage	  host	  tissues.	  	  
	  
Neutrophil	  apoptosis	   is	  a	  highly	   regulated	  and	  complex	  process	   that	  can	  proceed	  via	  
numerous	  signalling	  pathways	  and	   is	  mostly	  dependent	  on	   the	  activation	  of	  cysteine	  
proteases	  known	  as	  caspases,	  which	  cleave	  a	  host	  of	  proteins	   that	  are	   important	   for	  
maintaining	   cellular	   function	   (Cohen,	   1997).	   Essentially,	   the	   extrinsic	   apoptotic	  
pathway	  involves	  death	  receptor	  activation	  by	  extracellular	  ligands,	  which	  include	  TNF	  
binding	  to	  TNF-­‐related	  apoptosis-­‐inducing	  ligand	  receptor	  (TNFR)	  and	  Fas	  ligand	  (FasL)	  
binding	  to	  the	  Fas	  receptor	  (Renshaw	  et	  al.,	  2000;	  Renshaw	  et	  al.,	  2003).	  These	  lead	  to	  
assembly	   of	   the	   death-­‐inducing	   signalling	   complex	   (DISC)	   and	   clustering	   of	   inactive	  
caspase-­‐8	   peptides,	   which	   leads	   to	   their	   processing	   and	   activation	   (Cohen,	   1997).	  
Alternatively,	   neutrophil	   death	  may	   be	   induced	   via	   the	   intrinsic	   apoptotic	   pathway,	  
which	  involves	  permeabilisation	  of	  the	  mitochondrial	  outer	  membrane,	  either	  by	  pore	  
formation	  or	  the	  insertion	  of	  pro-­‐apoptotic	  proteins	  from	  the	  BCL-­‐2	  family	  such	  as	  BAX	  
(Crompton,	   1999).	   This	   intrinsic	   pathway	   can	   be	   induced	   by	   oxidative	   stress,	   DNA	  
damage	  or	  the	  presence	  of	  cytotoxic	  factors,	  and	  mitochondrial	  disruption	  leads	  to	  the	  
release	   of	   pro-­‐apoptotic	   agents	   into	   the	   cytosol	   (Hallett	   et	   al.,	   2008).	   These	   include	  
cytochrome	   c,	   apoptotic-­‐protease	   activating	   factor-­‐1	   (APAF-­‐1)	   and	   second	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mitochondria-­‐derived	   activator	   of	   caspases	   (SMAC),	   which	   inhibit	   IAP	   (inhibitor	   of	  
apoptosis)	  proteins	  to	  enable	   formation	  of	   the	  apoptosome	  and	  caspase-­‐9	  activation	  
(Hallett	   et	   al.,	   2008).	   Both	   the	   extrinsic	   and	   intrinsic	   apoptotic	   pathways	   lead	   to	  
cleavage	  and	  activation	  of	  the	  executioner	  caspases,	  such	  as	  caspase-­‐3,	  which	  cleave	  
key	  functional	  proteins	  (Cohen,	  1997).	  There	  is	  evidence	  that	  cross-­‐talk	  exists	  between	  
the	   intrinsic	   and	   apoptotic	   pathways,	   as	   the	   activation	  of	   caspase-­‐8	   via	   the	  extrinsic	  
pathway	  can	  cause	  cleavage	  of	  BID,	  resulting	   in	   its	  translocation	  to	  the	  mitochondria	  
and	  disruption	  of	  mitochondrial	  membrane	  potential	  (Li	  et	  al.,	  1998).	  
	  
Apoptotic	   neutrophils	   express	   ‘find	  me’	   and	   ‘eat	  me’	   signals	   such	   as	   sphingosine-­‐1-­‐
phosphate	  and	  phosphatidylserine	   residues,	   in	  order	   to	   facilitate	   their	  detection	  and	  
engulfment	  by	  phagocytic	  macrophages,	  a	  process	  known	  as	  efferocytosis	  (Bratton	  et	  
al.,	  2011).	  If	  correctly	  regulated,	  efferocytosis	  should	  occur	  in	  a	  non-­‐phlogistic	  manner,	  
inhibiting	   macrophage	   production	   of	   pro-­‐inflammatory	   mediators	   such	   as	  
thromboxanes,	   LTs,	   IL-­‐1β	   and	   GM-­‐CSF,	   and	   triggering	   the	   production	   of	   anti-­‐
inflammatory	   ones,	   such	   as	   transforming	   growth	   factor-­‐β1	   (TGF-­‐β1),	   IL-­‐10	   and	  
prostaglandin	   E2	   (PGE2)	   (Fadok	   et	   al.,	   1998).	   Macrophages	   can	   also	   function	   to	  
promote	   further	   neutrophil	   apoptosis	   at	   sites	   of	   inflammation.	   Upon	   ingestion	   of	  
apoptotic	   neutrophils,	  macrophages	   release	   FasL,	   initiating	   a	   positive	   feedback	   loop	  
that	   triggers	   Fas-­‐mediated	   neutrophil	   apoptosis	   (Brown	   et	   al.,	   1999).	   They	   can	   also	  
induce	   apoptosis	   of	   neighbouring	   neutrophils	   via	   a	   cell-­‐cell	   contact-­‐dependent	  
mechanism	  that	   involves	  integrin-­‐ligand	  binding	  (Meszaros	  et	  al.,	  2000).	  Efferocytosis	  
triggers	   the	   emigration	   of	  macrophages	   away	   from	   the	   site	   of	   inflammation	   via	   the	  
lymphatic	   system	   in	   order	   to	   clear	   the	   site	   of	   inflammation	   and	   promote	   resolution	  
(Bellingan	  et	   al.,	   1996).	  Apoptotic	  neutrophils	  may	  also	  be	   removed	   in	   exudates,	   for	  
example	  by	  egression	  into	  the	  lumen	  of	  the	  lung	  airways	  (Uller	  et	  al.	  ,	  2006).	  
1.3.2	  Neutrophil	  reverse	  migration	  
Neutrophil	   clearance	   is	   not	   limited	   to	   macrophage	   uptake,	   but	   may	   also	   be	  
accomplished	   by	   the	   movement	   of	   neutrophils	   away	   from	   sites	   of	   inflammation;	   a	  
process	  defined	  as	  reverse	  migration.	  This	  has	  been	  observed	  in	  vivo	  in	  a	  mouse	  model	  




reported	   to	   undergo	   reverse	   transendothelial	   migration	   and	   this	   process	   was	  
augmented	   following	  genetic	  or	  pharmacological	   inhibition	  of	   JAM-­‐C	  (Woodfin	  et	  al.,	  
2011).	   In	   this	   investigation,	   the	   reverse	  migrated	   neutrophils	   displayed	   elevated	   cell	  
surface	   expression	   of	   ICAM-­‐1.	   The	   up-­‐regulation	   of	   this	   adhesion	   molecule	   was	  
consistent	  with	  in	  vitro	  studies,	  in	  which	  cultured	  human	  neutrophils	  were	  observed	  to	  
reverse	   migrate	   back	   across	   an	   endothelial	   monolayer,	   and	   these	   neutrophils	  
displayed	   a	   unique	   cell-­‐surface	   receptor	   phenotype	   (Buckley	   et	   al.,	   2006).	   This	  
consisted	  of	  elevated	  expression	  of	  ICAM-­‐1	  and	  the	  cluster	  of	  differentiation	  molecule	  
11b	   (CD11b)	   and	   reduced	   expression	   of	   the	   key	   neutrophil	   chemokine	   receptors	  
CXCR1	   and	   CXCR2,	   in	   comparison	   to	   neutrophils	   that	   did	   not	   undergo	   reverse	  
migration.	   It	  may	  be	  that	   this	  altered	  expression	  of	  cell-­‐surface	  markers	   is	   important	  
for	   mediating	   neutrophil	   reverse	   migration,	   but	   currently	   the	   precise	   mechanisms	  
involved	  in	  the	  regulation	  of	  this	  process	  remain	  undefined.	  	  
	  
The	   lack	   of	   knowledge	   in	   this	   area	   may	   be	   partly	   due	   to	   the	   technical	   difficulties	  
associated	  with	  the	   investigation	  of	  this	  process	   in	  mammalian	  models.	  Over	  the	   last	  
few	   years,	   the	   zebrafish	   model	   has	   provided	   some	   much	   needed	   insight	   into	  
neutrophil	  reverse	  migration	  and	  this	  activity	  has	  been	  observed	  by	  multiple	  research	  
groups	  (Mathias	  et	  al.,	  2006;	  Hall	  et	  al.,	  2007;	  Elks	  et	  al.,	  2011;	  Yoo	  and	  Huttenlocher,	  
2011).	  Interestingly,	  it	  has	  been	  shown	  that	  hypoxia	  can	  regulate	  reverse	  migration	  in	  
zebrafish,	  as	  genetic	  or	  pharmacological	  activation	  of	  Hypoxia-­‐inducible	  factor-­‐1α	  (Hif-­‐
1α)	   can	   delay	   the	   resolution	   of	   inflammation,	   predominantly	   by	   causing	   increased	  
neutrophil	  retention	  at	  a	  wound	  (Elks	  et	  al.,	  2011).	  	  
	  
The	  significance	  of	  neutrophil	  reverse	  migration	   in	  vivo	   is	  not	  yet	  fully	  understood.	  A	  
small	  percentage	  of	  peripheral	  blood	  neutrophils	  have	  been	   reported	   to	  express	   the	  
reverse	  migrated	  receptor	  phenotype	  and	  this	  proportion	  is	  increased	  to	  1-­‐2%	  of	  total	  
circulating	  neutrophils	  in	  patients	  suffering	  with	  RA	  or	  atherosclerotic	  disease	  (Buckley	  
et	  al.,	  2006).	  It	  is	  likely	  that	  reverse	  migration	  functions	  as	  an	  alternative	  mechanism	  of	  
neutrophil	   removal	   from	   sites	   of	   inflammation,	   promoting	   their	   clearance	   by	   organs	  
such	   as	   the	   liver	   and	   spleen.	   However,	   some	   reports	   suggest	   that	   this	   primed	   and	  
activated	  subset	  of	  neutrophils	  might	  contribute	  to	  the	  dissemination	  of	  inflammation,	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which	  may	  have	  pathophysiological	  consequences	  (Buckley	  et	  al.,	  2006;	  Woodfin	  et	  al.,	  
2011).	   The	   function	   of	   reverse	  migrated	   neutrophils	   is	   currently	   under	   debate,	  with	  
evidence	   also	   indicating	   that	   neutrophils	   might	   influence	   the	   adaptive	   immune	  
response	   (Yamashiro	  et	   al.,	   2001).	   Further	  work	   is	   required	   in	  order	   to	  establish	   the	  
functional	  relevance	  of	  neutrophil	  reverse	  migration.	  	  
1.3.3	  Pro-­‐resolution	  signalling	  and	  tissue	  repair	  
A	   number	   of	  mediators	   have	   been	   identified	   that	   promote	   inflammation	   resolution,	  
shifting	  the	  balance	  from	  pro-­‐	  to	  anti-­‐inflammatory	  signalling.	  Some	  mediators,	  such	  as	  
TNF-­‐α,	  TGF-­‐β1	  and	  PGE2,	  have	  differential	  and	  temporal-­‐dependent	  effects	  throughout	  
the	   initiation	   and	   resolution	   phases	   of	   inflammation,	   illustrating	   the	   importance	   of	  
controlled	  regulation	  of	  the	  inflammatory	  response	  and	  mediator	  production	  (Nathan,	  
2002).	  The	  mechanisms	  governing	   inflammation	  resolution	  and	  tissue	  repair	  must	  be	  
tightly	  controlled	  in	  order	  to	  avoid	  failure	  of	  resolution	  or	  inadequate	  repair.	  	  	  
	  
Over	  the	  course	  of	  the	   inflammatory	  response,	  there	   is	  a	  co-­‐ordinated	  switch	   in	   lipid	  
mediator	  production,	  which	  promotes	  inflammation	  resolution.	  Production	  of	  the	  pro-­‐
inflammatory	  eicosanoids,	  leukotrienes	  (LTs)	  and	  prostaglandins	  (PGs),	  is	  reduced	  in	  a	  
self-­‐limiting	   manner,	   in	   favour	   of	   the	   generation	   of	   pro-­‐resolution	   lipids	   including	  
lipoxins,	   resolvins	   and	   protectins	   (Serhan	   &	   Savill,	   2005).	   LTs	   are	   formed	   by	   the	  
oxygenation	   of	   AA	   by	   5-­‐lipoxygenase	   (5-­‐LO),	   but	   this	   switches	   to	   15-­‐LO-­‐dependent	  
oxygenation	  and	  the	  biosynthesis	  of	  lipoxins,	  a	  process	  that	  is	  mediated	  by	  PGE2	  (Levy	  
et	  al.,	  2001).	  One	  of	  the	  main	  ways	  in	  which	  lipoxins	  promote	  inflammation	  resolution	  
is	   by	   reducing	   neutrophil	   recruitment	   to	   sites	   of	   inflammation	   by	   inhibiting	   their	  
chemotaxis	   and	   adhesion	   (Serhan	   et	   al.,	   1995).	   They	   also	   attenuate	   cytokine	  
production,	   superoxide	   anion	   generation	   and	   elastase	   secretion,	   and	   have	   both	  
vasodilatory	   and	   anti-­‐fibrotic	   properties	   (Hachicha	   et	   al.,	   1999;	   Levy	   et	   al.,	   2002;	  
Maderna	  &	  Godson,	  2009).	  Moreover,	  lipoxins	  A4	  and	  B4	  	  stimulate	  the	  recruitment	  of	  
monocytes	  to	  inflammatory	  sites,	  where	  they	  mature	  into	  macrophages	  and	  promote	  
wound	  healing	  (Maddox	  et	  al.,	  1996).	  These	  lipoxins	  have	  also	  been	  shown	  to	  enhance	  
the	   non-­‐phlogistic	   phagocytosis	   of	   apoptotic	   neutrophils	   by	   macrophages	   in	   vivo	  




released	   from	   neutrophils	   in	   NETs	   (Papayannopoulos	   et	   al.,	   2009).	   Resolvins	   and	  
protectins	   are	   synthesised	   from	   eicosapentaenoic	   and	   docosahexaenoic	   acid	  
precursors,	  respectively,	  are	  released	  from	  macrophages	  following	  uptake	  of	  apoptotic	  
material,	  and	  function	  similarly	  to	  lipoxins	  (Schwab	  et	  al.,	  2007;	  Serhan,	  2007).	  	  
	  
As	   mentioned	   previously,	   the	   ingestion	   of	   apoptotic	   neutrophils	   by	   macrophages	  
promotes	   a	   switch	   in	   signalling	   and	   the	   release	   of	   a	   number	   of	   pro-­‐resolution	  
mediators,	   one	   of	   the	   most	   important	   of	   which	   is	   TGF-­‐β1,	   a	   cytokine	   that	   aids	  
inflammation	  resolution	  and	  tissue	  repair	  (Fadok	  et	  al.,	  1998;	  Huynh	  et	  al.,	  2002).	  TGF-­‐
β1	   expression	   is	   enhanced	   by	   lipoxin	   A4	   (Serhan	   &	   Savill,	   2005).	   Macrophage	  
phagocytosis	   of	   apoptotic	   cells	   also	   causes	   release	   of	   vascular	   endothelial	   growth	  
factor	   (VEGF),	   which	   is	   required	   for	   the	   repair	   and	   proliferation	   of	   endothelial	   cells	  
(Golpon	  et	  al.,	  2004).	  The	  clearance	  of	  cells	  and	  debris	  by	  macrophages	  must	  of	  course	  
be	   tightly	   regulated	   to	  avoid	  excessive	   removal	   that	  might	   incorporate	   cells	   that	  are	  
required	   for	   the	   healing	   process.	   It	   is	   thought	   that	   the	   phagocytosis	   of	   apoptotic	  
neutrophils	  might	  act	  as	  a	  negative	  feedback	  mechanism	  to	  limit	  this	  function	  (Duffield	  
et	  al.,	  2001).	  Another	  factor	  secreted	  by	  macrophages	  to	  promote	  healing	  is	  secretory	  
leukocyte	   protease	   inhibitor	   (SLPI),	   which	   limits	   the	   activity	   of	   elastase	   and	   other	  
proteases	   and	   maintains	   TGF-­‐β1	   activity	   (Ashcroft	   et	   al.,	   2000).	   Overall,	   the	  
macrophage	  response	  is	  fundamental	  to	  efficient	  wound	  healing	  and	  the	  formation	  of	  
scar	  tissue.	  In	  macrophage-­‐ablated	  mouse	  models,	  the	  depletion	  of	  TGF-­‐β1	  and	  other	  
mediators	  contributes	  to	  reduced	  collagen	  deposition,	   limited	  neovascularisation	  and	  




1.4	  Inflammatory	  disease	  
	  
Neutrophil	  clearance	  is	  a	  critical	  prerequisite	  for	  successful	  resolution	  of	  inflammation	  
and	   evasion	   of	   host	   tissue	   damage.	   If	   the	   inflammatory	   response	   fails	   to	   resolve,	  
persistent	   neutrophilic	   inflammation	   may	   cause	   significant	   host	   tissue	   damage	   and	  
chronic	   inflammation,	   which	   contributes	   to	   the	   pathogenesis	   of	  many	   inflammatory	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diseases.	   Many	   of	   these	   are	   associated	   with	   dysregulation	   of	   the	   mechanisms	  
governing	   inflammation	   resolution	   and	   respond	   poorly	   to	   conventional	   treatments.	  
Uncovering	   new	  mechanisms	   by	   which	   inflammation	   can	   be	   resolved	   is	   key	   for	   the	  
development	  of	  novel,	  more	  effective	  therapies.	  Ideally	  these	  must	  have	  the	  potential	  
to	  override	  aberrant	  neutrophil	  survival	  signalling	  and	  counteract	  the	  damage	  caused	  
by	  persistent	  neutrophilic	  inflammation.	  
1.4.1	  Neutrophil	  mediated	  host	  tissue	  damage	  
The	   neutrophil	   has	   a	   powerful	   destructive	   capacity	   that	   is	   essential	   for	   the	   innate	  
immune	   response	   to	   infection.	   However,	   the	   combination	   of	   potent	   oxidative	   and	  
enzymatic	   killing	  mechanisms	   are	   not	   specific	   to	   invading	   pathogens	   and	   can	   cause	  
extensive	   damage	   to	   host	   cells	   if	   not	   precisely	   regulated.	   In	   the	   early	   stages	   of	   the	  
acute	  inflammatory	  response,	  the	  array	  of	  granule	  proteases,	  oxidants	  and	  other	  toxic	  
metabolites	  produced	  by	  neutrophils	   are	  necessary	   to	   ensure	   infection	   is	   contained.	  
Mice	   lacking	   essential	   proteases	   such	   as	   elastase	   and	   cathepsin	   G	   are	   unable	   to	  
prevent	   the	   spread	   of	   bacteria,	   rendering	   them	   susceptible	   to	   prolonged	   infections	  
(Belaaouaj	  et	  al.,	  1998;	  Tkalcevic	  et	  al.,	  2000).	  
	  
The	   phagocytosis	   of	   foreign	  microbes	   attempts	   to	   restrict	   cytotoxic	   enzymes	   to	   the	  
phagosome.	   However,	   sometimes	   it	   is	   necessary	   for	   neutrophils	   to	   degranulate,	  
releasing	  potent	  ROS	  and	  enzymes	  that	  can	  potentially	  damage	  the	  surrounding	  ECM	  
and	   other	   tissue	   resident	   cells.	   Host	   protease	   inhibitors	   function	   to	   keep	   small	  
amounts	   of	   leakage	   in	   check,	   but	   the	   release	  of	   ROS	   can	   inactivate	   these	   inhibitors,	  
allowing	  elastase	  and	  other	  proteases	  to	  degrade	  the	  ECM	  (Babior,	  1984;	  Weiss,	  1989).	  
If	   injurious	   degranulation	   continues	   unchecked	   it	   can	   wreak	   havoc	   on	   host	   tissues,	  
preventing	  successful	  inflammation	  resolution	  and	  contributing	  to	  the	  pathogenesis	  of	  
chronic	  inflammatory	  disease.	  	  	  
1.4.2	  Neutrophil	  dominated	  inflammatory	  diseases	  
Unresolved	  neutrophilic	  inflammation	  and	  the	  associated	  tissue	  damage	  is	  a	  hallmark	  
of	   many	   inflammatory	   diseases,	   affecting	   multiple	   organ	   systems.	   These	   are	   often	  
triggered	   by	   dysregulation	   of	   inflammation	   resolution	   and	   tissue	   repair,	   which	  




characteristic	   of	   neutrophilic	   inflammatory	   diseases	   such	   as	   COPD,	   inflammatory	  
bowel	  disease	  (IBD)	  and	  RA,	  and	  the	  prolonged	  presence	  of	  activated	  neutrophils	  can	  
amplify	  the	  immune	  response	  (Hallett	  et	  al.,	  2008).	  Enhanced	  levels	  of	  neutrophils	  and	  
cytokines	   such	   as	   IL-­‐1β,	   IL-­‐6	   and	   TNF-­‐α	   have	   been	   recorded	   in	   sputum	   from	   COPD	  
patients	  and	  up-­‐regulated	  expression	  of	  chemokines	  including	  IL-­‐8	  and	  LTB4	  is	  thought	  
to	  account	  for	  increased	  neutrophil	  recruitment	  (Chung,	  2005).	  Similarly,	  this	  has	  been	  
reported	  in	  acute	  respiratory	  distress	  syndrome	  (ARDS),	  in	  which	  enhanced	  levels	  of	  IL-­‐
8	   augments	   neutrophil	   accumulation	   and	   activation	   (Donnelly	   et	   al.,	   1992).	  
Neutrophilic	   inflammation	   is	   also	   directly	   implicated	   in	   the	   progression	   of	   other	  
inflammatory	   lung	   diseases,	   including	   idiopathic	   pulmonary	   fibrosis	   (IPF),	   in	   which	  
neutrophil	   numbers	   in	   the	   lung	   correlate	   with	   mortality	   (Kinder	   et	   al.,	   2008).	   High	  
neutrophil	   numbers	   are	   also	   observed	   at	   the	   cartilage-­‐pannus	   junction	   of	   affected	  
joints	   in	   RA	   sufferers	   (Bromley	   et	   al.,	   1984).	   Alternatively,	   chronic	   inflammatory	  
disease	  may	  arise	  when	  neutrophil	  function	  is	  impaired,	  such	  as	  in	  CGD,	  as	  mentioned	  
previously.	   In	   CGD	   patients,	   neutrophils	   are	   unable	   to	   destroy	   phagocytosed	  
pathogens	  due	  to	  mutations	  in	  the	  NADPH	  oxidase	  complex,	  which	  results	  in	  a	  failure	  
to	  generate	  ROS	  (Gallin	  et	  al.,	  1992).	  
	  
Neutrophil	  proteases	  are	  considered	  one	  of	  the	  main	  culprits	  of	  neutrophil	  mediated	  
tissue	  damage	  and	  enhanced	  protease	  activity	  is	  associated	  with	  chronic	  inflammatory	  
lung	   diseases	   including	   COPD	   and	   ARDS	   (Selby	   et	   al.,	   1991;	   Donnelly	   et	   al.,	   1992).	  
Neutrophil	  proteases	  are	  responsible	  for	  the	  destruction	  of	  elastic	  lung	  tissue	  that	  can	  
contribute	  to	  the	  development	  of	  emphysema	  (Stone	  et	  al.,	  1990)	  and	  can	  accelerate	  
the	  progression	  of	  RA	  by	  cartilage	  degradation	  (Edwards	  et	  al.,	  1997).	  
	  
Persistent	  neutrophilia	   is	  often	  associated	  with	  chronic	  inflammatory	  disease	  and	  the	  
failure	  of	  successful	  inflammation	  resolution	  and	  neutrophil	  clearance	  may	  be	  a	  result	  
of	   aberrant	  neutrophil	   survival	   signalling	   at	   inflammatory	   sites	   and	   the	  disruption	  of	  
constitutive	   apoptotic	   pathways.	   Extended	   neutrophil	   survival	   has	   been	   reported	   in	  
disease	  states,	  for	  example,	  little	  neutrophil	  apoptosis	  is	  observed	  in	  bronchoalveolar	  
lavage	   fluid	   extracted	   from	  ARDS	   patients	   compared	   to	   healthy	   volunteers	   (Matute-­‐
Bello	  et	   al.,	   1997).	  Additionally,	   in	   acute	  pancreatitis,	   there	  appears	   to	  be	  a	  delay	   in	  
	  40	  
neutrophil	   apoptosis	   that	   is	   mediated	   by	   altered	   caspase	   expression	   (O’Neill	   et	   al.,	  
2000).	   It	   is	   not	   only	   the	   apoptosis	   of	   neutrophils	   that	   is	   important	   for	   inflammation	  
resolution	   but	   also	   the	   removal	   of	   cell	   corpses.	   If	   apoptotic	   neutrophils	   are	   not	  
effectively	  cleared	  from	  sites	  of	  inflammation,	  they	  may	  ultimately	  undergo	  secondary	  
necrosis,	   losing	   their	   membrane	   integrity	   and	   releasing	   their	   destructive	   contents	  
(Majno	   et	   al.,	   1995).	   Thus,	   the	   impaired	   clearance	   of	   apoptotic	   neutrophils	   by	  
macrophages	  may	  also	  contribute	  to	  tissue	  damage	  and	  chronic	  inflammation	  and	  the	  
dysregulation	   of	   this	   process	   has	   been	   associated	   with	   multiple	   auto-­‐immune	  
inflammatory	  diseases,	  including	  COPD,	  CGD	  and	  cystic	  fibrosis	  (Bratton	  et	  al.,	  2011).	  	  
	  
Chronic	  inflammatory	  diseases	  remain	  a	  significant,	  worldwide	  problem	  and	  there	  is	  a	  
major	   unmet	   need	   to	   develop	   novel,	   more	   effective	   therapies.	   Although	   the	   acute	  
inflammatory	   response	   is	   required	   in	   order	   to	   promote	   tissue	   repair,	   this	   must	   be	  
controlled	  in	  order	  to	  limit	  host	  tissue	  destruction.	  A	  lack	  of	  neutrophil	  apoptosis	  and	  
clearance	  prevents	   inflammation	  resolution,	  even	   in	  circumstances	  when	  the	  original	  
inflammatory	   stimulus	   or	   infection	   has	   been	   eliminated.	   Targeting	   neutrophil	  
apoptosis	  and	  removal	  pathways	  to	  pharmacologically	  drive	  inflammation	  resolution	  is	  
required	  and	  is	  currently	  a	  key	  research	  aim.	  
1.4.3	  Existing	  inflammatory	  disease	  therapies	  
Most	   currently	   available	   therapeutics	   antagonise	   pro-­‐inflammatory	   signalling	  
pathways	   and	   limit	   the	   recruitment	   and	   accumulation	   of	   neutrophils	   at	   sites	   of	  
inflammation.	  Although	  these	  may	  alleviate	  symptoms,	  they	  do	  not	  specifically	  target	  
infiltrating	   neutrophils,	   often	   causing	   widespread	   adverse	   side	   effects	   that	   can	  
severely	   impair	   the	   immune	   system.	  Nor	  do	   they	  promote	   long-­‐lasting	   inflammation	  
resolution	   to	   cure	   the	   underlying	   condition.	   There	   is	   considerable	   evidence	   that	  
pharmacological	   inhibition	   of	   the	   components	   of	   key	   neutrophil	   survival	   pathways,	  
such	   as	   PI-­‐3K,	   MAPK	   and	   NF-­‐κB,	   might	   promote	   inflammation	   resolution	   in	   animal	  
models	   of	   inflammation	   by	   inducing	   neutrophil	   apoptosis	   (Hallett	   et	   al.,	   2008).	  
However,	   for	   these	   approaches	   to	   be	   successful	   therapeutically,	   the	   clearance	   of	  
apoptotic	   neutrophils	   by	   macrophages	   must	   be	   able	   to	   proceed	   unhindered.	   Other	  




agonise	   rather	   than	   antagonise	   endogenous	   signalling	   pathways,	  which	  might	   prove	  
more	   effective	   and	   limit	   potential	   side	   effects.	   A	   selection	   of	   current	   and	   potential	  




Most	  patients	  suffering	  from	  inflammatory	  diseases	  such	  as	  RA,	  asthma,	  IBD	  and	  COPD	  
are	  treated	  with	  glucocorticoids,	  however	  some	  patients	  are	  unresponsive	  and	  these	  
drugs	   can	   cause	   numerous	   side	   effects,	   likely	   due	   to	   the	   extensive	   effects	   of	  
glucocorticoids	  on	  gene	  expression	  (Stewart,	  2009).	  Glucocorticoids	  bind	  specifically	  to	  
intracellular	   type	   II	   glucocorticoid	   receptors,	   expressed	   in	   neutrophils	   and	   other	   cell	  
types,	  in	  which	  they	  can	  regulate	  a	  plethora	  of	  biochemical	  signalling	  events	  (Goulding	  
et	   al.,	   1998).	   They	   suppress	   neutrophilic	   inflammation	   predominantly	   by	   limiting	  
neutrophil	   recruitment,	   for	   example	   by	   inhibiting	   the	   release	   of	   pro-­‐inflammatory	  
mediators	   such	   as	   IL-­‐6	   and	   IL-­‐8,	   and	   down-­‐regulating	   the	   expression	   of	   adhesion	  
molecules	   including	   L-­‐selectin	   and	  β2-­‐integrins	   (Wertheim	  et	   al.,	   1993;	  Mianji	   et	   al.,	  
1996;	  Filep	  et	  al.,	  1997).	  
	  
Glucocorticoids	   may	   also	   potentiate	   inflammation	   resolution,	   by	   enhancing	   the	  
phagocytosis	  of	   apoptotic	  neutrophils	  by	  macrophages	   (Liu	  et	   al.,	   1999).	   It	   has	  been	  
proposed	   that	   this	   effect	  may	   be	  mediated	   by	   the	   extracellular	   protein	   Annexin-­‐A1	  
(Anx-­‐A1),	  which	  is	  released	  from	  both	  neutrophils	  and	  macrophages	  upon	  stimulation	  
with	  glucocorticoids	  (Goulding	  et	  al.,	  1990;	  Maderna	  et	  al.,	  2005).	  Anx-­‐A1	  is	  thought	  to	  
enhance	  efferocytosis	  by	  binding	  to	  the	  lipoxin	  receptor,	  ALX,	  thus	  there	  is	  a	  potential	  
link	  between	  this	  peptide	  and	  the	  lipid	  mediators	  of	  inflammation	  resolution	  (Scannell	  
et	  al.,	  2007).	  Glucocorticoids	  enhance	  protein	  expression	  and	  binding	  capacity	  of	  Anx-­‐
A1,	  which	  alongside	  its	  effects	  on	  phagocytosis,	  also	  inhibits	  proteolytic	  enzymes	  such	  
as	  elastase	  and	  cathepsin	  G	  and	  suppresses	  neutrophil	  transmigration	  (Mancuso	  et	  al.,	  
1995;	  Perretti	  et	  al.,	  1996).	  	  
	  
Anx-­‐A1	  binding	  capacity	  of	  neutrophils	  is	  reduced	  by	  90%	  in	  RA	  patients	  compared	  to	  
healthy	  controls,	  indicating	  that	  it	  may	  play	  a	  role	  in	  inflammatory	  disease	  progression	  
	  42	  
and	   might	   be	   a	   potential	   therapeutic	   target	   (Goulding	   et	   al.,	   1992).	   The	   active	   N-­‐
terminal	   peptide	   of	   Anx-­‐A1,	   Ac2-­‐26,	   has	   been	   shown	   to	   promote	   inflammation	  
resolution	   in	   vivo,	   in	   a	  model	  of	   LPS-­‐induced	  pleurisy	   (Vago	  et	   al.,	   2012).	   This	   effect	  
appeared	   to	   be	   a	   consequence	  of	   decreased	  neutrophil	   survival	   and	   indeed,	  Anx-­‐A1	  
has	   been	   shown	   to	   induce	   neutrophil	   apoptosis	   (Solito	   et	   al.,	   2003;	   Scannell	   et	   al.,	  
2007).	  	  
	  
The	   effect	   of	   Anx-­‐A1	   on	   neutrophil	   apoptosis	   is	   perhaps	   surprising	   given	   that	  
glucocorticoids	   are	   believed	   to	   directly	   promote	   neutrophil	   survival,	   but	   accelerate	  
apoptosis	  in	  other	  cell	  types,	  such	  as	  eosinophils	  (Cox,	  1995;	  Kato	  et	  al.,	  1995;	  Liles	  et	  
al.,	   1995).	   It	   has	   been	   suggested	   that	   glucocorticoids	   such	   as	   dexamethasone	   can	  
increase	   the	   stability	   of	  Mcl-­‐1	   in	   neutrophils	   but	   not	   in	   eosinophils	   (Sivertson	   et	   al.,	  
2007).	   	  These	  opposing	  effects	  may	  partially	  explain	  why	  glucocorticoids	  have	  proven	  
more	  beneficial	  in	  treating	  asthma,	  a	  predominantly	  eosinophilic	  disease,	  compared	  to	  
COPD,	  a	  largely	  neutrophil	  mediated	  disease,	  the	  progression	  of	  which	  is	  not	  reduced	  
with	   inhaled	   glucocorticoids	   (Barnes,	   2000).	   Glucocorticoids	   can	   act	   via	   a	   histone	  
deacetylase	  2	  (HDAC2)	  dependent	  mechanism	  to	  ‘switch	  off’	  pro-­‐inflammatory	  genes,	  
but	  evidence	  suggests	  that	  HDAC2	  expression	  and	  activity	  is	  down-­‐regulated	  in	  COPD	  
lungs	   (Ito	  et	  al.,	  2005).	  This	   is	  due	   to	  some	  extent	  by	   the	   increased	   level	  of	  nitrative	  
stress	   in	  the	  disease	  state,	  which	  causes	   increased	  ubiquitination	  and	  degradation	  of	  
HDAC2,	   reducing	  the	  ability	  of	   the	  glucocorticoid	  receptor	   to	  down-­‐regulate	  the	  pro-­‐
inflammatory	   transcription	   factor,	  NF-­‐κB	   (Ito	   et	   al.,	   2006).	   This	  may	   account	   for	   the	  
glucocorticoid	   resistance	  of	  COPD	  patients	  and	  novel	   therapies	  designed	   to	  augment	  




As	   PI-­‐3K	   signalling	   can	   regulate	   both	   neutrophil	   recruitment	   during	   the	   initiation	   of	  
inflammation	   and	   neutrophil	   survival,	   which	   can	   influence	   inflammation	   resolution,	  
the	   therapeutic	  blockade	  of	  PI-­‐3Ks	  has	  been	  explored.	   In	  mouse	  models	  of	  RA,	  both	  
the	  PI-­‐3Kγ	  inhibitor	  AS605240	  and	  genetic	  knockdown	  of	  PI-­‐3Kγ	  attenuate	  neutrophil	  




Similar	  effects	  are	  observed	  by	  inhibition	  of	  PI-­‐3Kδ	  (Randis	  et	  al.,	  2008).	  PI-­‐3K	  blockade	  
may	  also	  be	  a	  promising	  therapeutic	  candidate	  in	  COPD,	  as	  a	  dual-­‐specific	  inhibitor	  of	  
PI-­‐3Kδ	  and	  PI-­‐3Kγ,	  TG100-­‐115,	  has	  been	  shown	   to	   suppress	  neutrophil	   accumulation	  
and	  pulmonary	  inflammation	  in	  both	  cigarette	  smoke	  and	  LPS-­‐induced	  murine	  models	  
of	  COPD	  (Doukas	  et	  al.,	  2009).	  	  
	  
Chemokine	  receptor	  inhibitors	  
	  
Chemokines	  and	   their	   receptors	   represent	  another	  potential	   target	   for	   inflammatory	  
disease	   therapy.	   High	   levels	   of	   IL-­‐8,	   for	   example,	   have	   been	   reported	   in	   patients	  
suffering	   from	   COPD,	   RA	   and	   ARDS,	   and	   this	   is	   thought	   to	   contribute	   to	   increased	  
neutrophil	  recruitment	  and	  disease	  progression	  (Donnelly	  et	  al.,	  1992;	  Beaulieu	  et	  al.,	  
1994;	   Chung,	   2005).	   Some	   non-­‐steroidal	   anti-­‐inflammatory	   drugs	   (NSAIDs)	   and	  
corticosteroids	   have	   been	   shown	   to	   reduce	   the	   production	   of	   IL-­‐8	   and	   other	  
chemokines	   such	   as	   CCL2	   in	   both	   animal	   models	   of	   arthritis	   and	   human	   patients	  
(Loetscher	   et	   al.,	   1994;	   López-­‐Armada	   et	   al.,	   2002),	   however	   alternative	   strategies	  
have	  been	  developed	  in	  order	  to	  specifically	  target	  chemokines	  and	  their	  receptors.	  In	  
animal	  models	  of	  arthritis,	  antibodies	  against	  IL-­‐8,	  CXCL1,	  CXCL5	  and	  other	  chemokines	  
seem	   to	   limit	   disease	   severity,	   however	   they	   are	   only	   effective	   when	   administered	  
before	  the	  onset	  of	  disease,	  or	  in	  its	  early	  stages	  of	  progression	  (Akahoshi	  et	  al.,	  1994;	  
Kasama	  et	  al.,	  1995;	  Halloran	  et	  al.,	  1999).	   Inhibition	  of	  chemokine	  receptors	  such	  as	  
CXCR1	   and	   CXCR2	   has	   also	   provided	   some	   therapeutic	   benefit	   in	   arthritis	   models	  
(Podolin	  et	  al.,	  2002;	  Barsante	  et	  al.,	  2008).	  	  	  
	  
Despite	   some	   encouraging	   results	   from	   in	   vivo	   testing,	   neither	   chemokine	   receptor	  
inhibitors	   nor	   chemokine	   blockade	   using	   neutralising	   antibodies	   have	   been	   a	   huge	  
success	  in	  human	  clinical	  trials	  (Haringman	  et	  al.,	  2006;	  Lebre	  et	  al.,	  2011;	  Fleishaker	  et	  
al.,	   2012).	   Perhaps	   to	   design	   more	   effective	   chemokine-­‐based	   therapies,	   a	   more	  
complete	  knowledge	  of	  chemokine	  receptor	  signalling	  throughout	  the	  entire	  course	  of	  





Cyclin-­‐dependent	  kinase	  inhibitors	  
	  
Cyclin-­‐dependent	  kinases	  (CDKs)	  are	  members	  of	  the	  serine/threonine	  protein	  kinase	  
family.	  They	  were	  originally	  discovered	  as	  essential	  regulators	  of	  the	  cell	  cycle;	  hence	  it	  
is	   somewhat	   surprising	   that	   CDK	   inhibitors	   have	   any	   effect	   in	   the	   terminally	  
differentiated	   neutrophil.	   It	   is	   now	   widely	   accepted	   that,	   via	   their	   phosphorylating	  
activity,	  CDKs	  play	  critical	   roles	   in	  a	  number	  of	  physiological	  processes,	   including	  cell	  
differentiation	  and	  apoptosis	  (Leitch	  et	  al.,	  2009).	  	  
	  
Caspase-­‐dependent	   neutrophil	   apoptosis	   is	   enhanced	   in	   vitro	   by	   incubation	   with	  
roscovitine,	   a	   CDK	   inhibitor,	   which	   importantly	   can	   override	   the	   effects	   of	   powerful	  
survival	  factors	  such	  as	  GM-­‐CSF,	  TNF-­‐α	  and	  LPS	  (Rossi	  et	  al.,	  2006;	  Leitch	  et	  al.,	  2010).	  
Roscovitine	  significantly	  accelerates	  the	  resolution	  of	   inflammation	   in	  murine	  models	  
of	   neutrophil	   dominant	   inflammation,	   including	   bleomycin-­‐induced	   lung	   injury	   and	  
passively	   induced	   arthritis,	   by	   increasing	   granulocyte	   apoptosis	   and	   decreasing	   the	  
release	  of	  pro-­‐inflammatory	  cytokines	  such	  as	  IL-­‐6	  and	  IFN-­‐γ	  (Rossi	  et	  al.,	  2006).	  It	  also	  
effectively	   accelerates	   resolution	   in	   a	   zebrafish	   model	   of	   neutrophilic	   inflammation	  
(Loynes	   et	   al.,	   2009).	   The	   pro-­‐apoptotic	   effect	   of	   roscovitine	   is	   mediated	   by	   down-­‐
regulation	  of	  the	  neutrophil	  survival	  protein	  Mcl-­‐1	  at	  the	  mRNA	  level	  and	  this	  occurs	  
independently	  of	  an	  effect	  on	  NF-­‐κB	  or	  ERK	  survival	  signalling	   (Leitch	  et	  al.,	  2010).	   It	  
seems	  that	  this	  may	  be	  explained	  by	  the	  inhibition	  of	  CDK7	  and	  CDK9,	  which	  results	  in	  
dephosphorylation	   of	   the	   RNA	   polymerase	   II	   enzyme	   and	   disruption	   of	   the	   pre-­‐
initiation	   complex	   that	   is	   required	   for	   transcription	   (Leitch	   et	   al.,	   2012).	   This	   causes	  
down-­‐regulation	   of	   Mcl-­‐1	   and	   other	   genes	   that	   may	   be	   important	   regulators	   of	  
neutrophil	   survival.	   Additionally,	   it	   has	   been	   proposed	   that	   CDK	   regulation	   and	   the	  
effects	  on	  transcription	  may	  be	  responsible	  for	  the	  transition	  from	  a	  pro-­‐inflammatory	  
to	  anti-­‐inflammatory	  phenotype	  in	  neutrophils	  during	  the	  inflammatory	  response,	  but	  
further	  investigation	  is	  required	  (Leitch	  et	  al.,	  2009).	  	  
	  
Interestingly,	   an	   alternative	   mechanism	   of	   action	   for	   CDK	   inhibitors	   has	   also	   been	  
identified.	  Roscovitine	  and	  the	  CDK9	  inhibitor	  flavopiridol	  have	  been	  shown	  to	  inhibit	  




molecules,	   suggesting	   that	   they	   may	   also	   act	   in	   an	   anti-­‐inflammatory	   manner	   to	  
suppress	  neutrophil	  accumulation	  (Berberich	  et	  al.,	  2011;	  Schmerwitz	  et	  al.,	  2011).	  	  
	  
CDK	   inhibitors,	   including	  roscovitine,	   induce	  apoptosis	   in	  actively	  proliferating	  cancer	  
cell	  lines	  by	  disruption	  of	  the	  cell	  cycle	  (McClue	  et	  al.,	  2002),	  and	  some	  have	  reached	  
clinical	   trial	   stage	   as	   anti-­‐cancer	   therapies	   with	   reasonably	   manageable	   side-­‐effects	  
(Cicenas	  et	  al.,	  2011).	  Roscovitine	  induces	  apoptosis	  in	  various	  cancer	  cell	  lines	  and	  this	  
effect	   is	   also	  mediated	   by	   disruption	   of	   transcription	   and	   down-­‐regulation	   of	  Mcl-­‐1	  
(MacCallum	  et	  al.,	  2005;	  Bettayeb	  et	  al.,	  2010;	  Mitchell	  et	  al.,	  2010).	  For	  the	  successful	  
development	   of	   CDK	   inhibitors	   as	   anti-­‐inflammatory	   agents,	   their	   specificity	   and	  




Much	   current	   research	   focuses	   on	   targeting	   endogenous	   pro-­‐resolution	   signalling	  
pathways,	   particularly	   those	   regulated	   by	   lipid	   mediators	   such	   as	   lipoxins,	   resolvins	  
and	  protectins.	   The	   temporal	   switch	   in	   lipid	  mediator	  production	  over	   the	   course	  of	  
the	   inflammatory	   response	   is	   integral	   to	  driving	  active	   inflammation	   resolution,	   thus	  
promoting	  the	  function	  of	  these	  mediators	  pharmacologically	  may	  provide	  therapeutic	  
benefit	   in	   persistent	   inflammation.	   Indeed,	   a	   failure	   to	   synthesise	   lipoxins	   has	   been	  
associated	  with	  chronic	  inflammation	  and	  low	  levels	  of	  lipoxins	  have	  been	  reported	  in	  
the	   airways	   of	   cystic	   fibrosis	   and	   asthma	   patients,	   and	   in	   PMNs	   from	   RA	   patients	  
(Thomas	  et	  al.,	  1995;	  Levy	  et	  al.,	  2002;	  Karp	  et	  al.,	  2004).	   Interestingly,	   it	   is	  believed	  
that	   the	   NSAID	   aspirin	   exerts	   its	   therapeutic	   effects	   not	   only	   by	   inhibition	   of	  
prostaglandin	  and	  thromboxane	  synthesis,	  but	  also	  by	  stimulating	  the	  production	  of	  a	  
unique	   class	   of	   lipoxins,	   termed	   the	   aspirin-­‐triggered	   lipoxins	   (ATLs)	   (Clària	   et	   al.,	  
1995).	  These	  also	  bind	  ALX	  receptors,	  along	  with	   the	  peptide	  Anx-­‐A1,	   illustrating	   the	  
potential	   of	   currently	   available	   anti-­‐inflammatory	   drugs	   to	   activate	   pro-­‐resolution	  
signalling	  pathways	  (Perretti	  et	  al.,	  2002).	  
	  
Under	   normal	   conditions,	   lipoxins	   are	   rapidly	   metabolised	   and	   inactivated,	  
predominantly	  through	  dehydrogenation	  at	  carbon-­‐15,	  which	  prompted	  the	  design	  of	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more	   stable,	   synthetic	   lipoxin	   analogues	   for	   therapeutic	   use	   (Serhan	   et	   al.,	   1995).	  
Analogues	  of	  LXs	  and	  ATLs	  have	  been	  shown	  to	  reduce	  airway	  inflammation	  in	  murine	  
models	   of	   asthma	   (Levy	   et	   al.,	   2002;	   Levy	   et	   al.,	   2007)	   and	   inhibit	   neutrophil	  
accumulation	   in	   murine	   models	   of	   dermal	   inflammation	   (Bannenberg	   et	   al.,	   2004;	  
Guilford	   et	   al.,	   2004)	   and	  Crohn’s	   disease	   (Fiorucci	   et	   al.,	   2004).	  Other	  pro-­‐resolving	  
lipid	   mediators,	   the	   resolvins	   and	   protectins,	   may	   also	   have	   the	   potential	   for	  
therapeutic	  use.	  For	  example,	  resolvins	  are	  reported	  to	   improve	  symptoms	   in	  mouse	  
models	   of	   colitis,	   peritonitis	   and	   dermal	   inflammation	   (Arita,	   Bianchini,	   et	   al.,	   2005;	  
Arita,	  Yoshida,	  et	  al.,	  2005).	  	  
	  
There	   is	   a	   need	   to	   develop	   novel	   and	   more	   effective	   therapies	   for	   inflammatory	  
diseases.	   For	   this	   to	   be	   achieved,	   it	   is	   evident	   that	   understanding	   the	   molecular	  
mechanisms	   regulating	   inflammation	   resolution	   and	   a	   thorough	   knowledge	   of	   the	  
mediators	   involved	   is	   key.	   The	   identification	   of	   compounds	   that	   can	   stimulate	  
endogenous	  pro-­‐resolution	  signalling	  pathways	  and	  override	  neutrophil	  survival	  signals	  




1.5	  The	  zebrafish	  
	  
The	  zebrafish,	  Danio	  rerio,	  belongs	  to	  the	  teleostei	  class	  of	  ray-­‐finned	  fishes	  and	  over	  
the	   last	   few	   decades	   has	   emerged	   as	   a	   powerful	   and	   versatile	   vertebrate	   model,	  
bridging	   the	   gap	   between	   Drosophila	  melanogaster	   (D.	   melanogaster)	   and	   murine	  
systems.	   There	   are	   a	   growing	   number	   of	   publications	   describing	   the	   application	   of	  
zebrafish	   for	   biomedical	   and	   genetic	   research,	   reflecting	   the	   value	   of	   this	   emerging	  
whole-­‐animal	   model	   system.	   It	   is	   a	   useful	   organism	   not	   only	   for	   modelling	   human	  
disease,	  but	  also	  for	  the	  application	  of	  high-­‐throughput	  compound	  screening.	  	  	  
1.5.1	  The	  zebrafish	  as	  a	  model	  organism	  
From	   a	   practical	   perspective,	   the	   zebrafish	   is	   relatively	   cheap	   and	   easy	   to	  maintain.	  
This,	  combined	  with	  its	  high	  fecundity	  and	  generation	  time	  of	  only	  3	  months,	  makes	  it	  




genomic	   duplication	   event,	   zebrafish	   have	   a	   particularly	   high	   number	   of	   genes,	  
however	   many	   of	   these	   have	   been	   shown	   to	   function	   similarly	   to	   their	   human	  
counterparts.	   In	   addition,	   the	   zebrafish	   genome	  has	   higher	   homology	   to	   the	   human	  
genome	   than	   non-­‐vertebrate	   organisms	   such	   as	  Caenorhabditis	   elegans	   (C.	   elegans)	  
and	  D.	  melanogaster.	  The	  ability	  to	  study	  complex	  molecular	  and	  cellular	  events	  and	  
importantly	   the	  onset	   and	  progression	  of	  pathological	   processes	   in	   vivo	   also	   favours	  
the	  use	  of	  zebrafish	  over	  in	  vitro	  cell	  culture	  systems.	  	  
	  
Owing	   to	   the	   external	   fertilisation	   and	   rapid	   development	   of	   small,	   optically	  
transparent	   embryos	   that	   permit	   the	   in	   vivo	   visualisation	   of	   cellular	   processes,	   the	  
zebrafish	   has	   provided	   a	   useful	   and	   informative	   tool,	   particularly	   for	   developmental	  
studies.	   It	   is	   relatively	  straightforward	  to	   label	  specific	  cell	  populations	  or	  proteins	   in	  
transparent	  zebrafish	  larvae	  by	  the	  generation	  of	  fluorescent	  reporter	  lines,	  which	  can	  
be	  established	  simply	  by	  injecting	  DNA	  constructs	  into	  zebrafish	  embryos	  immediately	  
after	  fertilisation.	  Transgenesis,	  mutagenesis	  and	  cloning	  techniques	  have	  revealed	  the	  
genetic	   tractability	   of	   the	   zebrafish,	   leading	   to	   its	   successful	   use	   in	   large-­‐scale	  
mutagenic	  screens.	  These	  forward	  genetics	  approaches	  have	   led	  to	  the	   identification	  
of	  multiple	   orthologous	   human	   disease	   genes	  within	   the	   zebrafish	   genome	   and	   it	   is	  
now	  widely	  accepted	  that	  the	  zebrafish	   is	  an	   ideal	  candidate	  for	  the	  development	  of	  
translational	  models	   of	   human	   disease	   (Lieschke	   &	   Currie,	   2007;	   Renshaw	  &	   Trede,	  
2012;	  Santoriello	  &	  Zon,	  2012).	  It	  is	  now	  used	  extensively	  to	  study	  neurodegenerative	  
disorders	   (Xi	  et	  al.,	  2011),	  muscular	  dystrophies	   (Xi	  et	  al.,	  2011)	  cancers	   (Teittinen	  et	  
al.,	  2012)	  and	  infectious	  diseases	  (Novoa	  et	  al.,	  2012).	  
	  
The	  Danio	  rerio	  Sequencing	  Project	  has	  assisted	  the	  identification	  of	  mutations	  causing	  
disease	  and	  advances	   in	  reverse	  genetics	   techniques	  such	  as	  transient	  gene	  silencing	  
and	   overexpression,	   TILLING	   (targeting	   local	   lesions	   in	   genomes)	   and	   targeted	   gene	  
expression	  using	  the	  yeast	  GAL4-­‐UAS	  marker	  system,	  have	  enabled	  the	  development	  
of	  zebrafish	  disease	  models	  by	  a	  candidate	  gene-­‐driven	  approach.	  Genetic	  techniques	  
are	   becoming	   increasingly	   more	   advanced	   and	   zebrafish	   mutants	   are	   now	   being	  
generated	   by	   targeted	   mutagenesis	   using	   zinc	   finger	   nucleases	   (ZFNs)	   and	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transcription	   activator-­‐like	   effector	   nucleases	   (TALENs),	   which	   enable	   knockdown	   of	  
specific	  genes	  (Ekker,	  2008;	  Huang	  et	  al.,	  2011).	  	  
1.5.2	  Using	  zebrafish	  for	  high-­‐throughput	  compound	  screening	  
The	  discovery	  of	  new	  cures	  for	  human	  disease	  is	  an	  on-­‐going	  endeavour	  for	  scientific	  
research.	  Following	  the	  initial	  identification	  of	  a	  lead	  compound,	  it	  may	  take	  up	  to	  15	  
years	  of	  testing	  and	  development	  until	  it	  is	  safe	  and	  suitable	  to	  be	  marketed	  as	  a	  drug	  
for	  human	  patients	  (Bowman	  et	  al.,	  2010).	  It	  is	  estimated	  that	  under	  1%	  of	  new	  drugs	  
successfully	  pass	  through	  all	  the	  stages	  of	  research	  and	  development.	  New	  methods	  to	  
screen	   large	   numbers	   of	   compounds	   rapidly	   and	   robustly	   are	   required	   in	   order	   to	  
improve	  the	  development	  process	  and	  reduce	  long-­‐term	  costs.	  
	  	  	  
Over	  the	  last	  few	  years,	  the	  zebrafish	  has	  risen	  to	  the	  forefront	  of	  small	  molecule	  drug	  
discovery	  and	  numerous	  large	  scale,	  high-­‐throughput	  compound	  screens	  are	  currently	  
underway.	  Many	  of	   these	   incorporate	   the	  use	  of	   zebrafish	  models	  of	  human	  disease	  
and	   focus	   on	   discovering	   novel	   pharmacological	   agents	  with	   therapeutic	   properties.	  
The	   zebrafish	   has	   unique	   advantages	   for	   drug	   discovery,	   particularly	   over	   in	   vitro	  
screening	  assays,	  as	  the	  use	  of	  a	  whole-­‐organism	  system	  allows	  recognition	  of	  toxicity	  
and	  embryonic	  lethality	  at	  an	  early	  stage	  of	  drug	  development.	  As	  many	  drugs	  fail	  due	  
to	  problems	  associated	  with	  their	  absorption,	  distribution,	  metabolism,	  excretion	  and	  
toxicity	   (ADMET)	  properties	   in	  vivo,	   identifying	   these	   issues	   in	   the	  preliminary	  stages	  
would	   greatly	   improve	   the	   development	   process	   (Bowman	   et	   al.,	   2010).	   These	  
properties	  and	  any	  potential	  problems	  can	  be	  directly	  addressed	  in	  zebrafish,	  prior	  to	  
more	  costly	  and	  time-­‐consuming	  testing	  in	  mammalian	  systems.	  Other	  advantages	  of	  
the	  zebrafish	  that	  make	  them	  particularly	  valuable	  for	  high-­‐throughput	  drug	  screening	  
include	   their	   small	   size,	   which	   enables	   arraying	   of	   numerous	   larvae	   into	   multi-­‐well	  
plates,	   and	   their	   optical	   transparency,	   which	   facilitates	   phenotype-­‐based	   screening	  
approaches	   and	   allows	   changes	   induced	   by	   compound	   treatment	   to	   be	   readily	  
visualised.	   By	   using	   this	   system	   there	   is	   the	   potential	   to	   identify	   previously	  
undiscovered	   signalling	  pathways	   that	  are	  associated	  with	  human	  disease	  processes,	  





Small-­‐molecule	  screening,	  also	  known	  as	   ‘chemical	  genetics’,	   in	  zebrafish	  has	  already	  
effectively	  identified	  novel	  compounds	  that	  can	  suppress	  human	  disease	  phenotypes.	  
For	  example,	   the	  zebrafish	  gridlock	  mutant	  displays	  a	  comparable	  phenotype	  to	   that	  
seen	   in	   coarctation	  of	   the	  aorta,	  a	  human	  congenital	  disorder,	  and	  a	   screen	  of	  5000	  
small	   molecules	   identified	   2	   lead	   compounds	   that	   overcame	   this	   aortic	   defect	  
(Peterson	   et	   al.,	   2004).	   More	   recently,	   zebrafish	   have	   been	   used	   to	   screen	   for	  
compounds	   that	   can	   protect	   against	   tuberculosis	   (Takaki	   et	   al.,	   2012),	   leukaemia	  
(Ridges	  et	  al.,	  2012)	  and	  hearing	   loss	   (Owens	  et	  al.,	  2008).	  A	  particular	  success	  story	  
that	  reflects	  the	  value	  of	  the	  zebrafish	  model	  and	  its	  translation	  to	  human	  disease	  is	  a	  
zebrafish	   screen	   that	   identified	   dimethyl-­‐PGE2	   (dmPGE2)	   as	   a	   promoter	   of	  
haematopoietic	   stem	   cell	   (HSC)	   expansion	   (North	   et	   al.,	   2007).	   Therapeutic	   use	   of	  
dmPGE2	   to	   encourage	   HSC	   expansion	   following	   transplantation	   or	   bone	   marrow	  
depletion	   has	   now	   reached	   the	   clinical	   trial	   stage	   (Goessling	   et	   al.,	   2011).	   Another	  
example	   is	   the	   identification	   of	   a	   novel	   mechanism	   of	   action	   for	   the	   RA	   drug,	  
leflunomide,	  which	  has	  been	  shown	  to	  inhibit	  melanoma	  growth	  in	  zebrafish	  (White	  et	  
al.,	  2011).	  The	  application	  of	  high-­‐throughput	  zebrafish	  screening	  is	  not	  limited	  to	  the	  
direct	   search	   for	   potential	   therapeutics,	   but	   has	   also	   proved	   effective	   for	   the	  
identification	   of	   novel	   compounds	   that	   affect	   behaviour	   (Rihel	   et	   al.,	   2011),	   and	  
development	  (Hao	  et	  al.,	  2010).	  	  
1.5.3	  The	  zebrafish	  immune	  system	  
The	  unique	  advantages	  of	  the	  zebrafish	  make	   it	  a	  particularly	  useful	  model	  organism	  
for	  the	  study	  of	  inflammation,	  infection	  and	  immunity.	  The	  function	  of	  innate	  immune	  
cells	  including	  neutrophils	  and	  macrophages	  can	  be	  readily	  studied	  in	  zebrafish	  and	  it	  
has	   also	   been	   possible	   to	   investigate	   the	   link	   between	   inflammation	   and	   cancer	  
initiation	   (Feng	   et	   al.,	   2012).	   Models	   of	   inflammatory	   diseases	   such	   as	   colitis	   and	  
WHIM	  syndrome	  are	  emerging	   (Walters	  et	  al.,	  2010;	  Oehlers	  et	  al.,	  2011).	  There	  has	  
also	   been	   successful	   development	   of	   techniques	   to	   initiate	   both	   bacterial	   and	   viral	  
infections	   in	   zebrafish	   in	   order	   to	   study	   the	   effects	   of	   pathogens	   on	   the	   immune	  
response	   (LaPatra	   et	   al.,	   2000;	   Davis	   et	   al.,	   2002;	  Neely	   et	   al.,	   2002;	   Prajsnar	   et	   al.,	  
2008).	  This	  has	  enabled	  the	  development	  of	  models	  of	  infectious	  disease,	  for	  example	  
with	  Staphylococcus	  aureus	   (Li	  &	  Hu,	  2012;	  Prajsnar	  et	  al.,	  2012)	  and	  Mycobacterium	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marinum,	   which	   causes	   the	   formation	   of	   granulomas	   characteristic	   of	   tuberculosis	  
(Davis	   et	   al.,	   2002).	  Models	   such	   as	   these	   are	   currently	   under	   development	   for	   the	  
identification	  of	  novel	  therapeutics	  by	  drug	  screening	  approaches	  (Takaki	  et	  al.,	  2012;	  
Lore	  Lambein	  and	  Stephen	  Renshaw,	  personal	  communication).	  
	  
Despite	  450	  million	  years	  of	  divergence	  between	  zebrafish	  and	  humans,	  the	   immune	  
system	   remains	   remarkably	   highly	   conserved	   (Kumar	   &	   Hedges,	   1998).	   Zebrafish	  
possess	   both	   adaptive	   immunity	   and	   innate	   components,	   including	   phagocytic	  
macrophages	   and	   neutrophils,	   TLRs,	   complement	   factors	   and	   homologues	   to	  
mammalian	   cytokines	   such	   as	   tnfa	   and	   il1b	   (Lieschke	   &	   Currie,	   2007).	   Although	   C.	  
elegans	  and	  D.	  melanogaster	  have	  been	  used	  effectively	  to	  model	  vertebrate	  disease	  
and	   key	   physiological	   events	   such	   as	   apoptosis,	   they	   are	   less	   useful	   for	   studying	  
immunity.	  For	  instance,	  C.elegans	  lacks	  professional	  phagocytes	  such	  as	  macrophages,	  
D.	  melanogaster	  do	  not	  possess	  granulocytes,	  and	  adaptive	  immune	  components	  are	  
absent	   in	  both	  models	  (Eisenhut	  et	  al.,	  2005;	  Stramer	  et	  al.,	  2005;	  Lieschke	  &	  Currie,	  
2007).	  	  
	  
Zebrafish	   possess	   two	   types	   of	   granulocyte,	   one	   being	   analogous	   in	   structure	   and	  
function	  to	  the	  human	  neutrophil	  and	  another	  comparable	  to	  the	  human	  eosinophil,	  
but	  which	  also	  exhibits	  basophil-­‐like	  characteristics.	  Granulopoiesis	  occurs	  primarily	  in	  
the	   kidney,	   a	   site	   considered	   equivalent	   to	   haematopoietic	   human	   bone	   marrow	  
(Lieschke,	  2001;	  Crowhurst	  et	  al.,	  2002).	  Neutrophil	  granulocytes,	  sometimes	  referred	  
to	  as	  ‘heterophils’	  in	  other	  teleosts,	  have	  been	  observed	  by	  48	  hours	  post	  fertilisation	  
(hpf)	   in	   both	   the	   circulation	   and	   in	   tissue,	   whereas	   eosinophil	   granulocytes	   are	   not	  
evident	  until	  after	  5	  days	  post	  fertilisation	  (dpf)	  (Bennett	  et	  al.,	  2001;	  Lieschke,	  2001).	  
	  
Zebrafish	   neutrophils	   are	   morphologically	   similar	   to	   their	   human	   counterparts,	  
containing	   segmented	   nuclei	   and	   characteristic	   cytoplasmic	   granules.	   A	  
myeloperoxidase	   homologue,	   myeloid-­‐specific	   peroxidase	   (mpx),	   is	   specifically	  
expressed	  in	  zebrafish	  neutrophils	  and	  its	  expression	  is	  apparent	  in	  the	  posterior	  inner	  
cell	  mass	   (ICM)	  at	  18	  hpf.	  From	  24	  hpf,	  cells	  expressing	  mpx	  are	  detected	  within	  the	  




(Bennett	   et	   al.,	   2001;	   Lieschke,	   2001).	   These	   mpx-­‐expressing	   cells	   have	   functional	  
capacity	  analogous	  to	  human	  neutrophils	  as	  early	  as	  2	  dpf,	  as	  indicated	  by	  migration	  of	  
neutrophil	   granulocytes	   towards	   a	   site	   of	   inflammation	   induced	   by	   injury	   to	   the	  
zebrafish	  caudal	  fin	  (Lieschke,	  2001).	  	  
	  
Functional	   and	   motile	   macrophages	   are	   observed	   in	   zebrafish	   from	   the	   13-­‐somite	  
stage	   (15.5	   hpf),	   and	   they	   migrate	   through	   the	   circulation	   to	   become	   scattered	  
throughout	   the	   embryo	   by	   20	   hpf	   (Herbomel	   et	   al.,	   1999).	   Their	   role	   in	   zebrafish	   is	  
highly	  comparable	  to	  their	  human	  function,	  for	  example	  they	  phagocytose	  bacteria	  in	  
infected	  zebrafish	  (Herbomel	  et	  al.,	  1999;	  Davis	  et	  al.,	  2002;	  Prajsnar	  et	  al.,	  2008),	  and	  
have	   been	   implicated	   in	   the	   uptake	   of	   apoptotic	   neutrophils	   during	   inflammation	  
(Loynes	  et	  al.,	  2009).	  
	  
Markers	   for	   the	   adaptive	   immune	   system	   are	   not	   detectable	   until	   4	   dpf,	   when	  
expression	   of	   the	   recombination-­‐activating	   genes	   rag1	   and	   rag2	   is	   evident	   in	   the	  
thymus	   (Willett,	   Cherry,	   et	   al.,	   1997;	  Willett,	   Zapata,	   et	   al.,	   1997).	   These	   genes	   are	  
responsible	   for	   the	   rearrangement	   of	   immunoglobulin	   and	   T-­‐cell	   receptor	   genes	   in	  
immature	   B	   and	   T	   lymphocytes,	   respectively.	   In	   situ	   hybridisation	   techniques	   have	  
revealed	  the	  expression	  of	  other	  adaptive	  immune	  genes,	  such	  as	  T	  cell	  receptor	  alpha,	  
at	   4	   dpf	   (Danilova	   et	   al.,	   2004),	   however	   it	   is	   accepted	   that	   the	   adaptive	   immune	  
system	  is	  not	  fully	  differentiated	  and	  functional	  until	  4-­‐6	  weeks	  post	  fertilisation	  (Lam	  
et	  al.,	  2002).	  The	  advantage	  of	  this	  is	  that	  it	  allows	  the	  examination	  and	  manipulation	  
of	   innate	   immune	   system	   components,	  without	   interference	   from	   adaptive	   immune	  
modulators.	  
1.5.4	  The	  zebrafish	  as	  a	  model	  of	  inflammation	  and	  inflammatory	  disease	  
The	  striking	  homology	  between	  components	  of	  the	  zebrafish	  immune	  system	  and	  their	  
human	   counterparts	   permits	   in-­‐depth	   investigation	   into	   factors	   influencing	   the	  
immune	   response.	   Through	   knowledge	   of	   multiple	   inflammatory	   cell	   markers,	   it	   is	  
possible	  to	  generate	  transgenic	  zebrafish	  lines	  that	  allow	  straightforward	  examination	  
and	  manipulation	  of	  the	  immune	  response	  in	  vivo.	  For	  instance,	  the	  Renshaw	  lab	  have	  
developed	   a	   transgenic	   zebrafish	   line,	   Tg(mpx:GFP)i114,	   which	   expresses	   green	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fluorescent	   protein	   (GFP)	   under	   the	  mpx	   promoter	   to	   specifically	   label	   neutrophils,	  
allowing	   their	   in	   vivo	   visualisation	   and	   tracking	   (Renshaw	  et	   al.,	   2006).	   Injury	   to	   the	  
zebrafish	   tail	   fin	   initiates	   an	   acute	   inflammatory	   response,	   which	   spontaneously	  
resolves	  with	  kinetics	  comparable	  to	  mammalian	  systems.	  This	  model	  is	  susceptible	  to	  
pharmacological	   manipulation	   and	   exposure	   of	   zebrafish	   larvae	   to	   chemical	   agents	  
that	  are	  known	  to	  target	   the	  pathways	  regulating	  neutrophil	  apoptosis	  can	   influence	  
inflammation	   resolution	   (Loynes	   et	   al.,	   2009).	   Other	   transgenic	   lines	   labelling	  
neutrophils	  and	  macrophages	  have	  also	  been	  established	  (Ward	  et	  al.,	  2003;	  Mathias	  
et	  al.,	  2006;	  Redd	  et	  al.,	  2006;	  Hall	  et	  al.,	  2007;	  Ellett	  et	  al.,	  2011).	   In	  addition,	   it	  has	  
been	   possible	   to	   perform	   forward	   mutagenesis	   screens	   to	   identify	   mutants	   with	  
persistent	  inflammation,	  such	  as	  hai1,	  fad24	  and	  clint1	  (Mathias	  et	  al.,	  2007;	  Walters	  
et	   al.,	   2009;	   Martin	   et	   al.,	   2009).	   These	   have	   enabled	   the	   generation	   of	   zebrafish	  
models	   of	   chronic	   inflammation,	   which	   may	   provide	   insight	   into	   the	   mechanisms	  
regulating	   inflammation	   in	   disease	   states	   and	   facilitate	   high-­‐throughput	   compound	  
screening	  for	  novel	  inflammatory	  disease	  therapeutics.	  
	  
One	  of	   the	  most	   important	   findings	   from	  zebrafish	  research	  relating	  to	   inflammation	  
was	   the	   identification	   of	   hydrogen	   peroxide	   as	   the	   initial	   signal	   for	   neutrophil	  
recruitment.	   Following	   wounding,	   an	   extracellular	   gradient	   of	   hydrogen	   peroxide	   is	  
established	  at	  the	  site	  of	  injury	  via	  the	  activation	  of	  the	  NADPH	  oxidase	  enzyme,	  Dual	  
oxidase	   (Duox)	   (Niethammer	   et	   al.,	   2009).	   It	   is	   thought	   that	   neutrophils	   detect	   and	  
respond	  to	  this	  signal	  by	  activation	  of	  Lyn,	  a	  Src	   family	  kinase	  (Yoo	  et	  al.,	  2011),	  and	  
that	   this	   also	   provides	   a	   functional	   link	   between	   initiation	   of	   the	   inflammatory	  
response	  and	  the	  regeneration	  required	  for	  wound	  healing	  (Yoo	  et	  al.,	  2012).	  
	  
The	   zebrafish	   model	   has	   been	   particularly	   useful	   for	   investigating	   the	   dynamics	   of	  
neutrophil	  chemotaxis,	  due	  to	  the	  ease	  of	  visualising	  individual	  migrating	  cells	   in	  vivo	  
in	   real	   time.	   The	   signalling	   pathways	   that	   regulate	   neutrophil	   chemotaxis	   are	  
analogous	  to	  those	  in	  mammals,	  for	  example	  it	  has	  been	  shown	  that	   inhibition	  of	  PI-­‐
3Kγ	   in	   zebrafish	  disrupts	  neutrophil	  polarisation	  and	  directionality	   (Yoo	  et	  al.,	   2010).	  
The	   function	  of	  chemokine	  signalling	  pathway	  components	  such	  as	   the	  small	  GTPase	  




investigated	  in	  this	  system	  (Hartl	  et	  al.,	  2008;	  Deng	  et	  al.,	  2011;	  Sarris	  et	  al.,	  2012).	  As	  
described	  previously,	  the	  zebrafish	  has	  proved	  instrumental	  for	  the	  study	  of	  neutrophil	  
reverse	  migration	  as	   a	  mechanism	  of	  neutrophil	   clearance	  and	   factors	   that	  promote	  
neutrophil	   survival	   (Mathias	  et	  al.,	  2006;	  Hall	  et	  al.,	  2007;	  Elks	  et	  al.,	  2011).	  Findings	  




1.6	  Thesis	  aims	  
	  
Persistent	  neutrophilic	  inflammation	  and	  the	  associated	  tissue	  damage	  is	  a	  significant	  
cause	   of	   many	   chronic	   inflammatory	   diseases,	   which	   respond	   poorly	   to	   current	  
treatments.	  There	   is	  a	  major	  requirement	  to	  develop	  novel,	  more	  effective	  therapies	  
that	  specifically	  target	  the	  neutrophil,	  to	  promote	  the	  removal	  of	  these	  cells	  and	  drive	  
inflammation	  resolution.	  This	  may	  be	  accomplished	  by	  targeting	  neutrophil	  apoptosis	  
pathways	   or	   other,	   currently	   unknown	   signalling	   pathways	   that	   regulate	   alternative	  
neutrophil	  clearance	  mechanisms	  such	  as	  reverse	  migration.	  Ideally,	  novel	  compounds	  
must	   have	   the	   ability	   to	   override	   persistent	   neutrophil	   survival	   signalling	   and	   drive	  
inflammation	   resolution	   without	   compromising	   the	   host	   immune	   system.	   As	   it	   is	  
possible	  to	  initiate	  a	  robust	  inflammatory	  response	  in	  zebrafish	  larvae	  using	  the	  simple	  
tail	   fin	   injury	  assay,	   this	  model	  provides	  an	   ideal	   system	   for	   the	  screening	  of	  diverse	  
compound	  libraries.	  I	  hypothesised	  that	  novel	  accelerators	  of	  inflammation	  resolution	  
could	  be	  identified	  in	  this	  manner.	  	  
	  
The	  aims	  of	  this	  thesis	  are:	  
	  
-­‐ To	   design	   and	   optimise	   a	   screening	   assay	   in	   the	   Tg(mpx:GFP)i114	   zebrafish	  
model	  with	  the	  hypothesis	  that	  this	  approach	  will	  reveal	  novel	  accelerators	  of	  
inflammation	  resolution	  	  
	  
-­‐ To	   perform	   a	   robust	   screen	   of	   a	   diverse	   compound	   library	   and	   identify	  
compounds	  that	  can	  reproducibly	  drive	  inflammation	  resolution	  in	  zebrafish	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-­‐ To	   further	   investigate	   the	   activity	   of	   assay	   positive	   compounds	   in	   zebrafish,	  
explore	   any	   potential	   structure-­‐activity	   relationships	   and	   generate	   and	   test	  
new	  hypotheses	  to	  attempt	  to	  define	  their	  precise	  mechanisms	  of	  action	  	  
	  
-­‐ To	   investigate	   whether	   the	   effects	   of	   assay	   positive	   compounds	   can	   be	  
replicated	   in	   human	   neutrophils	   in	   vitro	   and	   in	   the	   presence	   of	   neutrophil	  
survival	  signals	  
	  









All	   general	   reagents	   and	   chemicals	   were	   obtained	   from	   Sigma-­‐Aldrich	   (Poole,	   UK),	  
unless	   stated	   otherwise.	   All	   positive	   hit	   compounds	   that	   were	   used	   in	   secondary	  
assays	  were	  acquired	  from	  Sigma-­‐Aldrich,	  with	  the	  exception	  of	  isopimpinellin	  and	  2-­‐
benzoyl-­‐5-­‐methoxybenzoquinone,	   which	   were	   obtained	   directly	   from	   MicroSource	  
Discovery	  Systems	  Inc.	  (Gaylordsville,	  CT,	  USA).	  Nedocromil	  was	  obtained	  as	  a	  kind	  gift	  
from	   Professor	   Rod	   Flower	   (William	   Harvey	   Research	   Institute,	   UK).	   The	   CXCR2	  
antagonist,	  SB225002	  was	  obtained	  from	  Tocris	  Bioscience	  (Bristol,	  UK).	  
2.1.1	  Compound	  libraries	  
The	   Spectrum	   compound	   collections	   were	   acquired	   from	   MicroSource	   Discovery	  
Systems,	  Inc.	  The	  natural	  product	  collection	  of	  caspase-­‐3	  activators	  was	  obtained	  from	  
Merlion	   Pharmaceuticals	   (Singapore).	   The	   library	   of	   known	   inflammatory	   signalling	  
pathway	  inhibitors	  was	  acquired	  from	  GlaxoSmithKline	  (GSK,	  Stevenage,	  UK).	  
2.1.2	  Antibodies	  for	  flow	  cytometry	  
Human	   CXCR1	   Fluorescein	   isothiocyanate	   (FITC)	   MAb,	   Human	   CXCR2	   Phycoerythrin	  
(PE)	   MAb,	   Mouse	   IgG2A	   FITC	   Isotype	   Control	   and	   Mouse	   IgG2A	   PE	   Control	   were	  
obtained	   as	   kind	   gifts	   from	   Professor	   Ian	   Sabroe	   and	   Dr	   Lisa	   Parker	   (University	   of	  
Sheffield).	   Additional	   Human	   CXCR2	   PE	  MAb	   and	  Human	   CXCR4	   FITC	  were	   acquired	  
from	  R	  &	  D	  Systems	  (Abingdon,	  UK).	  	  
	  
	  
2.2	  General	  zebrafish	  techniques	  
	  
2.2.1	  Zebrafish	  husbandry	  
Zebrafish	   were	   raised	   and	   maintained	   according	   to	   standard	   protocols	   (Nüsslein-­‐
Volhard	   and	   Dahm,	   2002),	   in	   a	   continuous	   re-­‐circulating	   closed	   aquarium	   system	   at	  
28oC	  and	  with	  a	  daily	  light	  cycle	  of	  14	  light	  hours	  and	  10	  dark	  hours,	  at	  UK	  Home	  Office	  
approved	   aquaria	   in	   the	  MRC	  Centre	   for	  Developmental	   and	  Biomedical	  Genetics	   at	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the	  University	  of	  Sheffield.	  At	  5	  days	  post	  fertilisation	  (dpf),	  zebrafish	  larvae	  were	  fed	  
Tetra	  A-­‐Z	  powdered	  fish	  feed,	  and	  from	  13	  dpf	  onwards,	  were	  fed	   live	  artemia	  twice	  
daily.	  Transgenic	  zebrafish	  lines	  used	  throughout	  this	  project	  are	  listed	  in	  Appendix	  1.	  
	  
Embryos	  were	  acquired	  through	  either	  individual	  pair	  mating	  or	  collective	  marble	  tank	  
mating.	  For	  pair	  mating,	  one	  female	  and	  one	  male	  zebrafish	  were	  placed	  into	  a	  small	  
mating	   tank	  with	   a	   plastic	   grid	   at	   the	   base	   to	   allow	   embryos	   to	   fall	   into	   a	   separate	  
space	  below.	  For	  collective	  mating,	  a	  ‘marble	  tank’	  was	  placed	  into	  a	  tank	  of	  up	  to	  40	  
adult	   zebrafish,	   consisting	   of	   a	   plastic	   container	   in	   which	   a	   wire-­‐mesh	   sieve	   was	  
inserted	   and	   filled	   with	   marbles.	   In	   all	   cases,	   mating	   set-­‐up	   was	   carried	   out	   in	   the	  
evening	  and	  embryos	  were	  collected	  the	  following	  morning	  by	  pouring	  the	  mating	  or	  
marble	   tank	   water	   through	   a	   plastic	   tea	   strainer.	   Fertilised,	   healthy	   embryos	   were	  
sorted	   using	   a	   Pasteur	   pipette	   into	   Petri	   dishes	   (Scientific	   Laboratory	   Supplies	   Ltd.	  
(SLS),	  Coatbridge,	  UK)	  containing	  approximately	  30	  ml	  of	  E3	  medium	  (Appendix	  2),	  at	  a	  
density	  of	  50-­‐60	  viable	  embryos	  per	  dish.	  All	  embryos	  were	   incubated	  at	  28oC	  unless	  
stated	   otherwise.	   At	   the	   endpoint	   of	   all	   experiments	   and	   prior	   to	   5.2	   dpf,	   embryos	  
were	  sacrificed	  by	  immersion	  in	  bleach.	  All	  procedures	  were	  performed	  in	  accordance	  
with	  UK	  Home	  Office	  legislation,	  which	  permits	  use	  of	  embryos	  up	  to	  5.2	  dpf	  outside	  of	  
the	  Animals	  (Scientific	  Procedures)	  Act.	  
2.2.2	  Microinjection	  of	  zebrafish	  embryos	  
For	   injection	  of	   ribonucleic	  acid	   (RNA),	  embryos	  were	  collected	  at	   the	  one-­‐cell	   stage	  
and	   viewed	   under	   a	   dissecting	  microscope	   (Leica	  Microsystems	   Ltd.,	  Milton	   Keynes,	  
UK).	   Embryos	   were	   positioned	   against	   a	   glass	   microscope	   slide	   (Menzel-­‐Gläser,	  
Braunschweig,	  Germany)	   in	  a	  Petri	  dish	   lid	  and	  excess	   liquid	  was	   removed.	  RNA	  was	  
prepared	  in	  sterile	  water	  at	  the	  appropriate	  concentration	  required,	  with	  10	  %	  phenol	  
red	  to	  allow	  visualisation.	  Injections	  were	  performed	  into	  the	  yolk	  using	  non-­‐filament	  
glass	   capillary	   needles	   (Kwik-­‐FilTM	   Borosilicate	   Glass	   Capillaries,	   World	   Precision	  
Instruments	  (WPI),	  Herts,	  UK)	  pulled	  using	  a	  Flaming	  Brown	  micropipette	  puller	  (Sutter	  
Instrument	  Co.,	  Novato,	  USA),	  and	  attached	   to	  a	  microinjection	   rig	   (WPI).	   	   Following	  
injection,	  embryos	  were	  incubated	  in	  E3	  at	  28oC	  and	  those	  that	  remained	  viable	  were	  




2.2.3	  Tail	  fin	  transection	  
Zebrafish	   larvae	   were	   anaesthetised	   by	   immersion	   in	   0.017%	   3-­‐amino	   benzoic	   acid	  
ethyl	  ester,	  referred	  to	  as	  tricaine,	  and	  were	  transferred	  onto	  a	  strip	  of	  masking	  tape	  
adhered	  to	  a	  Petri	  dish	  lid.	  Excess	  liquid	  was	  removed	  to	  ensure	  minimal	  movement	  of	  
the	  larvae,	  which	  were	  viewed	  under	  a	  dissecting	  microscope.	  A	  micro-­‐scalpel	  (15°,	  5.0	  
mm	   depth;	   WPI)	   was	   used	   to	   fully	   transect	   the	   caudal	   fin	   in	   order	   to	   initiate	   an	  
inflammatory	   response.	   For	   consistency,	   injury	   was	   always	   performed	   within	   the	  
region	   where	   the	   pigment	   pattern	   is	   disrupted,	   as	   posterior	   as	   possible	   to	   the	  
circulatory	   loop,	   as	   illustrated	  by	   the	   red	   line	   (Figure	  2.1).	   Following	   tail	   transection,	  
larvae	  were	  transferred	  to	  fresh	  E3	  medium	  and	  incubated	  at	  28oC	  to	  allow	  recovery.	  







Figure	  2.1:	  Site	  of	  zebrafish	  tail	  fin	  transection.	  
Image	  shows	  a	  3	  dpf	  Tg(mpx:GFP)i114	  zebrafish	  larva.	  Red	  line	  indicates	  point	  at	  which	  tail	  fin	  





2.2.4	  Compound	  treatment	  
Chemical	   compounds	   were	   dissolved	   in	   dimethyl	   sulfoxide	   (DMSO),	   E3	   or	   distilled	  
water,	  as	   indicated.	   Larvae	  were	   treated	  by	   immersion	   in	  either	  24-­‐	  or	  96-­‐well	  plate	  
format	  (SLS),	  as	  stated.	  The	  appropriate	  volume	  of	  stock	  solution	  was	  added	  to	  E3	  to	  
make	  a	  working	   solution	  at	  double	   the	   final	   concentration	  and	  half	   the	   final	   volume	  
required,	  then	  larvae	  in	  an	  equal	  volume	  of	  E3	  were	  added	  to	  result	  in	  the	  correct	  final	  
concentration.	   Compounds	   were	   always	   tested	   alongside	   the	   appropriate	   vehicle	  
control	  and	  a	  positive	  control	  as	   indicated.	  Unless	  otherwise	  stated,	  well	  plates	  were	  
wrapped	  in	  aluminium	  foil	  and	  incubated	  at	  28oC.	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2.2.5	  Mounting	  of	  larvae	  for	  microscopy	  
For	  imaging,	  larvae	  were	  anaesthetised	  in	  tricaine	  then	  transferred	  to	  a	  mounting	  dish,	  
prepared	  by	  adhering	  a	  coverslip	  (number	  0;	  SLS)	  underneath	  a	  10	  mm	  puncture	  in	  a	  
25	  mm	  Petri	  dish	  using	  high	  vacuum	  grease	  (Dow	  Corning®,	  Seneffe,	  Belgium).	  Excess	  
E3	   was	   removed	   then	   larvae	   were	   mounted	   in	   a	   1%	   solution	   of	   low	   melting	   point	  
(LMP)	  agarose	  dissolved	   in	  sterile	  water	  and	  containing	  0.017%	  tricaine.	  Larvae	  were	  
manipulated	   into	   a	   flat	   position	   using	   a	   human	   hair.	   For	   time-­‐lapse	  microscopy,	   E3	  
containing	   0.017%	   tricaine	   and	   if	   required,	   the	   appropriate	   concentration	   of	   drug	  
treatment,	   was	   applied	   to	   the	   Petri	   dish	   after	   the	   agarose	   had	   solidified,	   to	   avoid	  
dehydration	  of	  the	  larvae.	  	  
	  
	  
2.3	  Zebrafish	  drug	  screening	  
	  
The	   transgenic	   zebrafish	   line	   Tg(mpx:GFP)i114	   (Renshaw	   et	   al.,	   2006),	   which	  
specifically	   labels	   neutrophils	   with	   green-­‐fluorescent	   protein	   (GFP),	   was	   used	   for	   all	  
drug	  screening	  experiments	  in	  this	  project	  and	  is	  subsequently	  referred	  to	  as	  mpx:GFP.	  
The	  Merlion	  Collection	  was	  screened	  at	  a	   final	  concentration	  of	  250	  µg/ml	   for	  crude	  
extracts	  and	  62.5	  µg/ml	  for	  pre-­‐fractions.	  The	  Spectrum	  Collection	  was	  screened	  at	  25	  
µM	  and	  each	  plate	  was	  screened	  on	  2	  independent	  occasions.	  
2.3.1	  Compound	  library	  screening	  protocol	  
Tail	  fin	  transection	  was	  performed	  as	  described	  and	  at	  4	  hpi,	  larvae	  were	  viewed	  under	  
a	   fluorescent	  dissecting	  microscope	   (Leica	  MZ10F,	  GFP	  plus	   filter).	   Larvae	  with	  25-­‐30	  
neutrophils	  at	   the	  site	  of	   injury	  were	  selected	  and	  transferred	  to	   fresh	  E3.	  Screening	  
plates	  were	  set	  up	  blinded	  to	  experimental	  conditions,	   to	  contain	  4	  wells	  each	  of	  E3	  
control,	  DMSO	  vehicle	  control	  and	  either	  10	  µM	  GSK650394	  (Tocris	  Bioscience)	  or	  30	  
µM	   SP600125	   as	   a	   positive	   control.	   Selected	   larvae	   were	   added	   to	   the	   compounds	  
using	   a	   pipette,	   at	   a	   density	   of	   3	   larvae	   per	  well.	   Screening	   plates	  were	  wrapped	   in	  





At	   12	   hpi,	   larvae	   were	   anaesthetised	   and	   the	   well	   plate	   was	   imaged	   using	   the	  
Phenosight	  High-­‐Content	  plate	   reader	   (Ash	  Biotech,	  Cambridge,	  UK),	  which	   captured	  
both	   bright	   field	   and	  GFP	   images,	   at	   an	   exposure	   of	   40	  ms.	   Prior	   to	   imaging,	   larvae	  
were	  removed	  from	  any	  wells	  containing	  auto-­‐fluorescent	  compounds,	  which	  included	  
the	   SP600125	   positive	   control,	   and	   the	   wells	   were	   washed	   out	   using	   fresh	   E3	   to	  
remove	   remaining	   traces	   of	   auto-­‐fluorescence.	   Larvae	   were	   then	   returned	   to	   their	  
wells	  in	  fresh	  E3	  containing	  tricaine.	  	  
2.3.2	  Manual	  scoring	  procedure	  
Individual	  fluorescent	  and	  bright	  field	  .tif	  images	  were	  generated	  for	  each	  well	  by	  the	  
Phenosight	  plate	  scanner	  at	  12	  hpi,	  were	  observed	  in	  Preview	  (Macintosh)	  and	  given	  a	  
score	  between	  0	  and	  3	  (Table	  2.1).	  The	  scoring	  system	  was	  dependent	  on	  the	  number	  
of	   larvae	   within	   the	   well	   that	   were	   considered	   to	   have	   a	   significantly	   reduced	  
neutrophil	  population	  at	  the	  site	  of	  injury	  in	  comparison	  to	  the	  DMSO	  control	  larvae.	  
In	  all	  experiments,	  there	  was	  more	  than	  one	  well	  of	  3	  fish	  per	  compound,	  so	  a	  mean	  
score	  was	  calculated.	  	  
	  
Table	  2.1:	  Guidelines	  for	  the	  manual	  scoring	  method.	  
	  
Score	   Phenotype	  
0	   0	  out	  of	  3	  larvae	  with	  reduced	  neutrophil	  population	  at	  site	  of	  injury	  
1	   1	  out	  of	  3	  larvae	  with	  reduced	  neutrophil	  population	  at	  site	  of	  injury	  
2	   2	  out	  of	  3	  larvae	  with	  reduced	  neutrophil	  population	  at	  site	  of	  injury	  
3	   3	  out	  of	  3	  larvae	  with	  reduced	  neutrophil	  population	  at	  site	  of	  injury	  
	  
	  
2.3.3	  Automated	  analysis	  using	  a	  pilot	  version	  of	  the	  Phenosight	  software	  
Phenosight	   analysis	   software	   (Ash	  Biotech),	   designed	   to	   complement	   the	  automated	  
plate	   reader	  by	  generating	  a	  quantitative	   readout	  of	   fluorescence,	   is	  currently	  under	  
development.	   To	   aid	   progression,	   a	   trial	   version	   of	   the	   software	   was	   tested	   using	  
results	  from	  the	  Merlion	  Collection	  screen.	  Fluorescent	  images	  from	  each	  96-­‐well	  plate	  
were	   imported	   into	   the	   program	   and	   a	   ‘constellation’,	   indicated	   by	   a	   large	   yellow	  
circle,	   containing	  2	   ‘features’,	   indicated	  by	  2	   small	   red	   circles,	  was	  placed	  onto	  each	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larva	  (Figure	  2.2).	  One	  feature	  was	  placed	   in	  the	  tail	   region,	  covering	  as	  much	  of	  the	  
site	  of	  injury	  as	  possible,	  and	  the	  other	  feature	  was	  placed	  anterior	  to	  the	  first,	  at	  a	  site	  
where	   an	   unbiased	   background	   reading	   of	   fluorescence	   could	   be	   measured.	   Once	  
constellations	  were	  placed	  on	  all	  3	   larvae	   in	  all	  96	  wells,	   the	  software	  measured	   the	  
level	   of	   fluorescence	   within	   each	   feature,	   producing	   a	   Microsoft®	   Excel	   worksheet	  
containing	  these	  values	  expressed	  as	  ‘fluorescence	  per	  unit	  area’	  (FPU).	  The	  worksheet	  
was	  manipulated	  using	  a	  series	  of	  formulae	  to	  generate	  a	  final	  readout	  of	  FPU	  at	  the	  























Figure	  2.2:	   Illustrative	  example	  of	   constellation	   location	   in	   the	  Phenosight	  Analysis	  
software.	  
Constellations	   (1	   –	   3)	   containing	   2	   features	   were	   placed	   onto	   each	   larva.	   Feature	   1	   was	   placed	   in	   a	  
region	   where	   a	   representative	   level	   of	   background	   fluorescence	   could	   be	   measured.	   Feature	   2	   was	  
placed	  in	  the	  tail	  region	  to	  encompass	  the	  site	  of	  injury.	  




2.4	  Assays	  to	  analyse	  neutrophil	  response	  and	  behaviour	  in	  zebrafish	  
	  
2.4.1	  Neutrophil	  recruitment	  assay	  
To	  assess	   the	  ability	  of	   compounds	   to	   inhibit	  neutrophil	   recruitment,	  3	  dpf	  mpx:GFP	  
larvae	  were	   injured	   as	   described	   above	   and	   treated	   immediately	   by	   immersion	  with	  
compounds	   diluted	   in	   E3	   at	   the	   concentrations	   indicated.	   At	   6	   hpi,	   larvae	   were	  
anaesthetised	  and	  the	  numbers	  of	  neutrophils	  at	  the	  injury	  site	  were	  counted	  by	  eye	  
under	   a	   fluorescent	   dissecting	   microscope	   (Leica	   MZ10F,	   GFP	   plus	   filter).	   Where	  
possible,	  counting	  was	  performed	  blind	  to	  experimental	  conditions.	  
2.4.2	  Inflammation	  resolution	  assay	  
To	  investigate	  the	  effect	  of	  compounds	  on	  the	  acceleration	  of	  inflammation	  resolution,	  
3	   dpf	  mpx:GFP	   larvae	  were	   injured	   and	   good	   responders	  were	   selected	   at	   6	   hpi	   for	  
treatment	  by	  immersion.	  At	  12	  hpi,	  larvae	  were	  anaesthetised	  and	  neutrophil	  numbers	  
were	   counted	   as	   above.	  On	   all	   possible	   occasions,	   counting	  was	   performed	   blind	   to	  
experimental	  conditions.	  
2.4.3	  Analysis	  of	  total	  neutrophil	  number	  
To	  examine	  the	  effect	  of	  compounds	  on	  the	  total	  neutrophil	  number	  of	  intact	  larvae,	  3	  
dpf	   mpx:GFP	   larvae	   were	   treated	   with	   compounds	   by	   immersion	   for	   24	   hours,	  
anaesthetised	  and	  then	  mounted	  in	  1%	  LMP	  agarose.	  Imaging	  was	  carried	  out	  using	  an	  
Eclipse	   TE2000-­‐U	   inverted	   compound	   fluorescence	   microscope	   (Nikon	   UK	   Ltd.,	  
Kingston	   upon	   Thames,	   UK)	   with	   a	   1394	   ORCA-­‐ERA	   (Hamamatsu	   Photonics	   Inc.,	   NJ,	  
USA)	   camera	   and	   Volocity®	   software	   (PerkinElmer	   Life	   and	   Analytical	   Sciences,	  
Cambridge,	  UK).	   Images	  were	  acquired	  using	  a	  2x	  NA	  0.06	  Plan	  UW	  objective,	  with	  a	  
GFP-­‐specific	  filter	  and	  excitation	  at	  488	  nm,	  with	  10	  Z	  slices.	  Images	  were	  compressed	  
into	   a	   single	   focal	   plane	   and	   exported	   as	   .tif	   files.	   Automated	   analysis	   of	   total	  
neutrophil	   number	   was	   performed	   using	   ImageJ	   software.	   As	   each	   image	   acquired	  
contained	   3	   larvae,	   images	   were	   cropped	   to	   contain	   a	   single	   larva	   of	   interest,	   and	  
converted	   to	   8-­‐bit	   resolution	   and	   binary	   form	   after	   appropriate	   adjustment	   of	  
brightness	  and	  contrast	  to	  exclude	  background	  fluorescence.	  Neutrophil	  number	  was	  
measured	  in	  an	  unbiased	  manner	  using	  the	  ‘analyse	  particles’	  function.	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2.4.4	  Neutrophil	  tracking	  during	  recruitment	  to	  the	  site	  of	  injury	  
For	   investigation	   of	   changes	   in	   neutrophil	   behaviour	   during	   the	   initial	   recruitment	  
phase	   of	   the	   inflammatory	   response,	   3	   dpf	   mpx:GFP	   larvae	   were	   incubated	   with	  
compounds	   for	  2	  hours	  before	   tail	   fin	   injury.	  After	  approximately	  10	  minutes,	   larvae	  
were	  mounted	  in	  1%	  LMP	  agarose.	  A	  one	  hour	  time-­‐lapse	  series	  was	  captured	  using	  a	  
1394	   ORCA-­‐ERA	   camera	   on	   an	   Eclipse	   TE2000-­‐U	   inverted	   compound	   fluorescence	  
microscope.	  Acquisition	  occurred	  at	  2	  minute	  intervals,	  using	  a	  10x	  NA	  0.3	  Plan	  Fluor	  
objective,	  with	  10	  Z	  planes	  over	  a	  total	  focal	  depth	  of	  100	  μM,	  and	  using	  a	  GFP-­‐specific	  
filter	   with	   excitation	   at	   488	   nm.	   For	   analysis,	   a	   region	   of	   interest	   (ROI)	   was	   drawn	  
around	   each	   injured	   tail	   fin,	   to	   exclude	   stationary	   developing	   neutrophils	   in	   the	  
posterior	  blood	   island.	   	  Tracking	  of	  GFP-­‐labelled	  cells	  was	  performed	  using	  Volocity®	  
software,	   which	   generated	   various	   parameters	   for	   each	   neutrophil	   track,	   including	  
speed,	   displacement,	   meandering	   index	   and	   bearing.	   These	   data	   were	   also	   used	   to	  
calculate	  displacement	  towards	  the	  wound.	  
2.4.5	  Analysis	  of	  PI-­‐3K	  activity	  
To	   investigate	   PI-­‐3K	   activation	   during	   neutrophil	   recruitment	   in	   vivo,	   Tg(lyz:PHAkt-­‐
EGFP)	   larvae,	   subsequently	   referred	   to	   as	   lyz/PHAkt,	   were	   incubated	   with	   test	  
compounds	   for	   2	   hours	   prior	   to	   tail	   fin	   transection	   as	   described	   above.	   In	   all	  
experiments,	  compounds	  were	  tested	  alongside	  50	  μM	  LY294002	  and	  a	  DMSO	  vehicle	  
control.	   To	   avoid	   bias,	   experiments	   were	   performed	   blind	   to	   treatment	   conditions.	  
Approximately	  10	  minutes	  after	   injury,	   larvae	  were	  mounted	   in	  1%	  LMP	  agarose	  and	  
observed	  on	  an	  UltraVIEWVoX	  spinning	  disk	  confocal	  imaging	  system	  (PerkinElmer	  Life	  
and	  Analytical	  Sciences)	  with	  an	  inverted	  Olympus	  IX81	  microscope,	  using	  an	  Olympus	  
UPlanSApo	  60x	  oil	  immersion	  objective	  (Hamburg,	  Germany).	  GFP-­‐positive	  cells	  in	  the	  
region	  between	  the	  injury	  site	  and	  the	  posterior	  blood	  island	  were	  imaged	  individually,	  
using	  the	  488	  nm	  laser	  line	  with	  20	  Z	  slices.	  Single	  slices	  in	  which	  a	  leading	  and	  trailing	  
edge	  of	  each	  cell	  could	  be	  defined	  were	  exported	  as	  .tif	   files	  and	  analysed	  in	  ImageJ.	  
Using	  the	  straight-­‐line	  tool,	  a	  transection	  was	  drawn	  through	  each	  neutrophil	  from	  the	  
trailing	  edge	  towards	  the	  leading	  edge.	  In	  cases	  where	  there	  were	  no	  clear	  leading	  or	  
trailing	  edges,	  the	  straight	  line	  was	  drawn	  through	  the	  most	  longitudinal	  section	  of	  the	  




the	   length	   of	   the	   line	   (Figure	   2.3)	   and	   these	   values	  were	   inserted	   into	   a	  Microsoft®	  
Excel	  worksheet.	  A	  threshold	  was	  applied	  to	  account	  for	  background	  fluorescence,	  and	  
the	  trailing	  and	  leading	  edges	  were	  defined	  by	  selecting	  the	  appropriate	  pixels.	  Mean	  
intensity	  values	  for	  each	  parameter,	  as	  illustrated	  in	  Figure	  4.3,	  were	  used	  to	  calculate	  
the	  polarity	  index	  with	  the	  equation:	  







Figure	  2.3:	  Fluorescence	  intensity	  plot	  profile	  of	  a	  migrating	  neutrophil.	  
Figure	   shows	   representative	   plot	   profile	   generated	   in	   ImageJ	   by	   drawing	   a	   straight	   line	   through	   a	  
migrating	  neutrophil,	  from	  the	  trailing	  edge	  towards	  the	  leading	  edge.	  The	  fluorescence	  intensities	  per	  
pixel	  were	   imported	   into	   Excel,	   a	   threshold	  was	   applied	   and	   the	   appropriate	   pixels	  were	   selected	   to	  
define	  the	  trailing	  edge	  (a),	  leading	  edge	  (b)	  and	  the	  whole	  cell	  (c).	  	  
	   	  
a	   b	  c	  
	  64	  
2.4.6	  Reverse	  migration	  assay	  
Reverse	   migration	   assays	   were	   performed	   using	   embryos	   expressing	   the	  
photoactivatable	   fluorescent	   protein	   Kaede	   in	   neutrophils,	   raised	   from	   the	   double	  
transgenic	   line	   Tg(mpx:Gal4;UAS:Kaede)i222,	   subsequently	   termed	   mpx/Kaede.	   At	  
either	  2	  or	  3	  dpf	  as	  specified,	  Kaede-­‐positive	  larvae	  were	  selected	  and	  tail	  transection	  
was	  performed.	  At	  4	  hpi,	  larvae	  with	  high	  numbers	  of	  neutrophils	  recruited	  to	  the	  site	  
of	   injury	  were	   immersed	  with	  test	  compounds	  as	   indicated	  or	  DMSO	  vehicle	  control.	  
At	  5	  hpi	  for	  2	  dpf,	  and	  6	  hpi	  for	  3	  dpf,	  larvae	  were	  mounted	  in	  a	  chamber	  slide	  (SLS)	  in	  
1%	   LMP	  agarose	   containing	   the	   required	   concentration	  of	   test	   compound	  or	  DMSO.	  
Kaede-­‐labelled	   cells	   at	   the	   site	   of	   injury	   were	   photoconverted	   at	   10x	   magnification	  
using	  an	  UltraVIEWPhotoKinesisTM	  device	  (PerkinElmer	  Life	  and	  Analytical	  Sciences)	  on	  
the	  UltraVIEWVoX	   laser	   imaging	   system	  described	   above.	   The	   PhotoKinesisTM	   device	  
was	  calibrated	  using	  fluorescent	   ink	  (Stabilo	  BossTM	  Berks,	  UK)	  as	  a	  photo-­‐bleachable	  
substrate,	   drawn	  onto	   a	   glass	  microscope	   slide.	   The	   405	   nm	   laser	   line	  was	   used	   for	  
photoconversion,	  with	  120	  cycles	  at	  40%	  laser	  energy	  (settings	  optimised	  by	  previous	  
student,	   Giles	   Dixon	   and	   published	   in	   (Dixon	   et	   al.,	   2012)).	   A	   ROI	   was	   drawn	   to	  
selectively	   photoconvert	   neutrophils	   at	   the	   site	   of	   injury	   and	   successful	  
photoconversion	  of	  Kaede	  was	  ensured	  by	  observation	  of	  a	  loss	  of	  green	  fluorescence	  
in	  the	  488	  nm	  laser	  line	  and	  gain	  of	  red	  fluorescence	  in	  the	  561	  nm	  laser	  line.	  Larvae	  
were	   then	   transferred	   to	   the	   Eclipse	   TE2000-­‐U	   inverted	   compound	   fluorescence	  
microscope	  and	  a	  time-­‐lapse	  series	  was	  captured	  as	  described	  for	  neutrophil	  tracking	  
experiments	   (2.4.4),	  with	  2.5	  minute	   intervals,	   for	   the	  duration	   indicated.	  Both	  GFP-­‐	  
and	  RFP-­‐specific	  filters	  were	  used,	  with	  excitation	  at	  488	  nm	  and	  561	  nm	  respectively.	  
For	  analysis	  in	  Volocity®,	  a	  ROI	  was	  drawn	  in	  the	  first	  time	  frame,	  to	  exclude	  the	  site	  of	  
injury	  and	  majority	  of	  red	  photoconverted	  cells.	  The	  number	  of	  red	  cells	  that	  migrated	  
into	  the	  ROI	  was	  recorded	  at	  every	  subsequent	  time	  frame.	  	  
	  
The	   behaviour	   of	   reverse	   migrating	   neutrophils	   was	   also	   analysed	   using	   Volocity®	  
software	  as	  described	  in	  section	  2.4.4,	  to	  analyse	  the	  speed	  and	  meandering	  index	  of	  
red-­‐labelled	  cell	  tracks,	  without	  prior	  selection	  of	  a	  ROI.	  




2.5	  Zebrafish	  staining	  assays	  
	  
2.5.1	  Analysis	  of	  neutrophil	  apoptosis	  
To	  assess	  the	  rate	  of	  neutrophil	  apoptosis	  in	  vivo,	  resolution	  assays	  were	  carried	  out	  as	  
described	  above,	  using	  3	  dpf	  mpx:GFP	  larvae.	  At	  12	  hpi,	  rather	  than	  counting	  numbers	  
of	   neutrophils	   at	   the	   site	   of	   injury,	   larvae	   were	   fixed	   overnight	   at	   4oC	   in	   4%	  
paraformaldehyde	   (PFA;	   Fisher	   Scientific,	   Loughborough,	   UK).	   The	   following	   day,	  
Tyramide	   Signal	   Amplification	   (TSA)	   staining	   was	   performed	   using	   the	   TSATM-­‐Plus	  
Fluorescein	   System	   (PerkinElmer	   Life	   and	   Analytical	   Sciences),	   as	   per	   the	  
manufacturer’s	  instructions.	  This	  labels	  myeloperoxidase	  in	  neutrophils	  to	  enable	  their	  
visualisation	   under	   a	   GFP	   filter.	   Prior	   to	   staining,	   larvae	   were	   washed	   in	   PBT	  
(phosphate	  buffered	  saline	   (PBS)	  +	  0.1%	  tween	  20),	   followed	  by	  amp	  diluent.	   Larvae	  
were	  then	  incubated	  in	  50	  μl	  of	  1:50	  FITC	  TSA:amp	  diluent	  in	  the	  dark	  at	  28oC	  for	  10	  
minutes.	  To	  remove	  background	  staining,	  larvae	  were	  washed	  in	  PBT,	  then	  fixed	  for	  20	  
minutes	  in	  4%	  PFA	  at	  room	  temperature	  before	  storage	  in	  PBT	  overnight	  at	  4oC.	  
	  
The	  ApopTag®	  Red	   In	   Situ	  Apoptosis	  Detection	  Kit	   (Millipore	  Corporation,	  Herts,	  UK)	  
was	   used	   for	   terminal	   deoxynucleotidyl	   transferase	   (TdT)	   dUTP	   nick	   end	   labelling	  
(TUNEL)	  as	  per	  the	  manufacturer’s	  instructions.	  This	  stains	  the	  double	  strand	  breaks	  in	  
DNA	   to	   allow	   detection	   of	   apoptotic	   cell	   death.	   Initially,	   larvae	   were	   digested	   with	  
proteinase	  K	  at	  10	  μg/ml	  for	  90	  minutes,	  washed	  in	  PBT,	  then	  fixed	  for	  20	  minutes	  in	  
4%	  PFA	  at	  room	  temperature.	  After	  further	  washing	  in	  PBT,	  larvae	  were	  immersed	  in	  
1:2	  acetone:ethanol	   for	  7	  minutes	  at	   -­‐20oC,	  then	  rewashed	   in	  PBT.	  Larvae	  were	  then	  
incubated	   in	   50	   μl	   equilibration	   buffer	   for	   1	   hour	   at	   room	   temperature,	   which	   was	  
then	  replaced	  with	  30	  μl	  reaction	  buffer	  and	  16	  μl	  TdT	  enzyme,	  for	  90	  minutes	  at	  37oC.	  
This	  was	  replaced	  with	  200	  μl	  stop	  buffer	  for	  3	  hours	  at	  37oC.	  Following	  PBT	  washing,	  
larvae	   were	   incubated	   with	   62	   μl	   anti-­‐dig-­‐rhodamine	   and	   68	   μl	   blocking	   solution	  
overnight	  at	  4oC	  with	  gentle	  rocking.	  The	  next	  day,	   larvae	  were	  washed	   in	  PBT,	   fixed	  




For	   imaging,	   the	   tail	   fin	  was	   removed	   from	  each	   larva	  using	  a	   surgical	  blade	   (Swann	  
Morton	   Ltd.,	   Sheffield,	   UK),	  mounted	   on	   a	   glass	  microscope	   slide	   and	   held	   in	   place	  
with	  an	  adhered	  coverslip.	  The	  wound	  region	  was	   imaged	  at	  20x	  magnification	  using	  
the	   UltraVIEWVoX	   spinning	   disk	   confocal	   imaging	   system	   (PerkinElmer	   Life	   and	  
Analytical	  Sciences)	  with	  the	  488	  nm	  and	  561	  nm	  laser	  lines	  and	  20	  Z	  slices.	  The	  total	  
neutrophil	   number	   at	   the	   site	   of	   injury	   (cells	   labelled	   with	   TSA)	   and	   number	   of	  
apoptotic	   neutrophils	   (cells	   labelled	  with	   both	   TSA	   and	   TUNEL)	  were	   analysed	   using	  
Volocity®	  software	  (PerkinElmer	  Life	  and	  Analytical	  Sciences).	  
2.5.2	  Whole	  mount	  in	  situ	  hybridisation	  (WISH)	  
WISH	  studies	  were	  performed	  to	  examine	  the	  spatial	  expression	  of	  sdf-­‐1a	  during	  the	  
inflammatory	   response	   in	   injured	   3	   dpf	   zebrafish	   larvae.	   At	   the	   appropriate	   time	  
points,	   larvae	   were	   fixed	   in	   4%	   PFA	   overnight	   at	   4oC,	   then	   transferred	   through	   a	  
methanol	  series	  and	  stored	  in	  100%	  methanol	  at	  -­‐20oC	  until	  required.	  No	  more	  than	  20	  
larvae	  were	   stored	  per	   tube.	   For	   rehydration,	   the	   larvae	  were	   transferred	   through	  a	  
reverse	  methanol	  series	  and	  then	  washed	  in	  PBT.	  Following	  this,	  larvae	  were	  digested	  
with	  proteinase	  K	  at	  10	  μg/ml	  for	  40	  minutes,	  washed	  in	  PBT,	  then	  fixed	  for	  20	  minutes	  
in	   4%	   PFA	   at	   room	   temperature.	   After	   re-­‐washing	   in	   PBT,	   pre-­‐hybridisation	   was	  
performed	  by	   incubating	   larvae	  with	   PreHyb	  buffer	   for	   3	   hours	   at	   70oC.	   Buffers	   and	  
wash	   solutions	  were	   prepared	   as	   described	   (Appendix	   2).	   The	   PreHyb	  was	   replaced	  
with	  ProbeHyb	  and	  this	  was	  incubated	  overnight	  at	  70oC.	  The	  probe	  was	  removed	  the	  
following	  day	  by	   a	   series	  of	  washes	   consisting	  of	   3:1,	   1:1	   then	  1:3	  HybWash:2x	   SSC.	  
Following	   another	   wash	   in	   2x	   SSC	   at	   70oC,	   larvae	   were	   transferred	   through	   an	   SSC	  
series	   at	   room	   temperature	   until	   a	   final	   wash	   in	   PBT	   alone.	   Larvae	   were	   then	  
incubated	  with	  blocking	  solution	  (Appendix	  2)	  for	  2	  hours	  at	  room	  temperature,	  with	  
gentle	   rocking.	   This	   was	   followed	   by	   overnight	   incubation	   with	   an	   anti-­‐DIG-­‐AP	  
antibody	  (Roche,	  Herts,	  UK)	  at	  a	  1:5000	  dilution	  in	  blocking	  solution,	  at	  4oC	  with	  gentle	  
rocking.	   The	   antibody	   was	   removed	   and	   larvae	   were	   washed	   extensively	   in	   PBT	   at	  
room	  temperature,	  followed	  by	  further	  washes	  in	  staining	  wash	  (Appendix	  2).	  Staining	  
solution	  (Appendix	  2)	  was	  applied	  until	  staining	  developed	  and	  then	  the	  reaction	  was	  
terminated	   using	   1	   mM	   EDTA.	   Larvae	   were	   washed	   in	   PBT,	   fixed	   in	   4%	   PFA	   for	   20	  




were	   rehydrated	   through	   a	   methanol	   series	   then	   transferred	   into	   80%	   glycerol.	  
Imaging	  was	  performed	  using	  a	  fluorescent	  dissecting	  microscope	  with	  a	  Leica	  DFC310	  
camera	  and	  Leica	  Application	  Suite	  software.	  
	  
	  
2.6	  Molecular	  biology	  
	  
2.6.1	  Transformation	  
To	   transform	   DNA,	   1	   μl	   of	   the	   plasmid	   indicated	   was	   added	   to	   25	   μl	   of	   Top10	  
competent	  cells	  (Invitrogen,	  Paisley,	  UK),	  followed	  by	  gentle	  mixing	  and	  incubation	  on	  
ice	   for	   30	   minutes	   to	   allow	   membrane	   permeabilisation.	   The	   cells	   were	   then	   heat	  
shocked	   for	  45	   seconds	  at	  42oC	  and	   returned	   to	   ice	   for	   a	   further	  10	  minutes	  before	  
addition	   of	   150	   μl	   SOC	  medium	   (Invitrogen)	   and	   incubation	   for	   1	   hour	   at	   37oC	  with	  
vigorous	  shaking	  at	  200	  rpm.	  Following	  this,	  the	  cells	  were	  spread	  onto	  a	  dry	  selection	  
plate	   and	   cultured	   at	   37oC	   overnight.	   In	   all	   cases,	   selection	   plates	  were	  made	   using	  
autoclaved	  LB	  agar	  and	  50	  μg/ml	  carbenicillin.	  	  	  
2.6.2	  DNA	  purification	  
Following	  transformation,	  single	  isolated	  colonies	  were	  selected	  and	  grown	  overnight	  
in	  50	  ml	  of	  autoclaved	  LB	  broth	  containing	  50	  μg/ml	  carbenicillin,	  at	  37oC	  with	  vigorous	  
shaking	  at	  200	  rpm.	  The	  DNA	  was	  purified	  using	  a	  HiSpeed	  Plasmid	  Midi	  Kit	  (QIAGEN,	  
Manchester,	   UK)	   and	   addition	   purification	   was	   performed	   using	   a	   MinElute	   PCR	  
Purification	   Kit	   (QIAGEN),	   as	   per	   the	   manufacturers’	   instructions.	   The	   DNA	  
concentration	  was	   quantified	   using	   a	   NanodropTM	  1000	   spectrophotometer	   (Thermo	  
Scientific,	  Hemel	  Hempstead,	  UK).	  
2.6.3	  Whole	  mount	  in	  situ	  Hybridisation	  (WISH)	  probe	  synthesis	  
An	  RNA	  probe	  was	  synthesised	  for	  the	  WISH	  studies	  described	  above.	  A	  plasmid	  vector	  
containing	   the	  zebrafish	  sdf-­‐1a	   coding	   sequence	  was	  obtained	  as	  a	  kind	  gift	   from	  Dr	  
Stone	   Elworthy	   (University	   of	   Sheffield).	   Following	   transformation	   and	   DNA	  
purification	   as	   described,	   the	   vector	   was	   linearised	   by	   restriction	   digest	   with	   EcoR1	  
(New	  England	  Biolabs	  (NEB),	  Herts,	  UK).	  For	  this,	  20	  μg	  of	  vector	  was	  incubated	  with	  1	  
	  68	  
μl	  of	   EcoR1	  and	  20	  μl	  of	   EcoR1	  buffer	   (NEB)	   in	   a	   total	   volume	  of	  200	  μl	  with	   sterile	  
water	  at	  37oC	  for	  2	  hours.	  The	  linearised	  DNA	  was	  then	  extracted	  by	  adding	  200	  μl	  of	  
phenol:chloroform,	   vortexed	   for	   3	   minutes,	   then	   centrifuged	   at	   14000	   rpm	   for	   7	  
minutes.	   The	   upper	   phase	   was	   removed	   and	   added	   to	   a	   new	   tube,	   followed	   by	   an	  
equal	  volume	  of	  chloroform.	  This	  was	  vortexed	  for	  1	  minute	  and	  centrifuged	  at	  14000	  
rpm	  for	  5	  minutes,	  then	  the	  upper	  phase	  was	  transferred	  to	  a	  new	  tube.	  To	  precipitate	  
the	  DNA,	  10%	  of	  this	  volume	  of	  3	  M	  sodium	  acetate	  was	  added,	  followed	  by	  an	  equal	  
volume	   of	   isopropanol.	   The	   mixture	   was	   stored	   at	   -­‐20oC	   for	   20	   minutes,	   then	  
centrifuged	  at	  14000	   rpm	   for	  20	  minutes	   at	   4oC.	   The	   supernatant	  was	   removed	  and	  
the	  pellet	  washed	  carefully	   in	  200	  μl	  of	  70%	  ethanol,	  by	  centrifugation	  at	  14000	  rpm	  
for	  5	  minutes	  at	  4oC.	  The	  ethanol	  was	  removed	  and	  the	  pellet	  air-­‐dried	  for	  10	  minutes	  
before	  re-­‐suspension	  in	  20	  μl	  of	  sterile	  water.	  The	  DNA	  concentration	  was	  quantified	  
using	  a	  NanodropTM	  1000	  spectrophotometer.	  	  
	  
An	   SP6	  RNA	  digoxigenin-­‐labelling	   kit	   (Roche)	  was	  used	   to	   transcribe	   the	  RNA	  probe.	  
For	  this,	  1	  μg	  of	  linearised	  DNA	  was	  incubated	  with	  2	  μl	  NTP-­‐DIG-­‐RNA	  labelling	  mix,	  1	  
μl	  RNAse	  inhibitor,	  2	  μl	  transcription	  buffer	  and	  2	  μl	  SP6	  polymerase	  in	  a	  final	  volume	  
of	   20	  μl	  with	   sterile	  water	   for	   2	  hours	   at	   37	  oC.	   	   To	   remove	   the	  DNA	   template,	   4	  μl	  
DNAse	  was	  added	  for	  30	  minutes	  at	  37	  oC.	  For	  precipitation,	  1	  μl	  pH8	  0.5	  M	  EDTA,	  2.5	  
μl	  4	  M	  LiCl	  and	  75	  μl	  of	  100%	  ethanol	  were	  added	  followed	  by	  storage	  at	  -­‐80oC	  for	  1	  
hour.	  After	   centrifugation	  at	   14000	   rpm	   for	  30	  minutes	   at	   4oC,	   the	   supernatant	  was	  
removed	   and	   the	   pellet	   was	   carefully	   washed	   in	   100	   μl	   of	   70%	   ethanol,	   by	  
centrifugation	  at	  14000	  rpm	  for	  10	  minutes	  at	  4oC.	  The	  supernatant	  was	  removed	  and	  
the	   pellet	   air-­‐dried	   for	   5	  minutes	   before	   re-­‐suspension	   in	   20	   μl	   of	   sterile	   water.	   To	  
confirm	  the	  presence	  of	  RNA,	  gel	  electrophoresis	  was	  performed	  using	  1	  μl	  of	  the	  re-­‐
suspension	  and	  a	  1%	  agarose	  gel.	  After	  addition	  of	  80	  μl	   formamide,	   the	  RNA	  probe	  
was	  stored	  at	  -­‐80oC.	  
2.6.4	  RNA	  synthesis	  	  
A	  plasmid	  vector	  containing	  the	  dominant-­‐active	  hif-­‐1αb	  coding	  sequence	  (Elks	  et	  al.,	  
2011)	  was	  obtained	  as	  a	  kind	  gift	   from	  Dr	  Phil	  Elks	   (Leiden	  University)	  and	  DNA	  was	  




RNA	   was	   performed	   using	   the	   mMessage	   mMachine®	   High	   Yield	   Capped	   RNA	  
Transcription	   Kit	   (Invitrogen),	   according	   to	   the	   manufacturer’s	   instructions.	   For	   the	  
transcription	   reaction,	   6	  μl	   of	  DNA	  was	   incubated	  with	  10	  μl	   2x	  NTP/CAP,	   10	  μl	   10x	  
reaction	   buffer	   and	   2	   μl	   SP6	   enzyme	  mix	   for	   2	   hours	   at	   37oC.	   To	   remove	   the	   DNA	  
template,	  1	  μl	  TURBO	  DNAse	  was	  added	  and	  the	  solution	  was	  mixed	  and	  incubated	  for	  
30	  minutes	  at	  37oC.	  This	  was	  followed	  by	  addition	  of	  115	  μl	  nuclease	  free	  water	  and	  15	  
μl	  ammonium	  acetate	  stop	  solution.	  To	  extract	  the	  RNA,	  150	  μl	  phenol:chloroform	  was	  
added	  prior	   to	  vortexing	  and	  centrifugation	  at	  14000	  rpm	  for	  15	  minutes.	  The	  upper	  
phase	   was	   removed	   and	   transferred	   to	   a	   new	   tube	   with	   an	   equal	   volume	   of	  
chloroform,	  which	  was	  again	  vortexed	  and	  centrifuged	  at	  14000	  rpm	  for	  15	  minutes.	  
After	  transfer	  of	  the	  upper	  phase	  to	  a	  new	  tube,	  an	  equal	  volume	  of	  isopropanol	  was	  
added	   to	   precipitate	   the	   RNA.	   The	   mixture	   was	   stored	   at	   -­‐20oC	   for	   1	   hour,	   then	  
centrifuged	  at	  14000	  rpm	  for	  15	  minutes	  at	  4oC	  to	  pellet	  the	  RNA.	  The	  pellet	  was	  re-­‐
suspended	   in	   20	   μl	   sterile	   RNAse	   free	   water	   and	   stored	   at	   -­‐80oC.	   The	   RNA	  
concentration	  was	  quantified	  by	  gel	  electrophoresis	  and	  the	  appropriate	  volume	  was	  




2.7	  Human	  neutrophil	  techniques	  
	  
For	  the	  in	  vitro	  experiments	  described	  in	  this	  thesis,	  human	  neutrophils	  were	  acquired	  
following	  a	  preparation	  method	  performed	  by	  other	  members	  of	   the	   research	   team.	  
Neutrophils	   were	   isolated	   from	   peripheral	   venous	   blood	   donated	   by	   healthy	  
volunteers,	   under	   the	   approval	   of	   the	   South	   Sheffield	   Research	   Ethics	   Committee	  
(reference	  number:	  STH13927).	  At	  one	  tenth	  of	  the	  total	  blood	  volume,	  3.8%	  sodium	  
citrate	  (Martindale	  Pharmaceuticals,	  Essex,	  UK)	  was	  added	  to	  avoid	  coagulation,	  prior	  
to	   centrifugation	   at	   350	   x	   g	   for	   20	  minutes	   at	   20°C.	   This	   allowed	   separation	   of	   the	  
more	   dense	   blood	   cells	   from	   the	   platelet-­‐rich	   plasma	   (PRP),	   which	   was	   further	  
centrifuged	  at	  800	  x	  g	  for	  20	  minutes	  at	  20°C	  to	  pellet	  the	  platelets	  and	  form	  the	  upper	  
platelet-­‐poor	  plasma	  (PPP).	  The	  lower	  blood	  cell	  phase	  was	  made	  up	  to	  a	  total	  volume	  
of	   50	   ml	   by	   adding	   6	   ml	   of	   6%	   dextran	   and	   0.9%	   saline	   solution.	   Following	   gentle	  
mixing,	   this	  was	  allowed	   to	  sediment	   for	  20-­‐30	  minutes	   to	   separate	   the	  more	  dense	  
	  70	  
erythrocytes	   from	   the	   white	   blood	   cells.	   These	   formed	   an	   upper	   layer,	   which	   was	  
removed	  and	  centrifuged	  at	  320	  x	  g	   for	  6	  minutes	  at	  20°C.	  At	   this	  point,	  neutrophils	  
were	   separated	   from	  other	  white	  blood	   cells	   using	  either	   the	  Percoll®	  or	  Optiprep™	  
method	  of	  separation.	  There	  are	  no	  reported	  differences	  in	  constitutive	  apoptosis	  rate	  
or	   Mcl-­‐1	   regulation	   between	   neutrophils	   separated	   by	   either	   of	   these	   methods	  
(Wardle	  et	  al.,	  2011).	  
2.7.1	  Percoll®	  method	  of	  cell	  separation	  
A	   90%	   Percoll®	   solution	   was	   prepared	   with	   10%	   saline.	   This	   was	   used	   to	   make	   a	  
plasma-­‐Percoll®	  gradient,	  with	  the	  lower	  phase	  consisting	  of	  0.98	  ml	  90%	  Percoll®	  and	  
1.02	  ml	  PPP	  and	  an	  upper	  phase	  of	  0.84	  ml	  90%	  Percoll®	  and	  1.16	  ml	  PPP.	  Following	  
re-­‐suspension	   in	   2	   ml	   of	   PPP,	   the	   cell	   pellet	   was	   layered	   over	   the	   gradient	   and	  
centrifugation	  was	  performed	  at	  350	  x	  g	  for	  11	  minutes	  at	  20°C.	  This	  resulted	  in	  three	  
separate	   cell	   layers,	   with	   erythrocytes	   in	   the	   lowest	   phase,	   a	   layer	   of	   granulocytes	  
above	   this	  and	  an	  upper	   layer	  of	  PBMCs.	  A	  Pasteur	  pipette	  was	  used	   to	   remove	   the	  
PBMCs	   and	   neutrophils,	   which	   were	   counted	   using	   a	   haemocytometer.	   Neutrophils	  
were	  pelleted	  by	  centrifugation	  at	  320	  x	  g	  for	  6	  minutes	  at	  20°C,	  then	  re-­‐suspended	  at	  
a	  concentration	  of	  5	  x	  106	  neutrophils	  per	  ml	  in	  RPMI	  media	  with	  100	  U/ml	  penicillin,	  
100	  g/ml	  streptomycin	  (Life	  Technologies,	  Paisley,	  UK)	  and	  10%	  foetal	  calf	  serum	  (FCS)	  
(Invitrogen).	  
2.7.2	  OptiprepTM	  method	  of	  cell	  separation	  
The	  white	  blood	  cell	  pellet	  was	  re-­‐suspended	  in	  a	  solution	  of	  2	  ml	  Hank’s	  balanced	  salt	  
solution	   (HBSS;	   Invitrogen)	  with	  20%	  PPP	  and	  without	  Ca2+	  or	  Mg2+.	  Another	  6	  ml	  of	  
HBSS	   with	   20%	   PPP	   was	   added,	   followed	   by	   4	   ml	   of	   OptiPrep™	   (Axis-­‐Shield,	  
Huntingdon,	  UK).	  An	  OptiPrep™	  gradient	  was	  pipetted	  over	  this,	  firstly	  the	  1080	  layer	  
consisting	  of	  10.435	  ml	  HBSS	  with	  20%	  PPP	  and	  3	  ml	  OptiPrep™,	  followed	  by	  the	  1095	  
layer,	  consisting	  of	  8.036	  ml	  HBSS	  with	  20%	  PPP	  and	  3	  ml	  OptiPrep™.	  	  A	  further	  10	  ml	  
of	  HBSS	  with	  20%	  PPP	  was	  added	  prior	  to	  centrifugation	  of	  the	  gradient	  at	  1978	  x	  g	  for	  
30	  minutes	  at	  20°C.	  This	  resulted	  in	  three	  separate	  cell	  layers,	  with	  erythrocytes	  in	  the	  
lowest	  phase	  below	  the	  1095,	  a	  neutrophil	  layer	  between	  1095	  and	  1080	  and	  an	  upper	  
layer	  of	  PBMCs	  above	  the	  1080.	  A	  Pasteur	  pipette	  was	  used	  to	  remove	  the	  PBMCs	  and	  




by	   centrifugation	   at	   320	   x	   g	   for	   6	   minutes	   at	   20°C,	   then	   re-­‐suspended	   at	   a	  
concentration	  of	  5	   x	  106	  neutrophils	  per	  ml	   in	  RPMI	  media	  with	  100	  U/ml	  penicillin,	  
100	  g/ml	  streptomycin	  and	  10%	  FCS.	  
2.7.3	  Human	  neutrophil	  culture	  
For	  all	  experiments,	  preparation	  and	  compound	  treatment	  was	  performed	  in	  a	  Class	  II	  
Biosafety	   cabinet.	  Neutrophils	  were	   cultured	  at	   125	  µl	   per	  well	   in	   96-­‐well	   ‘Flexiwell’	  
plates	  (BD	  Falcon,	  Oxford,	  UK	  or	  Costar,	  High	  Wycombe,	  UK),	  ensuring	  that	  compounds	  
were	   added	   in	   minimal	   volume	   to	   avoid	   disruption	   of	   the	   final	   neutrophil	  
concentration.	   	   Unless	   stated	   otherwise,	   neutrophils	   were	   treated	   in	   duplicate,	   to	  
result	  in	  a	  total	  volume	  of	  250	  µl	  per	  condition.	  Neutrophils	  were	  cultured	  in	  a	  water-­‐
jacketed	   tissue	   culture	   incubator	   (Sanyo,	   Loughborough,	  UK)	   at	  37°C	  and	  5%	  CO2.	   In	  
experiments	   performed	   to	   investigate	   neutrophil	   survival	   signalling,	   GM-­‐CSF	  
(PeproTech,	  London,	  UK)	  was	  used	  at	  1:400.	  
2.7.4	  Measurement	  of	  neutrophil	  apoptosis	  by	  cytospin	  analysis	  
Neutrophil	   apoptosis	   was	   assessed	   at	   the	   time	   points	   indicated	   for	   each	   individual	  
experiment	   and	   in	   all	   cases	   two	   cytospins	   were	   taken	   per	   treatment.	   Using	   a	  
cytocentrifuge	   (Shandon	   Cytospin	   3,	   Thermo	   Scientific),	   100	   µl	   of	   neutrophil	  
suspension	  was	  centrifuged	  onto	  a	  glass	  microscope	  slide	  at	  300	  rpm	  for	  3	  minutes	  at	  
room	  temperature.	  The	  neutrophils	  were	  fixed	  using	  a	  small	  volume	  of	  100%	  MeOH.	  
Slides	   were	   immersed	   in	   Reastain	   Quick-­‐Diff	   Red	   (Gentaur,	   London,	   UK)	   to	   stain	  
cytoplasmic	  material,	   followed	  by	  Reastain	  Quick-­‐Diff	  Blue	   (Gentaur)	   to	  stain	  nuclear	  
material.	  Cells	  were	  covered	  with	  a	  glass	  coverslip	  (Menzel-­‐Gläser),	  attached	  using	  DPX	  
mounting	  medium	  (Fisher	  Scientific).	  	  
	  
To	  measure	  apoptosis,	  neutrophils	  were	  counted	  on	  a	  Zeiss	  Axioplan	  microscope	  (Carl	  
Zeiss	  Ltd.,	  Cambridge,	  UK)	  with	  a	  100	  x	  oil	  immersion	  lens	  and	  using	  a	  Microsoft	  Excel	  
macro	   designed	   to	   calculate	   percentage	   apoptosis.	   Neutrophils	   were	   allocated	   as	  
apoptotic	   or	   non-­‐apoptotic	   based	   on	   morphology,	   taking	   into	   account	   nuclear	  
condensation	   and	   cell	   shrinkage.	   A	   total	   of	   600	   neutrophils	   were	   counted	   per	  
condition,	   with	   300	   from	   each	   cytospin,	   and	   the	   percentage	   of	   apoptotic	   cells	   was	  
recorded.	   Counting	   was	   always	   performed	   blind	   to	   the	   experimental	   conditions.	   To	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assess	  the	  purity	  of	  the	  neutrophil	  preparation,	  a	  total	  of	  600	  cells	  were	  counted	  from	  
an	  untreated	  sample	  slide,	  including	  neutrophils,	  eosinophils	  and	  PBMCs.	  	  	  
2.7.5	  Flow	  cytometry	  
To	   look	   at	   the	   cell	   surface	  expression	   levels	   of	   various	   chemokine	   receptors,	   human	  
neutrophils	  were	   separated	   by	   the	   Percoll®	  method	  of	   separation,	   as	   described.	   For	  
each	   condition,	   100	   µl	   of	   neutrophil	   suspension	   at	   a	   concentration	   of	   5	   x	   106	  
neutrophils	  per	  ml	   in	  RPMI	  media	  was	   transferred	   to	  a	  1.5	  ml	   tube,	   followed	  by	   the	  
addition	  of	  100	  µl	  FACS	  buffer	  1	  (Appendix	  2).	  After	  centrifugation	  at	  2000	  rpm	  for	  2	  
minutes	  at	  4°C,	  the	  supernatant	  was	  removed	  and	  the	  cell	  pellet	  was	  re-­‐suspended	  in	  
the	   appropriate	   volume	   of	   FACS	   buffer	   1,	   such	   that	   the	   appropriate	   volume	   of	  
fluorescent-­‐conjugated	  antibody	  or	   isotype	  control	   could	  be	  added	   to	   result	   in	  a	  1:5	  
dilution.	  Unstained	  cells	  and	  the	  appropriate	  isotype	  controls	  were	  used	  at	  all	  times,	  to	  
account	   for	  any	  non-­‐specific	  binding.	  The	   tubes	  were	  wrapped	   in	  aluminium	  foil	  and	  
incubated	   for	   30	  minutes	   at	   4°C.	   This	   was	   followed	   by	   the	   addition	   of	   300	   µl	   FACS	  
buffer	  1,	   centrifugation	  at	  2000	   rpm	  for	  2	  minutes	  at	  4°C,	   then	   re-­‐suspension	  of	   the	  
pellet	  in	  300	  µl	  of	  FACS	  buffer	  1.	  The	  cell	  suspension	  was	  kept	  on	  ice	  at	  all	  times,	  unless	  
the	   samples	   could	   not	   be	   analysed	   immediately,	   in	   which	   case	   the	   cells	   were	   re-­‐
suspended	   in	  BD	  CellFIXTM	   (BD	  Biosciences,	  Oxford,	  UK).	  Analysis	  was	   always	   carried	  
out	  within	  the	  next	  24	  hours.	  
	  
Samples	  were	   analysed	   using	   a	   FACSCalibur	   flow	   cytometer	   (BD	   Biosciences),	   in	   the	  
Flow	   Cytometry	   Core	   Facility	   at	   the	   University	   of	   Sheffield	   Medical	   School.	   This	  
measured	  cell	  size	  using	  the	  Forward	  Scatter	  Channel	  (FSC)	  and	  granularity	  on	  the	  Side	  
Scatter	  Channel	  (SSC),	  capturing	  10,000	  events	  for	  each	  sample	  to	  generate	  a	  scatter	  
plot.	   Fluorescence	   associated	   with	   the	   cells	   was	   measured	   by	   the	   appropriate	  
Fluorescence	  channel	  (FL-­‐1	  for	  FITC-­‐conjugated	  antibodies	  and	  FL-­‐2	  for	  PE-­‐conjugated	  
antibodies).	   Data	  were	   analysed	   using	   FlowJo	   (TreeStar	   Inc.,	   OR,	   USA).	   A	   neutrophil	  
gate	   was	   applied	   to	   the	   scatter	   plot	   generated	   by	   the	   unstained	   control	   sample	   to	  
enable	   identification	   of	   the	   neutrophil	   population.	   The	   same	   gating	   was	   applied	   to	  
each	  subsequent	  sample,	  but	  adjusted	  if	  necessary	  to	  ensure	  that	  all	  neutrophils	  were	  




gated	  neutrophils	  in	  each	  FL	  channel	  and	  the	  mean	  fluorescence	  values	  were	  used	  to	  
compare	  cell	  surface	  receptor	  expression	  between	  samples.	  
	  
In	   experiments	   performed	   to	   investigate	   the	   effect	   of	   tanshinone	   IIA	   on	   cell	   surface	  
receptor	   expression,	   neutrophils	  were	   pre-­‐treated	  with	   either	   tanshinone	   IIA	   or	   the	  
appropriate	  DMSO	  vehicle	  control	  for	  2	  hours,	  prior	  to	  the	  flow	  cytometry	  protocol	  as	  
described	   above.	   At	   the	   appropriate	   time	   point,	   cytospins	   were	   acquired	   for	   each	  
condition,	  as	  previously	  described.	  
2.7.6	  Chemokine	  receptor	  internalisation	  assay	  
To	  investigate	  chemokine	  receptor	  internalisation,	  human	  neutrophils	  were	  separated	  
by	   the	   Percoll®	  method	   of	   separation,	   as	   described,	   and	   re-­‐suspended	   in	  HBSS	  with	  
0.25%	   BSA	   and	   10	   mM	   HEPES	   (FACS	   buffer	   2;	   Appendix	   2),	   such	   that	   5	   x	   105	  
neutrophils	  could	  be	  added	  to	  1.5	  ml	   tubes	   for	  each	  condition,	   in	  a	  volume	  of	  75	  µl.	  
The	   appropriate	   concentration	   of	   chemokine	   receptor	   ligand	  was	   added	   in	   25	   µl	   to	  
result	   in	   the	   correct	   final	   concentration,	   as	   indicated.	   Recombinant	   Human	   IL-­‐8	  
(PeproTech)	   was	   used	   to	   investigate	   CXCR1	   and	   CXCR2	   internalisation	   and	  
recombinant	  Human	  SDF-­‐1α	  (PeproTech)	  for	  CXCR4	  internalisation.	  For	  each	  antibody	  
and	   isotype,	   a	   control	   sample	   was	   stored	   on	   ice	   immediately	   to	   measure	   basal	  
expression	   levels	   before	   ligand	   stimulation.	   All	   other	   cells	   were	   incubated	   for	   30	  
minutes	   at	   37°C	   and	   then	   cooled	   rapidly	   by	   adding	   1	  ml	   of	   cold	   FACS	   buffer	   2	   and	  
transferring	   tubes	   to	   an	   ice-­‐water	   bath.	   Cells	   were	   centrifuged	   at	   2000	   rpm	   for	   2	  
minutes	   at	   4°C,	  washed	  with	   1	  ml	   FACS	  buffer	   2,	   re-­‐spun,	   then	   re-­‐suspended	   in	   the	  
appropriate	   volume	   of	   FACS	   buffer	   2	   for	   antibody	   staining	   as	   described	   in	   section	  
2.7.5.	  Samples	  were	  analysed	  using	  the	  FACSCalibur	  flow	  cytometer,	  as	  described,	  and	  
chemokine	   receptor	   internalisation	   was	   measured	   by	   calculating	   the	   mean	  
fluorescence	  of	  each	  sample	  as	  a	  percentage	  of	  the	  appropriate	  basal	  fluorescence.	  
	  
To	   explore	   the	   effects	   of	   tanshinone	   IIA	   on	   chemokine	   receptor	   internalisation,	  
neutrophils	  were	  exposed	  to	  tanshinone	  IIA	  or	  the	  appropriate	  DMSO	  vehicle	  control	  
in	  combination	  with	  the	  receptor	  ligand.	  In	  some	  cases,	  as	  indicated,	  neutrophils	  were	  
pre-­‐treated	  with	  either	  tanshinone	  IIA	  or	  DMSO	  for	  2	  hours,	  then	  centrifuged	  at	  2000	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rpm	  for	  2	  minutes	  at	  4°C,	  followed	  by	  re-­‐suspension	  in	  FACS	  buffer	  2	  as	  described	  at	  
the	  beginning	  of	  the	  protocol.	  	  
2.7.7	  Chemokine	  receptor	  recycling	  assay	  
The	   receptor	   internalisation	   assay	  was	  performed	  as	  described	  above,	   but	  more	   cell	  
samples	  were	  included	  to	  measure	  recycling	  of	  the	  receptors	  back	  to	  the	  cell	  surface	  
after	   internalisation.	   Following	   the	   ligand	   stimulation	   step	  as	  described	  above,	   these	  
samples	  were	   centrifuged	  at	  2000	   rpm	   for	  2	  minutes	  at	  4°C	  and	  washed	  extensively	  
with	   FACS	   buffer	   2	   to	   remove	   all	   traces	   of	   the	   ligand.	   Care	  was	   taken	   to	   ensure	   all	  
samples	   were	   kept	   on	   ice	   during	   washing	   steps.	   Cells	   were	   re-­‐suspended	   in	   100	   µl	  
FACS	  buffer	  2	  and	  incubated	  at	  37°C	  to	  permit	  receptor	  recycling.	  At	  the	  appropriate	  
time	   points,	   as	   indicated,	   cells	   were	   transferred	   to	   ice,	   followed	   by	   centrifugation,	  
washing,	  antibody	  staining	  and	  analysis	  as	  described	  previously.	  	  	  
	  
Investigation	  of	   the	  effect	  of	   tanshinone	   IIA	  on	   receptor	   recycling	  was	  performed	  as	  
described	   for	   the	   receptor	   internalisation	   assay.	   In	   all	   subsequent	   washing	   and	  
incubation	   steps,	   the	   required	   concentration	   of	   tanshinone	   IIA	   or	   DMSO	   vehicle	  
control,	  as	  indicated,	  was	  added	  to	  the	  appropriate	  FACS	  buffer	  2,	  to	  ensure	  constant	  
exposure	   of	   cells	   to	   the	   compound.	   At	   the	   appropriate	   time	   point,	   cytospins	   were	  
acquired	  for	  each	  condition,	  as	  previously	  described.	  
	  
	  
2.8	  Statistical	  and	  computational	  analyses	  
	  
2.8.1	  Statistical	  analyses	  
GraphPad	   Prism®	   software	   was	   used	   for	   all	   statistical	   analyses.	   The	   D’Agostino	   and	  
Pearson	  omnibus	  normality	   test	  was	  used	  to	   test	   for	  normal	  distribution	  of	   samples.	  
For	  comparisons	  between	  two	  groups,	  an	  unpaired	  two-­‐tailed	  t-­‐test	  was	  used,	  and	  the	  
variances	   were	   compared	   using	   an	   F	   test.	   For	   simultaneous	   comparisons	   between	  
multiple	  groups,	  a	  one-­‐way	  or	  two-­‐way	  ANOVA	  was	  used	  alongside	  either	  Dunnett’s	  or	  
Bonferroni’s	   multiple	   comparison	   post-­‐test,	   as	   indicated.	   Bartlett’s	   test	   for	   equal	  




non-­‐linear	   regression	  and	   IC50	   values	  were	   calculated.	   For	   reverse	  migration	  assays,	  
analysis	   was	   performed	   using	   either	   linear	   regression	   to	   compare	   the	   difference	  
between	   slopes	  or	  non-­‐linear	   regression	   to	   compare	   the	  difference	  between	   curves,	  
depending	  on	  which	  best	  fitted	  the	  data.	  On	  all	  figures,	  where	  *	  p	  <	  0.05,	  where	  **	  p	  <	  
0.01	  and	  where	  ***	  p	  <	  0.001.	  
2.8.2	  Computational	  clustering	  
For	   recruitment	   and	   resolution	   assays,	   data	   were	   normalised	   by	   expressing	   as	   a	  
percentage	   of	   the	   effect	   of	   the	   positive	   control.	   For	   total	   neutrophil	   number	  
experiments,	  data	  were	  expressed	  as	  the	  percentage	  change	  from	  the	  vehicle	  control.	  
Hierarchical	  cluster	  analysis	  was	  performed	  using	  Cluster	  3.0	  (developed	  by	  Michiel	  de	  
Hoon),	  with	  Pearson	  un-­‐centred	  correlation	  and	  an	  average	  linkage	  clustering	  method.	  
Results	  generated	  were	  displayed	  using	  Java	  TreeView	  (developed	  by	  Alok	  Saldanha).	  
Both	  programs	  were	  downloaded	  from	  http://www.eisenlab.org/eisen/?page_id=4.	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Neutrophil-­‐dominated	   inflammatory	   diseases	   respond	   poorly	   to	   current	   treatments.	  	  
The	  development	  of	  more	  effective	  therapies	  is	  required,	  particularly	  of	  those	  that	  can	  
specifically	  target	  the	  signalling	  pathways	  regulating	  neutrophil	  clearance.	  Mechanisms	  
involved	  in	  the	  resolution	  of	  inflammation	  remain	  to	  be	  fully	  defined	  and	  broadening	  
our	   understanding	   of	   this	   complex	   process	   is	   required,	   such	   that	   we	   can	  
therapeutically	   promote	   resolution	   via	   endogenous	   pathways	   and	   avoid	   unwanted	  
side	   effects.	   Considering	   the	   size	   of	   chemical	   space,	   it	   seems	   likely	   that	   compounds	  
must	  exist	  with	  the	  correct	  conformational	  structures	  to	  allow	  efficient	  binding	  to	  key	  
targets,	   to	   give	   a	   functional	   and	   desirable	   response.	   However,	   without	   a	   complete	  
knowledge	  of	  the	  precise	  cellular	  components	  and	  biochemical	  mediators	  involved,	  it	  
is	   not	   possible	   to	   employ	   target-­‐based	   approaches	   to	   pro-­‐resolution	   drug	   discovery.	  
Phenotype-­‐based	  assays	  might	   yield	   results	   that	   can	  be	  more	   readily	   translated	   into	  
clinical	  practice	  and	  new	  methods	  to	  screen	  large	  numbers	  of	  compounds	  rapidly	  and	  
robustly	  are	  required.	  	  
	  
In	  recent	  years,	  the	  zebrafish	  has	  emerged	  as	  a	  powerful	  model	  system.	  With	  the	  ease	  
of	   genetic	   and	   pharmacological	   manipulation,	   along	   with	   its	   rapid	   generation	   time,	  
small	  size	  and	  embryo	  transparency,	  it	  is	  an	  ideal	  model	  for	  high-­‐throughput	  screening.	  
Already	  there	  are	  multiple	  screening	  success	  stories,	  reflective	  of	  its	  value	  (North	  et	  al.,	  
2007;	  Cao	  et	  al.,	  2009;	  Tan	  et	  al.,	  2011;	  Cusick	  et	  al.,	  2012;	  Namdaran	  et	  al.,	  2012;	  Choi	  
et	  al.,	  2013).	  The	  Tg(mpx:GFP)i114	  zebrafish	  line,	  subsequently	  referred	  to	  as	  mpx:GFP,	  
provides	  a	  model	  for	  studying	  neutrophilic	  inflammation	  and	  enables	  the	  visualisation	  
and	  tracking	  of	  green-­‐fluorescent	  neutrophils	   in	  vivo	   (Renshaw	  et	  al.,	  2006).	   Injury	  to	  
the	  zebrafish	  tail	  fin	  initiates	  an	  acute	  inflammatory	  response,	  which	  is	  quantifiable	  by	  
counting	  the	  number	  of	  neutrophils	  present	  at	  the	  injury	  site	  at	  various	  experimental	  
time	   points.	   This	   response	   spontaneously	   resolves	   with	   kinetics	   comparable	   to	  




pharmacological	   manipulation	   and	   their	   post-­‐injury	   exposure	   to	   chemical	   agents	  
known	   to	   either	   inhibit	   or	   induce	   neutrophil	   apoptosis	   causes	   either	   a	   delay	   or	  
acceleration	   in	   inflammation	   resolution,	   respectively	   (Loynes	   et	   al.,	   2009).	   Based	   on	  
this	  experimental	  evidence,	  it	  was	  hypothesised	  that	  the	  mpx:GFP	  zebrafish	  would	  be	  
a	  suitable	  model	  for	  high-­‐throughput	  phenotype-­‐based	  drug	  discovery.	  
3.1.1	  A	  preliminary	  screen	  for	  accelerators	  of	  inflammation	  resolution	  
During	  my	   time	  as	  an	  undergraduate	   summer	   student	   in	  Dr.	  Renshaw’s	   laboratory,	   I	  
performed	   a	   preliminary	   drug	   screen	   to	   identify	   novel	   accelerators	   of	   inflammation	  
resolution	  using	   the	  mpx:GFP	  zebrafish	  model	   (Loynes	  et	  al.,	  2009).	   Larvae	  at	  3	  days	  
post	   fertilisation	  (dpf)	  were	   injured	  by	  complete	  transection	  of	  the	  tail	   fin,	   to	   initiate	  
an	   inflammatory	   response	   involving	   recruitment	   of	   neutrophils	   expressing	   green-­‐
fluorescent	  protein	  (GFP)	  to	  the	  site	  of	  injury.	  By	  4	  hours	  post	  injury	  (hpi),	  the	  number	  
of	   neutrophils	   present	   at	   the	   site	   of	   injury	   approaches	   the	   expected	   peak	   value	  
(Renshaw	  et	  al.,	  2006).	  At	  this	  time	  point,	  larvae	  with	  high	  numbers	  of	  neutrophils	  at	  
the	   site	  of	   injury	  were	   selected	   for	   treatment	  with	   chemical	   compounds.	  During	   the	  
resolution	   phase,	   at	   a	   time	   point	   relative	   to	   12	   hpi,	   numbers	   of	   neutrophils	   at	   the	  
wound	  were	  manually	   counted	  by	  eye.	   This	   enabled	   identification	  of	   any	   compound	  
treated	  larvae	  that	  appeared	  to	  have	  considerably	  fewer	  neutrophils	  remaining	  at	  the	  
site	   of	   injury	   compared	   to	   the	   vehicle	   controls.	   Compounds	   causing	   a	   reduction	   in	  
neutrophil	   number	   were	   subsequently	   defined	   as	   positive	   hits,	   or	   assay	   positive	  
compounds.	  
	  
A	  total	  of	  960	  compounds	  were	  screened,	  79	  of	  which	  were	  identified	  as	  positive	  hits	  
on	   initial	   testing.	   For	   validation,	   all	   positive	   hits	  were	   rescreened	   and	   8	   compounds	  
were	   found	   to	   have	   reproducible	   effects,	   including	   the	   known	   anti-­‐inflammatory	  
flumethasone	   (Loynes	   et	   al.,	   2009).	   This	   preliminary	   screen	   provided	   encouraging	  
evidence	  that	  by	  using	  simple	  experimental	  techniques,	  the	  mpx:GFP	  zebrafish	  model	  
could	  be	  used	  to	  identify	  compounds	  with	  anti-­‐inflammatory	  properties.	  	  
3.1.2	  Aims	  and	  hypotheses	  
The	  aims	  of	  this	  chapter	  are	  to	  design	  and	  optimise	  a	  high-­‐throughput	  screening	  assay	  
using	   the	   mpx:GFP	   zebrafish	   model,	   based	   on	   the	   preliminary	   screening	   work	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previously	  published	  (Loynes	  et	  al.,	  2009).	  I	  hypothesised	  that	  this	  unbiased	  screening	  
approach	  will	   lead	  to	   the	  discovery	  of	  novel	  compounds	  that	  can	  drive	   inflammation	  
resolution.	  I	  also	  hypothesised	  that	  the	  compounds	  identified	  might	  have	  the	  potential	  
to	  uncover	  currently	  unknown	  signalling	  mechanisms	  involved	  in	  neutrophil	  clearance	  
from	  sites	  of	  inflammation.	  
	  
	  
3.2	  Design	  and	  optimisation	  of	  a	  high-­‐throughput	  screening	  assay	  in	  zebrafish	  
to	  identify	  novel	  accelerators	  of	  inflammation	  resolution	  
	  
Despite	  being	   reasonably	  high-­‐throughput,	  with	  960	  compounds	  being	  screened	   in	  8	  
weeks,	  the	  preliminary	  screening	  protocol	  described	  above	  was	  certainly	  not	  without	  
its	   limitations.	   There	   were	   a	   number	   of	   ways	   in	   which	   the	   techniques	   could	   be	  
improved	   to	   develop	   a	   robust	   and	   reliable	   assay	   with	   therapeutic	   potential.	   The	  
percentage	  of	  compounds	  that	  were	   identified	  as	  positive	   in	  the	   initial	  screen	  (8.2%)	  
was	   almost	   ten-­‐fold	   higher	   than	   the	   percentage	   in	   which	   the	   effect	   could	   be	  
reproduced	   (0.83%),	   suggesting	   that	   the	   rate	   of	   detection	   of	   ‘false	   positives’	   was	  
reasonably	   high.	   It	   was	   apparent	   that	   multiple	   variables	   needed	   to	   be	   considered	  
when	   designing	   and	   optimising	   the	   screening	   assay	   to	   ensure	   its	   function	   and	  
reliability.	   In	  order	   to	   increase	   the	   throughput	  of	   the	  screening	  assay	  and	  determine	  
the	  optimum	  conditions,	  a	  number	  of	  experimental	   factors	  were	   taken	   into	  account.	  
Amongst	   others,	   these	   included	   age	   of	   the	   larvae,	   the	   optimum	   time	   points	   for	  
compound	  treatment	  and	  identification	  of	  assay	  positives,	  incubation	  temperature	  and	  
suitable	  positive	  control	  compounds.	  
3.2.1	  Characterisation	  of	  the	  Tg(mpx:GFP)i114	  zebrafish	  model	  
Initially,	  a	  series	  of	  experiments	  were	  carried	  out	  to	  determine	  whether	  the	  mpx:GFP	  
zebrafish	   was	   a	   suitable	   model	   for	   high-­‐throughput	   drug	   screening.	   Furthermore,	   I	  
wished	   to	   test	  whether	   the	  number	  of	  neutrophils	   participating	   in	   the	   inflammatory	  
response	   could	   be	   statistically	   analysed	   using	   standard	   parametric	   methods.	   For	  
parametric	  analyses	  to	  be	  appropriate,	  data	  should	  be	  drawn	  from	  a	  population	  with	  





I	   first	   performed	   a	   simple	   time	   course	   experiment	   to	   characterise	   the	   inflammatory	  
response	   in	   zebrafish	   larvae	   following	   tail	   fin	   transection.	   At	   3	   dpf,	  mpx:GFP	   larvae	  
were	  injured	  and	  the	  number	  of	  neutrophils	  present	  at	  the	  site	  of	  injury	  were	  recorded	  
at	  time	  intervals	  of	  2,	  4,	  6,	  8,	  12	  and	  24	  hpi	  (Figure	  3.1).	  This	  revealed	  that	  neutrophils	  
were	  recruited	  to	  the	  wound	  within	  2	  hours	  and	  this	  phase	  of	  recruitment	  continued	  
until	   around	   6	   hpi,	   when	   the	   peak	   number	   of	   neutrophils	  was	   reached.	   From	   6	   hpi	  
onwards,	   neutrophil	   number	   declined,	   characteristic	   of	   the	   resolution	   phase	   of	  
inflammation.	  By	  24	  hpi,	  neutrophil	  numbers	  had	  almost	  returned	  to	  basal	  levels.	  This	  
timely	  and	  spontaneous	  resolution	  of	  the	  inflammatory	  response	  was	  in	  keeping	  with	  
published	  data,	  occurring	  with	  comparable	  kinetics	   to	  mammalian	  systems	  (Renshaw	  
et	  al.,	  2006).	  
	  
Next,	   experiments	   were	   performed	   in	   order	   to	   determine	   some	   of	   the	   optimum	  
conditions	  for	  the	  screening	  assay.	  I	  also	  wished	  to	  test	  for	  normal	  distribution	  in	  the	  
number	   of	   neutrophils	   participating	   in	   the	   inflammatory	   response	   at	   certain	  
experimental	   time	   points.	   The	   initial	   variable	   considered	   was	   larval	   age.	   For	   these	  
experiments,	  mpx:GFP	  embryos	  were	  obtained	  by	  marble	   tank	  mating	   and	   raised	   to	  
either	  2	  or	  3	  dpf.	   Larvae	  were	   injured	  and	   the	  numbers	  of	  neutrophils	  at	   the	   site	  of	  
injury	  were	  counted	  in	  randomly	  selected	  populations	  of	  larvae	  at	  both	  6	  hpi,	  the	  peak	  
of	   inflammation,	   and	   at	   12	   hpi.	   These	   time	   points	   were	   chosen	   based	   on	   the	   data	  
obtained	  in	  Figure	  3.1	  and	  from	  the	  preliminary	  screen	  (Loynes	  et	  al.,	  2009),	  in	  which	  a	  
time	   point	   of	   12	   hpi	   was	   used	   to	   identify	   assay	   positive	   compounds.	   At	   12	   hpi,	  
neutrophil	  numbers	  in	  control,	  untreated	  larvae	  remain	  relatively	  high,	  but	  numbers	  in	  
larvae	  incubated	  with	  potential	  pro-­‐resolving	  compounds	  are	  likely	  to	  be	  considerably	  
lower.	  
	  
Neutrophil	  numbers	  at	  the	  wound	  were	  normally	  distributed	  in	  both	  2	  dpf	  (Figure	  3.2	  
A,	  B)	  and	  3	  dpf	  larvae	  (Figure	  3.2	  C,	  D)	  obtained	  by	  marble	  tank	  mating,	  at	  both	  time	  
points	   tested.	   Larvae	   at	   4	   dpf	   were	   not	   included	   in	   these	   experiments,	   as	   due	   to	  
development	   of	   the	   swim	   bladder	   they	   are	   buoyant	   and	   difficult	   to	   manipulate,	  















Figure	   3.1:	   The	   inflammatory	   response	   in	   mpx:GFP	   larvae	   spontaneously	   resolves	  
over	  time.	  
Tail	   transection	  was	  performed	  on	  mpx:GFP	   larvae	  at	  3	  dpf.	  The	  numbers	  of	  neutrophils	  at	  the	  site	  of	  
injury	  were	  counted	  at	  2,	  4,	  6,	  8,	  12	  and	  24	  hpi.	  Neutrophil	  number	  at	  the	  wound	  increases	  up	  to	  6	  hpi	  
then	  begins	  to	  decline.	  Neutrophilic	  inflammation	  appears	  to	  resolve	  from	  approximately	  24	  hpi	  (n	  =	  72;	  


















































Figure	  3.2:	  Neutrophil	  numbers	  at	  the	  site	  of	  injury	  are	  normally	  distributed	  at	  6	  and	  
12	  hours	  post	  injury.	  
(A,	  B)	  2	  dpf;	  (C,	  D)	  3	  dpf	  marbled;	  (E,	  F)	  3	  dpf	  paired;	  and	  (G,	  H)	  3	  dpf	  incubated	  at	  18°C	  mpx:GFP	  larvae	  
were	   injured	   and	   the	   numbers	   of	   neutrophils	   at	   the	   site	   of	   injury	   were	   counted	   at	   6	   and	   12	   hpi.	  
Frequency	  distributions	  in	  terms	  of	  the	  number	  of	  fish	  with	  a	  neutrophil	  number	  within	  each	  bin	  (width	  
=	   5)	   are	   represented	   in	   histograms.	  All	   data	  were	   consistent	  with	   a	   normal	   distribution	   (D’Agostino	   -­‐	  
Pearson	  omnibus	  K2	  normality	  test;	  where	  P	  <	  0.05	  represents	  a	  non-­‐Gaussian	  distribution;	  n	  =	  74	  for	  all	  
groups,	  performed	  on	  3	  independent	  occasions).	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It	  was	  clear	  that	  the	  neutrophil	  numbers	  in	  2	  dpf	  larvae	  were	  much	  lower	  than	  in	  3	  dpf	  
larvae	  and	  there	  was	  a	  significant	  difference	  in	  variance	  between	  these	  groups	  at	  both	  
time	  points	  (Bartlett’s	  test	  for	  equal	  variances;	  P	  <	  0.0001).	  As	  12	  hpi	  was	  the	  selected	  
time	   point	   at	   which	   to	   screen	   and	   identify	   compounds	   that	   can	   reduce	   neutrophil	  
numbers,	  it	  was	  essential	  to	  have	  a	  reasonably	  high	  number	  of	  neutrophils	  remaining	  
at	  the	  site	  of	  injury	  in	  control	  larvae,	  such	  that	  positive	  hits	  could	  be	  easily	  and	  reliably	  
detected.	  Neutrophil	  numbers	  were	  already	  comparatively	  low	  in	  2	  dpf	  larvae	  at	  12	  hpi	  
and	  of	  course	  there	  was	  still	  a	  degree	  of	  natural	  variation.	   It	   is	   likely	   that	   this	  would	  
make	   it	   potentially	   more	   difficult	   to	   detect	   any	   true	   effect	   on	   the	   reduction	   in	  
neutrophil	  number	  caused	  by	  pro-­‐resolution	  activity	  in	  compound	  treated	  2	  dpf	  larvae.	  
For	  this	  reason,	  subsequent	  comparisons	  to	  determine	  assay	  conditions	  were	  carried	  
out	  on	  larvae	  at	  3	  dpf	  only.	  
	  
Another	  variable	  to	  consider	  was	  the	  method	  of	  embryo	  generation.	  Larvae	  obtained	  
by	  pair	  mating	  were	  compared	  to	  those	  obtained	  from	  marble	  tank	  mating,	  following	  
the	  same	  experimental	  procedures.	  At	  both	  6	  and	  12	  hpi,	  neutrophil	  numbers	  at	  the	  
wound	   were	   normally	   distributed	   (Figure	   3.2	   E,	   F)	   and	   there	   was	   no	   significant	  
difference	  in	  variance	  compared	  to	  larvae	  obtained	  by	  marble	  tank	  mating	  (Bartlett’s	  
test	  for	  equal	  variances;	  P	  =	  0.5663).	  	  
	  
For	   practical	   reasons,	   the	   preliminary	   screen	   involved	   incubation	   of	   larvae	   at	   18°C	  
(Loynes	  et	  al.,	  2009).	  At	  this	  temperature,	  the	  rate	  of	  larval	  development	  and	  cellular	  
behaviours	   was	   slowed,	   to	   allow	   the	   identification	   of	   assay	   positive	   compounds	   24	  
hours	   after	   injury,	  which	  was	   relative	   to	   12	   hpi	   if	   the	   larvae	   had	   been	   incubated	   at	  
28°C.	   To	   investigate	   the	   effect	   of	   this	   temperature	   adjustment	   on	   variability,	   larvae	  
obtained	  by	  marble	  tank	  mating	  were	  incubated	  at	  18°C	  after	  the	  6	  hpi	  count	  and	  the	  
12	  hpi	  count	  was	  recorded	  after	   the	  appropriate	  number	  of	  hours	   incubation.	  Again,	  
neutrophil	   numbers	   at	   the	   wound	   were	   normally	   distributed	   at	   both	   time	   points	  
(Figure	  3.2	  G,	  H)	  and	  there	  was	  no	  significant	  difference	  in	  variance	  compared	  to	  larvae	  
obtained	   by	   either	  marble	   or	   pair	  mating	   and	   incubated	   at	   28°C	   (Bartlett’s	   test	   for	  




These	   experiments	   indicated	   that	   data	   obtained	   from	   all	   groups	   of	   larvae	   were	  
consistent	  with	  a	  normal	  distribution,	   supporting	   the	  use	  of	   this	   zebrafish	  model	   for	  
screening	  and	  parametric	  statistical	  analysis.	  	  
	  
I	  also	  wished	  to	  directly	  compare	  the	  mean	  number	  of	  neutrophils	  present	  at	  the	  site	  
of	   injury	   in	   all	   groups	   of	   larvae.	   This	   was	   calculated	   using	   the	   same	   data,	   which	  
revealed	  that	  the	  mean	  number	  of	  neutrophils	  at	  the	  wound	  was	  significantly	  lower	  in	  
2	  dpf	   larvae	   compared	   to	  3	  dpf	   larvae	   from	  all	   conditions,	   at	   both	  6	  hpi	   and	  12	  hpi	  
(Figure	  3.3).	  This	  further	  supported	  the	  use	  of	  3	  dpf	  larvae,	  given	  that	  a	  relatively	  high	  
number	  of	  neutrophils	  was	  required	   in	  order	  to	  detect	  assay	  positive	  compounds,	  as	  
discussed	  earlier.	  
	  
As	  the	  number	  of	  neutrophils	  at	  the	  site	  of	  injury	  was	  counted	  in	  individual	  larvae,	  the	  
percentage	  change	  in	  the	  number	  of	  neutrophils	  between	  6	  and	  12	  hpi	  could	  also	  be	  
calculated	   (Figure	   3.4).	   There	   was	   neither	   a	   statistically	   significant	   difference	   in	   the	  
percentage	  change	  between	  any	  of	  the	  3	  dpf	  groups,	  nor	  a	  significant	  difference	  in	  the	  
variance	  (Bartlett’s	  test	  for	  equal	  variances;	  P	  =	  0.5085).	  	  
	  
The	   results	   obtained	   from	   this	   series	   of	   experiments	   indicated	   that	   3	   dpf	   larvae	  
generated	  by	  either	  pair	  or	  marble	  tank	  mating	  would	  be	  suitable	  to	  use	  for	  screening.	  
If	  it	  were	  necessary	  to	  incubate	  larvae	  at	  18°C,	  there	  would	  be	  no	  significant	  effect	  on	  
the	   normal	   acute	   inflammatory	   response.	   However,	   for	   simplicity	   and	   to	   avoid	   any	  
potential	   issues	   with	   compound	   precipitation	   at	   lower	   temperatures,	   I	   chose	   to	  














Figure	   3.3:	   2	   dpf	   larvae	   have	   significantly	   fewer	   neutrophils	   present	   at	   the	   site	   of	  
injury	  compared	  to	  3	  dpf	  larvae	  at	  both	  6	  and	  12	  hours	  post	  injury.	  	  
Larvae	  at	  2	  dpf	  and	  3	  dpf	  were	  injured	  and	  the	  numbers	  of	  neutrophils	  at	  the	  site	  of	  injury	  were	  counted	  
at	   (A)	  6	  and	  (B)	  12	  hpi.	  At	  both	  time	  points,	  the	  mean	  number	  of	  neutrophils	  at	  the	  site	  of	   injury	  was	  
significantly	  lower	  in	  2	  dpf	  larvae,	  compared	  to	  3	  dpf	  larvae	  generated	  by	  either	  pair	  mating	  or	  marble	  
tank	  mating	  and	  3	  dpf	  larvae	  incubated	  at	  18°C	  from	  6	  hpi	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  
comparison	  post-­‐test;	  P	  <	  0.0001;	  n	  =	  74	  for	  all	  groups,	  performed	  on	  3	  independent	  occasions).	  


























































































Figure	  3.4:	  There	  is	  no	  difference	  in	  the	  percentage	  change	  in	  neutrophil	  number	  at	  
the	  site	  of	  injury	  between	  6	  and	  12	  hpi	  in	  paired,	  marbled	  or	  18°C	  incubated	  larvae.	  
At	  3	  dpf,	  larvae	  were	  injured	  and	  the	  numbers	  of	  neutrophils	  at	  the	  site	  of	  injury	  were	  counted	  at	  6	  and	  
12	  hpi.	  The	  percentage	  change	  in	  neutrophil	  number	  between	  the	  two	  time	  points	  was	  calculated.	  No	  
significant	  differences	  were	  found	  in	  the	  percentage	  change	  between	  paired,	  marbled	  or	  18°C	  incubated	  
larvae	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test;	  P	  =	  0.0711;	  n	  =	  74,	  performed	  
on	  3	  independent	  occasions).	  	  

















































3.2.2	  Selection	  of	  larvae	  that	  mount	  a	  substantial	  inflammatory	  response	  to	  injury	  
The	   previous	   data	   illustrate	   that	   there	   is	   a	   high	   level	   of	   natural	   variability	   in	   the	  
number	  of	  neutrophils	  participating	   in	  the	   inflammatory	  response	   in	  untreated	  3	  dpf	  
larvae.	  This	  was	  of	  particular	  concern	  at	  the	  12	  hour	  time	  point,	  when	  variability	  could	  
affect	  the	  reliable	  identification	  of	  positive	  hits	  and	  lead	  to	  an	  increased	  detection	  of	  
false	   positives.	   In	   an	   attempt	   to	   overcome	   this,	   I	   only	   selected	   larvae	   with	  
approximately	  25	  to	  30	  neutrophils	  recruited	  to	  the	  site	  of	  injury	  at	  4	  hpi	  (Figure	  3.5).	  I	  
also	   sought	   to	   ensure	   that	   all	   larvae	  were	   injured	   consistently,	  with	   the	   transection	  
being	  as	  posterior	  as	  possible	  to	  the	  circulatory	  loop	  whilst	  remaining	  within	  the	  break	  
in	  the	  pigment	  line.	  Experiments	  indicated	  that	  following	  this	  strict	  selection	  process,	  
approximately	  20%	  of	  injured	  larvae	  fell	  into	  the	  category	  of	  ‘good	  responders’.	  
3.2.3	  Use	  of	  the	  Phenosight	  High-­‐Content	  screening	  system	  
To	   date,	   most	   zebrafish	   drug	   screens	   use	   at	   least	   partially	   automated	   screening	  
technologies,	  to	  enable	  higher	  throughput	  and	  avoid	  excessive	  manual	  manipulation	  of	  
larvae	   (Peterson	   et	   al.,	   2011;	   Takaki	   et	   al.,	   2012;	   Wittmann	   et	   al.,	   2012).	   In	   an	  
endeavour	   to	   incorporate	   an	   automated	   element	   into	   the	   screening	   process,	   it	   was	  
carried	  out	  using	  a	  prototype	  automated	  plate	   reader	  designed	  by	  Ash	  Biotech.	  This	  
was	  able	  to	  perform	  a	  rapid	  scan	  of	  each	  96-­‐well	  plate,	  capturing	  both	  bright	  field	  and	  
fluorescent	   images	  of	  each	   individual	  well	   in	   just	  7	  minutes	   (Figure	  3.6).	   Fluorescent	  
images	   generated	   were	   of	   adequate	   resolution	   quality	   to	   enable	   positive	   hit	  
identification	   by	   either	   manual	   or	   automated	   analysis	   (described	   later),	   and	   also	  
allowed	   immediate	   recognition	   of	   drug	   toxicity.	   In	   comparison	   to	   the	   preliminary	  
screening	  method,	  using	  the	  automated	  plate	  scanning	  equipment	  was	  more	  efficient	  
than	   manually	   removing	   larvae	   from	   each	   well	   for	   examination	   by	   eye,	   and	   also	  
eliminated	  the	  need	  to	  make	  a	  subjective	  decision	  regarding	  which	  larvae	  appeared	  to	  






















Figure	  3.5:	  Selection	  of	  larvae	  that	  mount	  a	  substantial	  inflammatory	  response	  to	  tail	  
fin	  injury.	  	  
(A)	  mpx:GFP	   larvae	   were	   injured	   consistently,	   as	   posterior	   as	   possible	   to	   the	   circulatory	   loop	   whilst	  
remaining	  within	  the	  break	  in	  the	  pigment	  line,	  as	  indicated	  by	  the	  yellow	  line.	  (B)	  At	  4	  hpi,	  larvae	  were	  
viewed	  under	  a	  fluorescent	  dissecting	  microscope	  and	  only	  those	  with	  approximately	  25-­‐30	  neutrophils	  








Figure	   3.6:	   The	   Phenosight	   High-­‐Content	   screening	   system	   generates	   whole	   well	  
images	  to	  enable	  rapid	  identification	  of	  positive	  hits.	  	  
At	   12	   hpi,	   well	   plates	   were	   scanned	   on	   the	   Phenosight	   plate	   reader	   to	   generate	   bright	   field	   and	  
fluorescent	  images	  of	  each	  individual	  well.	  Compounds	  that	  accelerate	  inflammation	  resolution	  could	  be	  
immediately	  identified,	  for	  example	  in	  (A,	  B)	  DMSO	  control	  larvae	  have	  high	  numbers	  of	  neutrophils	  at	  
the	   site	  of	   injury	   compared	   to	   (C,	  D),	   larvae	   treated	  with	  a	   compound	   that	  has	   caused	  a	   reduction	   in	  
neutrophil	  numbers.	  






3.2.4	  Determination	  of	  n	  number	  
In	  the	  preliminary	  screen,	  each	  compound	  was	  tested	  in	  a	  well	  containing	  3	  larvae.	  In	  
general,	   increasing	   the	   number	   of	   fish	   per	   group	   (n)	   would	   decrease	   the	   inherent	  
variability	   of	   the	   screening	   assay.	   However,	   this	   comes	   at	   the	   price	   of	   potentially	  
reduced	   welfare	   and	   impaired	   imaging	   due	   to	   crowding	   of	   larvae	   in	   the	   wells.	   To	  
establish	   the	   optimum	   number	   of	   larvae	   to	   incubate	   in	   each	   well	   of	   the	   screening	  
plates	  so	  that	  their	  injured	  tail	  fins	  could	  be	  visualised	  for	  analysis,	  a	  test	  plate	  was	  set	  
up	  containing	  12	  wells	  each	  of	  3,	  4	  or	  5	   injured	  mpx:GFP	   larvae.	  At	  12	  hpi,	   the	  plate	  
was	  scanned	  using	  the	  Phenosight	  system,	  and	  the	  images	  generated	  were	  viewed	  to	  
calculate	   the	   number	   of	  wells	   in	  which	   the	   site	   of	   injury	   in	   all	   larvae	   could	   be	   seen	  
clearly,	  without	  obstruction	  by	  other	  overlapping	   larvae	  or	   the	  edges	  of	   the	  well.	  As	  
expected,	   the	   higher	   the	   number	   of	   larvae	   in	   each	   well,	   the	   lower	   the	   percentage	  
frequency	  that	  the	  tails	  of	  all	  larvae	  in	  each	  well	  could	  be	  visualized	  (Figure	  3.7).	  It	  was	  
concluded	   that	   3	   larvae	   per	   well	   was	   optimum	   for	   screening	   using	   the	   Phenosight	  
system,	  and	  as	  an	  additional	  measure	   to	   increase	  robustness	   it	  was	  determined	  that	  
each	  compound	  would	  be	  screened	  on	  2	  independent	  occasions.	  	  
3.2.5	  Development	  of	  a	  novel	  manual	  scoring	  method	  for	  analysis	  
Images	   generated	   by	   the	   automated	   plate	   reader	   were	   initially	   analysed	   using	   a	  
manual	  scoring	  process.	  Scoring	  was	  designed	  such	  that	  each	  well	  containing	  3	  larvae	  
was	   given	   a	   score	  between	  0	   and	  3,	   dependent	  on	   the	  number	  of	   larvae	  within	   the	  
well	   that	   appeared	   to	   have	   a	   reduced	   number	   of	   neutrophils	   at	   the	   site	   of	   injury	  















Figure	  3.7:	  Determination	  of	  the	  optimum	  number	  of	  larvae	  per	  well.	  
	  
At	  12	  hpi,	  a	  test	  plate	  containing	  12	  wells	  each	  of	  3,	  4	  or	  5	   injured	  mpx:GFP	  larvae	  was	  scanned	  using	  
the	  Phenosight	  system.	  The	   images	  were	  viewed	  to	  calculate	  the	  number	  of	  wells	   in	  which	  the	  site	  of	  
injury	  in	  all	  larvae	  within	  each	  well	  could	  be	  visualised	  to	  allow	  accurate	  analysis.	  The	  higher	  the	  number	  
of	  larvae	  in	  each	  well,	  the	  lower	  the	  percentage	  frequency	  that	  the	  tails	  of	  all	  larvae	  could	  be	  visualised,	  
indicating	   that	   3	   larvae	   per	   well	   was	   the	   optimum	   number	   for	   screening	   (n	   ≥	   108;	   performed	   on	   3	  





















































3.2.6	  Identification	  of	  a	  reliable	  positive	  control	  	  
To	   identify	   a	   reliable	   positive	   control	   and	   ensure	   the	   manual	   scoring	   process	   was	  
appropriate	   for	   the	   screening	   assay,	   compounds	   with	   known	   effects	   on	   neutrophil	  
lifespan	   were	   tested.	   These	   included	   roscovitine,	   a	   CDK	   inhibitor	   that	   induces	  
neutrophil	  apoptosis	  via	  down-­‐regulation	  of	  Mcl-­‐1	  (Leitch	  et	  al.,	  2010),	  and	  pyocyanin,	  
a	   phenazine	   pigment	   exotoxin	   produced	   by	   the	   bacteria	   Pseudomonas	   aeruginosa,	  
which	   has	   been	   shown	   to	   induce	   neutrophil	   apoptosis	   in	   vitro	   and	   in	   vivo	   in	   both	  
zebrafish	   and	  mouse	  models	   of	   inflammation	   (Usher	   et	   al.,	   2002;	   Allen	   et	   al.,	   2005;	  
Loynes	  et	  al.,	   2009).	  GSK650394,	  an	   inhibitor	  of	   serum-­‐	  and	  glucocorticoid-­‐regulated	  
kinase-­‐1	   (SGK-­‐1)	   has	   been	   shown	   to	   drive	   inflammation	   resolution	   in	   the	  mpx:GFP	  
zebrafish	  model	  (Burgon	  et	  al.,	  in	  submission)	  and	  as	  such	  it	  was	  also	  considered	  as	  a	  
potential	   positive	   control.	   The	   pan-­‐caspase	   inhibitor	   zVAD.fmk	   delays	   inflammation	  
resolution	  (Loynes	  et	  al.,	  2009)	  and	  was	  used	  to	  demonstrate	  the	  dynamic	  range	  of	  the	  
system.	  Following	  the	  usual	  protocol,	  3	  dpf	   larvae	  were	  injured	  and	  good	  responders	  
were	  selected	  at	  4	  hpi	  for	  treatment	  with	  the	  control	  compounds.	  At	  12	  hpi,	  the	  well	  
plate	   was	   scanned	   on	   the	   Phenosight	   plate	   reader.	   The	   fluorescent	   images	   were	  
analysed	  using	  the	  manual	  scoring	  method	  to	  assess	  reduction	  in	  neutrophil	  number	  at	  
the	  site	  of	  injury,	  blinded	  to	  the	  experimental	  conditions	  (Figure	  3.8).	  
	  
Wells	  containing	  larvae	  treated	  with	  GSK650394	  were	  given	  a	  significantly	  higher	  score	  
compared	   to	  wells	   containing	   larvae	   treated	  with	   either	   E3	   or	  DMSO,	   supporting	   its	  
use	   as	   a	   positive	   control.	   Neither	   pyocyanin	   nor	   roscovitine	  were	   given	   significantly	  
higher	  scores	  than	  the	  DMSO	  negative	  control,	  suggesting	  that	  they	  produced	  signals	  
of	   insufficient	   amplitude	   to	   be	   reliably	   detected	   by	   this	   method.	   As	   expected,	  
zVAD.fmk	   inhibited	  caspase-­‐dependent	  neutrophil	   apoptosis,	   and	  no	  wells	   contained	  
larvae	   with	   fewer	   neutrophils	   at	   the	   site	   of	   injury	   compared	   to	   larvae	   treated	  with	  
DMSO.	  
	  
To	   establish	   the	   optimum	   test	   dose,	   the	   experiment	   was	   repeated	   using	   varying	  
concentrations	   of	   GSK650394.	   At	   both	   9	   and	   10	   µM,	   GSK650394	   generated	   a	  
significantly	  higher	  score	  than	  the	  E3	  and	  DMSO	  vehicle	  controls	  (Figure	  3.9).	  At	  doses	  










Figure	   3.8:	   GSK650394	   was	   the	   most	   effective	   positive	   control	   in	   the	   preliminary	  
analysis	  performed	  using	  the	  manual	  scoring	  method.	  	  	  
At	  3	  dpf,	  larvae	  were	  injured	  and	  good	  responders	  were	  treated	  at	  4	  hpi	  with	  either	  E3,	  1	  %	  DMSO,	  10	  
µM	   GSK650394,	   75	   µM	   pyocyanin,	   40	   µM	   roscovitine	   or	   100	   µM	   zVAD.fmk.	   At	   12	   hpi,	   larvae	   were	  
imaged	   using	   the	   Phenosight	   system	   and	   each	   well	   was	   scored	   manually.	   Larvae	   treated	   with	  
GSK650394	  were	   given	   a	   significantly	   higher	   score	   (1.727	  ±	   0.304)	   than	   those	   treated	  with	   either	   E3	  
(0.400	  ±	  0.221)	  or	  DMSO	  (0.636	  ±	  0.152)	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐
test	   to	   compare	   selected	   columns;	   where	   *	   P	   <	   0.05	   and	   **	   P	   <	   0.01;	   n	   ≥	   11,	   performed	   on	   3	  
independent	  occasions).	  
















































Figure	  3.9:	  Wells	  containing	  larvae	  treated	  with	  GSK650394	  score	  significantly	  higher	  
than	  wells	  containing	  DMSO	  control	  treated	  larvae.	  	  
At	  3	  dpf,	  larvae	  were	  injured	  and	  good	  responders	  were	  treated	  at	  4	  hpi	  with	  E3,	  1	  %	  DMSO	  or	  varying	  
concentrations	   of	   GSK650394.	   At	   12	   hpi,	   larvae	  were	   imaged	   using	   the	   Phenosight	   system,	   and	   each	  
well	   was	   scored	   manually.	   Larvae	   treated	   with	   9	   and	   10	   µM	   GSK650394	   scored	   significantly	   higher	  
(1.833	  ±	  0.297	  and	  2.050	  ±	  0.170,	  respectively)	  than	  those	  treated	  with	  DMSO	  (0.750	  ±	  0.179)	  (One-­‐way	  
ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test	  to	  compare	  selected	  columns;	  where	  *	  P	  <	  0.05,	  
and	  ***	  P	  <	  0.001;	  n	  ≥	  12,	  performed	  on	  3	  independent	  occasions).	  
	  
	  
	   	  













3.2.7	  Summary	  of	  screening	  assay	  conditions	  
In	   addition	   to	   the	   optimisation	   experiments	   described	   above,	   experiments	   to	  
determine	  other	  conditions	  such	  as	   the	  volume	  of	   fluid	  per	  well	  and	  optimal	   type	  of	  
well	   plate	   to	   use	   on	   the	   Phenosight	   system	   were	   also	   performed.	   The	   final	   assay	  
conditions	   are	   summarised	   in	   Table	   3.1.	   These	   experimental	   parameters,	   along	  with	  
the	   implementation	  of	   the	  Phenosight	   screening	  platform	  to	  enable	  high-­‐throughput	  
data	   collection,	   aimed	   to	   improve	   the	   assay	   performance	   from	   that	   of	   the	   original	  
preliminary	   screen,	   and	   the	   functionality	   of	   the	   novel	   screening	  method	  was	   tested	  
using	  a	  small	  compound	  library,	  as	  described	  in	  the	  next	  section.	  
	  






Optimum	  condition	  determined	  by	  
experiments	  
	  
Method	  of	  embryo	  
generation	  
Pairing	  or	  marbling	  
Age	  of	  larvae	  
	  
3	  dpf	  
Natural	  variability	  in	  
numbers	  of	  neutrophils	  
recruited	  to	  site	  of	  injury	  
Attempt	  to	  overcome	  by	  consistent	  tail	  fin	  
injury	  and	  selection	  of	  ‘good	  responders’	  only	  
at	  4	  hpi	  
Time	  of	  compound	  
treatment	  
Immediately	  following	  selection	  at	  4	  hpi	  
n	  number	   3	  larvae	  on	  2	  independent	  occasions	  
Positive	  control	  
compound	  
10	  μM	  GSK650394	  









Time	  point	  for	  image	  







3.2.8	  Evaluation	  of	  the	  novel	  screening	  protocol	  using	  the	  Merlion	  collection	  
To	  test	  the	  design,	  function	  and	  performance	  of	  the	  novel	  screening	  method,	  a	  small	  
library	  of	  98	  natural	  products	  that	  were	  selected	  for	  induction	  of	  caspase-­‐3	  activity	  in	  a	  
high-­‐throughput	   in	   vitro	  assay	  was	  used	   for	  a	  pilot	   screen	   (Merlion	  Pharmaceuticals,	  
Singapore).	  Plates	  of	  compounds	  were	  screened	  as	  described	   in	   the	  previous	  section	  
and	  images	  generated	  by	  the	  Phenosight	  plate	  reader	  at	  12	  hpi	  were	  manually	  scored.	  
The	  results	   from	  this	  pilot	  screen	  were	  also	  used	  as	  a	  sample	  dataset	  upon	  which	  to	  
test	   an	   early	   version	   of	   automated	   analysis	   software,	   designed	   by	   Ash	   Biotech	   to	  
complement	  the	  plate	  reader.	  This	  produced	  a	  read-­‐out	  of	  fluorescence	  per	  unit	  area	  
(FPU)	   at	   the	   site	   of	   injury	   in	   each	   larva,	   then	   for	   each	   compound	   the	   read-­‐out	  was	  
converted	  to	  the	  mean	  percentage	  FPU	  at	  the	  site	  of	  injury	  (refer	  to	  Figure	  2.2).	  	  
	  
Many	   compounds	   caused	   toxicity,	   likely	   due	   to	   widespread	   apoptosis	   caused	   by	  
induction	  of	  caspase-­‐3,	  but	  9	  compounds	  were	  identified	  as	  positive	  hits,	  with	  a	  mean	  
score	  greater	  than	  or	  equal	  to	  1.5,	  and	  a	  mean	  percentage	  fluorescence	  of	  less	  than	  or	  
equal	  to	  40%.	  The	  thresholds	  for	  positive	  hit	  selection	  were	  based	  on	  data	  obtained	  for	  
the	  GSK650394	   positive	   control,	   for	  which	   the	  mean	   (±	   SEM)	  manual	   score	   from	  all	  
data	   combined	  was	  1.625	   (±	   0.160)	  and	   the	  mean	  percentage	   specific	   FPU	   from	   the	  
automated	  analysis	  was	  36.03%	  (±	  3.234)	  (Figure	  3.10).	  
	  
A	   significant	   correlation	   was	   observed	   between	   data	   generated	   by	   the	   Phenosight	  
analysis	  software	  and	  the	  manual	  scoring	  method,	  as	   illustrated	  by	  data	  from	  Plate	  2	  
of	   the	  Merlion	  collection	   (Figure	  3.11).	  This	   suggested	   that	  both	  methods	  of	  analysis	  
were	   adequate	   to	   produce	   valid	   and	   comparable	   results,	   however	   despite	   being	  
partially	  automated,	  this	  version	  of	  the	  analysis	  software	  still	  required	  a	  large	  amount	  











Figure	   3.10:	   GSK650394	   significantly	   increases	   manual	   scoring	   and	   significantly	  
decreases	  percentage	  of	  specific	  FPU	  at	  the	  site	  of	  injury.	  
The	  Merlion	  natural	  product	   collection	  was	   screened	  using	   injured	  3	  dpf	   larvae	   that	  were	   selected	  as	  
good	   responders	   at	   4	   hpi.	   Images	   generated	   by	   the	   Phenosight	   plate	   reader	   at	   12	   hpi	   were	   both	  
manually	  scored	  and	  analysed	  using	   the	  automated	  Phenosight	  analysis	   software.	  The	  mean	  score	   (A)	  
given	  to	  GSK	  treated	  larvae	  (1.625	  ±	  0.160)	  was	  significantly	  higher	  than	  both	  the	  E3	  (0.469	  ±	  0.110)	  and	  
DMSO	   (0.613	   ±	   0.111)	   negative	   controls,	   and	   the	   mean	   percentage	   specific	   FPU	   (B)	   of	   GSK	   treated	  
larvae	  measured	  by	  the	  Phenosight	  analysis	  software	  (36.03	  ±	  3.234)	  was	  significantly	  lower	  than	  both	  
the	  E3	  (68.53	  ±	  3.927)	  and	  DMSO	  (61.49	  ±	  3.341)	  negative	  controls	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  




















































Figure	   3.11:	   There	   is	   significant	   correlation	   between	   the	   manual	   scoring	   and	  
automated	  analysis	  techniques.	  
Graphs	  show	  data	  obtained	  from	  Plate	  2	  of	   the	  Merlion	  collection.	  Dotted	   lines	   indicate	  threshold	   for	  
positive	   hits.	   Compound	   B1	   was	   identified	   as	   a	   hit	   by	   both	   the	   manual	   scoring	   method	   (A)	   and	  
automated	  analysis	  software	  (B).	  B1	  was	  given	  a	  significantly	  higher	  mean	  score	  (2.00	  ±	  0.41)	  than	  the	  
DMSO	  control	  	  (0.25	  ±	  0.25),	  which	  was	  comparable	  to	  the	  score	  given	  to	  GSK650394	  (2.25	  ±	  0.48)	  (One-­‐
way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  P	  <	  0.001;	  n	  =	  12).	  Linear	  regression	  analysis	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3.3	   Identification	   and	   validation	   of	   novel	   compounds	   that	   can	   accelerate	  
inflammation	  resolution	  
	  
Following	  completion	  of	  the	  design	  and	  optimisation	  procedures,	  the	  novel	  screening	  
method	   was	   used	   to	   perform	   an	   unbiased	   screen	   of	   the	   new	   2010	   version	   of	   the	  
Spectrum	  Collection.	  This	  library	  was	  selected	  due	  to	  the	  broad	  biological	  activity	  and	  
structural	   diversity	   of	   its	   contents.	   Alongside	   some	   known,	   predominantly	   synthetic	  
drugs	  with	   confirmed	   targets	   and	   therapeutic	   action,	   it	   also	   contained	   some	  natural	  
products	  with	  undefined	  biological	   activity,	   and	  other	  bioactive	   components	   such	   as	  
enzyme	   inhibitors	   and	   receptor	   blockers.	   With	   screening	   of	   this	   type	   of	   chemical	  
library,	   there	   is	   the	   potential	   to	   reveal	   novel	   applications	   for	   compounds	   that	   are	  
already	  FDA-­‐approved	  and	  have	  known	   toxicology	  profiles,	  as	  well	   as	   identifying	  key	  
pathways	  involved	  in	  inflammation.	  
3.3.1	  Primary	  screening	  of	  the	  Spectrum	  Collection	  	  
The	   Spectrum	   Collection	   screen	   was	   performed	   following	   the	   new	   protocol	  
summarised	  in	  Table	  3.1.	  Compounds	  were	  screened	  at	  25	  μM,	  a	  higher	  concentration	  
than	  was	  used	  in	  the	  preliminary	  screen,	  to	  increase	  the	  potential	  to	  detect	  both	  pro-­‐	  
resolution	  activity	  of	  compounds	  and	  any	  toxic	  effects.	  Manual	  scoring	  results	  from	  a	  
representative	  example	  plate	  of	  the	  Spectrum	  Collection	  are	  shown	  in	  Figure	  3.12.	  	  
	  
In	  some	   instances	  during	   the	  screen,	   the	  GSK650394	  positive	  control	  compound	  was	  
observed	  to	  form	  a	  precipitate,	  perhaps	   indicating	  an	  unstable	  nature,	  and	   it	  did	  not	  
perform	  as	  effectively	  as	  in	  the	  pilot	  screen	  of	  the	  Merlion	  collection.	  As	  an	  alternative	  
positive	  control,	  SP600125,	  an	  inhibitor	  of	  c-­‐jun	  NH2-­‐terminal	  kinase	  (JNK),	  which	  has	  
been	   suggested	   to	   affect	   TNFα-­‐mediated	   neutrophil	   apoptosis	   (Hallett	   et	   al.,	   2008),	  	  
was	   tested	   for	   its	  ability	   to	  drive	   inflammation	   resolution	   in	   the	  zebrafish.	  SP600125	  
significantly	   reduced	  neutrophil	   numbers	  at	   the	   site	  of	   injury	  at	  12	  hpi	   compared	   to	  
the	  vehicle	  control	  (Figure	  3.13	  A),	  and	  replaced	  GSK650394	  as	  the	  positive	  control	  in	  
the	  screening	  assay.	  Although	  there	  was	  still	  a	  significant	  difference	  between	  the	  mean	  
score	  of	  wells	  containing	  GSK650394	  treated	  larvae	  compared	  to	  DMSO	  treated	  larvae,	  












Figure	   3.12:	   Manual	   scoring	   identifies	   10	   positive	   hits	   from	   primary	   screening	   of	  
Plate	  15	  of	  the	  Spectrum	  Collection.	  
Compounds	  from	  Plate	  15	  were	  tested	  following	  the	  optimised	  screening	  protocol.	  At	  12	  hpi,	  the	  well	  
plate	  was	  scanned	  using	  the	  Phenosight	  system	  and	  images	  generated	  were	  analysed	  by	  manual	  scoring.	  
Graph	  (A)	  shows	  scores	  given	  to	  compounds	  in	  well	  plate	  rows	  A	  –	  D,	  and	  (B)	  shows	  those	  from	  rows	  E	  –	  
H.	  With	  a	  threshold	  of	  1.5,	  as	  indicated	  by	  the	  dotted	  line,	  10	  compounds	  were	  identified	  as	  positive	  hits	  




























































































































































































































Figure	  3.13:	  SP600125	  is	  a	  more	  effective	  positive	  control	  than	  GSK650394.	  
(A)	  3	  dpf	  mpx:GFP	  larvae	  were	  injured	  and	  good	  responders	  were	  selected	  at	  4	  hpi	  for	  treatment	  with	  
DMSO	  or	  30	  μM	  SP600125.	  At	  12	  hpi,	  neutrophils	  at	  the	  site	  of	  injury	  were	  counted	  by	  eye.	  SP600125	  
caused	  a	  significant	  reduction	  in	  neutrophil	  number	  (8.67	  ±	  0.65)	  compared	  to	  the	  DMSO	  control	  (20.70	  
±	  1.08)	  (Unpaired	  t-­‐test;	  P	  <	  0.0001;	  n	  =	  30).	  (B)	  Graph	  shows	  combined	  scoring	  data	  from	  the	  Spectrum	  
Collection	  screen.	  Although	  GSK650394	  scored	  significantly	  higher	  (1.31	  ±	  0.07)	  than	  the	  DMSO	  control	  
(0.61	  ±	  0.04),	  SP600125	  scored	  significantly	  higher	  still	  (2.14	  ±	  011)	  than	  GSK650394	  (One-­‐way	  ANOVA	  
with	  Bonferroni’s	  multiple	  comparison	  post-­‐test	  to	  compare	  selected	  columns;	  P	  <	  0.001;	  n	  ≥	  129).	  	  

























































It	   should	   be	   noted	   that	   SP600125	   has	   also	   been	   reported	   to	   disrupt	   granulocyte	  
chemotaxis	  (Zhang	  et	  al.,	  2008),	  and	  its	  inhibitory	  effect	  on	  neutrophil	  recruitment	  to	  
damaged	   neuromasts	   in	   the	   lateral	   line	   system	   has	   since	   been	   demonstrated	   in	   a	  
chemically	  induced	  inflammation	  assay	  in	  zebrafish	  (d’Alençon	  et	  al.,	  2010).	  The	  effects	  
of	   SP600125	  on	  neutrophil	   recruitment	   to	   the	   tail	   fin	  wound	   following	   injury	  will	   be	  
discussed	  later.	  	  
	  
In	  the	  initial	  screen,	  95	  compounds	  were	  identified	  as	  positive	  hits,	  defined	  as	  having	  a	  
mean	   score	  equal	   to	  or	  greater	   than	  1.5	   (Figure	  3.14).	   The	   threshold	   for	  positive	  hit	  
selection	   was	  maintained	   at	   this	   level,	   as	   this	   resulted	   in	   a	   manageable	   number	   of	  
compounds	  to	  retest	   in	  secondary	  screening.	  Due	  to	  various	  constraints	  encountered	  
during	   development	   of	   an	   improved	   version	   of	   the	   automated	   analysis	   software,	  
analysis	  of	  the	  screening	  results	  relied	  exclusively	  on	  manual	  scoring.	  	  
3.3.2	  Secondary	  screening	  of	  the	  Spectrum	  Collection	  identifies	  21	  compounds	  with	  
pro-­‐resolution	  activity	  
To	  validate	  the	  95	  positive	  hits	  identified	  in	  the	  initial	  screen,	  these	  compounds	  were	  
retested	   in	  the	  same	  manner,	  but	  each	  was	  screened	  on	  4	   independent	  occasions	  to	  
generate	   a	   mean	   score	   from	   12	   larvae.	   Using	   the	   positive	   hit	   threshold	   of	   1.5,	   21	  
compounds	  were	  found	  to	  have	  reproducible	  effects,	  reducing	  neutrophil	  numbers	  at	  
the	  site	  of	  injury	  to	  a	  level	  comparable	  to	  or	  even	  lower	  than	  SP600125	  (Figure	  3.15).	  
The	   most	   efficacious	   compounds,	   those	   scoring	   greater	   than	   or	   equal	   to	   2,	   were	  
selected	   for	   further	   investigation	   of	   their	   effects	   on	   the	   neutrophilic	   inflammatory	  
response.	  These	  included	  some	  compounds	  with	  known	  anti-­‐inflammatory	  properties,	  
alongside	  some	  with	  undefined	  biological	  activity	  (Table	  3.2).	  
	  
In	  conclusion,	  this	  novel	  screening	  platform	  successfully	  identified	  21	  compounds	  that	  
appeared	   to	  accelerate	   the	   resolution	  of	   inflammation	   in	  a	  model	  of	  acute	   resolving	  
inflammation	   in	   the	   zebrafish.	   The	   overall	   positive	   hit	   rate	   from	   screening	   of	   the	  




Figure	  3.14:	  Primary	  screening	  of	  the	  Spectrum	  Collection	  identified	  95	  positive	  hits.	  
Representative	  heat	  map	  to	  display	  mean	  scores	  of	  all	  2000	  compounds	  from	  the	  Spectrum	  Collection.	  
Mean	  negative	  control	  scores	  from	  each	  screening	  plate	  are	  shown	  down	  the	  left	  hand	  side,	  and	  mean	  
positive	   control	   scores	   on	   the	   right.	   A	   total	   of	   95	   positive	   hits	  were	   identified	   in	   the	   primary	   screen,	  
scoring	  equal	  to	  or	  greater	  than	  1.5,	  as	  indicated	  by	  increasing	  colour	  (n	  ≥	  129	  for	  controls	  and	  n	  =	  6	  for	  





























































Figure	   3.15:	   Secondary	   screening	   identifies	   21	   compounds	   with	   reproducible	   pro-­‐
resolution	  activity.	  
Positive	   hits	   identified	   in	   the	  primary	   screen	  were	   rescreened	   following	   the	   same	  protocol	   and	  21	  of	  
these	  were	  found	  to	  be	  reproducibly	  positive,	  scoring	  greater	  than	  or	  equal	  to	  1.5	  (as	  indicated	  by	  the	  
dotted	   line	   at	   y	   =	   1.5).	   The	   most	   active	   compounds,	   those	   scoring	   greater	   than	   or	   equal	   to	   2	   (as	  
indicated	  by	  the	  dotted	  line	  at	  y	  =	  2),	  were	  defined	  as	  the	  best	  hits	  for	  further	  investigation	  (n	  =	  36	  for	  
controls	  and	  n	  =	  12	  for	  screening	  compounds,	  performed	  on	  4	  independent	  occasions).	  	  














Table	  3.2:	  Known	  anti-­‐inflammatory	  properties	  of	  hit	  compounds.	  
	  
Compound	   Sources	   Known	  anti-­‐inflammatory	  
properties	  
Cryptotanshinone	   Diterpine	  quinone	  
isolated	  from	  Salvia	  
miltiorrhiza	  
Traditional	  Chinese	  




Inhibition	  of	  iNOS	  and	  COX-­‐2	  
expression	  in	  macrophages	  via	  NF-­‐
κB	  and	  AP-­‐1	  inhibition	  (Jeon	  et	  al.,	  
2008;	  Li	  et	  al.,	  2011)	  	  
Reduction	  of	  TNF-­‐α	  and	  IL-­‐6	  via	  NF-­‐
κB	  and	  MAPK	  inhibition	  (Tang	  et	  al.,	  
2011)	  
Inhibition	  of	  macrophage	  
chemotaxis	  via	  PI-­‐3K	  inhibition	  (Don	  
et	  al.,	  2007)	  




Inhibition	  of	  fMLP-­‐induced	  
neutrophil	  and	  monocyte	  
chemotaxis	  (Chen	  et	  al.,	  2002)	  
Digitoxin	   Cardiac	  glycoside	  
isolated	  from	  Digitalis	  
lanata	  and	  Digitalis	  
purpurea	  
Inhibition	  of	  NF-­‐κB,	  MCP-­‐1	  
expression	  and	  monocyte	  migration	  
in	  endothelial	  cells	  (Jagielska	  et	  al.,	  
2009)	  
Attenuation	  of	  IL-­‐8	  hypersecretion	  
in	  cultured	  cystic	  fibrosis	  lung	  
epithelial	  cells	  via	  NF-­‐κB	  inhibition	  
(Srivastava	  et	  al.,	  2004)	  







Inhibition	  of	  IL-­‐8	  production	  and	  
neutrophil	  accumulation	  (Oishi	  et	  
al.,	  1994)	  
Inhibition	  of	  superoxide	  anion	  
generation	  in	  neutrophils	  
(Mitsuyama	  et	  al.,	  1995)	  
Enhancement	  of	  phagocytosis	  of	  
apoptotic	  neutrophils	  by	  
macrophages	  (Yamaryo	  et	  al.,	  2003)	  
Gitoxigenin	   Cardiac	  glycoside	  
isolated	  from	  Digitalis	  
lanata	  and	  Digitalis	  
purpurea	  
No	  published	  data	  –	  likely	  to	  be	  
similar	  to	  Digitoxin	  
Isopimpinellin	   Furanocoumarin	  
found	  in	  plants	  of	  the	  
Apiaceae	  family	  e.g.	  
carrot,	  celery,	  parsley	  
No	  published	  data	  
2-­‐Benzoyl-­‐5-­‐
methoxybenzoquinone	  
Synthetic	   Derivatives	  shown	  to	  inhibit	  5-­‐LO	  




3-­‐O-­‐Methylquercetin	   Derivative	  of	  
quercetin,	  flavonoid	  
widespread	  in	  fruit	  
and	  vegetables	  
Inhibition	  of	  degranulation	  and	  
superoxide	  generation	  in	  
neutrophils	  (Pečivová	  et	  al.,	  2012)	  
Inhibition	  of	  iNOS	  protein	  and	  
mRNA	  expression	  in	  macrophages	  
via	  STAT1	  and	  NF-­‐κB	  inhibition	  
(Hämäläinen	  et	  al.,	  2007)	  
Inhibition	  of	  TNF-­‐α	  and	  PDE3,	  
reduction	  in	  neutrophil	  number	  (Ko	  
et	  al.,	  2004)	  
Reduction	  of	  neutrophil	  recruitment	  
via	  inhibition	  of	  actin	  polymerisation	  
(Souto	  et	  al.,	  2011)	  
Naproxen	   Synthetic,	  available	  as	  
prescription	  NSAID,	  
used	  to	  treat	  chronic	  
pain	  from	  arthritis,	  
gout,	  menstrual	  
cramps	  etc.	  
Inhibition	  of	  COX-­‐1	  and	  COX-­‐2,	  
reduction	  of	  prostaglandin	  and	  
thromboxane	  production	  
	  
Scopoletin	   Naturally	  occurring	  
coumarin	  widespread	  
in	  flowering	  plants	  of	  
the	  Scopolia	  genus	  	  
Reduction	  of	  NO,	  TNF-­‐α	  and	  PGE2	  
(Chang	  et	  al.,	  2012)	  
Inhibition	  of	  NF-­‐κB	  and	  MAPK	  in	  
macrophages	  (Yao	  et	  al.,	  2012)	  
Tanshinone	  IIA	   Diterpine	  quinone	  
isolated	  from	  Salvia	  
miltiorrhiza	  
Traditional	  Chinese	  




Inhibition	  of	  NF-­‐κB	  and	  AP-­‐1	  
activation	  (Jang	  et	  al.,	  2006;	  Xu	  et	  
al.,	  2009;	  Yang	  et	  al.,	  2010;	  An	  et	  al.,	  
2011)	  	  
Inhibition	  of	  iNOS,	  IL-­‐1β,	  IL-­‐6	  and	  
TNF-­‐	  α	  expression	  (Fan	  et	  al.,	  2009)	  
Inhibition	  of	  PLA2	  activity	  (Xu	  et	  al.,	  
2009)	  
Xanthone	   Naturally	  occurring	  in	  





Inhibition	  of	  lysozyme	  release	  and	  
superoxide	  generation	  in	  
neutrophils	  (Lin	  et	  al.,	  1996)	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3.4	   Investigation	   into	   the	   effects	   of	   hit	   compounds	   on	   the	   neutrophilic	  
inflammatory	  response	  
	  
In	   order	   to	   characterise	   their	   specific	   effects	   on	   neutrophils,	   the	   highest	   scoring	  
compounds	  from	  the	  Spectrum	  Collection	  screen	  were	  tested	  in	  a	  range	  of	  secondary	  
assays	  in	  mpx:GFP	  zebrafish	  larvae.	  Cryptotanshinone,	  which	  obtained	  a	  mean	  score	  of	  
1.5,	   was	   also	   tested	   for	   interest	   due	   to	   its	   structural	   and	   potentially	   functional	  
similarity	  to	  tanshinone	  IIA.	  	  
3.4.1	  Effects	  on	  neutrophil	  recruitment	  
As	  described	  previously	   in	  the	  Tg(mpx:GFP)i114	  zebrafish	  model,	  neutrophil	  numbers	  
at	  the	  injury	  site	  approach	  their	  peak	  at	  4	  hpi,	  but	  further	  recruitment	  can	  continue	  to	  
occur	   up	   to	   approximately	   6	   hpi	   (Renshaw	   et	   al.,	   2006).	   In	   the	   screening	   assay,	  
chemical	   treatment	  began	   shortly	   after	   selection	  of	   larvae	  at	  4	  hpi;	   therefore	   it	  was	  
possible	  that	  the	  positive	  hits	  identified	  might	  have	  reduced	  neutrophil	  numbers	  at	  the	  
injury	  site	  by	  preventing	  their	  recruitment	  later	  during	  the	  course	  of	  the	  inflammatory	  
response.	   In	  order	   to	  more	   fully	  characterise	   the	  activity	  of	   the	  positive	  hits,	   specific	  
assays	   were	   designed	   to	   distinguish	   between	   their	   effects	   on	   the	   recruitment	   and	  
resolution	  phases	  of	   inflammation.	  For	  recruitment,	   larvae	  were	  treated	   immediately	  
following	  tail	  fin	  injury,	  and	  the	  number	  of	  neutrophils	  at	  the	  site	  of	  injury	  was	  counted	  
at	   6	   hpi.	   Each	   compound	   was	   tested	   at	   3	   different	   concentrations	   in	   order	   to	  
investigate	  dose	  dependency.	  
	  
Some,	   but	   not	   all,	   hit	   compounds	   caused	   a	   significant	   reduction	   in	   neutrophil	  
recruitment	  to	  the	  wound	  compared	  to	  the	  DMSO	  vehicle	  control	  (Figure	  3.16).	  At	  the	  
highest	   concentration	   tested,	   the	   compounds	   cryptotanshinone	   and	   2-­‐benzoyl-­‐5-­‐
methoxybenzoquinone	  caused	  mortality	  in	  almost	  all	  larvae.	  Signs	  of	  toxicity	  were	  also	  
observed	  in	  larvae	  treated	  with	  digitoxin	  and	  deoxycholic	  acid.	  	  	  	  








Figure	  3.16:	  A	  subset	  of	  the	  positive	  hit	  compounds	  inhibit	  neutrophil	  recruitment.	  	  
At	  3	  dpf,	  mpx:GFP	   larvae	  were	   injured	  and	  treated	   immediately	  with	  compounds	  at	  3	  different	  doses.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  6	  hpi.	  A)	  Cryptotanshinone	  B)	  Deoxycholic	  acid	  
C)	  Digitoxin	  D)	  Erythromycin	  estolate	  E)	  Gitoxigenin	  F)	   Isopimpinellin	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  
multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05,	  **	  P	  <	  0.01	  and	  ***	  P	  <	  0.001;	  n	  =	  18	  performed	  as	  3	  










































































































































































































































Figure	  3.16:	  A	  subset	  of	  the	  positive	  hit	  compounds	  inhibit	  neutrophil	  recruitment.	  	  
At	  3	  dpf,	  mpx:GFP	   larvae	  were	   injured	  and	  treated	   immediately	  with	  compounds	  at	  3	  different	  doses.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  6	  hpi.	  A)	  2-­‐Benzoyl-­‐5-­‐methoxybenzoquinone	  B)	  
3-­‐O-­‐Methylquercetin	  C)	  Naproxen	  D)	  Scopoletin	  E)	  Tanshinone	   IIA	  F)	  Xanthone	  (One-­‐way	  ANOVA	  with	  
Dunnett’s	   multiple	   comparison	   post-­‐test;	   where	   *	   P	   <	   0.05,	   **	   P	   <	   0.01	   and	   ***	   P	   <	   0.001;	   n	   =	   18	  









































































































































































































































3.4.2	  Effects	  on	  resolution	  of	  neutrophilic	  inflammation	  
To	   examine	   the	   effects	   of	   the	   positive	   hit	   compounds	   specifically	   on	   the	   resolution	  
phase	  of	   the	   inflammatory	   response,	   larvae	  were	   injured	  and	  good	   responders	  were	  
selected	  for	  treatment	  at	  6	  hpi,	  a	  time	  point	  at	  which	  most	  neutrophil	  recruitment	  has	  
already	  occurred.	  Numbers	  of	  neutrophils	  remaining	  at	  the	  site	  of	  injury	  were	  counted	  
at	  12	  hpi,	  to	  maintain	  consistency	  with	  the	  time	  point	  used	  to	  identify	  positive	  hits	  in	  
the	   screening	   assay.	   All	   of	   the	   positive	   hits	   accelerated	   resolution	   by	   significantly	  
reducing	  neutrophil	   numbers	   at	   the	  wound,	   and	  most	  of	   these	  appeared	   to	   act	   in	   a	  
concentration-­‐dependent	  manner	   (Figure	  3.17).	  Toxicity	  was	  apparent	   in	  deoxycholic	  
acid	   and	   2-­‐benzoyl-­‐5-­‐methoxybenzoquinone	   treated	   larvae	   and	   death	   occurred	   in	  
those	  treated	  with	  the	  highest	  doses	  of	  cryptotanshinone	  and	  digitoxin.	  
3.4.3	  Effects	  on	  total	  neutrophil	  number	  
To	   determine	   whether	   the	   hit	   compounds	   were	   acting	   specifically	   on	   activated	  
neutrophils	   participating	   in	   the	   inflammatory	   response,	   uninjured	   larvae	   were	  
incubated	   for	   24	   hours	   then	   mounted	   in	   agarose	   and	   imaged	   on	   an	   inverted	  
compound	   fluorescence	   microscope	   using	   Volocity®	   software.	   Each	   compound	   was	  
tested	  at	  the	  dose	  that	  caused	  the	  most	  significant	  effect	  on	  the	  resolution	  phase	  of	  
the	   inflammatory	   response	   in	   the	   previous	   assay.	   Total	   neutrophil	   numbers	   were	  
analysed	   using	   ImageJ	   software,	   which	   revealed	   that	   none	   of	   the	   hit	   compounds	  
caused	   a	   significant	   reduction	   in	   the	   total	   neutrophil	   population	   compared	   to	   the	  
vehicle	   control	   (Figure	   3.18).	   Death	   was	   observed	   in	   all	   larvae	   treated	   with	   25	   μM	  







Figure	   3.17:	   Positive	   hit	   compounds	   significantly	   reduce	   neutrophil	   numbers	   at	   12	  
hpi	  to	  accelerate	  the	  resolution	  of	  inflammation.	  	  
At	   3	   dpf,	  mpx:GFP	   larvae	   were	   injured	   and	   treated	   with	   compounds	   at	   3	   different	   doses	   at	   6	   hpi.	  
Neutrophil	  numbers	  at	   the	   site	  of	   injury	  were	  counted	  at	  12	  hpi.	  A)	  Cryptotanshinone	  B)	  Deoxycholic	  
acid	   C)	   Digitoxin	   D)	   Erythromycin	   estolate	   E)	   Gitoxigenin	   F)	   Isopimpinellin	   (One-­‐way	   ANOVA	   with	  
Dunnett’s	   multiple	   comparison	   post-­‐test;	   where	   *	   P	   <	   0.05,	   **	   P	   <	   0.01	   and	   ***	   P	   <	   0.001;	   n	   =	   18	  


















































































































































































































































Figure	   3.17:	   Positive	   hit	   compounds	   significantly	   reduce	   neutrophil	   numbers	   at	   12	  
hpi	  to	  accelerate	  the	  resolution	  of	  inflammation.	  	  
At	   3	   dpf,	  mpx:GFP	   larvae	   were	   injured	   and	   treated	   with	   compounds	   at	   3	   different	   doses	   at	   6	   hpi.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  12	  hpi.	  A)	  2-­‐Benzoyl-­‐5-­‐methoxybenzoquinone	  
B)	  3-­‐O-­‐Methylquercetin	  C)	  Naproxen	  D)	  Scopoletin	  E)	  Tanshinone	  IIA	  F)	  Xanthone	  (One-­‐way	  ANOVA	  with	  
Dunnett’s	   multiple	   comparison	   post-­‐test;	   where	   *	   P	   <	   0.05,	   **	   P	   <	   0.01	   and	   ***	   P	   <	   0.001;	   n	   =	   18	  


















































































































































































































































Figure	  3.18:	  Assay	  positive	  compounds	  have	  no	  significant	  effects	  on	  total	  neutrophil	  
number.	  	  
At	   3	   dpf,	   mpx:GFP	   larvae	   were	   incubated	   with	   hit	   compounds	   (using	   the	   dose	   that	   produced	   the	  
maximum	  response	  in	  the	  resolution	  assay)	  for	  24	  hours.	  Larvae	  were	  then	  mounted	  and	  imaged	  on	  an	  
inverted	  compound	  fluorescence	  microscope	  using	  Volocity®	  software	  and	  the	  total	  neutrophil	  number	  
in	  each	   larva	  was	  analysed	  using	   ImageJ	  software.	  No	  significant	  differences	  were	   found	  between	  the	  
mean	  total	  neutrophil	  number	  of	  DMSO	  control	  larvae	  and	  any	  of	  the	  hit	  compounds	  tested	  (One-­‐way	  
ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  n	  =	  18	  performed	  as	  3	  independent	  experiments).	  	  



















































































































































3.4.4	   Summary	   of	   the	   effects	   of	   hit	   compounds	   on	   the	   neutrophilic	   inflammatory	  
response	  
To	  summarise	  the	  data	  obtained	  in	  the	  secondary	  assays,	  hit	  compounds	  were	  ranked	  
according	  to	  their	  maximum	  response,	  expressed	  as	  a	  percentage	  of	  the	  effect	  of	  the	  
positive	  control,	  SP600125	  (Figure	  3.19).	  This	  enabled	  identification	  of	  the	  compounds	  
that	   had	   the	   greatest	   effect	   on	   both	   neutrophil	   recruitment	   and	   resolution.	  
Compounds	  that	  most	  significantly	  affected	  recruitment	  of	  neutrophils	   to	  the	  wound	  
included	   isopimpinellin	  and	  2-­‐benzoyl-­‐5-­‐methoxybenzoquinone.	  Those	  with	   the	  most	  
potent	   pro-­‐resolution	   properties	   included	   tanshinone	   IIA,	   cryptotanshinone	   and	  
naproxen.	  Digitoxin	  and	  deoxycholic	  acid	  were	  omitted	  from	  the	  ranking	  due	  to	  their	  
toxicity	   in	   the	   total	   neutrophil	   number	   assays,	   as	   it	   was	   determined	   that	   their	  
mechanisms	  of	  action	  would	  not	  be	  worthwhile	  pursuing.	  
3.4.5	   Comparison	   of	   positive	   hits	   with	   known	   pharmacological	   regulators	   of	  
inflammatory	  signalling	  pathways	  
Following	   investigation	   of	   the	   specific	   effects	   of	   each	   of	   the	   hit	   compounds	   on	  
neutrophil	   recruitment,	   resolution	   and	   total	   neutrophil	   number,	   I	   chose	   to	   compare	  
their	  activity	  in	  these	  assays	  with	  the	  activity	  profile	  of	  some	  known	  compounds	  with	  
established	   anti-­‐inflammatory	   activity,	   with	   the	   idea	   that	   this	   might	   provide	   clues	  
towards	   identifying	   their	   mechanisms	   of	   action.	   A	   small,	   focused	   compound	   library	  
was	   obtained	   from	   GlaxoSmithKline	   (GSK),	   containing	   known	   inhibitors	   of	   key	  
inflammatory	  signalling	  pathway	  components	   including	  PI-­‐3K,	  MAPK	  and	  PDE-­‐4.	  Each	  
of	   these	   compounds	   was	   tested	   in	   recruitment,	   resolution	   and	   total	   neutrophil	  
number	   assays,	   performed	   in	   the	   same	  manner	   as	   described	   above.	   In	   this	   instance	  
the	   recruitment	   and	   total	   neutrophil	   number	   assays	   were	   carried	   out	   by	   our	  
technician,	  Aleksandra	  Bojarczuk.	  
	  
To	   compare	   the	   compound	   activity	   profiles	   I	   used	   Cluster	   3.0;	   clustering	   software	  
originally	  designed	  for	  analysis	  of	  gene	  expression	  data,	  but	  which	  could	  be	  applied	  in	  





Figure	   3.19:	   Summary	   and	   ranking	   of	   the	   effects	   of	   positive	   hit	   compounds	   on	  
neutrophil	  recruitment	  and	  resolution	  of	  inflammation.	  
Compounds	  are	  ranked	  according	  to	  their	  maximum	  response,	  expressed	  as	  a	  percentage	  of	  the	  effect	  
of	  SP600125.	  (A)	  Effect	  of	  hit	  compounds	  on	  neutrophil	  recruitment	  to	  the	  site	  of	  injury	  at	  6	  hpi,	  after	  
treatment	   of	   injured	   3	   dpf	  mpx:GFP	   larvae	   immediately	   following	   injury.	   Doses	   shown	   are	   1	   μM	   for	  
erythromycin	  estolate,	  10	  μM	  for	  cryptotanshinone	  and	  benzoyl-­‐methoxybenzoquinone,	  and	  25	  μM	  for	  
all	   other	   compounds.	   (B)	   Effect	   of	   hit	   compounds	   on	   resolution	   in	   terms	   of	   neutrophil	   number	  
remaining	  at	  the	  site	  of	   injury	  at	  12	  hpi,	  following	  treatment	  of	   injured	  3	  dpf	  mpx:GFP	  larvae	  at	  6	  hpi.	  
Doses	  shown	  are	  25	  μM	  for	  scopoletin,	  xanthone,	  isopimpinellin,	  tanshinone	  IIA	  and	  naproxen,	  and	  10	  
μM	  for	  all	  other	  compounds.	  
	  





































































































































































































































For	   recruitment	   and	   resolution	   assays,	   data	   were	   normalised	   by	   expressing	   as	   a	  
percentage	   of	   the	   effect	   of	   the	   positive	   control	   SP600125,	   and	   for	   total	   neutrophil	  
number	  assays,	  data	  were	  expressed	  as	  the	  percentage	  change	  from	  the	  DMSO	  vehicle	  
control.	  Data	  were	  clustered	  according	  to	  assay	  activity,	  using	  a	  hierarchical	  average-­‐
linkage	   clustering	   method,	   and	   the	   resulting	   heat	   map	   was	   generated	   using	   Java	  
TreeView	   (Figure	   3.20).	   Digitoxin	   and	   deoxycholic	   acid	   were	   omitted	   due	   to	   their	  
toxicity	  in	  the	  total	  neutrophil	  number	  assays.	  
	  
This	   cluster	   analysis	   revealed	   that	   the	  majority	   of	   the	   positive	   hits	   identified	   in	   my	  
screening	   assay	   formed	   a	   group	   isolated	   from	   most	   of	   the	   known	   inhibitors	   of	  
inflammatory	   signalling	   pathways	   that	   were	   tested	   in	   parallel.	   These	   compounds	  
demonstrated	  potent	  pro-­‐resolution	  activity	  with	  only	  moderate	  effects	  on	  neutrophil	  
recruitment.	   Within	   this	   group,	   tanshinone	   IIA	   clustered	   with	   the	   PDE-­‐4	   inhibitor	  
roflumilast.	  
	  
Two	   of	   the	   positive	   hits,	   isopimpinellin	   and	   2-­‐benzoyl-­‐5-­‐methoxybenzoquinone,	  
displayed	   an	   alternative	   phenotype,	   diverging	   from	   the	   main	   collection	   of	   pro-­‐
resolution	  compounds	  and	  clustering	  closely	  with	  the	  pan	  PI-­‐3K	   inhibitor	  ZSTK474.	   In	  
addition	   to	   accelerating	   inflammation	   resolution,	   these	   compounds	   caused	   a	   highly	  










Figure	   3.20:	   Hierarchical	   cluster	   analysis	   reveals	   hit	   compounds	   fall	   into	   distinct	  
groups	  based	  on	  their	  activity	  profiles.	  	  
Clustergram	   represents	   secondary	   assay	   data	   for	   hit	   compounds	   (named	   in	   blue)	   and	   compounds	  
obtained	   from	   GSK	   (named	   in	   black).	   Recruitment	   and	   resolution	   assay	   data	   are	   normalised	   by	  
expressing	   as	   a	   percentage	   of	   the	   effect	   of	   SP600125,	   and	   total	   neutrophil	   number	   assay	   data	   are	  
expressed	  as	   the	  percentage	   change	   from	   the	  DMSO	  control.	  Data	  were	   clustered	  according	   to	   assay	  
activity	  using	  Cluster	  3.0	  and	  a	  hierarchical	  average-­‐linkage	  method,	  and	  the	  heat	  map	  was	  generated	  
using	  Java	  TreeView.	  Most	  hit	  compounds	  formed	  an	  isolated	  group,	  with	  potent	  pro-­‐resolution	  activity	  
and	   only	   moderate	   effects	   on	   neutrophil	   recruitment.	   Compounds	   outside	   of	   this	   cluster	   included	  
isopimpinellin	   and	   2-­‐benzoyl-­‐5-­‐methoxybenzoquinone,	   which	   exhibit	   powerful	   effects	   on	   both	  
recruitment	  and	  resolution,	  and	  gitoxigenin,	  which	  displays	  a	  recruitment	  only	  phenotype.	  























































In	  this	  chapter	  I	  have	  described	  the	  design,	  implementation	  and	  output	  of	  a	  novel	  drug	  
screen	   for	   accelerators	   of	   inflammation	   resolution	   in	   a	   zebrafish	   model	   of	   acute	  
inflammation.	   The	   screen	   identified	   21	   compounds	   that	   could	   reproducibly	   promote	  
resolution	   by	   reducing	   neutrophil	   numbers	   at	   the	   injured	   tail	   fin.	   Further	  
characterisation	  of	  the	  most	  active	  of	  these	  compounds	  has	  revealed	  a	  number	  which	  
significantly	   enhance	   the	   resolution	   phase	   of	   inflammation	   in	   a	   dose-­‐dependent	  
manner,	   along	   with	   a	   subset	   which	   have	   both	   anti-­‐recruitment	   and	   pro-­‐resolution	  
properties.	  	  
3.5.1	  The	  Tg(mpx:GFP)i114	  zebrafish	  as	  a	  model	  for	  pro-­‐resolution	  drug	  screening	  
As	   discussed	   in	   the	   introduction,	   the	   zebrafish	   immune	   system	   shares	   many	   of	   the	  
features	  of	  mammalian	  systems,	  and	  in	  injured	  Tg(mpx:GFP)i114	  larvae,	  the	  onset	  and	  
resolution	   phases	   of	   the	   acute	   inflammatory	   response	   proceed	   with	   comparable	  
kinetics	   (Renshaw	   et	   al.,	   2006).	   It	   is	   well	   established	   that	   neutrophil	   clearance	   is	   a	  
critical	   prerequisite	   for	   the	   resolution	   of	   acute	   inflammation	   in	   mammalian	   models	  
(Gilroy	  et	  al.,	  2003;	  Rossi	  et	  al.,	  2006;	  Sawatzky	  et	  al.,	  2006),	  and	  this	  has	  likewise	  been	  
demonstrated	  in	  zebrafish	  (Loynes	  et	  al.,	  2009).	  Simple	  analysis	  of	  neutrophil	  number	  
at	   the	   tail	   fin	   wound	   thus	   provides	   a	   relevant	   read-­‐out	   indicative	   of	   the	   degree	   of	  
inflammation,	   enabling	   identification	   of	   pharmacological	   agents	   that	   modulate	  
resolution.	   This	   approach	   has	   been	   validated	   by	   evidence	   showing	   that	   mediators	  
known	   to	   promote	   neutrophil	   survival,	   such	   as	   caspase	   inhibitors	   and	   LPS,	   prevent	  
resolution	  of	   inflammation	  by	  retaining	  neutrophils	  at	  the	  tail	   fin	  wound.	   In	  contrast,	  
known	   inducers	   of	   apoptosis	   including	   pyocyanin	   and	   roscovitine,	   reduce	  
inflammatory	  neutrophil	  numbers,	  accelerating	  resolution	  (Loynes	  et	  al.,	  2009).	  It	  must	  
not	  be	  forgotten	  that	  the	  neutrophil	  is	  only	  one	  component	  of	  the	  complex	  system	  of	  
cells	   and	   signalling	   molecules	   that	   contribute	   to	   the	   processes	   that	   define	  
inflammation	  resolution.	  
	  
Since	   the	   original	   investigation	   into	   granulocyte	   recruitment	   to	   an	   area	   of	   ‘minor	  
trauma’	  (Lieschke,	  2001),	  tail	  fin	  wounding	  by	  either	  scalpel	  or	  needle	  injury	  has	  been	  
used	   by	   a	   number	   of	   research	   groups	   as	   a	   model	   for	   studying	   the	   cellular	   and	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molecular	  dynamics	  of	   inflammation	  (Renshaw	  et	  al.,	  2006;	  Mathias	  et	  al.,	  2006;	  Hall	  
et	   al.,	   2007;	   Ellett	   et	   al.,	   2011).	   Similar	   research	   has	   also	   been	   undertaken	   by	  
stimulating	  an	  inflammatory	  response	  using	  small,	   laser	   induced	  wounds	  (Feng	  et	  al.,	  
2010;	   Yoo	   and	   Huttenlocher,	   2011).	   The	   inflammatory	   response	   induced	   by	   tail	   fin	  
injury	   can	   be	   genetically	   or	   pharmacologically	   manipulated	   to	   cause	   persistent	  
inflammation,	   being	   of	  more	   relevance	   to	   the	   human	   chronic	   inflammatory	   disease	  
state,	  and	  providing	  a	  useful	  tool	  to	  dissect	  the	  mechanisms	  involved	  (Mathias	  et	  al.,	  
2007;	  Elks	  et	  al.,	  2011).	  Of	  course,	  the	  results	  obtained	  from	  screening	  of	  the	  Spectrum	  
Collection	  are	   indicative	  of	  compounds	  that	  can	  promote	  the	  resolution	  phase	  of	  the	  
acute	  inflammatory	  response,	  and	  these	  need	  to	  be	  validated	  in	  models	  of	  persistent	  
inflammation,	   which	   will	   be	   discussed	   later.	   The	   preliminary	   compound	   screen	  
discussed	  in	  this	  chapter	  has	  already	  been	  published,	  illustrating	  the	  potential	  impact	  
of	   this	   model	   to	   identify	   novel	   lead	   candidates	   for	   inflammatory	   disease	   therapy	  
(Loynes	  et	  al.,	  2009).	  
	  
It	   is	  evident	   that	  as	  a	  model	   for	  high-­‐throughput	  drug	  screening,	   the	  zebrafish	  has	  a	  
number	  of	  advantages	  over	  mammalian	  systems,	  although	  it	   is	   important	  to	  consider	  
alternative	   zebrafish	   inflammation	   models,	   developed	   with	   chemical	   screening	   in	  
mind.	   One	   group	   have	   designed	   a	   chemically	   induced	   inflammation	   assay,	   termed	  
‘ChIn’	  assay,	  with	  the	  idea	  to	  reduce	  manual	  manipulation	  of	  larvae	  and	  avoid	  physical	  
fin	   injury	   (d’Alençon	   et	   al.,	   2010).	   Exposure	   of	   zebrafish	   larvae	   to	   copper	   sulphate,	  
which	   induces	  oxidative	   stress	   and	   selective	  damage	   to	   sensory	  hair	   cells	  within	   the	  
lateral	   line	  neuromasts	   (Olivari	  et	  al.,	  2008),	   initiates	  a	   rapid	   inflammatory	   response,	  
with	   recruitment	   of	   leukocytes	   after	   just	   15	  minutes	   and	   resolution	   around	   3	   hours	  
later.	  The	  response	  can	  be	  quantified	  in	  terms	  of	  cell	  numbers	  both	  manually	  and	  by	  
automated	  processing	   and	   is	   susceptible	   to	  pharmacological	  manipulation	  by	   known	  
anti-­‐inflammatory	  compounds.	  	  
	  
This	  model	   has	   been	   used	   to	   set	   up	   an	   automated	   screening	   platform	  with	   robotic	  
liquid	   handling	   and	   automated	   microscopy.	   However,	   some	   steps	   remain	   labour-­‐
intensive,	  such	  as	  sorting	  of	   larvae,	  arraying	  them	  into	  well	  plates,	  and	  ensuring	  they	  




et	  al.,	  2012).	  The	  authors	  screened	  a	  library	  of	  640	  compounds,	  initially	  identifying	  45	  
with	   anti-­‐inflammatory	   properties	   and	   7	   that	   appeared	   to	   promote	   resolution,	  
however	  on	  retesting	  of	  these	  potential	  pro-­‐resolution	  compounds,	  they	  were	  unable	  
to	   confirm	   their	   findings.	  Although	   it	   is	   obvious	  when	   there	  are	  profound	  effects	  on	  
leukocyte	   recruitment	   to	   the	   damaged	   neuromasts,	   perhaps	   this	   model	   is	   less	  
appropriate	   for	   reliable	  detection	  of	  novel	  compounds	  with	  pro-­‐resolving	  properties,	  
possibly	  due	   to	   the	   transitory	   time	   course	  of	   the	   inflammatory	   response	   induced	  by	  
copper	   sulphate	   treatment.	   This	   in	   addition	   makes	   it	   less	   analogous	   to	   the	   human	  
acute	   inflammatory	   response	   than	   the	   simple	   tail	   fin	   wounding	   assay.	   Leukocyte	  
recruitment	   to	   the	   damaged	   neuromast	   can	   be	   impaired	   genetically,	   for	   example	   in	  
the	   zebrafish	   was	   mutant	   (d’Alençon	   et	   al.,	   2010).	   It	   can	   also	   be	   inhibited	  
pharmacologically	   by	   known	   anti-­‐inflammatory	   drugs,	   such	   as	   indomethacin,	   and	   by	  
using	   diphenyleneiodonium	   (DPI)	   to	   inhibit	   NADPH	   oxidase,	   which	   implies	   that	  
formation	  of	  a	  H2O2	  gradient	  is	  important	  in	  copper-­‐mediated	  wounding	  as	  well	  as	  the	  
response	  induced	  by	  physical	  insult	  (Niethammer	  et	  al.,	  2009;	  d’Alençon	  et	  al.,	  2010).	  
Looking	   at	   the	   resolution	   phase	   of	   inflammation,	   the	   authors	   suggest	   that	   by	   a	  
reduction	  in	  prostaglandin	  synthesis,	  some	  NSAIDs	  cause	  leukocyte	  persistence	  in	  their	  
assay,	  though	  this	  observation	  is	  made	  just	  3	  hours	  after	  copper	  removal.	  This	  model	  
might	  be	  better	  applied	  to	  the	  identification	  of	  anti-­‐recruitment	  compounds,	  although	  
further	  characterisation	   is	  necessary,	   for	  example	  to	  determine	  why	  the	  sensory	  hair	  
cells	  of	  the	  lateral	  line	  are	  selectively	  susceptible	  to	  copper	  damage.	  	  
	  
To	   date,	   apart	   from	   those	   mentioned	   above,	   there	   are	   no	   other	   published	   anti-­‐
inflammatory	   or	   pro-­‐resolution	   drug	   screens	   in	   zebrafish.	   This	   highlights	   the	   impact	  
and	  novelty	  of	  this	  research	  and	  the	  demand	  to	  identify	  new	  therapeutic	  targets	  and	  
lead	   compounds	   that	  might	   be	   translatable	   to	   the	  human	  patient.	  Discovery	  of	   new	  
pro-­‐resolution	  compounds	  that	  can	  specifically	  act	  on	  neutrophil	  clearance	  pathways	  is	  
of	   particular	   importance,	   as	   there	   already	   exists	   a	   number	   of	   anti-­‐inflammatory	  
therapies	  that	  target	  neutrophil	  recruitment,	  but	  their	  effectiveness	  is	  limited.	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3.5.2	  Design	  and	  optimisation	  of	  the	  screening	  assay	  
The	  preliminary	  screen,	  implemented	  during	  my	  summer	  studentship,	  was	  performed	  
in	   order	   to	   test	   the	   hypothesis	   that	   novel	   pharmacological	   drivers	   of	   inflammation	  
resolution	   could	  be	  discovered	  using	   the	  mpx:GFP	   tail	   fin	   injury	  model.	  Almost	  1000	  
compounds	   were	   screened,	   identifying	   4	   compounds	   that	   significantly	   accelerated	  
resolution,	   including	   the	   known	   anti-­‐inflammatories	   flumethasone	   and	   thalidomide.	  
Though	   simple,	   the	   preliminary	   screen	   provided	   adequate	   enough	   evidence	   to	  
demonstrate	   that	   the	   concept	   was	   feasible,	   and	   that	   with	   some	   careful	   design	   and	  
optimisation,	   a	   relatively	   high-­‐throughput	   and	   robust	   screening	   platform	   could	   be	  
developed	  using	  this	  model.	  	  
	  
The	  mpx:GFP	  model	  was	   initially	   characterised	  by	  manual	   counting	  of	  neutrophils	   at	  
the	  site	  of	  injury	  at	  6	  and	  12	  hpi,	  to	  determine	  whether	  there	  were	  any	  differences	  in	  
the	   numbers	   of	   neutrophils	   participating	   in	   the	   inflammatory	   response	   in	   various	  
populations	  of	  larvae.	  These	  experiments	  also	  confirmed	  that	  inflammatory	  neutrophil	  
numbers	  were	  normally	  distributed,	  allowing	  statistical	  analysis	  to	  be	  performed	  using	  
standard	  parametric	   tests.	   It	  was	  concluded	  that	  3	  dpf	   larvae	  were	  most	  suitable	   for	  
screening,	  with	  no	  apparent	  differences	  in	  neutrophil	  numbers	  at	  the	  wound	  in	  larvae	  
drawn	   from	  any	  of	   the	  distinct	   populations	   tested.	   Though	   less	   variable,	   there	  were	  
significantly	  fewer	  neutrophils	  in	  2	  dpf	  larvae,	  the	  use	  of	  which	  would	  likely	  result	  in	  a	  
less	   robust	   assay,	   with	   increased	   probability	   of	   identifying	   false	   positives.	   It	   was	  
evident	  that	  measures	  needed	  to	  be	  taken	  to	  overcome	  the	  inherent	  natural	  variability	  
in	  neutrophil	  numbers	  observed	  in	  3	  dpf	  larvae.	  To	  approach	  this,	  I	  introduced	  a	  strict	  
selection	  process,	  whereby	  larvae	  were	  only	  chosen	  for	  screening	  if	  they	  had	  recruited	  
between	   approximately	   25	   and	   30	   neutrophils	   to	   the	   wound	   by	   4	   hpi.	   Larvae	   with	  
lower	  or	  much	  higher	  numbers	  of	  neutrophils	  were	  discarded.	  A	   time	  point	  of	  4	  hpi	  
was	   used	   for	   larvae	   selection,	   followed	   by	   immediate	   compound	   treatment,	   as	   this	  
allowed	   sufficient	   time	   to	   collect	   the	   appropriate	   number	   of	   good	   responders	   and	  
incubate	  them	  with	  the	  screening	  compounds	  well	  before	  the	  inflammatory	  response	  
would	  begin	  to	  resolve	  naturally.	  It	  was	  probable	  that	  some	  of	  the	  compounds	  tested	  
would	  have	   inhibitory,	  or	  even	  augmenting,	  effects	  on	   the	   later	   stages	  of	  neutrophil	  




experimental	  set	  up	  did	  not	  involve	  dealing	  with	  such	  large	  numbers	  of	  larvae	  to	  select	  
and	  pipette	  into	  well	  plates.	  The	  12	  hpi	  time	  point	  was	  chosen	  as	  the	  end	  point	  of	  the	  
assay,	   in	   concurrence	   with	   the	   preliminary	   screen,	   as	   this	   provided	   ample	   time	   for	  
compounds	   to	   exert	   their	   effects	   and	   high	   enough	   numbers	   of	   neutrophils	   were	  
remaining	  at	  the	  injury	  site	  in	  control	  larvae	  to	  reliably	  identify	  any	  active	  compounds	  
that	   caused	   significant	   neutrophil	   removal.	   During	   the	   initial	   stages	   of	   the	   primary	  
Spectrum	  Collection	  screen,	  one	  plate	  was	  screened	  at	  both	  the	  8	  hpi	  and	  12	  hpi	  time	  
points	   (data	   not	   shown)	   to	   compare	   the	   identification	   of	   positive	   hits,	   and	   in	   this	  
instance	  fewer	  hits	  were	  detected	  at	  8	  hpi,	  supporting	  use	  of	  the	  12	  hpi	  end	  point.	  	  
3.5.3	  Automation	  of	  the	  screening	  method	  
The	   development	   of	   automated	   equipment	   and	   analysis	   techniques	   is	   considered	  
essential	   to	   creating	   high-­‐throughput,	   robust	   and	   successful	   screening	   platforms.	  
Though	  there	  exist	  various	  technologies	  capable	  of	  aliquoting	  chemicals	  and	  zebrafish	  
larvae	  into	  multi-­‐well	  plates,	  there	  is	  currently	  no	  equipment	  that	  can	  perform	  tail	  fin	  
transection	  on	  large	  numbers	  of	  zebrafish	  larvae	  in	  an	  automated	  manner.	  While	  this	  
is	   theoretically	   possible,	   for	   this	   screening	   assay	   in	   particular,	   larvae	   would	   require	  
further	   processing	   through	   an	   automated	   fluorescence	   sorter	   capable	   of	   identifying	  
those	  with	   an	   above	   threshold	   level	   of	   GFP	   specifically	   at	   the	   tail	   fin	  wound.	   These	  
steps,	  along	  with	  aliquoting	  of	   selected	   larvae	   into	  prepared	  screening	  plates,	  would	  
likely	   remain	   relatively	   time	   consuming	   and	   realistically	   might	   not	   be	   beneficial	   in	  
terms	  of	  increasing	  assay	  performance	  and	  throughput.	  Considering	  these	  factors,	  the	  
chemically	   induced	   assay	   (d’	   Alençon	   et	   al.,	   2010)	   lends	   itself	   more	   readily	   to	  
automated	  technologies,	  emphasising	  one	  particular	  advantage	  over	  the	  injury	  model.	  	  
	  
As	   an	   alternative,	   to	   partially	   automate	   the	   screening	   assay	   the	   Phenosight	   High-­‐
Content	   plate	   reader	   was	   introduced,	   enabling	   rapid	   collection	   of	   bright	   field	   and	  
fluorescent	   images	  of	  each	   individual	  well,	  along	  with	   immediate	  recognition	  of	  drug	  
toxicity.	   This	   was	   an	   improvement	   from	   the	   preliminary	   screening	   method,	   which	  
required	   manual	   observation	   of	   each	   well	   by	   eye	   and	   subjective	   identification	   of	  
potential	  positive	  hits.	  One	  caveat	  of	  the	  plate	  reader	  was	  that	  it	  partially	  dictated	  the	  
possible	   n	   number	   that	   could	   be	   used	   in	   screening	   experiments,	   with	   experiments	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suggesting	   that	   3	   larvae	   per	  well	  was	   optimum	   to	   avoid	   the	   issue	   of	   data	   loss	   from	  
obscured	   tail	   fins.	   Though	   it	  might	   have	   been	   preferable	   to	   increase	   this	  n	   number,	  
larger	   numbers	   of	   larvae	   would	   need	   to	   be	   injured	   to	   generate	   enough	   good	  
responders	   for	   each	   experiment.	   In	   an	   effort	   to	   resolve	   this,	   each	   compound	   was	  
screened	   on	   3	   larvae	   on	   2	   independent	   occasions.	   For	   primary	   screening,	   testing	   of	  
each	  compound	  on	  a	  total	  of	  6	  larvae	  is	  at	  least	  consistent	  with	  if	  not	  higher	  than	  the	  n	  
numbers	  used	   in	   various	  published	   zebrafish	   screens	   (North	  et	   al.,	   2007;	   Tran	  et	   al.,	  
2007;	  Namdaran	  et	  al.,	  2012;	  Ridges	  et	  al.,	  2012).	  
	  
A	   manual	   scoring	  method	   was	   designed	   to	   enable	   simple	   and	   rapid	   analysis	   of	   the	  
fluorescent	  images	  generated	  by	  the	  Phenosight	  system,	  which	  resulted	  in	  a	  basic	  yet	  
accurate	  measure	   of	   pro-­‐resolution	   activity,	   and	   this	   approach	  was	   first	   tested	   on	   a	  
series	  of	   known	  compounds	  with	   the	  aim	   to	   identify	   a	   suitable	  positive	   control.	   The	  
SGK-­‐1	  inhibitor	  GSK650394	  scored	  significantly	  higher	  than	  the	  E3	  and	  DMSO	  controls,	  
the	  mechanism	  of	  which	  is	  at	  least	  in	  part	  due	  to	  neutrophil	  apoptosis	  (Burgon	  et	  al.,	  in	  
submission).	  Other	  known	  inducers	  of	  neutrophil	  apoptosis,	  roscovitine	  and	  pyocyanin	  
(Usher	   et	   al.,	   2002;	   Allen	   et	   al.,	   2005;	   Rossi	   et	   al.,	   2006),	   did	   not	   reliably	   score	  
significantly	   higher	   than	   the	   negative	   controls.	   Although	   previous	   data	   from	   our	  
laboratory	  (Loynes	  et	  al.,	  2009)	  has	  demonstrated	  that	  both	  of	  these	  compounds	  can	  
significantly	   drive	   resolution	   in	   zebrafish	   larvae,	   it	   is	   possible	   that	   in	   this	   particular	  
assay	  the	  Phenosight	  system	  is	  not	  sensitive	  enough	  to	  distinguish	  less	  potent	  activity,	  
and	   only	   those	   compounds	   that	   have	   a	   profound	   effect	   on	   reducing	   neutrophil	  
numbers	  at	  the	  injured	  tail	  fin	  will	  be	  detected.	  This	  is	  not	  necessarily	  a	  disadvantage	  
of	  the	  screening	  platform,	  but	  rather	  should	  ensure	  that	  only	  the	  most	  promising	  lead	  
compounds	  are	  identified	  for	  further	  investigation.	  	  	  
	  
Automated	   analysis	   software	   was	   designed	   to	   complement	   the	   plate	   reader	   and	  
provide	  a	  quantitative	  readout	  of	  neutrophil	  persistence	  at	  the	  wound	  in	  terms	  of	  the	  
level	  of	  fluorescence.	  The	  trial	  version	  of	  this	  software	  was	  unable	  to	  identify	  the	  tail	  
fin	  region	  in	  an	  automated	  manner;	  instead	  the	  appropriate	  area	  needed	  to	  be	  defined	  
by	  the	  user	  in	  each	  individual	  larva.	  By	  selecting	  the	  wound	  region	  and	  comparing	  this	  




calculated	  the	  mean	  specific	  fluorescence	  at	  the	  tail	  fin.	  This	  was	  a	  somewhat	  labour-­‐
intensive	  and	  time	  consuming	  process	  and	  also	  involved	  making	  a	  subjective	  decision	  
of	  where	  to	  define	  each	  region;	  not	  ideal	  attributes	  for	  an	  automated	  system.	  Despite	  
this,	   when	   the	   Merlion	   test	   screen	   was	   performed,	   results	   from	   the	   automated	  
analysis	  software	  correlated	  well	  with	  those	  from	  manual	  scoring,	   indicating	  that	  the	  
software	  held	  potential	  but	  that	  further	  development	  was	  necessary.	  This	  pilot	  screen	  
was	  a	  valuable	  test	  for	  the	  reliability	  and	  functionality	  of	  the	  novel	  screening	  protocol,	  
ensuring	   it	  was	   sufficiently	  optimised	   to	  proceed.	   It	   also	  provided	  an	  opportunity	   to	  
determine	   the	   appropriate	   sample	   size	   required	   to	   generate	   accurate	   results	   with	  
statistical	  power.	  	  
	  
At	  the	  time	  of	  writing,	  a	  fully	  automated	  version	  of	  the	  software	  was	  in	  the	  final	  stages	  
of	  development.	  Progress	  has	  been	  made,	  with	  the	  current	  program	  able	  to	  accurately	  
identify	  larvae	  and	  define	  their	  orientation,	  but	  no	  numerical	  data	  can	  be	  generated.	  
3.5.4	  The	  Spectrum	  Collection	  screen	  
The	  screening	  assay	  was	  designed	  with	  the	  primary	  aim	  of	  identifying	  compounds	  that	  
act	  to	  drive	  inflammation	  resolution,	  with	  translatable	  therapeutic	  potential.	  There	  are	  
of	   course	   hundreds	   of	   existing	   chemical	   libraries	   that	   are	   commercially	   available	   for	  
screening	  purposes.	  The	  Spectrum	  Collection	  was	  selected	  as	   it	  contained	  a	  range	  of	  
compounds	  with	   both	   defined	   and	  unknown	  biological	   activity,	   including	   some	   FDA-­‐
approved	   drugs	   and	   a	   variety	   of	   natural	   products.	   Using	   such	   a	   diverse	   library	  with	  
broad	  pharmacological	  potential	  seemed	  like	  a	  practical	  starting	  point	  for	  the	  screen,	  
particularly	  as	  it	  was	  phenotype-­‐driven	  and	  many	  of	  the	  precise	  mechanisms	  governing	  
the	   resolution	   of	   inflammation	   remain	   to	   be	   discovered.	   Screening	   of	  more	   focused	  
chemical	  libraries,	  such	  as	  those	  specifically	  targeting	  kinases,	  have	  since	  been	  carried	  
out	  in	  our	  laboratory	  now	  that	  the	  screening	  platform	  has	  been	  established.	  	  
	  
The	  novel	  screening	  method	  was	  designed	  to	  be	  relatively	  high-­‐throughput,	  with	  the	  
potential	  for	  one	  operator	  to	  screen	  up	  to	  640	  compounds	  per	  week.	  This	  performance	  
cannot	  easily	  be	  compared	  to	  other	  inflammation-­‐based	  zebrafish	  screens,	  as	  although	  
it	  is	  claimed	  that	  the	  ChIn	  assay	  is	  amenable	  to	  high-­‐throughput	  screening,	  evidence	  to	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date	  only	  describes	   results	   from	  a	   small	   library,	   and	   there	   is	   no	  published	   record	   to	  
indicate	   the	  actual	   rate	  at	  which	  compounds	  can	  be	  screened	  robustly	   (Wittmann	  et	  
al.,	  2012).	  Primary	  screening	  of	   the	  entire	  Spectrum	  Collection,	  with	  each	  compound	  
plate	  screened	  twice,	  was	  completed	  over	  the	  course	  of	  24	  weeks.	  This	  was	  somewhat	  
slower	  than	  estimated,	  with	  the	  limiting	  factor	  being	  embryo	  availability.	  	  
	  
A	  minor	  problem	  that	  arose	  intermittently	  during	  screening	  of	  the	  Spectrum	  Collection	  
was	  precipitation	  of	   the	  positive	  control	  GSK650394,	  which	   in	  many	  cases	  correlated	  
with	   its	   inactivity,	   resulting	   in	   a	   lower	   analysis	   score	   than	   expected.	   This	   is	   perhaps	  
indicative	  of	  an	  unstable	  tendency,	  and	  there	   is	   little	  published	   information	  available	  
relating	   to	   the	   stability	   of	   this	   compound.	   The	   precipitation	   seemed	   to	   occur	  
inconsistently	   with	   no	   obvious	   logical	   cause,	   and	   this	   prompted	   the	   use	   of	   an	  
alternative	  positive	  control,	  the	  JNK	  inhibitor	  SP600125.	  How	  JNK	  regulates	  neutrophil	  
apoptosis	  is	  not	  well	  defined,	  and	  there	  is	  controversial	  evidence	  over	  its	  potential	  role	  
during	  inflammation	  resolution	  (Nolan	  et	  al.,	  1999;	  Avdi	  et	  al.,	  2001;	  Kato	  et	  al.,	  2008),	  
though	  SP600125	   caused	  a	  highly	   significant	   reduction	   in	  neutrophil	   numbers	   at	   the	  
tail	   fin	  wound	   at	   12	   hpi	   in	  my	   zebrafish	   resolution	   assay.	   It	  would	   be	   of	   interest	   to	  
more	  fully	  examine	  the	  effect	  of	  this	  inhibitor	  on	  neutrophil	  apoptosis	  in	  zebrafish,	  for	  
example	   by	   TSA/TUNEL	   staining,	   and	   in	   purified	   human	  neutrophils,	   though	   there	   is	  
some	  evidence	  to	  suggest	  that	  freshly	  isolated,	  unstimulated	  neutrophils	  actually	  have	  
increased	  viability	  in	  the	  presence	  of	  SP600125	  (Geering	  et	  al.,	  2011).	  	  
	  
The	  effect	  of	   SP600125	  on	  neutrophil	   recruitment	   is	  better	  defined,	  and	   it	  has	  been	  
shown	  to	  attenuate	  JNK-­‐mediated	  recruitment	  of	  both	  neutrophils	  and	  monocytes	  to	  
the	   lung	   in	   murine	   models	   of	   LPS-­‐induced	   acute	   lung	   injury	   (Arndt,	   Young	   and	  
Worthen,	   2005;	   Arndt,	   Young,	   Lieber,	   et	   al.,	   2005;	   Young	   et	   al.,	   2009).	   Studies	   in	  
zebrafish	  suggest	  that	  SP600125	  inhibits	  macrophage	  migration	  to	  a	  tail	  fin	  wound	  and	  
that	  this	  is	  at	  least	  in	  part	  via	  the	  inhibition	  of	  MMP13	  (matrix	  metalloproteinase	  13),	  a	  
downstream	  target	  of	  the	  JNK	  -­‐	  AP-­‐1	  signal	  transduction	  pathway,	  which	  plays	  a	  role	  in	  
the	   degradation	   and	   remodelling	   of	   the	   extracellular	   matrix	   to	   assist	   chemotaxis	  
(Zhang	   et	   al.,	   2008).	   This	   research	   was	   carried	   out	   using	   the	   transgenic	   line	  




to	  label	  a	  large	  population	  of	  neutrophils,	  indicating	  that	  the	  recruitment	  of	  these	  cells	  
is	  also	  inhibited	  by	  SP600125.	  This	  is	  reflected	  in	  the	  data	  from	  my	  recruitment	  assays	  
in	  mpx:GFP	  larvae,	  which	  show	  a	  highly	  significant	  reduction	  in	  neutrophil	  numbers	  at	  
the	   wound	   at	   6	   hpi,	   and	   inhibition	   of	   neutrophil	   recruitment	   is	   also	   observed	   with	  
SP600125	  in	  the	  copper-­‐induced	  inflammation	  assay	  (d’Alençon	  et	  al.,	  2010).	  Although	  
the	   precise	   effects	   of	   SP600125	   on	   the	   inflammatory	   response	   in	   vivo	   are	   not	   fully	  
understood,	   this	   compound	   acted	   in	   a	   much	   more	   consistent	   and	   potent	   manner	  
during	   screening	   experiments	   than	   GSK650394,	   and	   was	   a	   reliable	   positive	   control	  
throughout	   the	   remainder	   of	   the	   Spectrum	   Collection	   screen	   and	   the	   secondary	  
assays.	  	  
	  
From	   the	   primary	   screen,	   95	   compounds	   were	   identified	   as	   positive	   hits	   using	   a	  
threshold	  score	  of	  1.5.	  This	  was	  slightly	  higher	  than	  the	  mean	  score	  of	  GSK650394,	  but	  
lower	  than	  that	  of	  SP600125,	  and	  resulted	  in	  a	  manageable	  number	  of	  hits	  to	  rescreen.	  
It	  was	   unfortunate	   that	   a	   completed	   version	   of	   the	   automated	   Phenosight	   software	  
was	  not	  available	  to	  perform	  a	  more	  thorough	  analysis	  of	  the	  screening	  results.	  Images	  
could	  have	  been	  processed	  using	  the	  early	  version	  of	  the	  software,	  however	  this	  would	  
have	   been	   incredibly	   time	   consuming	   and	   not	   worthwhile,	   as	   the	   manual	   scoring	  
technique	  was	   proven	   to	   be	   effective,	  with	   significant	   correlation	   to	   the	   automated	  
analysis,	  in	  the	  Merlion	  pilot	  screen.	  The	  initial	  positives	  were	  retested	  on	  much	  larger	  
numbers	   of	   larvae	   for	   validation,	   and	   21	   of	   the	   initial	   hits	   were	   found	   to	   be	  
reproducibly	  positive,	  resulting	  in	  a	  positive	  hit	  rate	  of	  1.1%,	  this	  being	  a	  comparable	  
hit	   rate	  to	  that	  expected	   in	  robust	  phenotype-­‐based	  zebrafish	  screens	  (Zhang	  &	  Yeh,	  
2012),	  and	  a	  false	  positive	  rate	  of	  3.7%.	  A	  certain	  number	  of	  false	  positives	  are	  likely	  to	  
be	  expected	  due	  to	  the	  natural	  variability	   in	  zebrafish	   larvae,	   though	  optimisation	  of	  
the	   screening	   process	   successfully	   reduced	   the	   false	   positive	   rate	   by	   half	   that	  






Table	   3.3:	   Comparison	   of	   the	   hit	   rates	   between	   the	   preliminary	   and	   optimised	  
screening	  protocols.	  	  
	  
	   Preliminary	  screen	   Final	  screen	  
Number	  of	  compounds	  screened	   960	   2000	  
Number	  of	  initial	  positives	   79	  (8.2%)	   95	  (4.8%)	  
Number	  of	  reproducible	  positives	   8	  (0.8%)	   21	  (1.1%)	  




It	   is	   also	   possible	   that	   some	   pro-­‐resolution	   compounds	   were	   not	   detected	   in	   the	  
primary	  screen,	  and	  the	  false	  negative	  rate	  can	  be	  predicted	  using	  the	  positive	  control	  
data.	   For	   instance,	   if	   I	   consider	  all	  of	   the	   screening	  assay	  data	   from	  wells	   containing	  
larvae	  treated	  with	  SP600125,	  a	  score	  of	  less	  than	  2	  was	  given	  to	  6	  wells,	  from	  a	  total	  
of	  55	  wells.	  This	  suggests	  there	   is	  a	  potential	   false	  negative	  rate	  of	  up	  to	  10.9%.	   It	   is	  
conceivable	   that	   this	   might	   explain	   why	   some	   compounds	   within	   the	   library,	   for	  
example	   those	   with	   known	   anti-­‐inflammatory	   properties	   such	   as	   indomethacin,	  
ibuprofen	   and	   other	   NSAIDs	   were	   not	   identified	   in	   the	   screen,	   though	   there	   are	   of	  
course	  many	   other	   explanations	   that	   could	   account	   for	   this,	   including	   inappropriate	  
dosage,	  absorption	  deficiency,	  toxicity	  or	  lack	  of	  function	  in	  zebrafish.	  	  
	  
For	  a	  more	  robust	  assay	  it	  would	  be	  beneficial	  to	  increase	  the	  n	  number	  in	  the	  primary	  
screen,	   though	   as	   discussed	   previously	   it	   would	   be	   difficult	   to	   obtain	   accurate	   data	  
from	   more	   than	   3	   fish	   per	   well.	   Increasing	   the	   number	   of	   replicates	   would	   be	  
preferable,	   but	   at	   the	   expense	   of	   throughput,	   and	   although	   there	   is	   likely	   to	   be	   a	  
number	   of	   potentially	   interesting	   candidates	   that	   were	   undetected,	   it	   is	   more	  
important	   to	   focus	   on	   the	   compounds	   that	   were	   identified	   as	   positive	   hits	   and	  
performed	  well	   in	  both	  primary	  and	  secondary	  screening.	  All	  of	   the	  compounds	   that	  
were	   validated	   in	   the	   secondary	   screen	   and	   selected	   for	   further	   investigation	  
significantly	  reduced	  neutrophil	  numbers	  at	  12	  hpi	  in	  the	  resolution	  assays,	  providing	  
clear	   supporting	   evidence	   for	   the	   optimised	   screening	   protocol	   in	   the	   successful	  




3.5.5	  Positive	  hits	  identified	  in	  the	  Spectrum	  Collection	  screen	  
A	  variety	  of	  hits	  were	  identified	  in	  the	  screen,	  including	  a	  number	  of	  compounds	  with	  
known	  anti-­‐inflammatory	  activity,	   as	   listed	   in	  Table	  3.2.	   	   The	  properties	  of	  12	  of	   the	  
best	  positive	  hits	  were	  validated	  through	  secondary	  assays	   in	  zebrafish	   larvae,	  which	  
were	  designed	  to	  dissect	  each	  phase	  of	  the	  inflammatory	  response	  in	  order	  to	  observe	  
the	  effect	  of	  compounds	  specifically	  on	  neutrophil	  recruitment	  or	  resolution.	  All	  of	  the	  
selected	  compounds	  caused	  significant	  and	  dose-­‐dependent	  acceleration	  of	  resolution,	  
and	   a	   subset	   of	   these	   had	   some	   inhibitory	   effects	   on	   neutrophil	   recruitment.	   Total	  
neutrophil	   number	   assays	  were	   also	   performed,	  which	   confirmed	   that	   all	   of	   the	   hit	  
compounds,	   excluding	   those	   with	   toxic	   effects,	   acted	   specifically	   on	   activated	  
neutrophils	  at	  the	  site	  of	  injury,	  rather	  than	  reducing	  neutrophil	  numbers	  throughout	  
the	  entire	  larvae.	  	  	  
	  
To	   investigate	  whether	   the	  hit	   compounds	   identified	   in	   the	   screen	  shared	   functional	  
activity	  with	   some	   known	   pharmacological	   regulators	   of	   key	   inflammatory	   signalling	  
pathways,	  a	  small	  panel	  of	  compounds	  was	  acquired	  from	  GSK.	  These	  were	  tested	  in	  
each	   of	   the	   secondary	   assays	   and	   hierarchical	   cluster	   analysis	   was	   performed	   to	  
compare	  their	  activity	  profiles	  with	   the	  positive	  hits,	   to	   identify	  any	  potential	   shared	  
mechanisms	  of	  action.	  Most	  of	  the	  hit	  compounds	  formed	  a	  distinct	  cluster	  separate	  to	  
almost	   all	   of	   the	   GSK	   compounds,	   due	   to	   their	   primarily	   pro-­‐resolution	   and	   only	  
moderate	  anti-­‐recruitment	  activity.	  This	  outcome	  was	  a	  good	  indication	  of	  the	  success	  
of	  the	  optimised	  screening	  assay,	  as	   it	  was	  designed	  with	  the	  primary	  aim	  to	  identify	  
novel	   compounds	   that	   could	   drive	   resolution.	   This	   group	   includes	   two	   known	   drugs	  
that	  have	  been	  used	  in	  clinical	  practice;	  the	  non-­‐selective	  COX	  inhibitor	  naproxen	  and	  
the	  macrolide	   antibiotic	   erythromycin	   estolate,	   which	  were	   not	   selected	   for	   further	  
investigation	   due	   to	   their	   well-­‐documented	   activity	   and	   known	   side	   effect	   profiles.	  
Detection	   of	   an	   antibiotic	   prompted	   the	   concern	   that	   the	   anti-­‐inflammatory	   effect	  
observed	   might	   be	   secondary	   to	   anti-­‐bacterial	   activity,	   so	   to	   investigate	   this,	   the	  
resolution	   assay	   for	   erythromycin	   estolate	   was	   repeated	   alongside	   penicillin-­‐
streptomycin	   (Appendix	   3),	   which	   confirmed	   that	   antibiotic	   activity	   alone	   was	   not	  
sufficient	   to	   drive	   inflammation	   resolution	   and	   that	   there	   was	   no	   additive	   anti-­‐
bacterial	  effect	  responsible	  for	  the	  reduction	  in	  neutrophil	  number	  when	  larvae	  were	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exposed	   to	   both	   erythromycin	   estolate	   and	   penicillin-­‐streptomycin	   in	   combination.	  
Recently	  the	  anti-­‐inflammatory	  properties	  of	  macrolide	  antibiotics	  have	  been	  realised,	  
which	   comprise	  modulation	   of	   a	   host	   of	   pro-­‐inflammatory	   responses,	   particularly	   in	  
neutrophils	  (Steel	  et	  al.,	  2012).	  
	  
A	  number	  of	  naturally	  occurring	   compounds	  were	  also	  present	   in	   the	  pro-­‐resolution	  
cluster,	   including	   scopoletin,	  methylquercetin	  and	   xanthone.	   These	   compounds	  have	  
some	   reported	   anti-­‐inflammatory	   activity	   (as	   listed	   in	   Table	   3.2)	   and	   have	   been	  
associated	   with	   ameliorative	   effects	   in	   mouse	   models	   of	   carrageenan-­‐induced	   paw	  
oedema	  and	  arachidonic	  acid-­‐induced	  ear	  oedema	  (Librowski	  et	  al.,	  2005;	  Kwon	  et	  al.,	  
2011;	  Chang	  et	  al.,	  2012).	  In	  zebrafish,	  it	  has	  been	  suggested	  that	  a	  related	  flavonoid,	  
quercetin,	  can	  down-­‐regulate	  the	  overexpression	  of	  IL-­‐1β,	  TNF-­‐α	  and	  COX-­‐2	  in	  a	  model	  
of	  dopaminergic	  neuron	  damage	  (Zhang	  et	  al.,	  2011).	  	  
	  
Although	   cryptotanshinone	   was	   not	   included	   in	   the	   category	   of	   ‘best	   hits’,	   it	   was	  
tested	   in	  the	  secondary	  assays	  due	  to	   its	  close	  structural	  similarity	  to	  tanshinone	  IIA.	  
Both	  of	  these	  compounds	  clustered	  into	  the	  pro-­‐resolution	  group,	  and	  tanshinone	  IIA	  
was	  closely	  associated	  with	  the	  PDE4	  inhibitor	  roflumilast,	  which	  has	  been	  reported	  to	  
reduce	   neutrophil	   numbers	   in	   animal	   models	   of	   inflammation	   (Underwood	   et	   al.,	  
1998;	  Bundschuh	  et	  al.,	  2001).	  As	  cryptotanshinone	  and	  tanshinone	  IIA	  were	  the	  most	  
potent	  accelerators	  of	  resolution	   identified	   in	  the	  screen,	  surpassed	  only	  by	  clinically	  
available	  naproxen	  (refer	  to	  Figure	  3.19),	  these	  compounds	  were	  selected	  for	  further	  
investigation,	  which	  will	  be	  described	  in	  Chapter	  5.	  	  
	  
Cluster	   analysis	   revealed	   a	   different	   activity	   profile	   for	   two	   of	   the	   positive	   hits,	  
isopimpinellin	   and	   2-­‐benzoyl-­‐5-­‐methoxybenzoquinone,	   which	   shared	   both	   highly	  
significant	  anti-­‐recruitment	  and	  pro-­‐resolution	  effects,	  and	  clustered	  closely	  with	  the	  
pan	  PI-­‐3K	  inhibitor	  ZSTK474.	  Due	  to	  a	  lack	  of	  published	  material	  describing	  any	  effect	  
of	   isopimpinellin	   on	   the	   inflammatory	   response,	   this	   was	   an	   interesting	   lead	  





Two	  of	   the	  positive	  hits,	  deoxycholic	  acid	  and	   the	  cardiac	  glycoside	  digitoxin,	   caused	  
mortality	  in	  the	  total	  neutrophil	  number	  assays,	  and	  as	  such	  these	  were	  not	  included	  
in	   the	   cluster	   analysis.	   Gitoxigenin	   is	   another	   cardiac	   glycoside	   closely	   related	   to	  
digitoxin,	  and	  although	  no	  toxicity	  was	  observed	  in	  the	  presence	  of	  this	  compound,	  it	  
was	  the	  least	  effective	  driver	  of	  resolution	  identified	  in	  the	  screen	  and	  hence	  was	  not	  
considered	  worthwhile	  pursuing.	  The	  mortality	  caused	  by	  digitoxin	  might	  be	  explained	  
by	  the	  well-­‐documented	  cardiotoxicity	  profile	  of	  this	  class	  of	  compounds,	  which	  have	  
also	  been	  described	  as	  neurotoxic	   in	  zebrafish	   (Sun	  et	  al.,	  2012),	   though	  despite	   this	  
there	  is	  on-­‐going	  research	  into	  their	  development	  as	  potential	  anti-­‐cancer	  therapeutics	  
(Elbaz	  et	  al.,	  2012).	  
3.5.6	  Conclusions	  
In	  conclusion,	  I	  have	  established	  a	  novel,	  partially	  automated	  screening	  platform	  using	  
a	   zebrafish	   model	   of	   acute	   inflammation,	   with	   the	   potential	   to	   discover	   lead	  
compounds	   that	   could	   be	   advantageous	   in	   the	   development	   of	   pro-­‐resolution	  
therapies.	   From	   screening	   of	   a	   large,	   diverse	   chemical	   library,	   I	   have	   successfully	  
identified	   21	   compounds	   that	   can	   reproducibly	   promote	   resolution	   in	   vivo,	   and	   a	  
number	   of	   the	   most	   effective	   of	   these	   compounds	   have	   been	   selected	   for	   further	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Chapter	  4:	  Investigation	  into	  the	  Structure-­‐Activity	  Relationships	  of	  the	  
Positive	  Hit	  Compounds	  	  
	  
4.1	  Introduction	  	  
In	   the	   previous	   chapter,	   the	   most	   promising	   lead	   compounds	   identified	   in	   the	  
Spectrum	  Collection	  screen	  were	  compared	  against	  a	  panel	  of	  known	  inhibitors	  of	  key	  
inflammatory	  signalling	  pathways,	   to	   indicate	   the	  potential	  mechanisms	  behind	   their	  
activity.	  Based	  on	  their	  activity	  profiles,	  most	  of	  the	  hit	  compounds	  clustered	  together	  
to	  form	  a	  pro-­‐resolution	  group	  separate	  from	  the	  known	  inhibitors.	  One	  exception	  of	  
particular	   interest,	   isopimpinellin,	   clustered	   closely	   with	   the	   pan-­‐PI-­‐3K	   inhibitor,	  
ZSTK474.	  This	  is	  an	  ATP-­‐competitive	  inhibitor,	  specific	  to	  class	  I	  PI-­‐3K	  isoforms	  (Kong	  &	  
Yamori,	  2010).	  The	  anti-­‐inflammatory	  properties	  of	  isopimpinellin	  are	  unknown,	  thus	  I	  
reasoned	  that	  it	  might	  be	  interesting	  to	  pursue	  this	  compound	  as	  a	  potential	  lead	  and	  
attempt	   to	   dissect	   the	   mechanisms	   responsible	   for	   its	   activity.	   Isopimpinellin	   is	   a	  
naturally	   occurring	   furanocoumarin	   found	   in	   plants	   of	   the	   Apiaceae	   family	   such	   as	  
carrot	  and	  parsley.	  Along	  with	  other	  similar	  compounds,	  it	  has	  been	  investigated	  for	  its	  
potential	  anti-­‐carcinogenic	  properties	  (Kleiner	  et	  al.,	  2002;	  Prince	  et	  al.,	  2006).	  	  
	  
In	   the	   secondary	   assays	   performed	   following	   the	   screen,	   isopimpinellin	   appeared	   to	  
have	   powerful	   effects	   on	   both	   the	   recruitment	   and	   resolution	   phases	   of	   the	  
inflammatory	   response	   induced	   by	   tail	   fin	   wounding	   in	   zebrafish	   larvae.	   As	   the	  
hierarchical	  clustering	  discussed	  in	  Chapter	  3	  paired	  this	  hit	  compound	  with	  a	  known	  
inhibitor	  of	  PI-­‐3K	  signalling,	  I	  hypothesised	  that	  isopimpinellin	  acts	  via	  PI-­‐3K	  to	  inhibit	  
neutrophil	  recruitment	  and	  potentially	  neutrophil	  survival	  during	  resolution.	  	  
4.1.1	  The	  role	  of	  PI-­‐3K	  in	  neutrophil	  recruitment	  
It	   is	  well	   established	   that	   PI-­‐3K	   is	   functionally	   important	   in	   neutrophil	   chemotaxis,	   a	  
role	  that	  was	  initially	  revealed	  using	  the	  pan-­‐PI-­‐3K	  inhibitor,	  wortmannin	  (Okada	  et	  al.,	  
1994).	   Since	   then	   studies	   have	   indicated	   that	   PI-­‐3Kγ	   is	   the	   principal	   class	   I	   isoform	  
involved	  in	  leukocyte	  migration.	  Neutrophils	  from	  PI-­‐3Kγ-­‐/-­‐	  mice	  are	  unable	  to	  produce	  
PIP3	   and	   phosphorylate	   AKT	   upon	   stimulation	  with	   chemotactic	   agents	   signalling	   via	  




respiratory	  burst	  (Hirsch,	  2000).	  PI-­‐3Kγ	  is	  important	  for	  multiple	  steps	  in	  the	  neutrophil	  
migration	  response,	  enabling	  morphological	  changes	  to	  occur	  within	  the	  cell	  to	  permit	  
polarisation	   and	   directional	   movement	   towards	   the	   chemotactic	   gradient.	   This	   is	  
dependent	   on	   the	   tightly	   controlled	   spatial	   and	   temporal	   accumulation	   of	   PIP3,	   AKT	  
and	   F-­‐actin	   at	   the	   leading	   edge,	   a	   process	  which	   is	   impaired	   in	   PI-­‐3Kγ-­‐/-­‐	   neutrophils	  
(Hannigan	   et	   al.,	   2002;	   Ferguson	   et	   al.,	   2007).	   Cytoskeletal	   rearrangements	   are	  
regulated	   by	   Rho	   family	   GTPases	   and	   a	   positive	   feedback	   loop	   exists	   between	   the	  
accumulation	  of	  PIP3	  and	  activation	  of	  Rac	  to	  amplify	  the	  chemotactic	  response,	  which	  
mediates	   asymmetric	   F-­‐actin	   assembly	   and	   specifies	   formation	   of	   the	   leading	   edge	  
(Weiner	  &	  Neilsen,	  2002;	  Costa	  et	  al.,	  2007).	  Another	  GTPase,	  Cdc42,	  is	  considered	  to	  
be	   important	   for	   directionality	   in	   neutrophils	   and	   for	   preserving	   stability	   of	   the	  
pseudopod	  (Srinivasan	  et	  al.,	  2003;	  Xu	  et	  al.,	  2003).	  There	  is	  evidence	  to	  suggest	  that	  
an	  alternative	  isoform,	  PI-­‐3Kδ,	  may	  also	  facilitate	  directional	  neutrophil	  migration.	  Its	  
specific	  blockade	  using	  the	  pharmacological	  inhibitor	  IC87114	  inhibits	  PIP3	  production	  
and	   polarisation	   (Sadhu	   et	   al.,	   2003)	   and	   reduces	   recruitment	   of	   neutrophils	   to	   the	  
lung	  in	  a	  mouse	  model	  of	  acute	  pulmonary	  inflammation	  (Puri	  et	  al.,	  2004).	  
	  
The	  zebrafish	  has	  provided	  insight	   into	  the	  molecular	  events	  regulating	  the	  dynamics	  
of	   neutrophil	   chemotaxis	   and	   is	   a	   particularly	   useful	   model	   due	   to	   the	   ease	   of	  
visualising	   individual	   migrating	   cells	   in	   vivo	   in	   real	   time.	   It	   has	   been	   shown	   that	  
inhibition	  of	  PI-­‐3Kγ	  in	  zebrafish	  also	  disrupts	  neutrophil	  polarisation	  and	  directionality	  
and	  that	  protrusion	  of	  the	  leading	  edge	  can	  be	  rescued	  using	  a	  photoactivatable	  form	  
of	  Rac,	  however	  this	  is	  not	  sufficient	  to	  fully	  induce	  migration	  (Yoo	  et	  al.,	  2010).	  Using	  
specific	   probes	   designed	   to	   detect	   both	   stable	   and	   dynamic	   F-­‐actin,	   the	   authors	  
demonstrated	  that	  PI-­‐3K	  regulates	  the	  anteroposterior	  polarity	  of	  F-­‐actin	  in	  parallel	  to	  
activation	  of	   Rac	   at	   the	   leading	   edge,	   suggestive	   of	   a	   novel	   two-­‐tiered	   regulation	  of	  
neutrophil	  migration	  by	  PI-­‐3K.	  
4.1.2	  The	  role	  of	  PI-­‐3K	  in	  neutrophil	  survival	  
Not	  only	  does	  PI-­‐3K	  play	  a	  critical	  and	  complex	  role	  in	  neutrophil	  chemotaxis,	  but	  also	  
in	   neutrophil	   survival,	   via	   the	   PI-­‐3K/AKT/mTOR	   (mammalian	   target	   of	   rapamycin)	  
signal	   transduction	   pathway.	   PI-­‐3K	   mediates	   the	   anti-­‐apoptotic	   effects	   of	   several	  
	  132	  
granulocyte	   survival	   signals	   through	   activation	   of	   AKT,	   which	   regulates	   a	   host	   of	  
downstream	   target	   proteins	   including	   various	   members	   of	   the	   BCL-­‐2	   family,	   the	  
Forkhead	   family	   of	   transcription	   factors,	  NF-­‐κB	   and	   cAMP	   response	   element-­‐binding	  
protein	  (CREB)	  (Brazil	  et	  al.,	  2002;	  Hallett	  et	  al.,	  2008).	  For	  example,	  GM-­‐CSF	  and	  TNF-­‐α	  
have	  been	  shown	  to	  promote	  neutrophil	  survival	  via	  PI-­‐3K	  dependent	  phosphorylation	  
and	  cytosolic	  translocation	  of	  BAD	  protein,	  in	  parallel	  with	  a	  reduction	  in	  transcription	  
of	   Bad	   mRNA	   (Cowburn	   et	   al.,	   2002).	   AKT	   can	   activate	   NF-­‐κB	   signalling	   by	  
phosphorylation	  of	  the	  IKK	  complex	  (Datta	  et	  al.,	  1999)	  and	  it	  has	  been	  shown	  that	  NF-­‐
κB	   nuclear	   translocation	   is	   inhibited	   in	   neutrophils	   from	   PI-­‐3Kγ-­‐/-­‐	   mice,	   leading	   to	  
reduced	   levels	   of	   the	   survival	   protein	   Bcl-­‐x(L)	   (Yang	   et	   al.,	   2003).	   Neutrophils	   from	  
these	  mice	  also	  have	  diminished	   levels	  of	  Mcl-­‐1,	  a	  key	  anti-­‐apoptotic	  protein,	  due	  to	  
reduced	   phosphorylation	   of	   CREB.	   Similarly,	   AKT	   can	   control	   the	   expression	   of	   pro-­‐
apoptotic	   factors,	   for	   example	  by	   the	  phosphorylation	   and	   inactivation	  of	   FKHR1,	   to	  
stimulate	  nuclear	  export	  and	  inhibit	  transcriptional	  activity	  (Biggs	  et	  al.,	  1999).	  	  
	  
PI-­‐3K/AKT/mTOR	   signalling	   is	   tightly	   regulated	   to	   prevent	   uncontrolled	   cell	  
proliferation	   and	   both	   PI-­‐3K	   and	   AKT	   inhibitors	   can	   induce	   neutrophil	   death.	  
Phosphatases	   act	   as	   endogenous	   regulators	   of	   AKT	   activity,	   for	   example	   survival	   is	  
prolonged	   in	   phosphatase	   and	   tensin	   homologue	   (PTEN)-­‐null	   neutrophils	   due	   to	  
accumulation	  of	  PIP3	  at	  the	  plasma	  membrane,	  which	  leads	  to	  enhanced	  AKT	  signalling	  
(Zhu	  et	  al.,	  2006).	  Depletion	  of	  PTEN	  and	  subsequent	  activation	  of	  AKT	  has	  also	  been	  
shown	   to	   increase	   actin	   polymerisation	   and	   neutrophil	   responsiveness	   to	  
chemoattractants	   and	   these	   properties	   are	   reflected	   in	   vivo	   by	   increased	   neutrophil	  
recruitment	  in	  a	  mouse	  model	  of	  peritonitis	  (Subramanian	  et	  al.,	  2007).	  	  
4.1.3	  Aims	  and	  hypotheses	  
The	  specific	  aim	  of	  this	  chapter	  is	  to	  investigate	  the	  effect	  of	  isopimpinellin	  on	  both	  the	  
recruitment	   and	   resolution	   phases	   of	   inflammation,	   with	   the	   hypothesis	   that	   this	  
activity	   can	  be	   attributed	   to	   an	   inhibition	  of	   PI-­‐3K	   signalling.	   I	  will	   also	  examine	  and	  
compare	   the	   chemical	   structures	   of	   the	   positive	   hit	   compounds	   identified	   in	   the	  





4.2	  Isopimpinellin	  significantly	  inhibits	  neutrophil	  recruitment	  
	  
With	  recruitment	  being	  the	  initial	  phase	  of	  the	  inflammatory	  response,	  it	  was	  logical	  to	  
first	   explore	   the	   mechanism	   governing	   the	   inhibition	   of	   neutrophil	   recruitment	  
observed	   with	   isopimpinellin	   treatment.	   To	   confirm	   these	   initial	   findings	   and	  
investigate	  the	  dose	  dependency	  more	  thoroughly,	  3	  dpf	  mpx:GFP	  larvae	  were	  injured	  
and	  treated	  immediately	  with	  a	  range	  of	  concentrations	  of	  isopimpinellin.	  Numbers	  of	  
neutrophils	   at	   the	   site	   of	   injury	   at	   6	   hpi	  were	   counted	   as	   described	   in	   the	   previous	  
recruitment	  assays.	  Isopimpinellin	  significantly	  inhibited	  neutrophil	  recruitment	  to	  the	  
wound	  from	  a	  concentration	  of	  10	  μM	  up	  to	  250	  μM,	  though	  at	  the	  highest	  dose	  some	  
signs	  of	  toxicity	  were	  observed	  (Figure	  4.1).	  
	  
A	   preliminary	   experiment	   was	   performed	   to	   further	   explore	   the	   effect	   of	  
isopimpinellin	   on	   specific	   aspects	   of	   neutrophil	   migratory	   behaviour	   during	   the	  
recruitment	  phase.	  At	  3	  dpf,	  mpx:GFP	  larvae	  were	  pre-­‐treated	  with	  isopimpinellin	  for	  2	  
hours,	  prior	  to	   injury	  and	  mounting	   in	  agarose	  for	  time-­‐lapse	   imaging	  on	  an	   inverted	  
compound	   fluorescence	   microscope.	   GFP-­‐labelled	   neutrophils	   were	   tracked	   for	   one	  
hour	  as	  they	  migrated	  towards	  the	  site	  of	   injury	  and	  Volocity®	  software	  was	  used	  to	  
analyse	   the	   speed	   and	   meandering	   index	   of	   each	   individual	   cell	   track.	   Meandering	  
index	  is	  calculated	  by	  dividing	  the	  displacement	  of	  each	  cell	  by	  the	  length	  of	  the	  path	  it	  
has	  travelled.	  This	  gives	  an	  indication	  of	  how	  directly	  the	  cell	  moves,	  though	  does	  not	  
take	   into	   account	   the	   actual	   direction	   in	   which	   it	   travels.	   A	   meandering	   index	   of	   1	  
indicates	   movement	   in	   a	   straight	   line.	   The	   results	   obtained	   from	   one	   experiment	  
suggested	   that	   isopimpinellin	   reduced	   both	   neutrophil	   speed	   and	  meandering	   index	  	  
(Figure	   4.2	   A,	   B).	   Displacement	   towards	   the	   wound	   was	   significantly	   lower	   in	  
neutrophils	  from	  isopimpinellin	  treated	  larvae	  (Figure	  4.2	  C).	  Despite	  this,	  neutrophils	  
still	   appeared	   to	  move	   towards	   the	  wound,	  as	   indicated	  by	   the	  bearing,	   in	  which	  an	  
angle	  of	  0-­‐180	  degrees	  represents	  movement	  towards	  the	  wound	  and	  an	  angle	  of	  180-­‐
360	   degrees	   represents	  movement	   away	   (Figure	   4.2	   D).	   This	   gives	   a	  more	   accurate	  
measure	  of	  directionality	   and	   suggested	   that	  even	   in	   the	  presence	  of	   isopimpinellin,	  















Figure	   4.1:	   Isopimpinellin	   significantly	   inhibits	   neutrophil	   recruitment	   in	   a	   dose	  
dependent	  manner.	  
At	   3	   dpf,	  mpx:GFP	   larvae	  were	   injured	   and	   treated	   immediately	  with	   varying	   doses	   of	   isopimpinellin.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  6	  hpi.	  Isopimpinellin	  caused	  a	  dose-­‐dependent	  
reduction	  in	  neutrophil	  recruitment	  to	  the	  wound,	  with	  significantly	  lower	  neutrophil	  numbers	  present	  
in	   larvae	   treated	  with	   isopimpinellin	  at	   a	   concentration	  of	  10	  μM	  and	  higher	   compared	   to	   the	  DMSO	  
vehicle	  control	   (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05	  and	  
***	  P	   <	   0.001;	  n	  =	   18,	   performed	   as	   3	   independent	   experiments).	   Dotted	   line	   at	   y	   =	   20.17	   indicates	  




















































Figure	  4.2:	  Isopimpinellin	  affects	  neutrophil	  chemotaxis	  but	  not	  directionality.	  
At	   3	   dpf,	  mpx:GFP	   larvae	   were	   pre-­‐treated	   with	   DMSO	   or	   25	   μM	   isopimpinellin	   before	   injury	   and	  
mounting.	   Larvae	   were	   imaged	   for	   1	   hour	   and	   individual	   GFP-­‐labelled	   neutrophils	   were	   tracked	   and	  
analysed	   using	   Volocity®	   software.	   Preliminary	   data	   suggested	   that	   isopimpinellin	   decreases	   (A)	  
neutrophil	  speed,	  (B)	  meandering	  index	  and	  (C)	  displacement	  towards	  the	  wound	  (Unpaired	  t-­‐test;	  P	  <	  
0.05;	  n	  =	  6,	  performed	  as	  1	  experiment).	  For	  bearing	  (D),	  an	  angle	  of	  0-­‐180	  degrees	  indicates	  movement	  
towards	  the	  wound	  and	  180-­‐360	  degrees	  indicates	  movement	  away.	  In	  both	  DMSO	  and	  isopimpinellin	  
treated	   larvae,	   neutrophils	   appeared	   to	   move	   in	   a	   directed	   fashion	   towards	   the	   wound	   (n	   =	   6,	  
performed	  as	  1	  experiment).	  	  	  























































































































4.3	  Development	  of	  an	  in	  vivo	  assay	  for	  PI-­‐3K	  activity	  
	  
In	  order	  to	  determine	  whether	  the	  effect	  of	  isopimpinellin	  on	  neutrophil	  migration	  to	  
the	  tail	  fin	  wound	  was	  occurring	  via	  an	  effect	  on	  PI-­‐3K	  signalling,	  I	  sought	  to	  establish	  
an	   assay	   similar	   to	   that	   described	   in	   (Yoo	   et	   al.,	   2010),	   which	   would	   allow	   me	   to	  
observe	   cell-­‐specific	   changes	   in	   PI-­‐3K	   activity	   in	   vivo.	   I	   used	   the	   Tg(lyz:PHAkt-­‐EGFP)	  
zebrafish	   line,	   a	   kind	   gift	   obtained	   through	   collaboration	  with	  Dr	   Xingang	  Wang	   and	  
Prof	  Philip	  Ingham	  (IMCB,	  Singapore),	  which	  expresses	  a	  mutant	  form	  of	  Akt	  with	  the	  
Pleckstrin	  Homology	  (PH)	  domain	  fused	  to	  EGFP	  (PHAkt-­‐EGFP),	  under	  the	  lyz	  promoter	  
(Wang	  et	  al.,	  in	  submission).	  This	  enables	  real	  time	  visualisation	  of	  the	  translocation	  of	  
PHAkt-­‐EGFP	   to	   the	  plasma	  membrane,	  which	  was	  originally	  demonstrated	   in	   vitro	   in	  
HL-­‐60	  cells	  following	  stimulation	  with	  the	  chemoattractants	  fMLP	  and	  C5a	  (Servant	  et	  
al.,	  2000).	  AKT	  binds	  directly	  to	  PIP3	  at	  the	  membrane	  via	  its	  PH	  domain,	  where	  once	  
activated	  it	  can	  in	  turn	  activate	  a	  host	  of	  downstream	  targets	  required	  for	  neutrophil	  
migration.	  Trafficking	  of	  PHAkt-­‐GFP	   to	   the	  membrane	   is	   therefore	  dependent	  on	   the	  
production	   of	   PIP3	   by	   activated	   Class	   I	   PI-­‐3Ks	   and	   a	   loss	   of	   this	   localisation	   would	  
indicate	  an	  inhibition	  of	  signalling	  either	  directly	  on	  or	  upstream	  of	  PI-­‐3K.	  	  
	  
I	  hypothesised	   that	   isopimpinellin	  would	  cause	  a	   reduction	   in	   the	  plasma	  membrane	  
localisation	   of	   PHAkt-­‐EGFP	   in	   neutrophils	   following	   tail	   fin	   injury,	   suggestive	   of	   an	  
inhibitory	  effect	  on	  PI-­‐3K	  signalling.	  	  	  
4.3.1	  LY294002	  is	  a	  potent	  inhibitor	  of	  neutrophil	  recruitment	  in	  vivo	  
To	   design	   a	   robust	   assay	   for	   PI-­‐3K	   activity,	   a	   reliable	   positive	   control	   was	   required,	  
ideally	   a	   known	   inhibitor	   of	   PI-­‐3K	   signalling	  with	   functional	   activity	   in	   zebrafish.	   The	  
readily	   available	   PI-­‐3K	   inhibitor	   LY294002	   had	   previously	   been	   shown	   to	   reduce	  
neutrophil	   migration	   to	   a	   laser	   induced	   wound	   in	   the	   caudal	   haematopoietic	   tissue	  
(Yoo	  et	  al.,	  2010).	  On	  testing	  this	  compound	  in	  a	  standard	  recruitment	  assay	  in	  3	  dpf	  
mpx:GFP	  larvae,	  I	  found	  that	  it	  significantly	  reduced	  neutrophil	  numbers	  at	  the	  tail	  fin	  
wound	   at	   6	   hpi	   (Figure	   4.3	   A).	   Interestingly,	   LY294002	   also	   caused	   a	   reduction	   in	  








Figure	  4.3:	   LY294002	  significantly	   inhibits	  neutrophil	   recruitment	  and	   inflammation	  
resolution.	  	  
Tail	   transection	   was	   performed	   on	  mpx:GFP	   larvae	   at	   3	   dpf.	   For	   the	   recruitment	   assay,	   larvae	   were	  
treated	   immediately,	  as	   indicated,	  and	  numbers	  of	  neutrophils	  at	   the	  site	  of	   injury	  were	  counted	  at	  6	  
hpi.	  For	  the	  resolution	  assay,	  larvae	  with	  a	  good	  inflammatory	  response	  were	  selected	  for	  treatment	  at	  
6	  hpi	  and	  counts	  were	  performed	  at	  12	  hpi.	  SP600125	  was	  used	  at	  30	  μM	  as	  a	  positive	  control.	  At	  both	  
concentrations	   tested,	  LY294002	  significantly	   inhibited	  neutrophil	   recruitment	   (A)	  and	  accelerated	  the	  
resolution	  of	   inflammation	  (B)	   (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  


































































































































To	   more	   thoroughly	   investigate	   the	   effect	   of	   this	   inhibitor	   on	   neutrophil	   migration	  
during	   the	   initial	   phase	   of	   neutrophil	   recruitment,	   3	   dpf	  mpx:GFP	   larvae	   were	   pre-­‐
treated	  with	  50	  μM	  LY294002	   for	  2	  hours	  before	   tail	   fin	   transection	  was	  performed,	  
then	  larvae	  were	  mounted	  in	  agarose	  for	  time-­‐lapse	  imaging	  and	  tracking.	  During	  the	  
first	  hour	  following	  injury,	  neutrophil	  speed	  was	  significantly	  reduced	  in	  the	  presence	  
of	  LY294002,	  but	  meandering	  index	  was	  unchanged	  (Figure	  4.4	  A,	  B).	  The	  displacement	  
was	  also	  significantly	  reduced	  in	  the	  LY294002	  treated	  neutrophils	  (Figure	  4.4	  C),	  but	  
those	  that	  did	  move,	  migrated	  directionally	  towards	  the	  wound	  (Figure	  4.4	  D).	  It	  seems	  
that	   in	   the	   presence	   of	   LY294002,	   chemotaxis	   is	   partially	   inhibited	   such	   that	   most	  
neutrophils	  either	  remain	  stationary	  or	  move	  only	  short	  distances	  slowly	  towards	  the	  
wound.	   The	  bearing	   analysis	   reveals	   that	   significantly	  more	  of	   these	  neutrophils	   can	  
detect	  the	  chemotactic	  gradient	  and	  move	  in	  the	  appropriate	  direction,	  compared	  to	  
the	  number	  that	  appear	  to	  move	  away	  from	  the	  wound.	   It	   is	  possible	  that	  LY294002	  
does	  not	   fully	   inhibit	  PI-­‐3K	   signalling	   in	   all	   of	   the	  neutrophils,	   or	  perhaps	  alternative	  
signalling	  mechanisms	  are	  overriding	  this	  inhibition	  to	  promote	  directed	  migration.	  	  
4.3.2	  LY294002	  inhibits	  PI-­‐3K	  activity	  and	  neutrophil	  polarisation	  	  
To	   investigate	   the	   effect	   of	   LY294002	   in	   migrating	   neutrophils	   in	   the	   Tg(lyz:PHAkt-­‐
EGFP)	  line,	  subsequently	  referred	  to	  as	  lyz:PHAkt,	  larvae	  at	  3	  dpf	  were	  incubated	  with	  
the	   inhibitor	   for	   2	   hours	   prior	   to	   tail	   fin	   transection,	   then	   mounted	   in	   agarose.	  
Individual	  neutrophils	   in	   the	  region	  between	  the	  wound	  site	  and	  the	  posterior	  blood	  
island	  were	  imaged	  on	  an	  UltraVIEWVoX	  spinning	  disk	  confocal	  imaging	  system	  with	  an	  
inverted	  Olympus	   IX81	  microscope,	  at	  60x	  magnification.	   It	  was	   immediately	  obvious	  
through	  observation	  by	  eye	  that	  neutrophils	  in	  larvae	  treated	  with	  LY294002	  displayed	  
a	   very	   different	   pattern	   of	   PHAkt-­‐EGFP	   localisation	   compared	   to	   the	   DMSO	   vehicle	  
control	   larvae,	  with	   the	  EGFP	   signal	   dispersed	  over	   the	  whole	   cell	   rather	   than	  being	  
















Figure	  4.4:	  LY294002	  significantly	  decreases	  neutrophil	  speed	  and	  displacement.	  	  
At	  3	  dpf,	  mpx:GFP	  larvae	  were	  pre-­‐treated	  with	  DMSO	  or	  50	  μM	  LY294002	  before	  injury,	  mounting	  and	  
imaging	   for	   1	   hour.	   Individual	   GFP-­‐labelled	   neutrophils	   were	   tracked	   and	   analysed	   using	   Volocity®	  
software.	   LY294002	   significantly	   decreased	   (A)	   neutrophil	   speed	   and	   (C)	   displacement	   towards	   the	  
wound	  (Unpaired	  t-­‐test;	  P	  <	  0.001;	  n	  ≥	  16	  performed	  as	  2	  independent	  experiments).	  Meandering	  index	  
was	  unchanged	  (B).	  For	  bearing,	  an	  angle	  of	  0-­‐180	  degrees	  indicates	  movement	  towards	  the	  wound	  and	  
180-­‐360	   degrees	   indicates	  movement	   away.	   In	   both	  DMSO	   and	   LY294002	   treated	   larvae,	   neutrophils	  
move	  in	  a	  directed	  fashion	  towards	  the	  wound	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  
post-­‐test	   to	  compare	  selected	  columns;	  where	  **	  P	  <	  0.01	  and	  ***	  P	  <	  0.001;	  n	  ≥	  16,	  performed	  as	  2	  
independent	  experiments).	  	  	  
	  






















































































































Neutrophils	   from	   DMSO	   vehicle	   control	   treated	   larvae	   appeared	   polarised,	   with	  
particularly	  strong	  expression	  of	  EGFP	  in	  pseudopodia	  at	  their	  leading	  edge	  and	  only	  a	  
faint	   EGFP	   signal	   within	   the	   cell	   body.	   When	   observed	   during	   short	   time-­‐lapses	   of	  
approximately	  30	  minutes,	  neutrophils	  from	  DMSO	  control	  larvae	  appeared	  to	  migrate	  
normally	  to	  the	  site	  of	  injury	  whereas	  neutrophils	  in	  LY294002	  treated	  larvae	  seemed	  
mostly	  static.	  
	  
In	   an	   attempt	   to	   quantify	   the	   images	   generated	   so	   that	   statistical	   analysis	   could	   be	  
applied,	  a	  measurement	   termed	   the	   ‘polarity	   index’	  was	  devised.	  This	  accounted	   for	  
the	  difference	  in	  EGFP	  intensity	  at	  the	  leading	  edge	  of	  the	  cell	  compared	  to	  the	  trailing	  
edge	  and	  also	  compared	  to	   the	   fluorescence	  within	   the	  cell.	   In	   ImageJ,	  a	   transecting	  
line	  was	  drawn	   through	  each	  cell	   towards	   the	   leading	  edge;	   to	   create	  a	  quantitative	  
readout	  of	  the	  fluorescence	  intensity	  per	  pixel	  (Figure	  4.5	  B,	  C).	  Using	  Microsoft	  Excel,	  
the	   mean	   intensities	   along	   sections	   of	   this	   line	   (as	   defined	   in	   Figure	   4.5	   C	   and	  
described	  in	  more	  detail	  in	  section	  2.4.5)	  were	  entered	  into	  the	  equation:	  
	   !"#$%&'(  !"#$% = !"#!" ! !   ×   ! + !! 	  !ℎ!"!  ! = !"#$%$&'  !"#!  !"  !"##;   ! = !"#$%&'  !"#!  !"  !"##; ! = !ℎ!"#  !"##	  
	  
Using	   this	   equation,	   LY294002	   appeared	   to	   significantly	   reduce	   the	  polarity	   index	  of	  
neutrophils	   compared	   to	   the	   DMSO	   control	   (Figure	   4.5	   D),	   suggesting	   reduced	  
activation	  and	  translocation	  of	  PHAkt-­‐EGFP	  to	  the	  plasma	  membrane	  and	  a	  loss	  of	  the	  





Figure	  4.5:	  LY294002	  significantly	  reduces	  neutrophil	  polarity	  index	  in	  Tg(lyz:PHAkt-­‐
EGFP)	  larvae.	  
At	  3	  dpf,	  lyz:PHAkt	  larvae	  were	  pre-­‐treated	  with	  either	  50	  μM	  LY294002	  or	  DMSO	  vehicle	  control	  for	  2	  
hours	  before	   tail	   fin	   injury	  and	  mounting	   for	  observation	  on	  a	   confocal	   spinning	  disk	   imaging	   system.	  	  
Representative	  images	  of	  individual	  neutrophils	  in	  the	  region	  between	  the	  wound	  site	  and	  the	  posterior	  
blood	  island	  are	  shown	  in	  (A).	  Scale	  bar	  represents	  11	  μm.	  To	  analyse	  polarity,	  the	  fluorescence	  intensity	  
in	  a	  transection	  of	  each	  neutrophil	  was	  measured	  in	  ImageJ	  to	  create	  intensity	  profiles	  as	  exampled	  in	  
(B)	   and	   (C).	   Polarity	   index	   was	   calculated	   using	   the	   equation	   described	   above	   and	   the	   parameters	  
illustrated	   in	   (B).	   LY294002	   significantly	   reduced	   neutrophil	   polarity	   index	   compared	   to	   the	   DMSO	  


























4.3.3	  Isopimpinellin	  significantly	  reduces	  neutrophil	  polarity	  index	  
Having	  designed	  an	  assay	  with	  the	  potential	  to	  identify	  compounds	  that	  inhibited	  PI-­‐3K	  
activity	   in	   vivo,	   I	   tested	   isopimpinellin	   in	   the	   same	   manner	   and	   found	   that	   after	   2	  
hours,	  neutrophils	  from	  isopimpinellin	  treated	  larvae	  did	  not	  migrate	  as	  readily	  to	  the	  
site	   of	   injury	   as	   neutrophils	   from	   vehicle	   only	   control	   treated	   larvae.	  Most	   of	   these	  
neutrophils	  did	  not	  appear	  to	  have	  a	  defined	  leading	  edge,	  comparable	  to	  those	  from	  
larvae	  treated	  with	  the	  positive	  control	  LY294002,	  and	  they	  displayed	  a	  similar	  pattern	  
of	   dispersed	   EGFP	   signal	   over	   the	   whole	   cell	   (Figure	   4.6).	   Using	   the	   polarity	   index	  
equation,	  isopimpinellin	  significantly	  reduced	  neutrophil	  polarisation,	  to	  a	  level	  almost	  
equal	   to	   that	  of	   LY294002	   (mean	  ±	  SEM	  of	   isopimpinellin	  polarity	   index	  =	  0.02684	  ±	  
0.004,	   compared	   to	   0.02404	   ±	   0.004	   for	   LY294002).	   These	   results	   suggest	   that	  
isopimpinellin	   acts	   either	   directly	   on	  or	   upstream	  of	   PI-­‐3K,	   to	  disrupt	  Akt	   activation,	  
neutrophil	   polarisation	   and	   directional	   migration,	   which	   may	   explain	   the	   inhibitory	  
effect	  of	  this	  compound	  on	  neutrophil	  recruitment.	  	  
	  
To	   test	   whether	   the	   effects	   observed	   on	   PHAkt-­‐EGFP	   localisation	   and	   neutrophil	  
polarity	   were	   specific	   to	   the	   individual	   compounds	   tested	   and	   not	   simply	   a	   general	  
consequence	   of	   exposing	   larvae	   to	   compounds	   that	   have	   been	   shown	   to	   affect	  
neutrophilic	   inflammation,	   I	  chose	  to	   investigate	  the	  effects	  of	  some	  of	  the	  other	  hit	  
compounds	  in	  this	  PI-­‐3K	  assay.	  Xanthone	  and	  tanshinone	  IIA	  were	  tested	  in	  the	  same	  
manner,	   alongside	   LY294002.	   In	   xanthone	   treated	   lyz:PHAkt	   larvae,	   neutrophils	  
adopted	  a	  similar	  phenotype	  to	  that	  observed	  in	  LY294002	  and	  isopimpinellin	  treated	  
larvae,	  which	  was	  reflected	   in	  a	  significantly	   reduced	  polarity	   index	  compared	  to	   the	  
DMSO	   control	   (Figure	   4.7	   D).	   Tanshinone	   IIA	   however,	   did	   not	   appear	   to	   have	   any	  
effect	   on	   the	   membrane	   localisation	   of	   PHAkt-­‐EGFP	   and	   polarity	   index	   remained	  
unchanged	  (Figure	  4.7	  E).	  
	  
These	  results	  suggested	  that	  the	  loss	  of	  membrane	  localisation	  of	  PHAkt-­‐EGFP	  was	  not	  
a	  universal	  property	  of	   the	  positive	  hits	   identified	   in	   the	  Spectrum	  Collection	  screen,	  
but	  a	  specific	  effect	  of	  some	  compounds,	  which	  could	  be	  explained	  by	  inhibition	  of	  PI-­‐











Figure	   4.6:	   Isopimpinellin	   significantly	   reduces	   neutrophil	   polarity	   index	   in	  
Tg(lyz:PHAkt-­‐EGFP)	  larvae.	  
At	  3	  dpf,	  lyz:PHAkt	  larvae	  were	  pre-­‐treated	  with	  either	  25	  μM	  isopimpinellin,	  50	  μM	  LY294002	  or	  DMSO	  
vehicle	   control	   for	   2	   hours	   before	   tail	   fin	   injury	   and	   imaging	   as	   described	   previously.	   	   Neutrophils	   in	  
isopimpinellin	   treated	   larvae	   exhibited	   similar	   fluorescence	   intensity	   profiles	   as	   neutrophils	   from	  
LY294002	  treated	   larvae.	  A	  representative	   intensity	  plot	   is	  shown	   in	   (A),	  matched	  to	  the	  neutrophil	   in	  
(B).	  Scale	  bar	  represents	  11	  μm.	  Isopimpinellin	  significantly	  reduced	  neutrophil	  polarity	  index	  compared	  
to	  the	  DMSO	  control	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  **	  P	  <	  0.01	  



























Figure	  4.7:	  Xanthone	  but	  not	  tanshinone	  IIA	  reduces	  neutrophil	  polarity	  index.	  
At	  3	  dpf,	  lyz:PHAkt	  larvae	  were	  pre-­‐treated	  with	  either	  25	  μM	  xanthone,	  25	  μM	  tanshinone	  IIA,	  50	  μM	  
LY294002	  or	  DMSO	  vehicle	  control	  for	  2	  hours	  before	  tail	  fin	  injury	  and	  imaging	  as	  described	  previously.	  
Representative	   images	   of	   neutrophils	   are	   shown	   in	   (A)	   along	   with	   matched	   fluorescence	   intensity	  
profiles	   for	   (B)	   xanthone	   and	   (C)	   tanshinone	   IIA.	   Scale	   bar	   represents	   11	   μm.	   Xanthone	   significantly	  
reduced	   neutrophil	   polarity	   index	   compared	   to	   the	   DMSO	   control	   (One-­‐way	   ANOVA	   with	   Dunnett’s	  
multiple	   comparison	   post-­‐test;	   P	   <	   0.001)	   whereas	   tanshinone	   IIA	   had	   no	   significant	   effect	   (n	   ≥	   27,	  















































4.4	  Chemical	  structural	  comparison	  reveals	  a	  common	  ‘chromone’	  group	  
	  
In	  lyz:PHAkt	  larvae,	  both	  isopimpinellin	  and	  xanthone	  appeared	  to	  inhibit	  recruitment	  
of	  Akt	   to	  the	  plasma	  membrane	  and	  reduced	  the	  neutrophil	  polarity	   index	  to	  a	   level	  
comparable	  to	  that	  of	  the	  known	  PI-­‐3K	   inhibitor,	  LY294002.	  With	  the	   idea	  that	  these	  
compounds	  might	  be	  exerting	  their	  effects	  on	  the	  inflammatory	  response	  by	  acting	  on	  
a	   common	   pathway	   or	   pathways,	   I	   hypothesised	   that	   their	   activity	  might	   be	   due	   to	  
shared	   structural	   similarity.	   The	   molecular	   structures	   of	   the	   positive	   hits	   were	  
identified	  using	  their	  unique	  Chemical	  Abstracts	  Service	  (CAS)	  numbers	  as	  provided	  in	  
the	   Spectrum	   Collection	   database.	   By	   simple	   visual	   comparison,	   it	   was	   obvious	   that	  
there	  was	   some	   structural	   similarity.	   A	   particular	   chemical	   group	  was	   common	   to	   a	  
subset	   of	   the	   hits,	   consisting	   of	   fused	   benzene	   and	   pyran	   rings	   with	   an	   attached	  
carbonyl	  group.	  Technically	  termed	  1,4-­‐benzopyrone	  and	  more	  commonly	  referred	  to	  
as	  ‘chromone’,	  this	  group	  or	  its	  isomer	  ‘coumarin’	  (1-­‐benzopyran-­‐2-­‐one)	  is	  present	  in	  4	  
of	   the	   best	   positive	   hits	   identified	   in	   the	   screen	   and	   interestingly	   also	   in	   LY294002	  
(Figure	   4.8).	   From	   the	   other	   10	   reproducible	   positive	   hits	   that	   weren’t	   tested	   in	  
secondary	  assays	  (those	  that	  scored	  greater	  than	  or	  equal	  to	  1.5	  but	  less	  than	  2	  in	  the	  
second	   round	   of	   screening),	   a	   further	   3	   compounds	   were	   derivatives	   of	   chromone	  
(Figure	  4.9).	  	  	  
4.4.1	  Investigation	  into	  the	  effects	  of	  chromone	  on	  the	  inflammatory	  response	  
As	   the	   chromone	   group	  was	   shared	   by	   a	   number	   of	   the	   positive	   hits	   and	   the	   PI-­‐3K	  
inhibitor	   LY294002,	   I	   hypothesised	   that	   this	   structure	   might	   be	   responsible	   for	   the	  
activity	  of	   these	  compounds,	  particularly	  on	  neutrophil	   recruitment.	  Notably	  the	  two	  
compounds	   that	  had	   similar	  effects	   to	   LY294002	   in	   the	  PI-­‐3K	  assay	  described	  above,	  
isopimpinellin	  and	  xanthone,	  both	  contain	  a	  chromone	  group,	  whereas	  tanshinone	  IIA,	  
which	   did	   not	   reduce	   neutrophil	   polarity	   index,	   does	   not	   share	   this	   structural	  
similarity.	   To	   test	   whether	   the	   effects	   of	   the	   chromone-­‐derived	   positive	   hits	   on	  
neutrophilic	   inflammation	   were	   specifically	   due	   to	   the	   presence	   of	   this	   structural	  




Figure	  4.8:	  Structural	  similarity	  searching	  reveals	  a	  common	  chromone	  structure.	  
Figure	   shows	   the	   chemical	   structures	   of	   12	   of	   the	   highest	   scoring	   hits	   from	   the	   Spectrum	   Collection	  
screen,	   in	   comparison	   to	   LY294002	   and	   chromone.	   LY294002	   and	   4	   of	   the	   hit	   compounds	   share	   the	  























Figure	   4.9:	   Chemical	   structure	   comparison	   of	   the	   remaining	   positive	   hits	   reveals	  
three	  additional	  chromone-­‐derivatives.	  
Figure	  shows	  the	  chemical	  structures	  of	  the	  remaining	  hits	  from	  the	  Spectrum	  Collection	  screen,	  which	  
scored	  greater	  than	  1.5	  but	  less	  than	  2	  and	  subsequently	  were	  not	  selected	  for	  further	  investigation	  in	  
secondary	   assays.	   Three	  of	   these	  hit	   compounds	   also	   share	   the	   chromone	  group,	   as	   indicated	  by	   the	  






















Figure	   4.10:	   Chromone	   has	   a	   more	   significant	   effect	   on	   the	   resolution	   of	  
inflammation	  than	  on	  neutrophil	  recruitment.	  
Chromone	  was	  tested	  in	  3	  dpf	  mpx:GFP	  larvae	  for	  its	  effects	  on	  (A)	  neutrophil	  recruitment	  at	  6	  hpi,	  (B)	  
resolution	  of	  neutrophilic	  inflammation	  at	  12	  hpi	  and	  (C)	  total	  neutrophil	  number	  after	  24	  hours	  of	  pre-­‐
treatment	   as	   previously	   described.	   Chromone	   caused	   a	   small	   but	   significant	   reduction	   in	   neutrophil	  
recruitment	   at	   the	  highest	   dose	   tested	   and	   significantly	   accelerated	   resolution	   in	   terms	  of	   neutrophil	  
numbers	  at	  12	  hpi	  at	  all	  doses	  tested	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  
where	  *	  P	  <	  0.05	  and	  ***	  P	  <	  0.001;	  n	  =	  18,	  performed	  as	  3	  independent	  experiments).	  Chromone	  had	  
































































































































Unexpectedly,	  chromone	  only	  had	  a	  small	  effect	  on	  neutrophil	  recruitment,	  but	  had	  a	  
more	   significant	   effect	   on	   resolution	   (Figure	   4.10).	   There	   was	   no	   effect	   on	   total	  
neutrophil	   number,	   confirming	   that	   chromone	   was	   acting	   specifically	   to	   reduce	  
numbers	  of	  activated	  neutrophils	  at	  the	  site	  of	   injury.	  These	  results	  suggested	   it	  was	  
unlikely	   that	   the	   chromone	   group	   was	   solely	   responsible	   for	   the	   effect	   of	   the	  
chromone-­‐derived	  hit	  compounds	  on	  neutrophil	  recruitment,	  but	  that	  it	  might	  in	  fact	  
play	   an	   important	   role	   in	   accelerating	   the	   resolution	   of	   inflammation.	   This	   could	  
explain	   the	   pro-­‐resolution	   activity	   of	   some	   of	   the	   hit	   compounds	   by	   acting	   on	   a	  
currently	  unidentified	  target.	  	  
4.4.2	   Investigation	   into	   the	   effects	   of	   chromone	   analogues	   on	   inflammation	  
resolution	  
With	   the	   idea	   that	   chromone	   might	   be	   an	   interesting	   lead	   candidate,	   I	   formed	   a	  
collaboration	  with	  Dr	  Simon	  Jones	  and	  Marco	  Meloni	  from	  the	  Chemistry	  Department	  
at	  the	  University	  of	  Sheffield,	  to	  further	  investigate	  the	  structure-­‐activity	  relationships	  
of	   chromone	   and	   its	   derivatives.	   The	   chemists	   initially	   synthesised	   a	   set	   of	   seven	  
chromone	   analogues,	   which	   I	   tested,	   blinded	   to	   chemical	   structure,	   on	   injured	  
mpx:GFP	   larvae	   to	   examine	   their	   effects	   on	   resolution.	   Most	   of	   the	   analogues	  
significantly	   reduced	   neutrophil	   numbers	   at	   the	   site	   of	   injury	   at	   12	   hpi,	   with	   some	  
indication	  of	   dose-­‐dependency	   (Figure	   4.11).	   By	   coincidence,	   one	  of	   the	   synthesised	  
analogues	   was	   xanthone,	   and	   its	   effect	   on	   resolution	   was	   comparable	   to	   the	   data	  
obtained	  previously	  (refer	  to	  Figure	  3.17).	  The	  compounds	  were	  ranked	  in	  order	  based	  
on	  their	  efficacy	  and	  their	  chemical	  structures	  were	  compared	  to	  identify	  any	  potential	  
trends	  that	  might	  explain	  their	  relative	  activity	   (Figure	  4.12).	  Xanthone	  and	  anthrone	  
reduced	  neutrophil	  numbers	  most	  significantly,	  suggestive	  that	  the	  addition	  of	  a	  third	  
hydrocarbon	  ring	  might	   increase	  potency,	  but	  with	  the	  exception	  of	  xanthene,	  which	  






Figure	  4.11:	  A	  subset	  of	  the	  synthesised	  chromone	  analogues	  accelerate	  resolution.	  
Chromone	   analogues	   were	   tested	   at	   varying	   doses	   in	   the	   standard	   resolution	   assay	   using	  mpx:GFP	  
larvae,	   with	   treatment	   at	   6	   hpi	   and	   neutrophil	   counts	   at	   the	   site	   of	   injury	   performed	   at	   12	   hpi.	   All	  
compounds	  except	  α-­‐tetralone	  caused	  a	  significant	  reduction	   in	  neutrophil	  number	  at	  one	  or	  more	  of	  
the	  doses	  tested	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05,	  **	  P	  
<	   0.01	   and	   ***	   P	   <	   0.001;	   n	   =	   18,	   performed	   as	   3	   independent	   experiments).	   SP	   refers	   to	   30	   μM	  
SP600125	  and	  Chr	  refers	  to	  25	  μM	  chromone,	  tested	  alongside	  as	  positive	  controls.	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Figure	  4.12:	  Summary	  and	  ranking	  of	  the	  effects	  of	  synthesised	  chromone	  analogues	  
on	  the	  resolution	  of	  inflammation.	  
Compounds	  are	   ranked	  according	   to	   their	  maximum	  response	   in	   the	  previous	   resolution	  assay.	  Doses	  
shown	  are	  1	  μM	  for	  4-­‐chromanone	  and	  1,2,3,4-­‐tetrahydronapthalene,	  10	  μM	  for	  dihydrocoumarin	  and	  





































































































Though	  these	  were	  intriguing	  results,	  it	  was	  evident	  when	  carrying	  out	  the	  resolution	  
assays	  that	  chromone,	  which	  was	  tested	  alongside	  as	  a	  control,	  was	  not	  functioning	  as	  
effectively	  as	   in	  the	  previous	  experiments.	  With	  the	  hypothesis	  that	  chromone	  might	  
be	  sensitive	  to	  degradation	  over	  time,	  a	  resolution	  assay	  was	  performed	  to	  compare	  
the	   effectiveness	   of	   the	   original,	   ‘old’	   chromone	   stock	   compared	   to	   a	   ‘new’	   stock	  
solution	  prepared	  in	  fresh	  DMSO	  at	  the	  beginning	  of	  each	  experiment.	  Anthrone	  was	  
also	   tested	   in	   the	   same	   manner	   and	   the	   data	   obtained	   suggested	   that	   both	  
compounds	  became	  less	  potent	  with	  age	  (Figure	  4.13).	  	  
	  
Based	  on	  the	  hypothesis	  that	  the	  presence	  of	  a	  third	  hydrocarbon	  ring	  increased	  pro-­‐
resolution	  activity	  of	   the	  chromones,	  a	  set	  of	   tricyclic	  analogues	  were	  synthesised	  to	  
test	  whether	  their	  activity	  could	  be	  improved	  by	  the	  addition	  of	  other	  chemical	  groups.	  
Two	  of	  these	  significantly	  reduced	  neutrophil	  numbers	  at	  the	  highest	  dose	  tested,	  but	  
these	   effects	   were	   much	   smaller	   than	   those	   observed	   with	   the	   previous	   tricyclic	  
analogues,	   suggesting	   that	   the	   addition	   of	   these	   particular	   moieties	   was	   not	  
functionally	  advantageous	  (Figure	  4.14).	   In	  these	  experiments,	  freshly	  prepared	  stock	  
solutions	   of	   chromone	   and	   anthrone	   were	   used	   as	   controls	   each	   time.	   Activity	  
appeared	  to	  be	  preserved	  with	  anthrone	  only.	  
	  
It	  was	  hypothesised	  that	  the	  instability	  of	  chromone	  could	  be	  due	  to	  a	  tendency	  to	  be	  
oxidised	  and	  subsequently	  rapidly	  degraded.	  However	  as	  phenolic	  compounds	  typically	  
have	   an	   antioxidant	   nature,	   it	   was	   also	   possible	   that	   the	   functional	   activity	   of	   the	  
chromones	   might	   be	   at	   least	   partially	   attributed	   to	   an	   ability	   to	   scavenge	   reactive	  
oxygen	  species.	  To	   investigate	   this,	  a	   third	  series	  of	  analogues	  was	  synthesised,	  with	  
increasing	  ability	  to	  undergo	  oxidation	  (Figure	  4.15).	  Compound	  MMM115,	  which	  has	  
the	   highest	   oxidation	   level	   and	   is	   therefore	   least	   likely	   to	   undergo	   oxidation,	  
significantly	   reduced	   neutrophil	   numbers	   at	   all	   doses	   tested	   (Figure	   4.15	   A).	  
Coincidentally	   MMM115,	   composed	   of	   the	   chromone	   backbone	   with	   an	   attached	  
phenyl	  group,	   is	   identical	  to	  the	  naturally	  occurring	  flavone.	  This	   is	  a	  plant	  secondary	  
metabolite,	   forms	   of	   which	   are	   found	   commonly	   in	   fruit,	   vegetables	   and	   traditional	  
herbal	   medicines	   (Havsteen,	   2002).	   Flavones	   identified	   as	   reproducible	   hits	   in	   the	  
















Figure	  4.13:	  Chromone	  and	  anthrone	  become	  less	  effective	  with	  age.	  
Anthrone	  (10	  μM)	  and	  chromone	  (25	  μM)	  were	  tested	  in	  the	  standard	  resolution	  assay	  using	  mpx:GFP	  
larvae,	  with	   treatment	   at	   6	   hpi	   and	  neutrophil	   counts	   at	   the	   site	   of	   injury	   performed	   at	   12	   hpi.	  New	  
stock	  refers	  to	  fresh	  compounds	  prepared	  shortly	  before	  treatment;	  old	  stock	  refers	  to	  frozen	  aliquots	  
of	  compound	  prepared	  previously.	  Fresh	  anthrone	  significantly	  reduced	  neutrophil	  numbers	  at	  the	  site	  
of	  injury	  compared	  to	  the	  DMSO	  vehicle	  control,	  but	  this	  effect	  was	  not	  maintained	  with	  the	  old	  stock.	  
Neither	  fresh	  nor	  old	  chromone	  stock	  significantly	  reduced	  neutrophil	  numbers	  (One-­‐way	  ANOVA	  with	  
Bonferroni’s	  multiple	  comparison	  post-­‐test;	  P	  <	  0.01;	  n	  =	  12,	  performed	  as	  2	  independent	  experiments).	  



























































Figure	  4.14:	  Some	  tricyclic	  chromone	  analogues	  significantly	  accelerate	  inflammation	  
resolution.	  
Tricyclic	   chromone	   analogues	   were	   tested	   at	   varying	   doses	   in	   the	   standard	   resolution	   assay	   using	  
mpx:GFP	  larvae,	  with	  treatment	  at	  6	  hpi	  and	  neutrophil	  counts	  at	  the	  site	  of	  injury	  performed	  at	  12	  hpi.	  
(A)	  Anthraquinone	  and	  (B)	  MMM101	  caused	  a	  significant	  reduction	  in	  neutrophil	  number	  at	  the	  highest	  
dose	  tested,	  whereas	  (C)	  MMM103	  had	  no	  effect	  (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  
post-­‐test;	  P	  <	  0.05;	  n	  =	  18,	  performed	  as	  3	  independent	  experiments).	  SP	  refers	  to	  30	  μM	  SP600125,	  Chr	  
refers	  to	  25	  μM	  chromone	  and	  Ant	  refers	  to	  10	  μM	  anthrone,	  tested	  alongside	  as	  positive	  controls	  and	  





































































































































Figure	  4.15:	  Pro-­‐resolution	  activity	  of	  chromone	  derivatives	  does	  not	  correlate	  with	  
their	  potential	  antioxidant	  activity.	  	  	  
Chromone	  analogues	  with	  increasing	  ability	  to	  be	  oxidised	  were	  tested	  at	  varying	  doses	  in	  the	  standard	  
resolution	   assay	   using	  mpx:GFP	   larvae,	   with	   treatment	   at	   6	   hpi	   and	   neutrophil	   counts	   at	   the	   site	   of	  
injury	   performed	   at	   12	   hpi.	   (A)	   MMM115	   caused	   a	   significant	   reduction	   in	   neutrophil	   number	   and	  
appeared	  to	  act	  in	  a	  dose-­‐dependent	  manner.	  (B)	  MMM116	  significantly	  reduced	  neutrophil	  number	  at	  
10	   μM,	   but	   no	   effect	  was	   seen	  with	   either	   (C)	  MMM117	   3F	   or	   (D)	  MMM117	   (One-­‐way	   ANOVA	  with	  
Dunnett’s	   multiple	   comparison	   post-­‐test;	   *	   P	   <	   0.05	   and	   ***	   P	   <	   0.001;	   n	   =	   18,	   performed	   as	   3	  
independent	  experiments).	  SP	  refers	  to	  30	  μM	  SP600125,	  Chr	  refers	  to	  25	  μM	  chromone	  and	  Ant	  refers	  
to	  10	  μM	  anthrone,	  tested	  alongside	  as	  positive	  controls	  and	  to	  investigate	  their	  reliability.	  (E)	  Chemical	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Compounds	  MMM117	  3F	  and	  MMM117,	  which	  have	  the	   lowest	  oxidation	   levels	  due	  
to	   removal	  of	   the	  ketone	  group,	  did	  not	  have	  any	  effect	  on	   inflammation	   resolution	  
(Figure	  4.15	  C,	  D).	  This	  might	  be	  explained	  by	  their	  increased	  potential	  to	  be	  oxidised,	  
which	  perhaps	  results	   in	   loss	  of	  their	  functional	  activity	  and	  subsequent	  degradation.	  
These	  data	   indicated	  that	  the	  active	  chromone	  analogues	  were	  unlikely	  to	  be	  driving	  
resolution	   by	   antioxidant	  mechanisms.	   However,	   these	   experiments	   did	   not	   help	   to	  
clarify	  why	  chromone,	  in	  which	  the	  ketone	  is	  present,	  was	  unreliable.	  Perhaps	  in	  such	  
simple	  form,	  chromone	  is	  a	  particularly	  reactive	  molecule.	  	  
	  
Due	  to	  the	  unstable	  nature	  of	  chromone	  I	  decided	  not	  to	  pursue	  the	  synthesis	  of	  new	  
chromone	   analogues	   with	   the	   Chemistry	   Department.	   I	   returned	   the	   focus	   of	   my	  
investigation	   to	   the	   positive	   hits	   identified	   in	   the	   Spectrum	   Collection	   screen,	  
specifically	   isopimpinellin,	   which,	   out	   of	   all	   of	   the	   chromone-­‐related	   compounds	  
identified	  in	  the	  screen,	  had	  the	  greatest	  effect	  on	  inflammation	  resolution.	  
	  
	  
4.5	  Investigation	  into	  the	  pro-­‐resolution	  activity	  of	  isopimpinellin	  
	  
Having	   previously	   established	   that	   the	   mechanism	   responsible	   for	   the	   effect	   of	  
isopimpinellin	  on	  neutrophil	  recruitment	  in	  zebrafish	  larvae	  was	  at	  least	  in	  part	  due	  to	  
an	  inhibition	  of	  PI-­‐3K	  signalling,	  I	  sought	  to	  investigate	  the	  effect	  of	  this	  compound	  on	  
the	   resolution	   phase	   of	   the	   acute	   inflammatory	   response.	   Data	   obtained	   in	   the	  
secondary	  assays	  performed	   following	   the	  Spectrum	  Collection	   screen	   indicated	   that	  
isopimpinellin	  significantly	  accelerated	  resolution.	  To	  confirm	  these	  findings,	  mpx:GFP	  
larvae	  were	  injured	  at	  3	  dpf	  and	  those	  which	  mounted	  a	  good	  response	  were	  selected	  
for	   treatment	   with	   a	   range	   of	   concentrations	   of	   isopimpinellin	   at	   6	   hpi.	   Neutrophil	  
numbers	   at	   the	   site	   of	   injury	   were	   counted	   at	   12	   hpi.	   Isopimpinellin	   significantly	  
accelerated	   the	   resolution	  of	   inflammation	   at	   25	   and	  100	  μM,	   though	   some	   toxicity	  















Figure	  4.16:	  Isopimpinellin	  significantly	  accelerates	  inflammation	  resolution	  in	  a	  dose	  
dependent	  manner.	  
At	   3	   dpf,	  mpx:GFP	   larvae	  were	   injured	   and	   those	  which	  mounted	   a	   good	  neutrophilic	   response	  were	  
treated	   at	   6	   hpi	   with	   varying	   doses	   of	   isopimpinellin.	   Neutrophil	   numbers	   at	   the	   site	   of	   injury	   were	  
counted	   at	   12	   hpi.	   Isopimpinellin	   caused	   a	   dose-­‐dependent	   reduction	   in	   neutrophil	   number	   at	   the	  
wound,	  with	   significantly	   lower	  neutrophil	   numbers	  present	   in	   larvae	   treated	  with	   isopimpinellin	   at	   a	  
concentration	   of	   25	   μM	   and	   higher	   compared	   to	   the	   DMSO	   vehicle	   control	   (One-­‐way	   ANOVA	   with	  
Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  **	  P	  <	  0.01	  and	  ***	  P	  <	  0.001;	  n	  =	  18,	  performed	  as	  3	  
independent	  experiments).	  Dotted	  line	  at	  y	  =	  18.5	  indicates	  mean	  neutrophil	  number	  at	  site	  of	  injury	  in	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4.5.1	  Isopimpinellin	  enhances	  resolution	  in	  vivo	  by	  causing	  neutrophil	  apoptosis	  
Neutrophil	   apoptosis	   at	   sites	   of	   inflammation,	   followed	   by	   phagocytic	   uptake	   of	  
corpses	   by	   macrophages,	   is	   the	   best	   described	   process	   by	   which	   neutrophils	   are	  
removed	   during	   resolution	   (Savill	   et	   al.,	   1989).	   This	   has	   been	   shown	   to	   play	   a	  
particularly	  important	  role	  in	  mammalian	  models	  of	  inflammation	  (Gilroy	  et	  al.,	  2003;	  
Rossi	   et	   al.,	   2006;	   Sawatzky	   et	   al.,	   2006).	   More	   recent	   evidence	   has	   indicated	   that	  
neutrophil	   apoptosis	   is	   also	   one	   of	   the	   mechanisms	   responsible	   for	   driving	  
inflammation	  resolution	  in	  the	  zebrafish	  (Renshaw	  et	  al.,	  2006;	  Loynes	  et	  al.,	  2009;	  Elks	  
et	  al.,	  2011).	  	  
	  
I	  hypothesised	  that	  isopimpinellin	  was	  accelerating	  resolution	  by	  causing	  an	  increase	  in	  
neutrophil	   apoptosis	   and	   investigated	   this	   in	   zebrafish	   larvae	   using	   dual	   TSA/TUNEL	  
staining.	  Following	  the	  standard	  resolution	  assay	  protocol,	  3	  dpf	  mpx:GFP	  larvae	  were	  
injured	   and	   treated	   with	   isopimpinellin	   at	   6	   hpi.	   	   At	   12	   hpi,	   rather	   than	   counting	  
neutrophil	   numbers	   at	   the	   site	   of	   injury,	   larvae	   were	   fixed	   in	   4%	   PFA	   overnight	   in	  
preparation	   for	   fluorescence	   labelling.	   A	   TSA	   stain	   was	   performed	   for	   endogenous	  
neutrophil-­‐specific	   myeloperoxidase	   activity,	   followed	   by	   TUNEL	   staining	   for	   double	  
stranded	  DNA	  breaks	  as	  an	  indicator	  of	  apoptosis.	  Injured	  tail	  fins	  were	  imaged	  on	  an	  
UltraVIEWVoX	   spinning	  disk	   confocal	   imaging	   system	  with	  an	   inverted	  Olympus	   IX81	  
microscope,	  at	  20x	  magnification	  (Figure	  4.17).	  The	  total	  neutrophil	  number	  at	  the	  site	  
of	  injury	  and	  number	  of	  dual-­‐labelled	  apoptotic	  neutrophils	  was	  analysed	  in	  each	  larva,	  
to	   calculate	   the	  mean	   percentage	   of	   neutrophil	   apoptosis	   in	   each	   treatment	   group.	  
Isopimpinellin	  significantly	  increased	  the	  percentage	  of	  neutrophil	  apoptosis	  at	  the	  site	  
of	   injury	   compared	   to	   the	   DMSO	   vehicle	   control	   (Figure	   4.18	   A).	   These	   data	   were	  
consistent	  with	   the	   rates	   of	   apoptosis	   expected	   in	   both	   age-­‐matched	   control	   larvae	  
and	  larvae	  treated	  with	  a	  known	  inducer	  of	  neutrophil	  apoptosis,	  GSK650394	  (Burgon	  
et	  al.,	  in	  submission).	  	  





Figure	   4.17:	   TSA/TUNEL	   staining	   indicates	   that	   isopimpinellin	   increases	   neutrophil	  
apoptosis	  during	  inflammation	  resolution.	  
Tail	  transection	  was	  performed	  on	  3	  dpf	  mpx:GFP	  larvae	  and	  good	  responders	  were	  treated	  with	  25	  μM	  
isopimpinellin	  or	  DMSO	  at	  6	  hpi.	   Larvae	  were	   fixed	   in	  4%	  PFA	  at	  12	  hpi	  and	  neutrophils	  were	  stained	  
with	  TSA,	  followed	  by	  TUNEL	  staining	  for	  apoptosis.	  Tail	   fins	  were	  mounted	  and	   imaged	  on	  a	  confocal	  
spinning	   disk	   imaging	   system	  at	   20x	  magnification.	   Images	   from	   (A)	   a	  DMSO	   control	   larva	   and	   (B)	   an	  
isopimpinellin	  treated	  larva	  are	  shown.	  Apoptotic	  neutrophils	  are	   indicated	  by	  the	  white	  arrows.	  Scale	  











Figure	   4.18:	   Isopimpinellin	   and	   flavone	   significantly	   increase	   neutrophil	   apoptosis	  
during	  inflammation	  resolution.	  
Tail	  transection	  was	  performed	  on	  3	  dpf	  mpx:GFP	  larvae	  and	  good	  responders	  were	  treated	  with	  25	  μM	  
isopimpinellin	  or	  DMSO	  at	  6	  hpi.	   Larvae	  were	   fixed	   in	  4%	  PFA	  at	  12	  hpi	  and	  neutrophils	  were	  stained	  
with	  TSA,	  followed	  by	  TUNEL	  staining	  for	  apoptosis.	  Tail	   fins	  were	  mounted	  and	   imaged	  on	  a	  confocal	  
spinning	  disk	  imaging	  system	  at	  20x	  magnification.	  The	  total	  number	  of	  neutrophils	  at	  the	  site	  of	  injury	  
and	   the	   number	   of	   apoptotic	   neutrophils	   were	   counted	   to	   calculate	   the	   percentage	   apoptosis.	   (A)	  
Isopimpinellin	  caused	  a	  significant	  increase	  in	  neutrophil	  apoptosis	  (Unpaired	  t-­‐test;	  P	  <	  0.001;	  n	  ≥	  111,	  
performed	   as	   2	   independent	   experiments).	   (B)	   Preliminary	   data	   indicated	   that	   flavone	   also	   causes	   a	  
significant	   increase	   in	   neutrophil	   apoptosis	   (Unpaired	   t-­‐test;	   P	   <	   0.01;	   n	   ≥	   55,	   performed	   as	   1	  
experiment).	  	  
























































































Interestingly,	  preliminary	  data	   from	  a	  TSA/TUNEL	  assay	  performed	  on	   larvae	   treated	  
with	   flavone	   (compound	  MMM115	   as	   synthesised	   by	  Marco	  Meloni)	   also	   showed	   a	  
highly	  significant	  increase	  in	  neutrophil	  apoptosis	  (Figure	  4.18	  B),	  suggesting	  that	  this	  
might	   be	   a	   common	   mechanism	   of	   action	   by	   which	   these	   chromone-­‐related	  
compounds	   drive	   inflammation	   resolution.	   In	   support	   of	   this	   hypothesis,	   another	  
research	   group	   has	   since	   reported	   that	   a	   series	   of	   flavones	   can	   induce	   apoptosis	   in	  
isolated	  human	  neutrophils,	  even	  in	  the	  presence	  of	  various	  neutrophil	  survival	  factors	  
(Lucas	   et	   al.,	   2012).	   They	   also	   show	   that	   one	   of	   these	   flavones,	   wogonin,	   can	   drive	  
inflammation	  resolution	  in	  the	  mpx:GFP	  zebrafish,	  in	  a	  caspase-­‐dependent	  manner.	  
4.5.2	   Isopimpinellin	   does	   not	   increase	   the	   reverse	   migratory	   behaviour	   of	  
neutrophils	  during	  inflammation	  resolution	  in	  vivo	  
Having	  determined	  that	  isopimpinellin	  accelerated	  inflammation	  resolution	  by	  causing	  
a	   significant	   increase	   in	   neutrophil	   apoptosis,	   I	   wished	   to	   explore	   an	   alternative	  
mechanism	  by	  which	  neutrophils	  might	  also	  be	  removed	  from	  the	  site	  of	  injury.	  There	  
is	  a	  growing	  body	  of	  evidence	  to	  suggest	  that	  neutrophils	  can	  be	  cleared	  from	  sites	  of	  
inflammation	  by	   reverse	  migration,	   a	  phenomenon	  which	  has	   also	  been	   reported	   to	  
occur	  in	  mammalian	  systems	  (Hughes	  et	  al.,	  1997;	  Buckley	  et	  al.,	  2006;	  Nourshargh	  et	  
al.,	   2011).	   This	   can	   be	   visualised	   more	   readily	   and	   in	   real	   time	   using	   transparent	  
zebrafish	   larvae,	   in	   which	   various	   research	   groups	   have	   observed	   large	   numbers	   of	  
fluorescently-­‐labelled	  neutrophils	  leaving	  a	  wound	  site	  (Mathias	  et	  al.,	  2006;	  Hall	  et	  al.,	  
2007;	  Elks	  et	  al.,	  2011;	  Yoo	  &	  Huttenlocher,	  2011).	  
	  
In	   order	   to	   investigate	   the	  migratory	   behaviour	   of	   neutrophils	   during	   the	   resolution	  
phase	   of	   inflammation	   in	   the	   presence	   of	   isopimpinellin,	   I	   performed	   a	   reverse	  
migration	   assay	   using	   larvae	   raised	   from	   the	   double	   transgenic	   line	  
Tg(mpx:Gal4;UAS:Kaede)i222,	   subsequently	  referred	  to	  as	  mpx/Kaede.	  Neutrophils	   in	  
these	  larvae	  express	  photoactivatable	  Kaede,	  a	  fluorescent	  protein	  originally	  found	  in	  
stony	   coral.	   This	   converts	   from	   green	   to	   red	   fluorescence	   upon	   exposure	   to	   certain	  
wavelengths	   of	   light,	   enabling	   the	   photoconversion	   and	   tracking	   of	   distinct	  
populations	   of	   neutrophils.	   To	   examine	   the	   effects	   of	   isopimpinellin	   on	   neutrophil	  
reverse	  migration,	  tail	  fin	  transection	  was	  performed	  on	  mpx/Kaede	  larvae	  at	  3	  dpf.	  At	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4	  hpi,	  those	  that	  mounted	  a	  good	  inflammatory	  response	  were	  incubated	  with	  either	  
isopimpinellin	   or	   DMSO	   as	   a	   vehicle	   control.	   At	   6	   hpi,	   larvae	   were	   mounted	   in	   a	  
chamber	   slide,	   in	   agarose	   containing	   the	   appropriate	   treatment	   to	   ensure	   their	  
continued	  exposure.	  Larvae	  were	  viewed	  on	  the	  UltraVIEWVoX	  spinning	  disk	  confocal	  
imaging	  system	  and	  Kaede-­‐labelled	  neutrophils	  at	  the	  site	  of	  injury	  were	  converted	  to	  
red	  fluorescence	  using	  an	  UltraVIEWPhotoKinesisTM	  device,	  with	  the	  405	  nm	  laser	  line	  
at	  40%	  laser	  energy	  (optimum	  parameters	  defined	  by	  a	  former	  BMedSci	  student,	  Giles	  
Dixon).	   Larvae	   were	   then	   transferred	   to	   an	   inverted	   compound	   fluorescence	  
microscope	  and	  neutrophils	   in	  both	   the	   red	  and	  green	   channels	  were	   imaged	  at	   2.5	  
minute	   intervals	   for	   approximately	   300	   minutes.	   To	   analyse	   reverse	   migration,	   red	  
neutrophils	  that	  migrated	  away	  from	  the	  site	  of	  injury	  into	  a	  defined	  distal	  region	  (as	  
illustrated	  in	  Figure	  4.19	  A)	  were	  quantified	  over	  the	  course	  of	  the	  time-­‐lapse.	  	  
	  
In	  DMSO	  control	   larvae,	  neutrophils	  gradually	  migrated	  away	   from	  the	  site	  of	   injury,	  
with	   some	   movement	   back	   and	   forth	   within	   the	   injured	   region,	   characteristic	   of	  
patrolling	  behaviour.	  Fewer	  neutrophils	  appeared	  to	  reverse	  migrate	  in	  isopimpinellin	  
treated	   larvae	   and	   linear	   regression	   analysis	   indicated	   that	   there	   was	   a	   highly	  
significant	  difference	   in	  neutrophil	  movement	  compared	   to	   the	  controls	   (Figure	  4.19	  
B).	  On	  observation	  of	  the	  time-­‐lapse	  movies	  it	  became	  apparent	  that	  in	  the	  majority	  of	  
cases,	   in	  preference	  to	   leaving	  the	  site	  of	   injury	  via	   reverse	  migration,	  neutrophils	   in	  
isopimpinellin	   treated	   larvae	   remained	   static	   and	   adopted	   a	   rounded	   morphology,	  
characteristic	  of	  the	  apoptotic	  phenotype	  that	  has	  been	  described	  previously	  (Loynes	  
et	   al.,	   2009).	   This	   occurred	   in	   both	   red-­‐labelled	   neutrophils	   at	   the	   site	   of	   injury	   and	  
green-­‐labelled	  neutrophils	  that	  migrated	  into	  the	  wound	  region	  after	  photoconversion	  
was	  performed.	  Apoptosis	  and	  the	  subsequent	  loss	  of	  fluorescence	  appeared	  to	  occur	  
more	  frequently,	  or	  at	  least	  earlier	  in	  the	  course	  of	  the	  time-­‐lapse,	  in	  red-­‐labelled	  cells	  












Figure	  4.19:	  Isopimpinellin	  does	  not	  increase	  reverse	  migration	  of	  neutrophils	  during	  
inflammation	  resolution.	  
Tail	   fin	   transection	   was	   performed	   on	  mpx/Kaede	   larvae	   at	   3	   dpf,	   and	   those	   that	   mounted	   a	   good	  
neutrophilic	   response	   were	   selected	   for	   treatment	   with	   25	   μM	   isopimpinellin	   or	   the	   DMSO	   vehicle	  
control	   at	   4	   hpi.	   At	   6	   hpi,	   larvae	   were	   mounted	   and	   neutrophils	   at	   the	   site	   of	   injury	   were	  
photoconverted	   from	   green	   to	   red	   fluorescence	   as	   illustrated	   in	   (A,	   left),	   on	   a	   confocal	   spinning	   disk	  
system	  using	  an	  UltraVIEWPhotoKinesisTM	  device,	  with	  the	  405	  nm	  laser	  line	  at	  40%	  laser	  energy.	  Scale	  
bar	  represents	  60	  μm.	  Larvae	  were	  then	  time-­‐lapsed	  on	  an	  inverted	  compound	  fluorescence	  microscope	  
for	   3.5	   hours	   and	   the	   number	   of	   red	   cells	   that	   migrated	   away	   from	   the	   site	   of	   injury	   into	   a	   region	  
defined	   as	   illustrated	   in	   (A,	   right)	   were	   quantified	   over	   the	   time-­‐course.	   Isopimpinellin	   caused	   a	  
significant	   change	   in	   neutrophil	   reverse	   migration	   compared	   to	   the	   DMSO	   vehicle	   control	   (B),	   with	  
fewer	   neutrophils	   migrating	   away	   from	   the	   wound	   over	   time	   (n	   =	   18,	   performed	   as	   3	   independent	  
experiments,	  data	  expressed	  as	  mean	  ±	  SEM).	  	  
	  
	   	  



















































Figure	   4.20:	   Morphological	   changes	   characteristic	   of	   neutrophil	   apoptosis	   can	   be	  
observed	  in	  the	  presence	  of	  isopimpinellin	  during	  inflammation	  resolution.	  	  
Tail	  fin	  transection	  was	  performed	  on	  mpx/Kaede	  larvae	  at	  3	  dpf	  and	  good	  responders	  were	  selected	  for	  
treatment	  with	  25	  μM	  isopimpinellin	  at	  4	  hpi.	  At	  6	  hpi,	  larvae	  were	  mounted	  and	  neutrophils	  at	  the	  site	  
of	  injury	  were	  photoconverted	  from	  green	  to	  red	  fluorescence	  on	  a	  confocal	  spinning	  disk	  system	  using	  
an	  UltraVIEWPhotoKinesisTM	  device,	  with	  the	  405	  nm	  laser	   line	  at	  40%	  laser	  energy.	  Larvae	  were	  then	  
time-­‐lapsed	   on	   an	   inverted	   compound	   fluorescence	   microscope	   for	   up	   to	   5	   hours.	   Neutrophils	   are	  
observed	  to	  adopt	  a	   rounded,	  apoptotic	  morphology	  within	  1	  hour,	  as	   indicated	  by	   the	  white	  arrows.	  
Multiple	   apoptotic	   events	   can	  be	   visualised	  over	   the	   course	   of	   the	   time-­‐lapse	   (note	   not	   all	   apoptotic	  
neutrophils	   are	   indicated),	   with	   few	   red	   neutrophils	   remaining	   at	   the	   final	   time	   point.	   Scale	   bar	  







4.5.3	  Conclusions	  on	  the	  pro-­‐resolution	  activity	  of	  isopimpinellin	  in	  vivo	  
The	   TSA/TUNEL	   staining	   revealed	   a	   significant	   increase	   in	   neutrophil	   apoptosis	   in	  
isopimpinellin	  treated	  larvae.	  This,	  combined	  with	  the	  striking	  observation	  of	  multiple	  
apoptotic	  events	  occurring	  at	  the	  site	  of	  injury	  during	  the	  time-­‐lapse	  movies	  generated	  
in	   the	   reverse	   migration	   assay,	   indicated	   that	   the	   primary	   mechanism	   by	   which	  
isopimpinellin	   could	   drive	   inflammation	   resolution	   in	   zebrafish	   larvae	   was	   by	  
promoting	  neutrophil	  apoptosis.	  On	  searching	  through	  the	  literature,	  I	  discovered	  that	  
isopimpinellin	   is	   a	   structural	   isomer	   of	   khellin	   (Figure	   4.21	   A),	   an	   extract	   of	   Ammi	  
visnaga	  from	  the	  Apiaceae	  family	  of	  plants,	  various	  species	  of	  which	  are	  also	  sources	  
of	  isopimpinellin.	  This	  was	  of	  particular	  interest,	  as	  a	  series	  of	  drugs	  that	  are	  now	  used	  
clinically	   to	   treat	  allergic	  conditions	  were	  originally	  developed	  based	  on	  khellin	  and	   I	  
realised	   that	   these	   are	   in	   fact	   termed	   the	   ‘cromolyns’	   or	   ‘cromones’.	   The	  mast	   cell	  
stabilising	   properties	   of	   this	   group	   of	   compounds	   are	   well	   known,	   although	   it	   is	  
believed	   that	   they	   have	   additional	   anti-­‐inflammatory	   properties,	   the	  mechanisms	   of	  
which	  remain	  elusive.	  I	  sought	  to	  investigate	  the	  activity	  of	  these	  compounds,	  with	  the	  
idea	   that	   isopimpinellin	   might	   share	   some	   of	   their	   functional	   activity	   due	   to	   their	  
common	   chromone-­‐derived	   origin.	   As	   isopimpinellin	   had	   such	   a	   profound	   effect	   on	  
neutrophil	   apoptosis,	   I	   hypothesised	   that	   this	   might	   be	   a	   previously	   unidentified	  
mechanism	  of	  action	  of	  the	  cromones,	  which	  might	  lead	  to	  interesting	  implications	  for	  
their	  therapeutic	  use	  in	  inflammatory	  disease.	  
	  
For	   clarity,	   the	   clinically	   available	   drugs	   originally	   developed	   from	   khellin,	   including	  
sodium	  cromoglycate	  and	  nedocromil,	   are	   collectively	   referred	   to	  as	   the	   ‘cromones’.	  
Use	  of	  the	  word	  ‘chromone’	  refers	  to	  any	  compound	  with	  a	  structural	  formula	  based	  
on	   the	   1,4-­‐benzopyrone	   backbone,	   for	   example	   the	   hits	   isopimpinellin	   and	  
methylquercetin.	   It	   should	  be	  noted	  that	   the	  cromones	  are	  derivatives	  of	  chromone,	  
therefore	  in	  circumstances	  when	  experiments	  were	  carried	  out	  on	  both	  these	  and	  the	  
hit	   compounds	   together,	   all	   of	   the	   compounds	   are	   collectively	   referred	   to	   as	  
‘chromones’	  or	  ‘chromone-­‐derivatives’.	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4.6	  Investigation	  into	  the	  effects	  of	  cromones	  on	  neutrophil	  apoptosis	  
	  
4.6.1	  History	  and	  development	  of	  the	  cromones	  
The	  ancient	  herb	  ‘khella’	  was	  originally	  used	  in	  Egyptian	  folk	  medicine	  as	  a	  remedy	  for	  
renal	   colic	   due	   to	   its	   diuretic	   and	   smooth	   muscle	   relaxant	   properties	   (Edwards	   &	  
Howell,	   2000),	   but	   it	   was	   not	   until	   1947	   that	   it	   was	   discovered	   that	   the	   isolated	  
component	  khellin	  was	  highly	  effective	  in	  the	  treatment	  of	  bronchial	  asthma	  (Anrep	  &	  
Barsoum,	   1947).	   This	   triggered	   the	   synthesis	   and	   development	   of	  more	   soluble	   and	  
efficacious	   analogues	   of	   khellin,	   one	   of	   the	   first	   being	   K18,	  which	  was	   shown	   to	   be	  
protective	  against	  the	  potentially	  fatal	  bronchoconstriction	  induced	  by	  albumin	  in	  pre-­‐
sensitised	   ‘Herxheimer’	   guinea	   pigs	   (Herxheimer,	   1952;	   Edwards	  &	  Howell,	   2000).	   It	  
was	   also	   discovered	   that	   another	   chromone	   analogue,	   sodium	   cromoglycate,	  
possessed	   an	   additional	   mechanism	   of	   action	   alongside	   its	   bronchodilator	   effects;	  
inhibition	   of	   the	   allergic	   reaction	   mediators	   histamine	   and	   SRS-­‐A	   (slow	   releasing	  
substance	  of	   anaphylaxis)	   (Sheard	  &	  Blair,	   1970).	  However,	   the	   significance	  of	   these	  
findings	  was	  not	  fully	  realised	  until	  the	  now	  famous	  research	  carried	  out	  by	  Dr	  Roger	  
Altounyan	  in	  the	  late	  1950s.	  Altounyan	  suffered	  from	  severe	  chronic	  asthma,	  and	  used	  
himself	   as	   a	   human	  model	   to	   test	   the	   preventative	   action	   of	   the	   newly	   synthesised	  
khellin	   analogues	   on	   asthma	   attacks	   following	   inhaled	   bronchial	   antigen	   challenge.	  
Throughout	  his	  lifetime,	  Altounyan	  self-­‐tested	  over	  200	  compounds,	  some	  of	  his	  work	  
being	  carried	  out	  in	  secret	  due	  to	  the	  chromone	  project	  being	  temporarily	  shut	  down	  
as	   it	  was	  considered	  ‘quite	  useless	  and	  unproven’	  (Edwards	  &	  Howell,	  2000).	  Despite	  
this	  minor	  setback,	  Altounyan	  was	  able	  to	  recognise	  the	  structure-­‐activity	  relationships	  
emerging	   from	   the	   series	   of	   compounds	   he	   tested	   and	   the	  most	   protective	   against	  
antigen	  challenge	  were	  used	  in	  several	  small	  patient	  trials.	  Disodium	  cromoglycate	  was	  
one	  of	  the	  first	  bis-­‐chromones	  (Figure	  4.21	  B)	  to	  be	  developed,	  and	  was	  launched	  by	  
Fisons	  Pharmaceuticals	  as	  Intal®	  for	  inhaled	  asthma	  treatment	  in	  the	  late	  1960s	  (Cox,	  
1967).	   The	   related	   nedocromil	   sodium	   followed	   a	   few	   years	   later	   and	  was	   found	   to	  
have	   greater	   potency	   than	   sodium	   cromoglycate,	   being	   particularly	   effective	   in	  
patients	  with	  moderate	  asthma	  (Edwards	  &	  Stevens,	  1993).	  Due	  to	  their	   limited	  side	  
effects,	   the	  cromones	  began	  to	  be	  used	   in	  the	  treatment	  of	  other	  allergic	  conditions	  




4.6.2	  Known	  anti-­‐inflammatory	  properties	  of	  the	  cromones	  
The	   cromones	  were	  originally	  defined	  as	   ‘mast	   cell	   stabilisers’	  due	   to	   their	   ability	   to	  
inhibit	   mast	   cell	   degranulation	   and	   histamine	   release	   (Cox,	   1967).	   It	   is	   now	   widely	  
accepted	  that	  this	  is	  not	  the	  only	  clinically	  relevant	  mechanism	  of	  action	  of	  these	  drugs	  
but	   that	   their	   therapeutic	   benefit	   in	   asthma	   patients	   can	   be	   attributed	   to	   their	  
additional	  anti-­‐inflammatory	  activities.	  Evidence	  indicates	  that	  disodium	  cromoglycate	  
can	   inhibit	   leukocyte	   activation	   (Kay	   et	   al.,	   1987)	   and	   neutrophil	   chemotaxis	  
(Szkudlińska	   et	   al.,	   1996).	   Nedocromil	   sodium	   has	   been	   reported	   to	   inhibit	   cytokine	  
and	   eicosanoid	   release	   from	   bronchial	   epithelial	   cells,	   eosinophils	   and	  macrophages	  
(Mattoli	   et	   al.,	   1990;	   Radeau	   et	   al.,	   1993;	   Devalia	   et	   al.,	   1996)	   and	   down-­‐regulate	  
expression	  of	  the	  adhesion	  molecule	  ICAM-­‐1	  (Sacco	  et	  al.,	  1999).	  	  
	  
The	  molecular	  mechanisms	  by	  which	  the	  cromones	  modulate	  their	  anti-­‐inflammatory	  
effects	   remained	   elusive	   until	   the	   last	   few	   years,	   during	   which	   developments	   have	  
been	  made	  towards	  understanding	  the	  complex	  activity	  of	  these	  compounds.	  Although	  
their	   effects	   on	   neutrophil	   trafficking	   could	   be	   secondary	   to	   the	   inhibition	   of	   pro-­‐
inflammatory	   mediator	   release	   from	   mast	   cells	   (Kubes	   &	   Granger,	   1996),	   evidence	  
now	   indicates	   that	   cromones	   have	   a	  more	   direct	   effect	   on	   neutrophils.	   One	   line	   of	  
research	  suggests	  this	  may	  be	  mediated	  via	  the	  extracellular	  protein	  Annexin-­‐A1	  (Anx-­‐
A1),	   which	   is	   released	   from	   neutrophils	   and	   other	   cell	   types	   upon	   stimulation	   with	  
glucocorticoids	   (Goulding	  et	   al.,	   1990;	  Ahluwalia	  et	   al.,	   1994).	   Secretion	  of	  Anx-­‐A1	   is	  
dependent	  upon	  its	  phosphorylation	  at	  Ser27	  by	  protein	  kinase	  C	  (PKC).	  Its	  subsequent	  
translocation	   to	   the	   cell	  membrane	   can	  be	  prevented	  by	  PI-­‐3K	  and	  MAPK	   inhibitors,	  
suggestive	  of	  a	   role	   for	   these	  kinases	   in	  Anx-­‐A1	  trafficking	   (Solito,	  2003;	  Solito	  et	  al.,	  
2006).	  Once	  secreted,	  Anx-­‐A1	  signals	  through	  receptors	  of	  the	  formyl	  peptide	  receptor	  
family,	   most	   likely	   ALX,	   in	   an	   autocrine	   or	   paracrine	   fashion,	   to	   inhibit	   neutrophil	  
activation	  (Perretti	  &	  Flower,	  2004;	  Brancaleone	  et	  al.,	  2011).	  	  
	  
Cromones	  were	  initially	  reported	  to	  exert	  their	  activity	  through	  an	  Anx-­‐A1	  dependent	  
mechanism	   in	   the	   U937	   human	   monocytic	   cell	   line,	   in	   which	   activation	   of	   PKC	  
combined	  with	   the	  phosphorylation,	   translocation	  and	   release	  of	  Anx-­‐A1	   is	   triggered	  
by	  glucocorticoids	  (Yazid	  et	  al.,	  2009).	  	  Disodium	  cromoglycate	  and	  sodium	  nedocromil	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alone	   had	   only	   a	   weak	   effect	   in	   these	   cells,	   however	   in	   combination	   with	   a	   fixed	  
concentration	   of	   dexamethasone	   these	   activities	   were	   greatly	   enhanced.	   They	   also	  
caused	   a	   more	   pronounced	   inhibition	   in	   the	   generation	   of	   the	   eicosanoid	   TxB2,	   to	  
levels	   above	   those	   recorded	  with	   dexamethasone	   alone.	   Importantly,	   the	   cromones	  
were	  found	  to	  directly	  inhibit	  protein	  phosphatase	  2A	  (PP2A),	  which	  limits	  the	  activity	  
of	  PKC,	  leading	  to	  the	  conclusion	  that	  this	  might	  be	  the	  main	  mechanism	  by	  which	  they	  
act	  to	  promote	  Anx-­‐A1	  release.	  It	  is	  likely	  that	  this	  occurs	  in	  a	  synergistic	  manner	  with	  
the	  activation	  of	  PKC	  by	  glucocorticoids.	  These	  effects	  have	  also	  been	  demonstrated	  in	  
neutrophils,	   in	  which	  the	  inhibition	  of	  Anx-­‐A1	  release	  by	  cromones	  is	  associated	  with	  
reduced	   neutrophil	   adhesion	   and	   emigration	   (Yazid,	   Leoni,	   et	   al.,	   2010).	   As	   further	  
evidence	   to	   support	   the	   Anx-­‐A1	   dependent	   mechanism	   of	   action	   of	   the	   cromone	  
drugs,	   nedocromil	   was	   found	   to	   inhibit	   neutrophil	   migration	   in	   a	   murine	   model	   of	  
acute	  peritonitis,	  having	  no	  effect	  in	  Anx-­‐A1-­‐/-­‐	  mice	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  
4.6.3	  Disodium	  cromoglycate	  accelerates	  the	  resolution	  of	  inflammation	  in	  vivo	  
To	   begin	   to	   explore	   the	   function	   of	   the	   cromone	   drugs	   on	   the	   resolution	   of	  
inflammation	  in	  vivo,	  I	  investigated	  the	  activity	  of	  disodium	  cromoglycate	  in	  a	  standard	  
resolution	  assay.	  Tail	  transection	  was	  performed	  on	  mpx:GFP	  larvae	  at	  3	  dpf,	  and	  those	  
that	  mounted	   a	   good	   response	   to	   injury	   at	   6	   hpi	   were	   selected	   for	   treatment	   with	  
disodium	  cromoglycate.	  Preliminary	  data	  suggested	  that	  low	  doses	  of	  this	  compound,	  
in	  the	  range	  of	  0.01	  to	  10	  μM	  were	  ineffective,	  with	  mean	  neutrophil	  numbers	  at	  the	  
site	   of	   injury	   not	   significantly	   lower	   than	   in	   control	   larvae.	   This	  was	   in	   keeping	  with	  
published	   in	  vivo	  data,	   in	  which	  the	  doses	  of	  cromones	  used	  were	  higher	  than	  those	  
estimated	   from	   in	   vitro	   studies,	   likely	   due	   to	   poor	   absorption,	   rapid	   degradation	   or	  
other	  pharmacokinetic	  properties	  of	  these	  compounds	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  In	  an	  
effort	  to	  negate	  the	  possibility	  that	  the	  compound	  might	  be	  metabolised	  into	  inactive	  
components	  too	  quickly,	  larvae	  were	  re-­‐dosed	  with	  disodium	  cromoglycate	  every	  hour	  
after	  6	  hpi.	  At	  12	  hpi,	   a	   significant	   reduction	   in	  neutrophil	   number	  at	   the	   injury	   site	  







Figure	   4.21:	   The	   khellin	   derivate	   disodium	   cromoglycate	   significantly	   accelerates	  
inflammation	  resolution	  in	  vivo.	  
(A)	   Isopimpinellin	   is	   a	   structural	   isomer	   of	   khellin,	   the	   compound	   from	  which	   a	   group	   of	   anti-­‐allergic	  
drugs	   were	   developed,	   including	   disodium	   cromoglycate	   (B).	   To	   investigate	   its	   effect	   in	   vivo,	   3	   dpf	  
mpx:GFP	   larvae	  were	   injured	   and	   treated	  with	   varying	   concentrations	   of	   disodium	   cromoglycate	   at	   6	  
hpi.	  Neutrophil	  counts	  were	  performed	  at	  12	  hpi	  as	  per	  the	  standard	  resolution	  assay	  protocol,	  using	  30	  
μM	  SP600125	  as	  a	  positive	  control	  (referred	  to	  as	  SP).	  (C)	  Disodium	  cromoglycate	  significantly	  reduced	  
neutrophil	  numbers	  at	  the	  site	  of	  injury	  at	  12	  hpi	  compared	  to	  the	  E3	  vehicle	  control	  (One-­‐way	  ANOVA	  
with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05,	  **	  P	  <	  0.01	  and	  ***	  P	  <	  0.001;	  n	  =	  18,	  
performed	  as	  3	  independent	  experiments).	  	  
	  










































4.6.4	  Disodium	  cromoglycate	  and	  other	  chromone-­‐derived	  compounds	  do	  not	  cause	  
neutrophil	  apoptosis	  in	  vitro	  
Cromones	   have	   been	   shown	   to	   increase	   Anx-­‐A1	   phosphorylation	   and	   release	   by	  
directly	   inhibiting	   PP2A	   in	   neutrophils	   (Yazid,	   Leoni,	   et	   al.,	   2010).	   In	   these	   studies,	  
similar	   levels	   of	   PKC	   and	   Anx-­‐A1	   phosphorylation	   were	   observed	   with	   a	  
pharmacological	   inhibitor	  of	  PP2A,	  okadaic	   acid.	  Disodium	  cromoglycate,	  nedocromil	  
and	  okadaic	  acid	  caused	  enhanced	  Anx-­‐A1	  release	  compared	  to	  dexamethasone	  alone.	  
These	  findings	  were	  of	  particular	  interest,	  as	  PP2A	  inhibition	  by	  okadaic	  acid	  has	  been	  
shown	   to	   induce	   hyper-­‐phosphorylation	   of	   the	   anti-­‐apoptotic	   protein	   Mcl-­‐1	   in	  
neutrophils	  (Derouet	  et	  al.,	  2004).	  This	  leads	  to	  instability	  and	  accelerated	  turnover	  of	  
Mcl-­‐1,	  resulting	  in	  increased	  neutrophil	  apoptosis.	  	  	  
	  
As	  mentioned	  previously,	  a	  potential	  structure-­‐activity	  relationship	  exists	  between	  the	  
known	   cromone	   drugs	   and	   the	   chromone-­‐derived	   hit	   compounds	   identified	   in	   the	  
Spectrum	   Collection	   screen.	   These	   include	   isopimpinellin,	   which	   I	   have	   shown	   to	  
increase	   neutrophil	   apoptosis	   in	   zebrafish.	   Additionally,	   disodium	   cromoglycate	  
appeared	  to	  accelerate	  resolution	  of	  inflammation	  in	  the	  zebrafish	  tail	  fin	  injury	  model.	  
In	   light	   of	   these	   data,	   I	   hypothesised	   that	   the	   cromones	   might	   drive	   resolution	   by	  
inducing	  neutrophil	  apoptosis	  via	  inhibition	  of	  PP2A.	  	  
	  
To	  investigate	  this	  hypothesis,	  I	  initially	  tested	  disodium	  cromoglycate	  in	  vitro,	  in	  order	  
to	   investigate	   its	   effect	   on	   human	   neutrophil	   apoptosis.	   Neutrophils	   were	   isolated	  
from	   peripheral	   whole	   blood	   by	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
purification,	   as	   described,	   and	   were	   treated	   with	   multiple	   doses	   of	   disodium	  
cromoglycate.	  After	  8	  hours	  in	  culture,	  two	  cytospins	  were	  acquired	  per	  condition	  and	  
the	  percentage	  of	  neutrophil	  apoptosis	  was	  calculated	  based	  on	  nuclear	  morphology.	  
No	   significant	   difference	   in	   constitutive	   apoptosis	   was	   found	   in	   neutrophils	   treated	  
with	   disodium	   cromoglycate	   compared	   to	   the	   vehicle	   control,	   however	   in	   these	  












Figure	   4.22:	   Chromone-­‐derived	   compounds	   do	   not	   induce	   human	   neutrophil	  
apoptosis	  in	  vitro.	  
Neutrophils	   were	   isolated	   from	   whole	   blood	   using	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
separation	  and	  were	  incubated	  with	  (A)	  disodium	  cromoglycate	  for	  8	  hours,	  (B)	  disodium	  cromoglycate	  
for	  6	  hours,	  (C)	  isopimpinellin	  for	  6	  hours	  or	  (D)	  methylquercetin	  for	  6	  hours.	  In	  each	  case,	  2	  cytospins	  
were	   acquired	   and	   percentage	   neutrophil	   apoptosis	   calculated	   based	   on	   nuclear	   morphology.	   No	  
significant	  change	  in	  neutrophil	  apoptosis	  was	  observed	  in	  any	  condition,	  although	  there	  appeared	  to	  be	  
a	   trend	   towards	  neutrophil	   survival	  with	   (C)	   isopimpinellin	  and	   (D)	  methylquercetin	   (One-­‐way	  ANOVA	  























































































































































It	  was	   possible	   that	   the	   concentration	   of	   disodium	   cromoglycate	   used	  was	   not	   high	  
enough	  to	  cause	  an	  effect	  on	  neutrophil	  apoptosis,	  therefore	  the	  previous	  experiment	  
was	  repeated	  using	  doses	  up	  to	  1	  mM.	  Another	  factor	  to	  consider	  was	  that	  any	  effect	  
on	  neutrophil	  apoptosis	  could	  be	  occurring	  very	  rapidly;	  within	  the	  first	  few	  hours	  of	  
culture,	   and	   that	   the	   disodium	   cromoglycate	  might	   become	   less	   effective	   over	   time	  
due	  to	  degradation.	  By	  8	  hours,	  the	  normal	  levels	  of	  constitutive	  apoptosis	  occurring	  in	  
the	  controls	  might	  mask	  any	  early	  effect	  on	  apoptosis	  caused	  by	  the	  cromone.	  For	  this	  
experiment,	  cytospins	  were	  acquired	  after	  6	  hours	  of	  culture,	  as	  at	  this	  time	  point	  the	  
levels	   of	   constitutive	   apoptosis	   in	   untreated	   neutrophils	   are	   expected	   to	   be	  
approximately	   15%	   lower	   than	   at	   8	   hours	   (personal	   communication,	   Joseph	   Burgon	  
and	  Dr	  Stephen	  Renshaw).	  However,	  even	  at	  6	  hours	  and	  with	  the	  maximum	  dose	  of	  1	  
mM,	   no	   increase	   in	   neutrophil	   apoptosis	  was	   observed	   in	   the	   presence	   of	   disodium	  
cromoglycate	   compared	   to	   the	   vehicle	   control	   (Figure	   4.22	   B).	   To	   investigate	   the	  
effects	  of	  other	  chromone-­‐derived	  compounds	  on	  neutrophil	  apoptosis	  in	  vitro,	  the	  hit	  
compounds	   isopimpinellin	  and	  methylquercetin	  were	  also	   tested	   in	   this	  assay.	  There	  
was	   no	   significant	   increase	   in	   neutrophil	   apoptosis	   with	   either	   compound	   and	  
somewhat	  surprisingly	  there	  appeared	  to	  be	  a	  trend	  towards	  survival	  with	   increasing	  
dose	  (Figure	  4.22	  C,	  D).	  
4.6.5	  Chromone-­‐derived	  compounds	  do	  not	  affect	  GM-­‐CSF	  induced	  survival	  signalling	  
As	   no	   effect	   on	   constitutive	   apoptosis	   was	   observed	   in	   the	   presence	   of	   disodium	  
cromoglycate,	   isopimpinellin	   or	   methylquercetin,	   I	   hypothesised	   that	   these	  
compounds	   might	   interfere	   with	   neutrophil	   survival	   signalling,	   for	   example	   by	   the	  
endogenous	   survival	   signal,	   granulocyte-­‐macrophage	   colony-­‐stimulating	   factor	   (GM-­‐
CSF).	  GM-­‐CSF	  is	  known	  to	  activate	  multiple	  signalling	  pathways	  including	  the	  PI-­‐3K	  and	  
JAK/STAT	  pathways	   (Epling-­‐Burnette	  et	  al.,	  2001)	  and	  delays	  neutrophil	  apoptosis	  by	  
regulation	  of	  Mcl-­‐1	  (Moulding	  et	  al.,	  1998).	  At	  this	  point	  I	  was	  also	  able	  to	  obtain	  some	  














Figure	  4.23:	  Chromone-­‐derived	  compounds	  do	  not	  affect	  GM-­‐CSF	  induced	  neutrophil	  
survival.	  
Neutrophils	   were	   isolated	   from	   whole	   blood	   using	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
separation	  and	  were	  incubated	  for	  8	  hours	  with	  (+)	  and	  without	  (-­‐)	  GM-­‐CSF	  as	  indicated	  and	  with	  (A)	  10	  
μM	   disodium	   cromoglycate	   (DSCG),	   (B)	   10	   μM	   isopimpinellin,	   (C)	   10	   μM	   methylquercetin	   or	   (D)	  
nedocromil	   at	   the	   dose	   indicated.	   In	   each	   case,	   2	   cytospins	   were	   acquired	   and	   the	   percentage	   of	  
neutrophil	   apoptosis	   was	   calculated	   based	   on	   nuclear	   morphology.	   GM-­‐CSF	   significantly	   reduced	  
apoptosis	  in	  control	  groups	  and	  this	  survival	  did	  not	  appear	  to	  be	  inhibited	  in	  the	  presence	  of	  any	  of	  the	  
chromone	   derivatives	   (One-­‐way	   ANOVA	  with	   Bonferroni’s	   multiple	   comparison	   post-­‐test	   to	   compare	  
selected	   columns;	  where	  *	  P	  <	  0.05,	  **	  P	  <	  0.01	  and	  ***	  P	   <	  0.001;	  n	  =	  2).	  A	   significant	   reduction	   in	  






















































































































































































For	   these	   experiments,	   neutrophils	   were	   isolated	   from	   peripheral	   whole	   blood,	   as	  
previously	  described,	   and	   treated	  with	  each	   compound	  at	   the	  dose	   indicated,	   in	   the	  
presence	   and	   absence	   of	   GM-­‐CSF.	   After	   8	   hours	   in	   culture,	   two	   cytospins	   were	  
acquired	   per	   condition	   and	   the	   percentage	   of	   neutrophil	   apoptosis	   was	   calculated	  
based	  on	  nuclear	  morphology.	   In	   all	   cases,	  GM-­‐CSF	   caused	  a	   significant	   reduction	   in	  
neutrophil	  apoptosis	  in	  untreated	  and	  vehicle	  control	  neutrophils,	  as	  expected	  (Figure	  
4.23).	   The	   level	  of	  GM-­‐CSF	   induced	   survival	   in	   the	  presence	  of	   all	   chromones	   tested	  
was	  comparable	  to	  the	  appropriate	  vehicle	  controls,	  suggesting	  that	  these	  compounds	  
did	  not	   interfere	  with	  GM-­‐CSF	   survival	   signalling	  pathways.	  Although	  not	   statistically	  
significant,	  there	  was	  a	  clear	  reduction	  in	  the	  percentage	  of	  neutrophil	  apoptosis	  when	  
neutrophils	   were	   treated	  with	   GM-­‐CSF	   in	   combination	  with	   disodium	   cromoglycate,	  
isopimpinellin	   and	   methylquercetin	   (Figure	   4.23	   A-­‐C).	   This	   lack	   of	   significance	   was	  
most	  likely	  due	  to	  their	  slightly	  lower	  rates	  of	  constitutive	  apoptosis	  compared	  to	  the	  
vehicle	   controls.	   In	   contrast	   to	   the	   other	   chromones,	   methylquercetin	   caused	  
significant	  neutrophil	   survival	   (Figure	  4.23	  C).	  Nedocromil	  did	  not	  have	  any	  effect	  on	  
constitutive	   neutrophil	   apoptosis	   or	   GM-­‐CSF	   induced	   survival	   at	   either	   dose	   tested	  
(Figure	  4.23	  D).	  These	  results	   indicated	  that	  the	  chromones	  were	  not	  affecting	  either	  
constitutive	   neutrophil	   apoptosis	   or	   GM-­‐CSF	   induced	   survival	   pathways,	   with	   the	  
exception	  of	  methylquercetin,	  which	  in	  contrast	  to	  the	  original	  hypothesis	  appeared	  to	  
promote	  neutrophil	  survival.	  	  
4.6.6	   Chromone-­‐derived	   compounds	   do	   not	   induce	   neutrophil	   apoptosis	   in	   the	  
presence	  of	  dexamethasone	  
As	   an	   alternative	   mechanism	   by	   which	   the	   chromones	   might	   affect	   neutrophil	  
apoptosis,	   I	   chose	   to	   investigate	   their	  effects	   in	   the	  presence	  of	  another	  activator	  of	  
neutrophil	  survival	  signalling,	  dexamethasone.	  Glucocorticoids	  such	  as	  dexamethasone	  
are	  not	  particularly	  effective	  in	  the	  treatment	  of	  inflammatory	  diseases	  characterised	  
by	  neutrophilic	  inflammation	  (Barnes,	  2000;	  Green	  et	  al.,	  2002).	  This	  is	  believed	  to	  be	  
due	  to	  their	  inhibitory	  effect	  on	  neutrophil	  apoptosis	  (Cox,	  1995;	  Kato	  et	  al.,	  1995;	  Liles	  
et	   al.,	   1995)	   in	   contrast	   to	   their	   apoptosis-­‐inducing	   properties	   in	   other	   cell	   types,	  
including	   eosinophils	   and	   T	   cells	   (Smoak	   &	   Cidlowski,	   2004).	   Although	   the	   precise	  




it	  is	  thought	  to	  be	  associated	  with	  up-­‐regulation	  of	  Mcl-­‐1	  (Sivertson	  et	  al.,	  2007).	  Other	  
anti-­‐apoptotic	  proteins	  such	  as	  XIAP	  may	  also	  be	  involved	  (Saffar	  et	  al.,	  2011).	  	  
	  
As	   discussed	   previously,	   studies	   have	   indicated	   that	   cromones	   can	   potentiate	   the	  
effect	   of	   glucocorticoids,	   resulting	   in	   enhanced	   Anx-­‐A1	   release	   (Yazid	   et	   al.,	   2009;	  
Yazid,	   Leoni,	   et	   al.,	   2010).	   Despite	   the	   fact	   that	   glucocorticoids	  maintain	   neutrophil	  
survival,	   there	   is	   evidence	   to	   support	   a	   pro-­‐apoptotic	   role	   for	   Anx-­‐A1	   in	   human	  
neutrophils	   (Solito	  et	   al.,	   2003),	  which	   is	   dependent	  on	   calcium	  entry	   and	   caspase-­‐3	  
activation	  (Perretti	  &	  Solito,	  2004).	  I	  hypothesised	  that	  by	  treating	  human	  neutrophils	  
in	  combination	  with	  dexamethasone	  and	  cromones,	  there	  would	  be	  increased	  Anx-­‐A1	  
release	  and	  this	  might	  be	  sufficient	  to	  override	  the	  survival	  effect	  of	  dexamethasone	  to	  
induce	  neutrophil	  apoptosis.	  	  
	  
To	   investigate	   this	   hypothesis,	   freshly	   isolated	   neutrophils	   were	   treated	   with	   each	  
compound	  at	  the	  dose	  indicated,	  in	  the	  presence	  and	  absence	  of	  dexamethasone	  at	  1	  
μM.	   This	   concentration	   was	   selected	   based	   on	   published	   data,	   in	   which	   1	   μM	   is	  
sufficient	  to	  cause	  a	  significant	   increase	   in	  neutrophil	  survival	   (Cox,	  1995;	  Liles	  et	  al.,	  
1995).	   Methylquercetin	   was	   not	   tested	   in	   these	   experiments	   due	   to	   its	   significant	  
effect	   on	   neutrophil	   survival	   in	   the	   previous	   assay.	   Ketotifen,	   a	   histamine	   receptor	  
antagonist,	  was	   tested	   instead,	   as	   this	   compound	  has	   been	   shown	   to	   exhibit	   similar	  
pharmacological	  properties	   to	  disodium	  cromoglycate	   (Kubes	  &	  Granger,	  1996;	  Cook	  
et	   al.,	   2002).	   Studies	   indicate	   that,	   like	   both	   the	   cromones	   and	   glucocorticoids,	  
ketotifen	   triggers	   phosphorylation	   of	   Anx-­‐A1	   at	   Ser27	   and	   its	   translocation	   to	   the	  
plasma	  membrane	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  
	  
Following	  8	  hours	  of	  culture,	  two	  cytospins	  were	  acquired	  for	  each	  condition	  and	  the	  
percentage	   of	   neutrophil	   apoptosis	   was	   calculated.	   Dexamethasone	   induced	  
neutrophil	   survival	   in	   untreated,	   vehicle	   control	   and	   compound	   treated	   neutrophils	  
with	   the	   exception	   of	   nedocromil	   (Figure	   4.24).	   In	   this	   case	   there	   was	   still	   a	   clear	  
reduction	  in	  apoptosis	  in	  the	  presence	  of	  dexamethasone	  and	  the	  lack	  of	  significance	  










Figure	   4.24:	   Chromone-­‐derived	   compounds	   do	   not	   override	   the	   survival	   effect	   of	  
dexamethasone.	  
Neutrophils	   were	   isolated	   from	   whole	   blood	   using	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
separation	   and	   were	   incubated	   for	   8	   hours	   with	   (+)	   and	   without	   (-­‐)	   1	   μM	   dexamethasone	   (Dex)	   as	  
indicated	   and	   with	   (A)	   10	   μM	   disodium	   cromoglycate	   (DSCG),	   (B)	   10	   μM	   nedocromil,	   (C)	   10	   μM	  
isopimpinellin	  or	   (D)	  10	  μM	  ketotifen.	   In	  each	  case,	  2	   cytospins	  were	  acquired	  and	   the	  percentage	  of	  
neutrophil	   apoptosis	   was	   calculated	   based	   on	   nuclear	   morphology.	   Dexamethasone	   significantly	  
reduced	  apoptosis	  in	  control	  groups	  and	  this	  survival	  did	  not	  appear	  to	  be	  inhibited	  in	  the	  presence	  of	  
any	  of	  the	  chromone	  derivatives	  or	  ketotifen	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  















































































































































































The	   results	   from	   these	   experiments	   indicated	   that	   neither	   the	   clinically	   available	  
cromones	  nor	  isopimpinellin	  caused	  apoptosis	  of	  isolated	  neutrophils	  in	  vitro.	  If	  there	  
was	  an	  increase	  in	  release	  of	  Anx-­‐A1	  in	  the	  combined	  presence	  of	  dexamethasone	  and	  
the	  cromones,	  this	  was	  either	  not	  a	  pro-­‐apoptotic	  signal	  or	  not	  sufficient	  to	  override	  
the	  survival	  signalling	  activated	  by	  glucocorticoid-­‐receptor	  binding.	  	  	  
4.6.7	  Disodium	  cromoglycate	  might	  potentiate	  the	  effect	  of	  glucocorticoids	  in	  vivo	  
Data	  obtained	   in	   the	   in	   vitro	   human	  neutrophil	   experiments	   strongly	   suggested	   that	  
the	   chromone-­‐derived	   compounds	   tested	   did	   not	   have	   a	   direct	   effect	   on	   neutrophil	  
survival.	   I	   had	   previously	   shown	   that	   disodium	   cromoglycate	   could	   accelerate	  
inflammation	  resolution	   in	  zebrafish.	   It	  was	  possible	  that	  either	   this	  effect	  was	  not	  a	  
consequence	  of	  neutrophil	  apoptosis	  but	  rather	  an	  alternative	  resolution	  mechanism,	  
or	  that	  some	  necessary	  stimulus	  was	  missing	  from	  the	   in	  vitro	  system.	  To	   investigate	  
whether	   the	   effect	   of	   disodium	   cromoglycate	   in	   vivo	   was	   likely	   to	   be	   Anx-­‐A1	  
dependent,	   a	   resolution	   assay	   was	   performed	   on	   3	   dpf	   mpx:GFP	   larvae	   with	   the	  
hypothesis	   that	   there	   would	   be	   a	   greater	   reduction	   in	   neutrophil	   number	   in	   the	  
combined	  presence	  of	  disodium	  cromoglycate	  and	  a	  glucocorticoid	  compared	  to	  either	  
alone.	   Betamethasone	   was	   used	   in	   these	   experiments,	   as	   this	   glucocorticoid	   was	  
known	  to	  be	  functionally	  active	  in	  other	  zebrafish	  assays,	  implying	  that	  there	  would	  be	  
no	   issues	  with	   its	   absorption	   or	  metabolism	   (personal	   communication,	  Dr	   Freek	   van	  
Eeden).	  Larvae	  were	  injured	  and	  those	  that	  mounted	  a	  good	  response	  to	  injury	  were	  
selected	   for	   treatment	  at	  6	  hpi.	   Larvae	  were	   re-­‐dosed	  every	  hour	  until	  12	  hpi,	  when	  
neutrophil	  numbers	  at	  the	  site	  of	   injury	  were	  counted.	  Betamethasone	  alone	  did	  not	  
significantly	  reduce	  the	  neutrophil	  count	  compared	  to	  the	  vehicle	  control	  (Figure	  4.25).	  	  
In	   these	   experiments,	   disodium	   cromoglycate	   alone	   did	   not	   cause	   a	   significant	  
reduction	  in	  neutrophil	  number	  at	  either	  dose	  tested,	  although	  there	  were	  significantly	  
fewer	  neutrophils	  at	  the	  site	  of	  injury	  in	  the	  larvae	  treated	  with	  both	  betamethasone	  
and	   2.5	   mM	   disodium	   cromoglycate	   in	   combination	   (Figure	   4.25).	   Despite	   this,	   the	  
results	   were	   inconclusive,	   as	   the	   combined	   effect	   was	   not	   significantly	   different	   to	  
either	   betamethasone	   or	   2.5	   mM	   disodium	   cromoglycate	   alone.	   From	   these	  
experiments,	  I	  was	  unable	  to	  determine	  whether	  or	  not	  disodium	  cromoglycate	  could	  











Figure	   4.25:	   Resolution	   of	   inflammation	   is	   accelerated	   in	   vivo	   in	   the	   combined	  
presence	  of	  disodium	  cromoglycate	  and	  a	  glucocorticoid.	  
At	   3	   dpf,	   mpx:GFP	   larvae	   were	   injured	   and	   treated	   in	   the	   presence	   (+)	   or	   absence	   (-­‐)	   of	   10	   μM	  
betamethasone	  (Bet)	  and	  with	  either	  250	  μM	  or	  2.5	  mM	  disodium	  cromoglycate	  (DSCG)	  as	  indicated	  at	  
6	   hpi.	   Neutrophil	   counts	   were	   performed	   at	   12	   hpi.	   There	   was	   a	   significant	   reduction	   in	   neutrophil	  
number	  at	  the	  site	  of	  injury	  at	  12	  hpi	  in	  larvae	  treated	  with	  disodium	  cromoglycate	  and	  betamethasone	  
in	   combination	   compared	   to	   the	   vehicle	   control,	   but	   not	   compared	   to	   either	   drug	   alone	   (One-­‐way	  






	   	  
















































In	   this	   chapter	   I	   have	   investigated	   the	   activity	   of	   a	   subset	   of	   the	   hit	   compounds	  
identified	   in	   the	   Spectrum	   Collection	   screen.	   Work	   has	   primarily	   focused	   on	  
isopimpinellin,	  a	  naturally	  occurring	  furanocoumarin	  with	  both	  anti-­‐inflammatory	  and	  
pro-­‐resolving	  properties.	  An	  assay	  designed	  to	  measure	  PI-­‐3K	  activity	  in	  vivo	  indicated	  
that	  the	  inhibitory	  properties	  of	  isopimpinellin	  on	  neutrophil	  recruitment	  were	  at	  least	  
in	  part	  due	  to	  inhibition	  of	  the	  PI-­‐3K	  signalling	  pathway.	  This	  mechanism	  of	  action	  was	  
shared	   by	   another	   hit	   compound,	   xanthone,	   which	   prompted	   a	   comparison	   of	   the	  
chemical	  structures	  of	  the	  hit	  compounds.	  Structural	  similarity	  was	  identified	  within	  a	  
subset	   of	   the	   hits,	   in	   the	   form	  of	   a	   shared	   1,4-­‐benzopyrone	   group,	  more	   commonly	  
referred	   to	   as	   chromone.	   Neutrophil	   apoptosis	   was	   identified	   as	   the	  mechanism	   by	  
which	   isopimpinellin	   could	   drive	   inflammation	   resolution	   and	   this	   led	   to	   an	  
investigation	  of	  the	  apoptotic	  potential	  of	  chromone	  derivatives.	  	  
4.7.1	  An	  in	  vivo	  assay	  for	  PI-­‐3K	  assay	  
Isopimpinellin	   is	   a	   naturally	   occurring	   furanocoumarin,	   the	   anti-­‐inflammatory	  
properties	  of	  which	  have	  not	  yet	  been	  defined.	  Similar	  compounds	  such	  as	  imperatorin	  
and	  byakangelicin	  have	  been	  shown	  to	  inhibit	  PGE2	  and	  COX-­‐2	  production	  (Ban	  et	  al.,	  
2003).	   Isopimpinellin	   was	   found	   to	   both	   significantly	   reduce	   neutrophil	   recruitment	  
and	  accelerate	  resolution	  during	  the	  acute	  inflammatory	  response	  initiated	  by	  tail	  fin	  
transection	   in	   zebrafish	   larvae.	   These	   properties	   were	   identified	   in	   the	   previous	  
chapter	  and	   further	   investigation	  confirmed	   that	   they	  occurred	   in	  a	  dose	  dependent	  
manner.	   Based	   on	   the	   hierarchical	   cluster	   analysis	   performed	   in	   Chapter	   3,	   which	  
revealed	  that	  isopimpinellin	  shared	  a	  similar	  activity	  profile	  to	  the	  pan-­‐PI-­‐3K	  inhibitor	  
ZSTK474,	   it	   was	   hypothesised	   that	   this	   compound	   acted	   via	   inhibition	   of	   PI-­‐3K	  
signalling.	  To	  explore	  this,	  an	   in	  vivo	  assay	  was	  designed	  to	  measure	  PI-­‐3K	  activity	   in	  
neutrophils	  during	   recruitment	   to	   the	  wound.	  A	   similar	  assay	  has	  been	  described	  by	  
(Yoo	  et	  al.,	  2010),	   in	  which	  a	  double	  transgenic	  zebrafish	   line	  was	  created	  expressing	  
the	  PHAkt-­‐EGFP	  construct	  under	  the	  mpx	  promoter,	  alongside	  an	  mCherry	  construct	  to	  
measure	  cytoplasmic	  volume.	  This	  enabled	  ratiometric-­‐imaging	  analysis	  to	  account	  for	  
any	  background	  signal	  caused	  by	  changes	  in	  cell	  volume.	  In	  these	  studies,	  polarisation	  
of	  PHAkt-­‐EGFP	  at	  the	  leading	  edge	  of	  neutrophils	  was	  visualised	  during	  recruitment	  to	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a	  small	   laser	  or	  needle	  induced	  wound,	  in	  a	  similar	  manner	  to	  the	  localisation	  of	  GFP	  
observed	  in	  neutrophils	  following	  tail	  fin	  injury	  of	  the	  lyz/PHAkt	  larvae	  used	  here.	  The	  
authors	   reported	   loss	   of	   this	   polarity	   and	   a	   reduction	   in	   neutrophil	  migration	   in	   the	  
presence	  of	   the	  PI-­‐3K	   inhibitor	   LY294002.	   I	   tested	   this	   compound	   in	  mpx:GFP	   larvae	  
using	   similar	   concentrations	   and	  also	   found	  a	   significant	   reduction	   in	   the	  number	  of	  
neutrophils	  recruited	  to	  the	  tail	  fin	  following	  wounding.	  Tracking	  analysis	  of	  individual	  
neutrophils	   during	   the	   first	   hour	   of	   recruitment	   revealed	   that	   LY294002	   treated	  
neutrophils	  migrated	  more	   slowly	   than	   those	   from	   control	   larvae,	   in	   keeping	  with	   a	  
loss	   of	   polarity	   and	   ability	   to	   undergo	   chemotaxis.	   As	   directed	   neutrophil	  migration	  
relies	   on	   cell	   polarisation,	   a	   loss	   of	   directionality	   might	   be	   expected	   when	   PI-­‐3K	  
signalling	   is	   inhibited.	  However,	   in	   the	   presence	   of	   LY294002,	  most	   neutrophils	   that	  
did	   undergo	   migration	   appeared	   to	   move	   preferentially	   towards	   the	   wound.	   It	   has	  
been	   proposed	   that	   during	   neutrophil	   migration,	   PI-­‐3K	   signalling	   is	   activated	   by	  
intermediary	   chemoattractants	   such	   as	   IL-­‐8,	   but	   that	   end-­‐target	   chemoattractants	  
such	  as	  fMLP	  and	  C5a	  signalling	  via	  p38	  MAPK	  can	  take	  precedence	  (Heit	  et	  al.,	  2002).	  
Thus,	   perhaps	   some	   neutrophils	   are	   able	   to	   respond	   to	   the	   latter	   chemotactic	  
signalling	  gradients	  and	  migrate	  towards	  the	  wound	  even	  in	  the	  presence	  of	  LY294002.	  
A	  similar	  observation	  has	  been	  made	  in	  PI-­‐3Kγ	  -­‐/-­‐	  mice,	  in	  which	  some	  neutrophils	  are	  
still	  able	  to	  undergo	  chemotaxis	  following	  fMLP	  or	  C5a	  stimulation	  (Hirsch,	  2000).	  
	  
In	   lyz/PHAkt	   larvae,	   LY294002	   treatment	   resulted	   in	   a	   loss	   of	   plasma	   membrane	  
localisation	  of	  PHAkt-­‐EGFP	  and	  a	  rounded	  tail	  phenotype	  as	  previously	  observed	  (Yoo	  
et	   al.,	   2010).	   I	   wished	   to	   quantify	   the	   distribution	   of	   EGFP	   signal	   in	   order	   to	   make	  
accurate	   and	   statistically	   valid	   comparisons	   between	   treatment	   groups.	   The	   polarity	  
index	  equation	  was	  devised,	  to	  enable	  quantitative	  measurement	  of	  the	  fluorescence	  
at	  the	  leading	  edge	  of	  the	  cell	  compared	  to	  the	  trailing	  edge	  and	  also	  compared	  to	  the	  
fluorescence	  within	  the	  cell.	  Though	  basic,	  this	  equation	  was	  seemingly	  effective,	  as	  in	  
all	  experiments	  the	  mean	  polarity	   index	  of	  neutrophils	   from	  LY294002	  treated	   larvae	  
was	  significantly	  lower	  than	  the	  mean	  from	  DMSO	  vehicle	  control	  treated	  larvae.	  	  	  
	  
However,	   there	  were	  a	  number	  of	   caveats	  associated	  with	   this	  assay.	  Within	   the	  3D	  




making	   identification	  of	  the	  dominant	   leading	  edge	  quite	  difficult.	   In	  some	  cases	  this	  
issue	  could	  be	  overcome	  by	  observing	  the	  cell	  movements	  over	  a	  short	  period	  of	  time	  
to	  make	   a	  more	   informed	   estimate	   as	   to	  which	  was	   the	   leading	   pseudopodium.	  On	  
occasions	  where	  it	  was	  still	  unclear	  where	  to	  transect	  the	  cell	   in	  ImageJ,	  the	  line	  was	  
drawn	  across	  the	  most	  longitudinal	  section.	  The	  nature	  of	  this	  assay	  made	  it	  difficult	  to	  
avoid	   bias,	   particularly	   when	   deciding	   which	   cells	   to	   image	   within	   the	   larvae.	   To	  
account	   for	   this,	   experiments	  were	  performed	  blind	   to	   treatment	   conditions	  and	   for	  
each	  replicate	  experiment,	  3	  neutrophils	  from	  each	  of	  3	  larvae	  were	  imaged	  per	  group	  
to	  generate	  high	  enough	  n	  numbers	  for	  reliability.	  Care	  was	  also	  taken	  to	  confirm	  that	  
only	  neutrophils	  situated	  between	  the	  wound	  site	  and	  the	  posterior	  blood	  island	  were	  
imaged,	   not	   those	   directly	   at	   the	   wound,	   as	   the	   behaviour	   of	   these	   cells	   would	   be	  
somewhat	  different	   to	   the	  migrating	  ones.	   	  Despite	   the	   limitations	  of	   this	   assay	  and	  
the	  polarity	  index	  equation,	  there	  was	  an	  obvious	  phenotypic	  difference	  between	  the	  
intracellular	   distribution	  of	   PHAkt-­‐EGFP	   in	   neutrophils	   from	   LY294002	   treated	   larvae	  
compared	  to	  the	  controls	  and	  this	  was	  reflected	  in	  the	  statistically	  lower	  mean	  polarity	  
index.	   It	   was	   apparent	   that	   in	   some	   instances,	   neutrophils	   from	   the	   DMSO	   control	  
larvae	   displayed	   a	   low	   polarity	   index,	   more	   comparable	   to	   the	   value	   expected	   in	  
neutrophils	  exposed	  to	  LY294002.	  It	  might	  be	  that	  at	  the	  time	  of	   imaging,	  these	  cells	  
had	   not	   yet	   detected	   the	   chemokine	   gradient	   and	   subsequently	   had	   not	   begun	   to	  
polarise.	  There	  might	  have	  been	   less	  variability	   in	   the	  assay	   if	   imaging	   took	  place	  an	  
hour	  or	   two	  after	   injury	   rather	   than	  within	   the	   first	   30	  minutes,	  however	   this	  might	  
have	  made	   imaging	   of	   individual	   cells	  more	   tricky	   as	   there	   would	   have	   been	   larger	  
numbers	  of	  neutrophils	  closer	  to	  the	  wound,	  particularly	  in	  the	  control	  larvae.	  	  
	  
LY294002	   acts	   as	   a	   competitive	   inhibitor	   of	   PI-­‐3K	  by	   binding	   to	   the	  ATP-­‐binding	   site	  
(Walker	   et	   al.,	   2000)	   resulting	   in	   reduced	   phosphorylation	   of	   AKT.	   Although	   initially	  
developed	  as	  a	  specific	  PI-­‐3K	  inhibitor,	  there	  is	  some	  evidence	  to	  suggest	  that	  in	  some	  
cell	   types	   LY294002	   may	   inhibit	   other	   protein	   kinases	   such	   as	   mTOR	   (Brunn	   et	   al.,	  
1996)	  or	  reduce	  the	  DNA-­‐binding	  activity	  of	  NF-­‐κB	  (Kim	  et	  al.,	  2005).	  These	  potential	  
off-­‐target	   effects	   must	   be	   considered	   when	   interpreting	   the	   data.	   In	   addition,	  
LY294002	  has	  broad	  inhibitory	  activity	  spanning	  throughout	  the	  different	  classes	  of	  PI-­‐
3K	  and	  in	  hindsight	  it	  might	  have	  been	  more	  relevant	  to	  use	  a	  γ-­‐specific	  PI-­‐3K	  inhibitor,	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as	   this	   is	   considered	   to	   be	   the	   most	   important	   isoform	   in	   mammalian	   neutrophil	  
recruitment	   (Hirsch,	  2000;	  Hannigan	  et	  al.,	   2002;	   Ferguson	  et	  al.,	   2007).	  Morpholino	  
knockdown	   of	   PI-­‐3Kγ	   has	   demonstrated	   that	   this	   isoform	   is	   also	   required	   for	  
neutrophil	  chemotaxis	  in	  zebrafish	  (Yoo	  et	  al.,	  2010).	  	  
	  
Evidence	  revealed	  that	  PI-­‐3K	  is	  also	  important	  during	  reverse	  migration	  of	  neutrophils,	  
which	   can	   be	   observed	   to	   repolarise	   and	   migrate	   away	   from	   a	   wound	   (Yoo	   et	   al.,	  
2010).	   In	   these	   studies,	   inflammation	   is	   initiated	  by	  only	   a	   very	   small	   incision	   in	   the	  
tissue,	  rather	  than	  complete	  transection	  of	  the	  tail	  fin.	  Although	  it	  would	  be	  interesting	  
to	  investigate	  PI-­‐3K	  signalling	  during	  resolution	  in	  my	  assay,	  it	  would	  be	  very	  difficult	  to	  
image	  individual	  cells	  due	  to	  the	  large	  numbers	  of	  neutrophils	  recruited	  to	  the	  tail	  fin	  
in	   this	   model,	   and	   combining	   the	   PHAkt-­‐EGFP	   transgenic	   with	   the	  mpx/Kaede	   line	  
would	  be	  technically	  highly	  complex.	  	  
4.7.2	  Isopimpinellin	  inhibits	  neutrophil	  recruitment	  by	  disruption	  of	  PI-­‐3K	  signalling	  
In	   this	   in	   vivo	   PI-­‐3K	   assay,	   isopimpinellin	  was	   found	   to	   reduce	  neutrophil	   polarity	   as	  
determined	  by	  the	  polarity	   index	  equation	  discussed	  above.	  In	  these	  neutrophils,	  the	  
cellular	   localisation	   of	   PHAkt-­‐EGFP	   was	   dispersed	   with	   lack	   of	   any	   defined	   leading	  
edge,	   similar	   to	   the	   phenotype	   observed	   in	   neutrophils	   from	   larvae	   treated	   with	  
LY294002.	   These	   data	   suggested	   that	   the	   inhibitory	   effect	   of	   isopimpinellin	   on	  
neutrophil	  recruitment	  might	  be	  explained	  by	  reduced	  phosphorylation	  and	  activation	  
of	  Akt	  and	  loss	  of	  the	  downstream	  signalling	  events	  required	  for	  cell	  polarisation	  and	  
directed	   migration.	   Notably,	   the	   preliminary	   tracking	   experiments	   performed	   to	  
analyse	  the	  migratory	  behaviour	  of	  neutrophils	  during	  the	  recruitment	  phase	  indicated	  
that	   isopimpinellin	   altered	   the	   chemotactic	   behaviour	   in	   a	   similar	   manner	   to	  
LY294002.	  Both	  compounds	  significantly	  reduced	  neutrophil	  speed	  and	  displacement,	  
however	  to	  be	  certain	  of	  the	  effects	  of	  isopimpinellin,	  this	  experiment	  would	  need	  to	  
be	  repeated.	  	  
	  
It	  has	  not	  been	  determined	  whether	  isopimpinellin	  acts	  directly	  on	  PI-­‐3K,	  for	  example	  
by	   competitive	   binding	   to	   the	   ATP-­‐binding	   site	   in	   a	   similar	  manner	   to	   LY294002,	   or	  




receptor	   level.	   It	   is	   theoretically	   possible	   that	   rather	   than	   acting	   in	   an	   inhibitory	  
fashion,	   isopimpinellin	   might	   be	   activating	   a	   phosphatase	   such	   as	   PP2A,	   which	   can	  
directly	   dephosphorylate	   AKT,	   or	   PTEN,	   which	   converts	   PIP3	   to	   PIP2	   (Liao	   &	   Hung,	  
2010).	  Both	  might	  result	  in	  inactivation	  of	  Akt	  and	  impaired	  chemotaxis	  in	  zebrafish.	  It	  
is	   also	   possible	   that	   the	   effect	   observed	   is	   not	   neutrophil	   specific	   and	   that	  
isopimpinellin	  could	  be	  inhibiting	  PI-­‐3K	  in	  other	  cell	  types,	  or	  that	  it	  could	  be	  affecting	  
a	  wide	  range	  of	  other	  protein	  kinases.	  
	  
Another	  hit	  compound,	  xanthone,	  also	  significantly	  reduced	  polarity	  index	  but	  this	  was	  
not	  found	  to	  be	  a	  universal	  effect	  of	  exposure	  of	  zebrafish	   larvae	  to	  pharmacological	  
agents,	  as	  tanshinone	  IIA	  had	  no	  effect	   in	  this	  assay.	   Interestingly,	   in	  the	  presence	  of	  
xanthone,	   neutrophils	   sometimes	   appeared	   to	   distribute	   PHAkt-­‐EGFP	   at	   the	   cell	  
membrane,	   but	   this	   was	   at	   a	   universal	   intensity	   rather	   than	   localised	   to	   a	   defined	  
leading	  edge.	  This	  could	  indicate	  that	  xanthone	  was	  acting	  further	  downstream	  in	  the	  
PI-­‐3K/Akt	  signalling	  pathway,	  enabling	  Akt	  to	  be	  recruited	  to	  the	  membrane	  but	  then	  
perhaps	   blocking	   further	   downstream	   signalling	   associated	   with	   leading	   edge	  
specification.	  It	   is	  also	  possible	  that	  xanthone	  could	  be	  inhibiting	  another	  component	  
of	  the	  PI-­‐3K/Akt	  signalling	  pathway,	  for	  example	  phosphoinositide-­‐dependent	  kinase-­‐1	  
(PDK1)	   (Alessi	   et	   al.,	   1997)	   or	   mTOR	   complex	   2	   (mTORC2)	   (Sarbassov	   et	   al.,	   2005),	  
which	   function	   downstream	   of	   PI-­‐3K	   to	   phosphorylate	   and	   activate	   AKT	   once	   it	   has	  
been	   recruited	   to	   the	   plasma	   membrane.	   Indeed,	   inhibition	   of	   PDK1	   by	   either	  
pharmacological	  or	  siRNA	  knockdown	  is	  associated	  with	  impaired	  neutrophil	  migration	  
(Yagi	  et	  al.,	  2009).	  
4.7.3	  Structure-­‐activity	  relationships	  between	  hit	  compounds	  
The	   discovery	   of	   a	   potential	   shared	   mechanism	   of	   action	   between	   two	   of	   the	   hit	  
compounds,	   xanthone	   and	   isopimpinellin,	   prompted	   an	   investigation	   to	   determine	  
whether	   any	   structure-­‐activity	   relationships	   existed	   between	   the	   compounds	  
identified	   in	   the	   Spectrum	   Collection	   screen.	   Structural	   similarity	   in	   the	   form	   of	   a	  
shared	  1,4-­‐benzopyrone	  group,	  more	  commonly	  referred	  to	  as	  chromone,	  was	  found	  
in	   7	   out	   of	   the	   21	   reproducible	   positive	   hits.	   An	   interesting	   observation	   was	   the	  
presence	  of	  the	  chromone	  group	  in	  LY294002,	  which	  is	  in	  fact	  a	  derivative	  of	  quercetin	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and	  was	  originally	  synthesised	  alongside	  a	  number	  of	  other	  chromones	  in	  a	  search	  for	  
more	  specific	  PI-­‐3K	   inhibitors	   (Vlahos	  et	  al.,	  1994).	  Quercetin	   is	  suspected	  to	  directly	  
inhibit	  PI-­‐3K	  by	  associating	  with	  the	  ATP-­‐binding	  site	  (Matter	  et	  al.,	  1992)	  and	  evidence	  
also	   suggests	   that	   it	   can	   disrupt	   neutrophil	   recruitment	   by	   inhibiting	   actin	  
polymerisation	   (Souto	   et	   al.,	   2011).	   It	   might	   have	   been	   interesting	   to	   explore	   the	  
activity	   of	   the	   positive	   hit	   methylquercetin	   in	   the	   PI-­‐3K	   assay,	   although	   if	   the	  
assumption	  were	  made	  that	  it	  would	  act	  similarly	  to	  its	  analogue	  quercetin,	  then	  it	  is	  
possible	   that	   it	   might	   have	   more	   potent	   inhibitory	   activity	   against	   PI-­‐3Kα	   and	   δ	  
isoforms,	  as	  has	  been	  demonstrated	  for	  similar	  flavonoids	  (Kong	  et	  al.,	  2011).	  	  
	  
As	  the	  chromone	  group	  was	  common	  to	  a	  number	  of	  the	  positive	  hit	  compounds	  and	  
LY294002,	   it	   was	   hypothesised	   that	   this	   structure	   might	   be	   responsible	   for	   their	  
inhibitory	  effects	  on	  neutrophil	  recruitment.	  However,	  when	  tested	  alone,	  chromone	  
itself	   was	   actually	   found	   to	   have	   a	   more	   potent	   effect	   on	   the	   resolution	   phase	   of	  
inflammation.	   These	   data	   led	   to	   the	   hypothesis	   that	   the	   chromone-­‐derived	  
compounds	  had	  been	  identified	  in	  the	  screen	  due	  to	  a	  shared	  and	  novel	  pro-­‐resolution	  
mechanism	   of	   action.	   With	   the	   idea	   that	   the	   chromone	   group	   was	   responsible	   for	  
driving	   resolution,	  a	  number	  of	   chromone	  analogues	  were	   synthesised	  and	   tested	   in	  
the	  zebrafish.	  These	  compounds	  were	  found	  to	  have	  varying	  degrees	  of	  pro-­‐resolution	  
activity,	  allowing	  the	  prediction	  to	  be	  made	  that	   the	  addition	  of	  a	   third	  hydrocarbon	  
ring	   might	   promote	   their	   effects.	   It	   was	   reassuring	   that	   one	   of	   the	   most	   potent	  
compounds	  synthesised	  by	  the	  chemists	  turned	  out	  to	  be	  xanthone,	  emphasising	  the	  
robustness	  and	  reproducibility	  of	  the	  zebrafish	  resolution	  assay.	  	  	  
	  
Unfortunately,	   issues	   arose	  over	   the	   course	  of	   these	  experiments,	   in	   that	   chromone	  
appeared	   to	   lose	   its	   effectiveness	   over	   time,	   although	   it	   could	   not	   be	   determined	  
whether	   this	  was	   due	   to	   a	   tendency	   to	   be	   oxidised	   and	  degraded	  or	   a	   result	   of	   the	  
inherent	   reactivity	   of	   this	   compound.	   The	   effect	   of	   chromone	   on	   the	   resolution	   of	  
inflammation	  was	  greater	  when	  the	  stock	  solution	  was	  prepared	  from	  new,	  unopened	  
purified	  solid,	  suggesting	  that	  a	  reaction	  took	  place	  once	  the	  compound	  was	  exposed	  




differences	   in	   batches	   of	   chromone	   obtained	   from	   the	   supplier.	   Regardless	   of	   the	  
underlying	  cause,	  it	  was	  impractical	  to	  purchase	  new	  chromone	  for	  each	  experiment.	  	  
	  
As	   no	   promising	   lead	   compounds	   had	   been	   generated	   from	   the	   chemical	   synthesis,	  
other	   than	   the	   already	   naturally	   occurring	   xanthone	   and	   flavone,	   this	   project	   was	  
deprioritised	   in	  favour	  of	  other	  hits	   identified	   in	  the	  Spectrum	  Collection	  screen.	  The	  
identification	   of	   flavone	   as	   a	   chromone	   analogue	   led	   to	   the	   realisation	   that	   many	  
compounds,	   particularly	   those	   that	   can	   be	   isolated	   from	   plant	   species,	   may	   be	  
chromone-­‐derived.	  Flavones	  are	  just	  one	  of	  the	  classes	  of	  plant	  secondary	  metabolites	  
known	   as	   the	   flavonoids.	   It	   may	   be	   that	   the	   correlation	   found	   here	   between	  
chromone-­‐derived	  compounds	  and	  pro-­‐resolution	  activity	  is	  simply	  circumstantial	  and	  
that	   the	   functional	   activity	   of	   this	   subset	   of	   hit	   compounds	   is	   principally	   due	   to	   the	  
other	   structural	   moieties	   attached	   to	   the	   chromone	   backbone,	   which	  might	   dictate	  
target	   binding	   and	   affinity.	   Flavones	   are	   particularly	   known	   for	   their	   antioxidant	  
activity,	  although	  the	  series	  of	  analogues	  tested	  here	  indicated	  that	  the	  most	  effective	  
drivers	  of	  resolution	  were	  the	  least	  likely	  to	  act	  via	  antioxidant	  mechanisms.	  However	  
only	   a	   handful	   of	   compounds	  were	   tested	   and	   their	   potency	   in	   the	   resolution	   assay	  
was	  by	  no	  means	  a	  direct	  measure	  of	  their	  antioxidant	  capacity.	  	  
4.7.4	  Isopimpinellin	  drives	  neutrophil	  apoptosis	  during	  inflammation	  resolution	  
The	   hit	   compound	   isopimpinellin	   significantly	   accelerated	   the	   resolution	   of	  
inflammation	   in	  vivo,	   alongside	   its	   inhibitory	  action	  on	  neutrophil	   recruitment.	  Using	  
TSA/TUNEL	  staining	  in	  fixed	  larvae,	  it	  was	  revealed	  that	  there	  was	  a	  significant	  increase	  
in	   the	   rate	   of	   neutrophil	   apoptosis	   at	   the	   site	   of	   injury	   in	   the	   presence	   of	   this	  
compound.	  Experiments	  performed	  in	  the	  previous	  chapter	  showed	  that	  there	  was	  no	  
change	   in	   total	   neutrophil	   number	   following	  24	  hours	  of	   exposure	   to	   isopimpinellin,	  
suggesting	  that	  the	  effect	  on	  neutrophil	  apoptosis	  was	  specific	  to	  activated	  neutrophils	  
participating	   in	   the	   inflammatory	   response.	   However,	   what	   cannot	   be	   determined	  
from	   these	   data	   is	   whether	   the	   apoptosis-­‐inducing	   properties	   of	   isopimpinellin	   are	  




Although	   the	   endogenous	   rates	   of	   apoptosis	   identifiable	   at	   any	   one	   time	   during	  
inflammation	   resolution	   in	   very	   young	   zebrafish	   larvae	   are	   low	   (Elks	   et	   al.,	   2011,	  
Burgon	   et	   al.,	   in	   submission),	   the	   data	   obtained	   here	   indicate	   that	   it	   is	  
pharmacologically	   possible	   to	   drive	   resolution	   via	   this	   mechanism,	   as	   has	   been	  
previously	  described	  (Loynes	  et	  al.,	  2009).	  It	  is	  difficult	  to	  measure	  precisely	  how	  much	  
neutrophil	  apoptosis	  takes	  place	  using	  this	  assay,	  as	  larvae	  are	  fixed	  at	  a	  specific	  time	  
point,	  illustrating	  only	  a	  snapshot	  of	  the	  entire	  resolution	  phase.	  It	  would	  be	  useful	  and	  
informative	   to	   observe	   apoptosis	   occurring	   in	   real	   time.	   To	   this	   end,	   a	   novel	  
Tg(mpx:FRET)sh237	  reporter	  line	  has	  been	  developed,	  in	  which	  the	  FRET	  signal	  is	  lost	  
following	  caspase-­‐3	  mediated	  cleavage	  of	  the	  FRET	  reporter	   (Dr	  Nikolay	  Ogryzko	  and	  
Dr	   Stephen	   Renshaw,	   personal	   communication).	   Preliminary	   experiments	   performed	  
using	  this	  line	  revealed	  a	  significant	  increase	  in	  apoptotic	  events	  at	  the	  site	  of	  injury	  in	  
isopimpinellin	  treated	  larvae,	  associated	  with	  a	  loss	  of	  the	  FRET	  signal.	  These	  data	  not	  
only	   provide	   supportive	   evidence	   for	   the	   apoptotic	   potential	   of	   isopimpinellin	   in	  
driving	   inflammation	   resolution	  but	  also	   suggest	   that	   this	   is	  occurring	   in	  a	   caspase-­‐3	  
dependent	  manner.	  	  	  
	  
It	  has	  been	  proposed	   that	  neutrophil	   apoptosis	  does	  not	   contribute	   to	   inflammation	  
resolution	  in	  zebrafish	  (Mathias	  et	  al.,	  2006).	   In	  these	  studies,	  wounding	  consisted	  of	  
only	   a	   small	   incision	   in	   the	   ventral	   fin,	   resulting	   in	   relatively	   low	   numbers	   of	  
neutrophils	   recruited	   compared	   to	   the	   tail	   fin	   transection	   model.	   With	   fewer	   cells	  
present	  it	  would	  therefore	  be	  even	  less	  likely	  to	  observe	  apoptosis,	  but	  this	  does	  not	  
necessarily	   mean	   that	   it	   does	   not	   occur	   at	   all.	   The	   authors	   claim	   that	   the	   main	  
mechanism	   responsible	   for	   driving	   resolution	   in	   zebrafish	   is	   by	   their	  migration	   away	  
from	  the	  wound,	  which	  has	  also	  been	  reported	  by	  others	  (Hall	  et	  al.,	  2007;	  Elks	  et	  al.,	  
2011;	  Yoo	  &	  Huttenlocher,	  2011).	  In	  the	  presence	  of	  isopimpinellin,	  reverse	  migration	  
was	  inhibited	  and	  in	  fact	  during	  time-­‐lapse	  microscopy	  neutrophils	  at	  the	  site	  of	  injury	  
could	   be	   observed	   to	   round	   up	   and	   undergo	   apoptosis	   in	   real	   time.	   These	   data	  
provided	   further	   evidence	   that	   apoptosis	   was	   the	   main	   mechanism	   of	   neutrophil	  
clearance	  by	  isopimpinellin.	  Preliminary	  TSA/TUNEL	  data	  indicated	  that	  flavone	  might	  




shown	  to	  drive	  inflammation	  resolution	  in	  zebrafish	  and	  isolated	  human	  neutrophils	  in	  
a	  caspase-­‐dependent	  manner	  (Lucas	  et	  al.,	  2012).	  
4.7.5	  Investigation	  into	  the	  effect	  of	  chromone	  derivatives	  on	  neutrophil	  apoptosis	  	  
Isopimpinellin	   was	   discovered	   to	   be	   an	   isomer	   of	   khellin,	   a	   naturally	   occurring	  
compound	  from	  which	  a	  series	  of	  clinically	  available	  anti-­‐histamine	  drugs	  collectively	  
termed	   the	   cromones	   was	   developed.	   The	   anti-­‐inflammatory	   activity	   of	   these	  
compounds	   has	   not	   yet	   been	   fully	   defined.	  Due	   to	   the	   structural	   similarity	   between	  
isopimpinellin	  and	  khellin,	   I	  hypothesised	  that	   the	  anti-­‐inflammatory	  potential	  of	   the	  
cromones	  might	  be	  associated	  with	  neutrophil	  apoptosis,	  which	  would	  support	  the	  use	  
of	   these	   already	   clinically	   available	   drugs	   in	   the	   treatment	   of	   neutrophilic	  
inflammatory	  diseases.	  The	  archetypal	  cromone,	  disodium	  cromoglycate,	  significantly	  
accelerated	   inflammation	   resolution	   in	   the	   zebrafish	   model.	   To	   observe	   an	   effect,	  
relatively	   high	   doses	   of	   the	   drug	   were	   required	   compared	   to	   those	   used	   in	   most	  
zebrafish	  assays	  and	  it	  was	  necessary	  to	  re-­‐dose	  larvae	  with	  fresh	  drug	  solution	  every	  
hour.	  This	  may	  be	  a	   result	  of	   the	  poor	  pharmacokinetic	  properties	  of	   the	  cromones,	  
which	  has	  been	  suggested	  in	  other	  systems	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  This	  observation	  
might	   also	   explain	   the	   variable	   effects	   observed	   previously	   in	   the	   resolution	   assays	  
carried	   out	   using	   chromone.	   In	   hindsight,	   perhaps	   its	   activity	   would	   have	   been	  
maintained	  by	   re-­‐dosing	   the	   larvae.	  Much	  of	   the	   early	  work	   that	  was	   carried	  out	   to	  
develop	  more	  stable	  and	  effective	  khellin	  analogues	  indicated	  that	  tricyclic	  chromone	  
derivatives	   were	   more	   active,	   one	   of	   these	   being	   nedocromil	   sodium	   (Edwards	   &	  
Howell,	   2000).	   In	   light	   of	   this,	   it	   is	   interesting	   that	   the	   chromone	   derivatives	  
synthesised	  earlier	  for	  this	  project	  displayed	  more	  significant	  effects	  on	  inflammation	  
resolution	  with	  the	  addition	  of	  a	  third	  hydrocarbon	  ring.	  	  
	  
The	  cromones	  directly	  inhibit	  the	  phosphatase	  PP2A	  in	  neutrophils	  to	  promote	  release	  
of	   the	   protein	   Anx-­‐A1,	   which	   may	   at	   least	   in	   part	   mediate	   their	   effects	   on	   the	  
inflammatory	  response	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  PP2A	  inhibition	  can	  result	  in	  hyper-­‐
phosphorylation	  and	  instability	  of	  Mcl-­‐1,	  accelerating	  neutrophil	  apoptosis	  (Derouet	  et	  
al.,	   2004).	   This	   supports	   the	   hypothesis	   that	   chromone	   derivatives	   might	   promote	  
inflammation	   resolution	   via	   this	   mechanism.	   Disodium	   cromoglycate,	   nedocromil	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sodium	   and	   two	   of	   the	   hit	   compounds,	   isopimpinellin	   and	   methylquercetin,	   were	  
investigated	   for	   their	   effects	   on	   apoptosis	   in	   freshly	   isolated	  human	  neutrophils.	  No	  
increase	  in	  constitutive	  neutrophil	  apoptosis	  was	  observed	  with	  any	  of	  the	  compounds	  
tested,	  disputing	   the	  original	  hypothesis.	   It	  was	  possible	   that	   rather	   than	   influencing	  
constitutive	   apoptosis	   the	   chromones	   might	   interfere	   with	   neutrophil	   survival	  
signalling,	  for	  example	  by	  inhibiting	  some	  component	  of	  the	  MAPK,	  PI-­‐3K	  or	  JAK/STAT	  
pathways.	  However	  there	  was	  no	  inhibition	  of	  GM-­‐CSF	  induced	  neutrophil	  survival	   in	  
the	  presence	  of	   the	   chromones	   tested.	   Interestingly,	  but	   in	  even	  greater	   contrast	   to	  
the	  original	  hypothesis,	  methylquercetin	  appeared	  to	  promote	  neutrophil	  survival.	  This	  
also	   does	   not	   correlate	   with	   published	   data,	   which	   describe	  Mcl-­‐1	   down-­‐regulation	  
and	   induction	  of	  neutrophil	  apoptosis	   in	  vitro	  by	  highly	  similar	   flavones	   (Lucas	  et	  al.,	  
2012).	  In	  these	  studies,	  the	  flavones	  tested	  are	  also	  shown	  to	  override	  survival	  factors	  
including	   GM-­‐CSF	   and	   dexamethasone.	   It	   may	   be	   that	   subtle	   differences	   in	   the	  
chemical	  structure	  of	  the	  various	  chromone	  derivatives	  affect	  target	  binding,	  or	  even	  
the	  ability	  to	  permeate	  the	  cell	  membrane.	  	  
	  
The	  data	  obtained	  in	  these	  in	  vitro	  experiments	  did	  not	  support	  a	  direct	  pro-­‐apoptotic	  
effect	   caused	   by	   inhibition	   of	   PP2A	   and	   Mcl-­‐1	   down-­‐regulation	   by	   chromones.	  
Although	  disodium	  cromoglycate	  and	  nedocromil	  are	  associated	  with	  PP2A	  inhibition,	  
this	   did	   not	   appear	   to	   correlate	   with	   the	   instability	   of	   Mcl-­‐1	   as	   described	   by	   the	  
pharmacological	  inhibitor	  of	  PP2A,	  okadaic	  acid	  (Derouet	  et	  al.,	  2004).	  In	  this	  particular	  
study,	   neutrophils	   were	   treated	  with	   okadaic	   acid	   in	   combination	  with	   the	   de	   novo	  
protein	  synthesis	   inhibitor	  cyclohexamide	  and	  no	  control	  data	  are	  presented	  to	  show	  
the	  effect	  of	  okadaic	  acid	  alone,	  making	  it	  difficult	  to	  interpret	  the	  results.	  Experiments	  
performed	  using	  alternative	  PP2A	  inhibitors	  suggest	  that	  PP2A	  can	  promote	  neutrophil	  
apoptosis	  (Alvarado-­‐Kristensson	  &	  Andersson,	  2005).	  Indeed,	  PP2A	  is	  known	  to	  play	  a	  
role	   in	   survival	   and	   can	   directly	   inhibit	   the	   PI-­‐3K/AKT	   signalling	   pathway	   by	  
dephosphorylating	   and	   inactivating	   AKT	   (Liao	   &	   Hung,	   2010).	   In	   neutrophils,	   AKT	  
promotes	  survival	   in	  multiple	  ways,	  for	  example	  by	  phosphorylation	  and	  inhibition	  of	  
the	  pro-­‐apoptotic	  BCL-­‐2	  family	  members	  BAX	  and	  BAD	  (Datta	  et	  al.,	  1999;	  Gardai	  et	  al.,	  




of	   chromones	   is	   associated	   with	   PP2A	   inhibition,	   then	   increased	   neutrophil	   survival	  
would	  be	  expected,	  as	  observed	  here.	  
4.7.6	  The	  effects	  of	  chromones	  on	  glucocorticoid	  induced	  neutrophil	  survival	  	  
Studies	   suggest	   that	   cromones	   can	   potentiate	   the	   effect	   of	   glucocorticoids	   via	  
enhanced	  release	  of	  Anx-­‐A1	  (Yazid	  et	  al.,	  2009;	  Yazid,	  Leoni,	  et	  al.,	  2010),	  which	  has	  a	  
pro-­‐apoptotic	   effect	   in	   human	   neutrophils	   (Solito	   et	   al.,	   2003).	   This	   is	   somewhat	  
contradictory,	   as	   glucocorticoids	   are	   known	   to	   directly	   promote	   neutrophil	   survival	  
(Cox,	   1995;	   Kato	   et	   al.,	   1995;	   Liles	   et	   al.,	   1995).	   I	   hypothesised	   that	   the	   combined	  
activity	   of	   dexamethasone	   and	   cromones	   might	   enhance	   Anx-­‐A1	   release	   to	   a	   level	  
sufficient	  to	  override	  the	  anti-­‐apoptotic	  effect	  of	  the	  glucocorticoid.	  However,	  the	  data	  
obtained	   from	   isolated	   human	   neutrophils	   revealed	   that	   dexamethasone	   induced	  
neutrophil	  survival	  was	  maintained	  in	  the	  presence	  of	  all	   the	  compounds	  tested.	  The	  
histamine	   receptor	   antagonist	   ketotifen	  was	   also	   investigated,	  which	   although	  not	   a	  
chromone	   derivative,	   is	   believed	   to	   function	   via	   the	   same,	   Anx-­‐A1	   dependent	  
mechanism	  (Yazid,	  Leoni,	  et	  al.,	  2010).	  No	   increase	   in	  apoptosis	  was	  observed	   in	   the	  
presence	  of	  ketotifen,	  suggesting	  that	  either	  under	  these	  experimental	  conditions	  Anx-­‐
A1	  is	  not	  pro-­‐apoptotic,	  or	  that	  the	  concentration	  of	  ketotifen	  used	  was	  not	  optimal.	  It	  
may	  be	  that	  much	  higher	  doses	  of	  the	  chromone	  derivatives	  were	  required	  to	  induce	  
sufficient	  Anx-­‐A1	  release	  to	  override	  the	  survival	  effect	  of	  dexamethasone.	  
	  
From	  data	  obtained	  in	  these	  in	  vitro	  experiments,	  it	  was	  concluded	  as	  unlikely	  that	  the	  
chromone	   derivatives	   had	   a	   direct	   effect	   on	   neutrophil	   apoptosis	   as	   a	   result	   of	  
enhanced	  Anx-­‐A1	  release.	  It	  is	  possible	  that	  some	  necessary	  stimulus	  was	  missing	  from	  
the	   in	   vitro	   system,	   which	   might	   explain	   the	   significant	   effect	   observed	   on	  
inflammation	   resolution	   in	   the	   presence	   of	   disodium	   cromoglycate	   and	   other	  
chromone	  derivatives	  in	  vivo.	  Indeed,	  the	  lack	  of	  neutrophil	  apoptosis	  in	  isopimpinellin	  
treated	   neutrophils	   did	   not	   correlate	   with	   the	   significant	   increase	   in	   neutrophil	  
apoptosis	   revealed	   by	   the	   in	   vivo	   data,	   suggesting	   that	   it	   does	   not	   cause	   neutrophil	  
apoptosis	   directly	   but	   that	   another	   cell	   type	   or	   stimulus	   is	   involved.	   In	   particular,	   it	  
would	   be	   interesting	   to	   assess	   whether	   isopimpinellin	   can	   still	   cause	   neutrophil	  
apoptosis	   in	   macrophage-­‐ablated	   zebrafish	   larvae.	   Experiments	   performed	   to	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investigate	   the	   combined	   effect	   of	   glucocorticoids	   and	   disodium	   cromoglycate	   on	  
inflammation	   resolution	   in	   vivo	   were	   inconclusive,	   as	   in	   this	   instance	   the	   effect	   of	  
disodium	   cromoglycate	   alone	   was	   not	   significant.	   This	   may	   have	   been	   a	   result	   of	  
excessive	  degradation.	  	  	  
	  
Despite	   their	  ability	   to	  promote	  neutrophil	   survival,	  glucocorticoids	  can	   function	   in	  a	  
pro-­‐resolution	   manner,	   for	   example	   by	   enhancing	   the	   non-­‐phlogistic	   phagocytic	  
clearance	   of	   apoptotic	   neutrophils	   by	   macrophages	   (Liu	   et	   al.,	   1999).	   	   It	   has	   been	  
proposed	  that	  one	  of	  the	  mechanisms	  regulating	  this	  activity	  is	  Anx-­‐A1	  dependent	  as	  
macrophages	   release	   Anx-­‐A1	   in	   the	   presence	   of	   dexamethasone	   (Maderna	   et	   al.,	  
2005).	   Anx-­‐A1	   enhances	   phagocytosis	   of	   apoptotic	   neutrophils	   by	   binding	   to	   ALX	  
receptors	   (Scannell	  et	  al.,	  2007).	  The	  phagocytic	  capacity	  can	  be	  abrogated	  using	  the	  
receptor	  antagonist	  Boc2,	  an	  annexin	  blocking	  antibody,	  or	  by	  removal	  of	  Anx-­‐A1	  from	  
the	  supernatant	  of	  apoptotic	  neutrophils	  (Maderna	  et	  al.,	  2005;	  Scannell	  et	  al.,	  2007).	  
Thus,	  it	  may	  be	  that	  in	  the	  in	  vitro	  experiments	  performed	  here,	  the	  lack	  of	  phagocytic	  
macrophages	   prevented	   an	   increase	   in	   Anx-­‐A1	   mediated	   neutrophil	   apoptosis.	   This	  
would	   also	   fit	   with	   the	   in	   vivo	   data	   obtained	   for	   isopimpinellin	   and	   it	   would	   be	  
interesting	  to	  investigate	  the	  effect	  of	  both	  this	  compound	  and	  disodium	  cromoglycate	  
in	   vivo	   following	   macrophage	   ablation.	   However,	   there	   is	   evidence	   to	   suggest	   that	  
endogenous	   Anx-­‐A1	   is	   not	   only	   released	   by	   phagocytic	   macrophages	   but	   also	   by	  
apoptotic	   cells.	   For	   example,	   in	   apoptotic	   Jurkat	   T	   cells,	   Anx-­‐1	   is	   exported	   and	   co-­‐
localises	  with	  phosphatidylserine	  on	  the	  cell	  membrane	  to	  function	  as	  an	  engulfment	  
ligand	   (Arur	   et	   al.,	   2003).	   This	   is	   also	   believed	   to	   occur	   in	   neutrophils,	   in	   a	   caspase-­‐
dependent	   manner	   (Scannell	   et	   al.,	   2007).	   It	   is	   possible	   that	   Anx-­‐A1	   acts	   via	   two	  
distinct	   but	   complementary	  mechanisms,	   being	   released	  by	  both	   the	  phagocyte	   and	  
target	  cell	  for	  pro-­‐phagocytic	  activity.	  
4.7.7	  Conclusions	  	  
Much	   of	   the	   work	   presented	   in	   this	   chapter	   focuses	   on	   the	   structure-­‐activity	  
relationship	  between	  the	  chromone-­‐derived	  hit	  compounds	  identified	  in	  the	  Spectrum	  
Collection	  screen	  and	  the	  group	  of	  clinically	  available	  cromones.	  It	  is	  possible	  that	  this	  




compounds,	  although	  the	  precise	  mechanism	  could	  not	  be	  defined	  here.	  Their	  activity	  
does	  not	  appear	  to	  be	  due	  to	  increased	  neutrophil	  apoptosis,	  or	  the	  enhanced	  release	  
of	  Anx-­‐A1,	   although	   this	  was	  not	  measured	  directly.	  One	  of	   the	  most	   interesting	  hit	  
compounds,	  isopimpinellin,	  was	  investigated	  due	  to	  the	  similarity	  of	  its	  activity	  profile	  
with	   a	   known	   PI-­‐3K	   inhibitor.	   The	   activity	   of	   isopimpinellin	   in	   vivo	   is	   two-­‐fold;	  
recruitment	  of	  neutrophils	  to	  the	  site	  of	  injury	  is	  reduced,	  which	  occurs	  at	  least	  in	  part	  
by	   PI-­‐3K	   inhibition,	   and	   resolution	   of	   inflammation	   is	   accelerated	   by	   enhanced	  
neutrophil	  apoptosis.	  Due	  to	  the	  lack	  of	  apoptosis	  observed	  in	  vitro	  in	  the	  presence	  of	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Screening	  of	  the	  Spectrum	  Collection	  identified	  21	  compounds	  with	  the	  ability	  to	  drive	  
inflammation	   resolution	   in	   the	   zebrafish	   model.	   The	   best	   of	   these	   were	   further	  
investigated	  to	  examine	  their	  specific	  effects	  on	  neutrophil	  number	  at	  the	  site	  of	  injury	  
during	  both	  the	  recruitment	  and	  resolution	  phases	  of	  inflammation.	  When	  comparing	  
their	  activity	  against	  a	  panel	  of	  known	  inflammatory	  signalling	  pathway	  inhibitors	  from	  
GlaxoSmithKline,	  most	   of	   the	   hit	   compounds	   formed	   a	   distinct	   cluster,	   with	   greater	  
effects	   on	   resolution	   rather	   than	   neutrophil	   recruitment.	   Aside	   from	   the	   chromone	  
derivatives	   discussed	   in	   the	   previous	   chapter,	   two	   other	   closely	   structurally	   related	  
compounds	   were	   present	   within	   the	   pro-­‐resolution	   cluster,	   cryptotanshinone	   and	  
tanshinone	   IIA.	   These	  were	   the	  most	  potent	   accelerators	  of	   inflammation	   resolution	  
identified	  in	  the	  screen,	  surpassed	  only	  by	  the	  NSAID	  naproxen	  (refer	  to	  Figure	  3.19).	  	  
	  
Tanshinone	   IIA	   and	   cryptotanshinone	   are	   both	   natural	   extracts	   from	   Salvia	  
miltiorrhiza,	  more	  commonly	  referred	  to	  as	  Danshen,	  a	  Chinese	  medicinal	  herb	  that	  is	  
traditionally	   used	   to	   treat	   cardiovascular	   disorders	   (Zhou	   et	   al.,	   2005).	   These	  
compounds	   are	   known	   to	   possess	   some	   anti-­‐inflammatory	   activity,	   for	   instance	  
tanshinone	   IIA	   has	   protective	   effects	   against	   LPS-­‐induced	   lung	   injury	   in	   mammalian	  
systems	   (Shi	   et	   al.,	   2007;	   Xu	   et	   al.,	   2009).	   These	   reports,	   along	  with	   evidence	   from	  
other	  mammalian	  models	  of	  inflammation,	  suggest	  that	  the	  anti-­‐inflammatory	  effects	  
of	   tanshinone	   IIA	   are	   due	   to	   an	   inhibition	   of	   NF-­‐κB	   activation,	   however	   the	   precise	  
mechanisms	  are	  not	  well	  defined	  (Bai	  et	  al.,	  2008;	  Xu	  et	  al.,	  2008;	  An	  et	  al.,	  2011;	  Yin	  
et	   al.,	   2012).	   This	   is	   supported	   by	   evidence	   from	   in	   vitro	   systems.	   In	   the	   RAW264.7	  
mouse	  macrophage-­‐like	  cell	  line,	  tanshinone	  IIA	  inhibits	  NF-­‐κB	  activation	  following	  LPS	  
stimulation,	  the	  downstream	  effects	  of	  which	  include	  reduction	  of	  COX-­‐2	  and	  inducible	  
nitric	  oxide	  synthase	  (iNOS)	  activity	  (Jang	  et	  al.,	  2006;	  Jeon	  et	  al.,	  2008).	   Inhibition	  of	  
MAPK	   signalling	   in	   LPS	   treated	   RAW264.7	   cells	   by	   both	   tanshinone	   IIA	   and	  




downstream	  effects	  of	  cryptotanshinone	  are	  similar	  to	  those	  described	  for	  tanshinone	  
IIA,	   such	   as	   down-­‐regulation	   of	   iNOS	   and	   COX-­‐2	   (Jeon	   et	   al.,	   2008)	   and	   in	   addition,	  
reduced	  production	  of	  TNF-­‐α	  and	   IL-­‐6	   (Tang	  et	  al.,	  2011).	   It	  has	  also	  been	  suggested	  
that	  cryptotanshinone	  can	  directly	   inhibit	  COX-­‐2	  enzymatic	  activity,	  without	  affecting	  
mRNA	   or	   protein	   expression	   (Jin	   et	   al.,	   2006).	   Aside	   from	   NF-­‐κB,	   tanshinones	   have	  
been	   implicated	   in	   the	   inhibition	   of	   other	   transcription	   factors	   such	   as	   activator	  
protein-­‐1	   (AP-­‐1)	   and	   STAT1	   (Kogut	   et	   al.,	   2008;	   Yang	   et	   al.,	   2010).	   In	   the	   secondary	  
assays	  performed	  in	  Chapter	  3,	  there	  appeared	  to	  be	  some	  toxicity	  in	  the	  presence	  of	  
cryptotanshinone	   and	   subsequently	   the	   majority	   of	   the	   work	   described	   here	   was	  
carried	  out	  using	  tanshinone	  IIA.	  
	  
Evidence	   indicates	  that	   tanshinone	   IIA	  can	   induce	  apoptosis	   in	  human	   leukaemia	  cell	  
lines	  by	   activation	  of	   caspase-­‐3	   (Sung	  et	   al.,	   1999).	   It	   has	   also	  been	   shown	   to	   cause	  
apoptosis	  in	  other	  cell	  types,	  including	  multiple	  cancer	  cell	  lines	  (Won	  et	  al.,	  2010;	  Jiao	  
et	  al.,	  2011;	  Chen	  et	  al.,	  2012;	  Wei	  et	  al.,	  2012).	  A	  pro-­‐apoptotic	  effect	  of	  tanshinone	  
IIA	   on	   human	   peripheral	   blood	   neutrophils	   has	   not	   been	   reported.	   Given	   that	  
neutrophil	  apoptosis	  is	  known	  to	  be	  one	  of	  the	  main	  mechanisms	  by	  which	  neutrophils	  
are	   removed	  during	   inflammation	   resolution	   (Savill	   et	  al.,	   1989),	   it	  was	  possible	   that	  
this	   could	   explain	   the	   acceleration	   in	   resolution	   observed	   in	   the	   presence	   of	  
tanshinone	  IIA	  in	  the	  zebrafish	  model.	  	  
	  
In	  the	  hierarchical	  cluster	  analysis	  performed	  in	  Chapter	  3,	  tanshinone	  IIA	  was	  closely	  
associated	  with	  roflumilast.	  This	  PDE4	  inhibitor	  is	  clinically	  effective	  in	  the	  treatment	  of	  
COPD,	  in	  part	  by	  reducing	  neutrophil	  numbers	  in	  the	  lung	  (Grootendorst	  et	  al.,	  2007).	  
Another	  PDE4	  inhibitor,	  rolipram,	  has	  been	  shown	  to	  enhance	  resolution	  in	  a	  murine	  
model	  of	  LPS-­‐induced	  pleurisy	  by	  promoting	  neutrophil	  apoptosis	  (Sousa	  et	  al.,	  2010).	  
This	   appeared	   to	   be	   partially	   mediated	   via	   inhibition	   of	   the	   PI-­‐3K/AKT	   signalling	  
pathway	  and	  was	  dependent	  on	  caspase	  activation	  and	  down-­‐regulation	  of	  Mcl-­‐1.	  This	  
provides	   supportive	   evidence	   for	   a	   pro-­‐apoptotic	   role	   of	   tanshinone	   IIA,	   considering	  
that	  this	  compound	  might	  function	  in	  a	  similar	  manner	  to	  the	  PDE4	  inhibitors	  to	  drive	  
inflammation	  resolution.	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5.1.1	  Aims	  and	  hypotheses	  
The	  aim	  of	  this	  chapter	  is	  to	  investigate	  the	  profound	  effect	  of	  tanshinone	  IIA	  on	  the	  
resolution	   of	   inflammation,	   with	   the	   hypothesis	   that	   this	   action	   might	   be	   due	   to	  
enhanced	   neutrophil	   apoptosis.	   This	   chapter	   also	   aims	   to	   investigate	   alternative	  
mechanisms	  by	  which	  tanshinone	  IIA	  might	  drive	  resolution.	  
	  
	  
5.2	  Tanshinone	  IIA	  does	  not	  significantly	  affect	  neutrophil	  recruitment	  	  
	  
In	   the	   secondary	   assays	   performed	   following	   the	   Spectrum	   Collection	   screen,	  
tanshinone	   IIA	  was	   found	   to	   have	   only	   a	   small	   effect	   on	   neutrophil	   recruitment.	   To	  
confirm	  this	  observation,	  3	  dpf	  mpx:GFP	  larvae	  were	  injured	  and	  treated	  immediately	  
with	  a	  range	  of	  concentrations	  of	  tanshinone	  IIA	  until	  6	  hpi,	  when	  neutrophil	  numbers	  
at	   the	   site	   of	   injury	   were	   recorded.	   In	   these	   experiments,	   tanshinone	   IIA	   did	   not	  
significantly	  affect	  neutrophil	  recruitment	  at	  6	  hpi,	  although	  there	  was	  a	  trend	  towards	  
a	   reduction	   in	   neutrophil	   numbers	   at	   the	   site	   of	   injury	  with	   increasing	   dose	   (Figure	  
5.1).	  	  
	  
The	  effect	  of	  tanshinone	  IIA	  on	  neutrophil	  migratory	  behaviour	  during	  recruitment	  was	  
investigated	   further	   by	   pre-­‐treatment	   of	  mpx:GFP	   larvae	   with	   tanshinone	   IIA	   for	   2	  
hours,	   followed	   by	   injury	   and	   time-­‐lapse	   imaging	   on	   an	   inverted	   compound	  
fluorescence	  microscope.	  GFP-­‐labelled	  neutrophils	  were	  tracked	  for	  one	  hour	  as	  they	  
migrated	   towards	   the	   site	   of	   injury	   and	  Volocity®	   software	  was	   used	   to	   analyse	   the	  
speed	   and	   meandering	   index	   of	   each	   individual	   cell	   track,	   as	   previously	   described.	  
There	   was	   no	   difference	   in	   either	   neutrophil	   speed	   or	   meandering	   index	   in	   the	  
presence	  of	   tanshinone	   IIA	   compared	   to	   the	  DMSO	  vehicle	   control	   (Figure	  5.2	  A,	  B).	  
There	  was	  also	  no	  change	  in	  displacement	  towards	  the	  wound	  (Figure	  5.2	  C),	  indicating	  
that	  neutrophils	  in	  tanshinone	  IIA	  treated	  larvae	  moved	  a	  comparable	  distance	  in	  the	  




































Figure	  5.1:	  Tanshinone	  IIA	  does	  not	  significantly	  reduce	  neutrophil	  recruitment.	  
At	  3	  dpf,	  mpx:GFP	   larvae	  were	   injured	  and	   treated	   immediately	  with	  varying	  doses	  of	   tanshinone	   IIA.	  
Neutrophil	   numbers	   at	   the	   site	   of	   injury	   were	   counted	   at	   6	   hpi.	   Tanshinone	   IIA	   did	   not	   cause	   a	  
significant	  reduction	  in	  neutrophil	  recruitment	  to	  the	  wound,	  although	  there	  was	  a	  trend	  towards	  lower	  
neutrophil	   numbers	  with	   increasing	  dose	   (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	   comparison	  post-­‐
test;	   n	   =	   18,	   performed	   as	   3	   independent	   experiments).	   Dotted	   line	   at	   y	   =	   18.11	   indicates	   mean	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Figure	  5.2:	  Tanshinone	  IIA	  has	  no	  effect	  on	  neutrophil	  chemotaxis.	  
At	   3	   dpf,	  mpx:GFP	   larvae	   were	   pre-­‐treated	   with	   DMSO	   or	   25	   μM	   tanshinone	   IIA	   before	   injury	   and	  
mounting.	   Larvae	   were	   imaged	   for	   1	   hour	   and	   individual	   GFP-­‐labelled	   neutrophils	   were	   tracked	   and	  
analysed	  using	  Volocity®	  software.	  Tanshinone	  IIA	  had	  no	  significant	  effect	  on	  (A)	  neutrophil	  speed,	  (B)	  
meandering	   index	   or	   (C)	   displacement	   towards	   the	   wound	   (Unpaired	   t-­‐test;	   n	   =	   18,	   performed	   as	   3	  
independent	   experiments).	   For	   bearing,	   an	   angle	   of	   0-­‐180	   degrees	   indicates	  movement	   towards	   the	  
wound	   and	   180-­‐360	   degrees	   indicates	   movement	   away.	   In	   both	   DMSO	   and	   tanshinone	   IIA	   treated	  
larvae,	  neutrophils	  move	  in	  a	  directed	  fashion	  towards	  the	  wound	  (One-­‐way	  ANOVA	  with	  Bonferroni’s	  
multiple	  comparison	  post-­‐test	  to	  compare	  selected	  columns;	  where	  ***	  P	  <	  0.001;	  n	  =	  18,	  performed	  as	  





























































































































Neutrophil	  bearing	  also	  remained	  unchanged,	  which	  suggested	  that	  the	  cells	  remained	  
able	   to	   respond	   to	   directional	   chemotactic	   cues	   in	   the	   presence	   of	   tanshinone	   IIA	  
(Figure	  5.2	  D).	  These	  data	  were	  consistent	  with	  the	  PI-­‐3K	  assay	  described	  in	  Chapter	  4,	  
in	   which	   tanshinone	   IIA	   appeared	   to	   have	   no	   effect	   on	   PHAkt-­‐EGFP	   localisation	   or	  
directed	  migration	  and	  did	  not	  alter	  neutrophil	  polarity	   index	  during	  the	  recruitment	  
phase	  of	  inflammation.	  
	  
5.3	  Tanshinone	  IIA	  significantly	  accelerates	  inflammation	  resolution	  in	  vivo	  
	  
To	  confirm	  the	  pro-­‐resolution	  activity	  of	   tanshinone	   IIA	  before	  embarking	  on	  a	  more	  
thorough	   investigation	   into	   the	   potential	   mechanisms	   involved,	   concentration-­‐
response	  experiments	  were	  carried	  out	  to	  examine	  its	  effects	  on	  the	  resolution	  phase	  
of	  inflammation.	  Tail	  fin	  transection	  was	  performed	  on	  3	  dpf	  mpx:GFP	  larvae	  and	  those	  
larvae	   which	   recruited	   high	   numbers	   of	   neutrophils	   at	   6	   hpi	   were	   selected	   for	  
treatment	  with	  varying	  doses	  of	  tanshinone	  IIA.	  Neutrophil	  numbers	  remaining	  at	  the	  
wound	  were	  assessed	  at	  12	  hpi.	  Tanshinone	  IIA	  significantly	  accelerated	  inflammation	  
resolution	  by	  reducing	  neutrophil	  numbers	  at	  the	  site	  of	   injury,	  from	  a	  concentration	  
of	  1	  μM	  up	  to	  25	  μM	  (Figure	  5.3).	  Toxicity	  was	  observed	  at	  100	  μM	  and	  250	  μM.	  
	  
	  
5.4	  Tanshinone	  IIA	  and	  cryptotanshinone	  induce	  human	  neutrophil	  apoptosis	  
	  
An	  important	  prerequisite	  for	  successful	  resolution	  of	  inflammation	  is	  the	  constitutive	  
apoptosis	  of	  neutrophils	  and	  their	  subsequent	  recognition	  and	  clearance	  by	  phagocytic	  
macrophages	  (Savill	  et	  al.,	  1989).	  I	  first	  hypothesised	  that	  the	  mechanism	  responsible	  
for	   the	   reduction	   in	   neutrophil	   numbers	   observed	   during	   the	   resolution	   of	  
inflammation	   in	   vivo	   might	   be	   due	   to	   an	   increase	   in	   neutrophil	   apoptosis.	   To	  
investigate	  this	  hypothesis	  I	  initially	  tested	  tanshinone	  IIA	  in	  an	  in	  vitro	  setting,	  in	  order	  
to	  look	  at	  its	  direct	  effect	  on	  neutrophils	  without	  the	  possible	  involvement	  of	  other	  cell	  
types	   or	   factors	   within	   the	   inflammatory	   environment.	   Despite	   its	   toxicity	   at	   high	  














Figure	  5.3:	  Tanshinone	  IIA	  significantly	  accelerates	  inflammation	  resolution.	  
At	   3	   dpf,	   tail	   transection	   was	   performed	   on	   mpx:GFP	   larvae	   and	   those	   which	   mounted	   a	   good	  
neutrophilic	  response	  at	  6	  hpi	  were	  treated	  with	  varying	  doses	  of	  tanshinone	  IIA.	  Neutrophil	  numbers	  at	  
the	   site	   of	   injury	   were	   counted	   at	   12	   hpi.	   At	   doses	   of	   1	   μM	   and	   higher,	   tanshinone	   IIA	   significantly	  
reduced	  neutrophil	   numbers	   at	   the	  wound	   compared	   to	   the	  DMSO	   vehicle	   control	   (One-­‐way	  ANOVA	  
with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05,	  **	  P	  <	  0.01	  and	  ***	  P	  <	  0.001;	  n	  =	  24,	  
performed	  as	  4	  independent	  experiments).	  Dotted	  line	  at	  y	  =	  18.42	  indicates	  mean	  neutrophil	  number	  
at	  site	  of	  injury	  in	  control	  larvae.	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Human	   neutrophils	   were	   isolated	   from	   peripheral	   whole	   blood	   by	   either	   the	  
OptiprepTM	   or	   Percoll®	  method	   of	   purification,	   as	   described,	   and	  were	   treated	  with	  
multiple	  doses	  of	  tanshinone	  IIA	  or	  cryptotanshinone.	  After	  8	  hours	  in	  culture	  at	  37°C,	  
two	   cytospins	   per	   condition	   were	   prepared	   and	   the	   percentage	   of	   neutrophil	  
apoptosis	   was	   calculated	   based	   on	   nuclear	   morphology.	   A	   small	   but	   significant	  
increase	   in	   constitutive	   apoptosis	  was	   found	   in	   neutrophils	   treated	  with	   10	   μM	  and	  
100	   μM	   tanshinone	   IIA	   compared	   to	   the	   DMSO	   vehicle	   control	   (Figure	   5.4	   A).	  
Cryptotanshinone	  had	  a	  more	  profound	  effect	  on	  neutrophil	  apoptosis,	  with	  a	  highly	  
significant	  increase	  at	  both	  10	  μM	  and	  100	  μM	  (Figure	  5.4	  B).	  	  
5.4.1	  Tanshinones	  abrogate	  GM-­‐CSF	  induced	  neutrophil	  survival	  in	  vitro	  
The	   previous	   data	   indicated	   that	   both	   tanshinone	   IIA	   and	   cryptotanshinone	   directly	  
increased	  the	  rate	  of	  constitutive	  neutrophil	  apoptosis	  in	  vitro.	  At	  sites	  of	  inflammation	  
in	  vivo,	  a	  number	  of	  host-­‐derived	  pro-­‐survival	  factors	  are	  thought	  to	  delay	  neutrophil	  
apoptosis,	   such	   as	   GM-­‐CSF,	   ATP	   and	   hypoxia,	   the	   functions	   of	   which	   have	   been	  
demonstrated	  in	  culture	  (Lee	  et	  al.,	  1993;	  Hannah	  et	  al.,	  1995;	  Vaughan	  et	  al.,	  2007).	  
Novel	  anti-­‐inflammatory	  therapies	  designed	  to	  drive	  inflammation	  resolution	  must	  be	  
able	   to	  override	  these	  survival	  signals,	  which	  persist	  during	  chronic	   inflammation.	  To	  
examine	   the	   potential	   of	   the	   tanshinones	   to	   promote	   neutrophil	   apoptosis	   in	   the	  
presence	  of	  survival	  signalling,	  their	  effects	  were	  investigated	  in	  combination	  with	  GM-­‐
CSF.	   	  Exposure	  of	  neutrophils	  to	  GM-­‐CSF	  results	   in	  prolonged	  neutrophil	  survival	  due	  
to	  stabilisation	  of	  the	  anti-­‐apoptotic	  protein	  Mcl-­‐1	  (Moulding	  et	  al.,	  1998).	  	  
	  
Neutrophils	  were	   isolated	   from	  peripheral	  whole	  blood,	  as	  previously	  described,	  and	  
treated	  with	  10	  μM	  of	  either	  tanshinone	  IIA	  or	  cryptotanshinone,	  in	  the	  presence	  and	  
absence	  of	  GM-­‐CSF.	  After	  8	  hours,	  two	  cytospins	  were	  acquired	  per	  condition	  and	  the	  
percentage	  of	  neutrophil	  apoptosis	  was	  calculated	  based	  on	  nuclear	  morphology.	  GM-­‐
CSF	   caused	   a	   significant	   reduction	   in	   neutrophil	   apoptosis	   in	   untreated	   and	   vehicle	  
control	  neutrophils,	  but	  this	  survival	  was	  lost	  in	  the	  presence	  of	  either	  tanshinone	  IIA	  
or	   cryptotanshinone	   (Figure	  5.5).	   These	  data	   suggested	   that	   these	   compounds	   could	  







Figure	  5.4:	  Tanshinones	  increase	  constitutive	  neutrophil	  apoptosis	  in	  vitro.	  
Neutrophils	   were	   isolated	   from	   whole	   blood	   using	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
separation	  and	  were	   incubated	  with	  (A)	  tanshinone	  IIA	  or	  (B)	  cryptotanshinone	  for	  8	  hours	  at	  37°C.	   In	  
each	  case,	  2	  cytospins	  were	  acquired	  and	  percentage	  neutrophil	  apoptosis	  calculated	  based	  on	  nuclear	  
morphology.	  Both	  compounds	  significantly	   increased	  neutrophil	  apoptosis	  at	  doses	  of	  10	  μM	  and	  100	  
μM	   (One-­‐way	   ANOVA	   with	   Dunnett’s	   multiple	   comparison	   post-­‐test;	   where	   *	   P	   <	   0.05	   and	   ***	   P	   <	  
0.001;	  n	  =	  4).	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Figure	  5.5:	  Tanshinones	  abrogate	  GM-­‐CSF	  induced	  neutrophil	  survival	  in	  vitro.	  
Neutrophils	   were	   isolated	   from	   whole	   blood	   using	   either	   the	   OptiprepTM	   or	   Percoll®	   method	   of	  
separation	  and	  were	   incubated	   for	   8	  hours	   at	   37°C	  with	   (+)	   and	  without	   (-­‐)	  GM-­‐CSF	  as	   indicated	  and	  
with	  (A)	  10	  μM	  tanshinone	  IIA	  or	  (B)	  10	  μM	  cryptotanshinone.	  In	  each	  case,	  2	  cytospins	  were	  acquired	  
and	   the	   percentage	   of	   neutrophil	   apoptosis	   was	   calculated	   based	   on	   nuclear	   morphology.	   GM-­‐CSF	  
significantly	   reduced	   apoptosis	   in	   control	   groups	   but	   this	   survival	   was	   lost	   in	   the	   presence	   of	   either	  
tanshinone	   IIA	  or	  cryptotanshinone	   (One-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test	  




























































































5.4.2	  Tanshinone	  IIA	  increases	  neutrophil	  apoptosis	  in	  vivo	  	  
Having	   established	   that	   tanshinone	   IIA	   could	   promote	   both	   constitutive	   neutrophil	  
apoptosis	   and	   apoptosis	   in	   the	   presence	   of	   GM-­‐CSF	   survival	   signalling	   in	   vitro,	   I	  
hypothesised	   that	   this	   compound	   would	   also	   cause	   apoptosis	   in	   vivo,	   to	   reduce	  
neutrophil	   numbers	   at	   the	   site	   of	   injury	   and	   drive	   inflammation	   resolution	   in	   the	  
zebrafish	  model.	  To	  investigate	  this,	  tail	  transection	  was	  performed	  on	  3	  dpf	  mpx:GFP	  
larvae	  and	   those	   that	  mounted	  a	  good	   inflammatory	   response	  were	   treated	  with	  25	  
μM	  tanshinone	  IIA	  at	  6	  hpi.	  	  At	  12	  hpi,	  larvae	  were	  fixed	  in	  4%	  PFA	  prior	  to	  TSA	  staining	  
to	   label	   neutrophil-­‐specific	   myeloperoxidase	   activity,	   followed	   by	   TUNEL	   staining	   to	  
label	  apoptosis.	  The	  tail	  fins	  were	  imaged	  on	  an	  UltraVIEWVoX	  spinning	  disk	  confocal	  
imaging	  system	  at	  20x	  magnification.	  The	  total	  neutrophil	  number	  at	  the	  site	  of	  injury	  
and	  number	  of	  dual-­‐labelled	  apoptotic	  neutrophils	  was	  assessed	  in	  individual	  larvae,	  to	  
calculate	  the	  mean	  percentage	  of	  neutrophil	  apoptosis.	  This	  revealed	  that	  tanshinone	  
IIA	  significantly	   increased	  the	  percentage	  of	  neutrophil	  apoptosis	  at	  the	  site	  of	   injury	  
compared	   to	   the	   DMSO	   vehicle	   control	   (Figure	   5.6).	   The	   rate	   of	   apoptosis	   in	   the	  
control	   larvae	   was	   comparable	   to	   that	   observed	   in	   the	   experiments	   performed	  
previously,	   although	   tanshinone	   IIA	   was	   a	   less	   potent	   inducer	   of	   apoptosis	   than	  
isopimpinellin	  (refer	  to	  Figure	  4.18).	  	  
	  
It	  was	  evident	   that	   tanshinone	   IIA	  could	  drive	   inflammation	   resolution	  by	  promoting	  
neutrophil	  apoptosis.	  However,	  its	  effect	  in	  the	  TUNEL	  assay	  appeared	  relatively	  small	  
given	   that	   this	   compound	   was	   one	   of	   the	   best	   hits	   identified	   in	   the	   Spectrum	  
Collection	   screen.	  Due	   to	   the	   nature	   of	   this	   assay,	   neutrophil	   apoptosis	   can	   only	   be	  
measured	   at	   one	   time	   point,	   which	   might	   not	   necessarily	   be	   representative	   of	   the	  
entire	   resolution	   phase,	   as	   discussed	   previously.	   The	   resolution	   assay	   data	   indicate	  
that	   there	   is	   a	   highly	   significant	   reduction	   in	   neutrophil	   number	   at	   the	   wound	   in	  
tanshinone	   IIA	   larvae	  at	  12	  hpi	  compared	   to	  control	   larvae.	  This	   suggests	   that	  either	  
neutrophil	   apoptosis	   is	   occurring	   much	   earlier	   and	   apoptotic	   corpses	   cannot	   be	  
observed	  by	  TSA/TUNEL	  staining	  as	  they	  have	  already	  been	  removed	  by	  macrophages	  
by	  12	  hpi,	  or	  that	  there	  is	  an	  additional	  pro-­‐resolution	  mechanism	  responsible	  for	  the	  

















Figure	   5.6:	   Tanshinone	   IIA	   significantly	   increases	   neutrophil	   apoptosis	   during	  
inflammation	  resolution	  in	  vivo.	  
Tail	  transection	  was	  performed	  on	  3	  dpf	  mpx:GFP	  larvae	  and	  good	  responders	  were	  treated	  with	  25	  μM	  
tanshinone	  IIA	  or	  DMSO	  at	  6	  hpi.	  Larvae	  were	  fixed	   in	  4%	  PFA	  at	  12	  hpi	  and	  neutrophils	  were	  stained	  
with	  TSA,	  followed	  by	  TUNEL	  staining	  for	  apoptosis.	  Tail	   fins	  were	  mounted	  and	   imaged	  on	  a	  confocal	  
spinning	  disk	  imaging	  system	  at	  20x	  magnification.	  The	  total	  number	  of	  neutrophils	  at	  the	  site	  of	  injury	  
and	   the	   number	   of	   apoptotic	   neutrophils	   were	   counted	   to	   calculate	   the	   percentage	   apoptosis.	  
Tanshinone	  IIA	  caused	  a	  significant	  increase	  in	  neutrophil	  apoptosis	  (Unpaired	  t-­‐test;	  P	  <	  0.05;	  n	  ≥	  161,	  
performed	  as	  3	  independent	  experiments).	  	  






































5.5	  Tanshinone	  IIA	  increases	  neutrophil	  reverse	  migration	  
	  
Recently	  is	  has	  become	  accepted	  that	  apoptosis	  is	  not	  the	  only	  mechanism	  responsible	  
for	   neutrophil	   clearance,	   but	   that	   potentially	   viable	   neutrophils	   can	   leave	   sites	   of	  
inflammation	   by	   reverse	   migration.	   This	   has	   been	   reported	   in	   mammalian	   systems	  
(Buckley	  &	  Ross,	  2006;	  Woodfin	  et	  al.,	  2011)	  and	  in	  zebrafish	  (Mathias	  et	  al.,	  2006;	  Hall	  
et	   al.,	   2007;	   Elks	   et	   al.,	   2011;	   Yoo	  &	   Huttenlocher,	   2011),	   but	   the	   precise	   signalling	  
pathways	   involved	   remain	   undefined.	   I	   hypothesised	   that	   an	   increase	   in	   neutrophil	  
reverse	  migration	  might	   be	   an	   additional	   mechanism	   to	   explain	   the	   significant	   pro-­‐
resolution	  effect	  of	  tanshinone	  IIA	  in	  zebrafish.	  	  
	  
To	   investigate	   this	  hypothesis,	   reverse	  migration	  assays	  were	  performed	  using	  3	  dpf	  
mpx/Kaede	  larvae,	  as	  described	  in	  the	  previous	  chapter.	  At	  4	  hpi,	  larvae	  that	  mounted	  
a	   good	   inflammatory	   response	   were	   treated	   with	   either	   25	   μM	   tanshinone	   IIA	   or	  
DMSO	  vehicle	  control.	  At	  6	  hpi,	  Kaede-­‐labelled	  neutrophils	  at	   the	  site	  of	   injury	  were	  
photoconverted	   from	   green	   to	   red	   fluorescence	   using	   an	   UltraVIEWPhotoKinesisTM	  
device,	   with	   the	   405	   nm	   laser	   line	   at	   40%	   laser	   energy.	   Larvae	   were	   imaged	   for	  
approximately	  300	  minutes	  and	  the	  number	  of	  red-­‐labelled	  neutrophils	  that	  migrated	  
away	   from	  the	  site	  of	   injury	   into	  a	  defined	  distal	   region	   in	  each	   larva	  was	  quantified	  
(refer	  to	  Figure	  4.19	  A).	  Strikingly,	  this	  analysis	  revealed	  that	  neutrophils	  in	  tanshinone	  
IIA	   treated	   larvae	   moved	   away	   from	   the	   site	   of	   injury	   more	   quickly	   than	   in	   DMSO	  
control	  larvae	  (Figure	  5.7	  A).	  The	  most	  rapid	  movement	  appeared	  to	  occur	  within	  the	  
first	   2	   hours	   following	   photoconversion,	   as	   illustrated	   in	   (Figure	   5.7	   B).	   Neutrophils	  
tended	  to	  migrate	  away	  through	  the	  tissue,	  rather	  than	  re-­‐entering	  the	  vasculature.	  
	  
These	   results	   suggested	   that	   tanshinone	   IIA	   exerts	   its	   predominant	   pro-­‐resolution	  
effect	  by	  accelerating	   the	  endogenous	   reverse	  migratory	  behaviour	  of	  neutrophils	   in	  
vivo,	   promoting	   neutrophil	   clearance	   from	   the	   wound.	   This,	   combined	   with	   the	  
apoptosis-­‐inducing	  properties	  of	  tanshinone	  IIA,	  may	  account	  for	   its	  highly	  significant	  








Figure	   5.7:	   Tanshinone	   IIA	   accelerates	   reverse	   migration	   of	   neutrophils	   during	  
inflammation	  resolution.	  
Tail	   fin	   transection	   was	   performed	   on	  mpx/Kaede	   larvae	   at	   3	   dpf,	   and	   those	   that	   mounted	   a	   good	  
neutrophilic	   response	   were	   selected	   for	   treatment	   with	   25	   μM	   tanshinone	   IIA	   or	   the	   DMSO	   vehicle	  
control	   at	   4	   hpi.	   At	   6	   hpi,	   larvae	   were	   mounted	   and	   neutrophils	   at	   the	   site	   of	   injury	   were	  
photoconverted	   from	   green	   to	   red	   fluorescence	   on	   a	   confocal	   spinning	   disk	   system	   using	   an	  
UltraVIEWPhotoKinesisTM	  device,	  with	  the	  405	  nm	  laser	  line	  at	  40%	  laser	  energy.	  Larvae	  were	  imaged	  on	  
an	  inverted	  compound	  fluorescence	  microscope	  for	  4.5	  hours	  and	  the	  number	  of	  red	  cells	  that	  migrated	  
away	  from	  the	  site	  of	  injury	  into	  the	  defined	  region	  was	  quantified	  over	  the	  time-­‐course.	  Tanshinone	  IIA	  
accelerated	   neutrophil	   reverse	   migration	   compared	   to	   the	   DMSO	   vehicle	   control	   (A),	   with	   the	   most	  
rapid	  movement	  occurring	  within	  the	  first	  2	  hours	  following	  photoconversion,	  as	   illustrated	   in	  (B)	   (n	  =	  
18,	   performed	   as	   3	   independent	   experiments,	   data	   expressed	   as	  mean	   ±	   SEM).	   Dotted	   line	   indicates	  
photoconverted	   region	   and	   yellow	  box	   indicates	   region	   in	  which	   neutrophil	   number	  were	   quantified.	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5.5.1	  Tanshinone	  IIA	  overrides	  hypoxic	  signalling	  in	  vivo	  
Having	  already	  shown	  that	  tanshinone	  IIA	  could	  override	  pro-­‐inflammatory	  stimuli	  and	  
drive	  neutrophil	  apoptosis	  in	  vitro,	  I	  hypothesised	  that	  it	  might	  also	  drive	  resolution	  in	  
vivo	  by	  promoting	  reverse	  migration	  even	  under	  prolonged	  hypoxic	  conditions,	  which	  
would	   more	   accurately	   reflect	   the	   inflammatory	   environment	   of	   the	   persistent	  
neutrophilic	   inflammation	   characteristic	   of	   disease	   states.	   It	   has	   been	   shown	  
previously	  that	  reverse	  migration	  in	  zebrafish	  is	  regulated	  by	  Hypoxia-­‐inducible	  factor	  
(Hif)	  and	  that	  dominant-­‐active	  forms	  of	  Hif-­‐1α	  can	  delay	  resolution	  of	  inflammation	  by	  
causing	   a	   reduction	   in	   reverse	   migration	   and	   increased	   neutrophil	   retention	   at	   the	  
wound	  (Elks	  et	  al.,	  2011).	  	  
	  
To	   investigate	   whether	   tanshinone	   IIA	   could	   accelerate	   reverse	   migration	   in	   the	  
presence	   of	   dominant-­‐active	   Hif	   signalling,	   mpx/Kaede	   larvae	   were	   injected	   with	  
dominant-­‐active	  hif-­‐1αb	  RNA	  at	  the	  one-­‐cell	  stage.	  Tail	  transection	  was	  performed	  at	  2	  
dpf	  and	  larvae	  that	  mounted	  a	  good	  response	  were	  selected	  at	  4	  hpi.	  Following	  1	  hour	  
of	   pre-­‐treatment	   with	   either	   25	   μM	   tanshinone	   IIA	   or	   the	   DMSO	   vehicle	   control,	  
Kaede-­‐labelled	  neutrophils	  at	  the	  site	  of	  injury	  were	  photoconverted	  from	  green	  to	  red	  
fluorescence	   using	   an	   UltraVIEWPhotoKinesisTM	   device,	   as	   described.	   Larvae	   were	  
imaged	   for	   approximately	   5	   hours	   and	   the	   number	   of	   red-­‐labelled	   neutrophils	   that	  
migrated	   away	   from	   the	   site	   of	   injury	   was	   quantified.	   Tanshinone	   IIA	   appeared	   to	  
promote	  reverse	  migration	  even	   in	  the	  presence	  of	  hypoxia	  signalling,	  whereas	  most	  
neutrophils	   were	   retained	   at	   the	   wound	   in	   the	   DMSO	   treated	   larvae,	   in	   a	   manner	  
consistent	  with	  published	  data	   (Elks	  et	  al.,	  2011)	   (Figure	  5.8	  A).	  Control	  experiments	  
were	   also	   performed	   by	   microinjection	   of	   phenol	   red	   instead	   of	   the	   RNA,	   which	  
showed	   that	   the	   effect	   of	   tanshinone	   IIA	   was	  maintained	   and	   that	   there	  was	  more	  
reverse	  migration	   in	   the	  DMSO	  treated	   larvae	   injected	  with	  phenol	   red	  compared	  to	  
those	   injected	   with	   dominant-­‐active	   hif-­‐1αb	   RNA,	   which	   increased	   neutrophil	  








Figure	   5.8:	   Tanshinone	   IIA	   overrides	   hypoxia	   signalling	   to	   accelerate	   reverse	  
migration	  of	  neutrophils	  during	  inflammation	  resolution	  in	  vivo.	  
At	   the	  one-­‐cell	   stage,	  mpx/Kaede	   larvae	  were	   injected	  with	  either	   (A)	  dominant-­‐active	  hif-­‐1αb	  RNA	  or	  
(B)	  phenol	  red.	  Tail	  fin	  transection	  was	  performed	  at	  2	  dpf	  and	  larvae	  that	  mounted	  a	  good	  neutrophilic	  
response	  were	  selected	  for	  treatment	  with	  25	  μM	  tanshinone	  IIA	  or	  the	  DMSO	  vehicle	  control	  at	  4	  hpi.	  
At	  5	  hpi,	  larvae	  were	  mounted	  and	  neutrophils	  at	  the	  site	  of	  injury	  were	  photoconverted	  from	  green	  to	  
red	  fluorescence	  on	  a	  confocal	  spinning	  disk	  system	  using	  an	  UltraVIEWPhotoKinesisTM	  device,	  with	  the	  
405	  nm	  laser	  line	  at	  40%	  laser	  energy.	  Larvae	  were	  time-­‐lapsed	  on	  an	  inverted	  compound	  fluorescence	  
microscope	  for	  approximately	  5	  hours	  and	  the	  number	  of	  red	  cells	  that	  migrated	  away	  from	  the	  site	  of	  
injury	   into	   the	   defined	   region	   was	   quantified	   over	   the	   time-­‐course.	   Tanshinone	   IIA	   accelerated	  
neutrophil	   reverse	   migration	   compared	   to	   the	   DMSO	   vehicle	   control	   in	   the	   presence	   of	   both	   (A)	  
dominant-­‐active	  hif-­‐1αb	  RNA	  and	  (B)	  phenol	  red	  (n	  =	  18,	  performed	  as	  3	  independent	  experiments,	  data	  
































































These	   results	   indicated	   that	   tanshinone	   IIA	   could	   not	   only	   drive	   inflammation	  
resolution	   in	   the	  model	   of	   acute	   inflammation,	   but	   also	   in	   a	   model	   with	   attributes	  
more	  comparable	  to	  the	  persistent	  inflammatory	  environment	  found	  in	  disease	  states,	  
by	  overriding	  the	  effects	  of	  hypoxic	  signalling.	  	  
	  
The	  ability	  of	   tanshinone	   IIA	   to	   increase	   reverse	  migration	  of	  neutrophils	   away	   from	  
the	   site	   of	   inflammation	   was	   both	   an	   interesting	   and	   novel	   observation.	   Although	  
there	  is	  some	  knowledge	  of	  the	  mechanisms	  governing	  neutrophil	  chemotaxis	  during	  
recruitment	  to	  sites	  of	   inflammation,	  those	  regulating	  the	  reverse	  of	  this	  process	  are	  
largely	  undefined.	   In	  zebrafish,	   the	  migration	  of	  neutrophils	  away	   from	  a	  wound	  has	  
been	   termed	   ‘retrograde	   chemotaxis’	   or	   ‘fugetaxis’,	   implying	   that	   it	   is	   an	   active	  
process,	   in	   which	   the	   cells	   are	   driven	   away	   by	   pro-­‐resolution	   chemorepellents	  
(Mathias	   et	   al.,	   2006).	   It	   has	   been	   demonstrated	   that	   high	   concentrations	   of	   the	  
chemokine	  IL-­‐8	  can	  repel	  neutrophils	  both	  in	  vitro	  and	  in	  vivo	  (Tharp	  et	  al.,	  2006).	  This	  
phenomenon	   has	   also	   been	   observed	   in	   other	   leukocytes,	   for	   example	   high	  
concentrations	   of	   the	   CXCR4	   ligand	   SDF-­‐1	   can	   repel	   T	   cells	   (Poznansky	   et	   al.,	   2000).	  
Alternatively,	   it	   has	   been	   suggested	   that	   neutrophils	   respond	   to	   competing	  
chemoattractant	   signals	   emanating	   from	   the	   vasculature,	   which	   might	   draw	   them	  
away	  from	  the	  wound	  (Starnes	  et	  al.,	  2012).	  However,	   in	  the	  experiments	  performed	  
here,	   neutrophils	   were	   not	   observed	   to	   preferentially	   undergo	   transendothelial	  
reverse	  migration	  rather	  than	  migrate	  away	  via	  the	  tissues,	  in	  either	  tanshinone	  IIA	  or	  
DMSO	  treated	  larvae.	  	  
	  
Other	   evidence	   directly	   disputes	   the	   theory	   of	   active	   reverse	   migration,	   instead	  
describing	  it	  as	  a	  process	  of	  passive	  redistribution	  (Holmes,	  Dixon,	  et	  al.,	  2012;	  Holmes,	  
Anderson,	  et	  al.,	  2012).	   In	   these	  studies,	  a	   thorough	  analysis	  of	  neutrophil	  migratory	  
behaviour	  during	  the	  resolution	  of	  inflammation	  was	  performed	  using	  time-­‐lapse	  data	  
generated	  from	  reverse	  migration	  assays	  carried	  out	  on	  injured	  mpx/Kaede	  larvae,	   in	  
the	   same	   manner	   as	   described	   here.	   Using	   both	   drift-­‐diffusion	   analysis	   and	  
Approximate	  Bayesian	  Computation	  Sequential	  Monte	  Carlo	  (ABC	  SMC)	  techniques,	  it	  
was	  revealed	  that	  the	  process	  of	  reverse	  migration	  is	  best	  fitted	  to	  a	  model	   in	  which	  




is	  in	  contrast	  to	  the	  ‘drift-­‐diffusion’	  model,	  in	  which	  an	  element	  of	  ‘drift’	  would	  imply	  
directed	  movement	  away	  from	  the	  wound,	  characteristic	  of	  chemorepulsion.	  
	  
As	   tanshinone	   IIA	   appeared	   to	   promote	   reverse	  migration	   away	   from	   the	  wound,	   it	  
was	   hypothesised	   that	   this	   compound	  might	   directly	   activate	   fugetaxis.	   To	   examine	  
this,	   dynamic	   modelling	   of	   the	   neutrophils	   in	   tanshinone	   IIA	   treated	   larvae	   was	  
performed,	  in	  order	  to	  characterise	  their	  migration	  dynamics.	  	  
5.5.2	  Neutrophils	  migrate	  by	  ‘pure-­‐diffusion’	  in	  the	  presence	  of	  tanshinone	  IIA	  
To	  investigate	  the	  migratory	  behaviour	  of	  neutrophils	  undergoing	  reverse	  migration	  in	  
the	   presence	   of	   tanshinone	   IIA,	   the	   data	   obtained	   in	   the	   reverse	   migration	   assays	  
described	   above	   were	   analysed	   using	   the	   dynamic	   modelling	   methods	   outlined	   in	  
(Holmes,	  Anderson,	  et	  al.,	  2012).	  The	  results	  described	  here	  are	  generated	  from	  data	  
analysis	   that	   was	   performed	   by	   Geoffrey	   Holmes	   (Automatic	   Control	   and	   Systems	  
Engineering,	  University	  of	  Sheffield).	  It	  was	  hypothesised	  that	  the	  increased	  neutrophil	  
reverse	  migration	  observed	  in	  tanshinone	  IIA	  treated	  larvae	  might	  be	  explained	  by	  the	  
production	   of	   a	   repelling	   gradient	   at	   the	  wound,	  which	  would	   drive	   the	   neutrophils	  
away	  more	  rapidly.	  
	  
To	  give	  an	  indication	  of	  how	  far	  the	  neutrophils	  travelled	  over	  the	  course	  of	  the	  time-­‐
lapse,	   the	   co-­‐ordinates	  of	   each	  neutrophil	   centroid	  were	   identified	   in	  Volocity®.	   The	  
distance	   from	   the	   wound	   of	   each	   neutrophil	   in	   each	   individual	   time	   frame	   was	  
measured	   and	   used	   to	   calculate	   the	   mean	   squared	   distance	   (MSD).	   When	   plotted	  
against	   time,	   it	   was	   clear	   that	   neutrophils	   in	   tanshinone	   IIA	   treated	   larvae	   moved	  
further	  over	  time	  than	  those	  from	  DMSO	  control	  larvae	  (Figure	  5.9).	  This	  indicated	  that	  
not	   only	   did	   more	   neutrophils	   move	   away	   from	   the	   wound	   in	   the	   presence	   of	  
tanshinone	  IIA,	  but	  those	  that	  did	  move	  away	  also	  travelled	  further	  over	  time.	  These	  
analyses	  appeared	  to	  show	  a	  linear	   increase	  in	  MSD,	  consistent	  with	  a	  pure-­‐diffusion	  
model.	   There	   was	   a	   clear	   difference	   in	   the	   slope	   of	   the	   line	   generated	   from	   the	  
tanshinone	   IIA	   treated	   larvae	  data	   compared	   to	   the	   control	  data,	   indicating	   that	   the	  















Figure	  5.9:	  The	  mean	  squared	  distance	  of	  neutrophils	  from	  the	  wound	  is	  increased	  in	  
the	  presence	  of	  tanshinone	  IIA.	  	  
Data	  analysis	  and	  generation	  of	  this	  figure	  was	  performed	  by	  Geoffrey	  Holmes	  (Automatic	  Control	  and	  
Systems	  Engineering,	  University	  of	  Sheffield),	  as	  described	  in	  (Holmes,	  Anderson,	  et	  al.,	  2012).	  In	  brief,	  
the	  distance	  from	  the	  wound	  of	  each	  neutrophil	  in	  each	  individual	  time	  frame	  was	  measured	  using	  the	  
co-­‐ordinates	  of	  each	  neutrophil	  centroid,	  as	  identified	  in	  Volocity®.	  This	  was	  used	  to	  calculate	  the	  mean	  
squared	  distance	  over	  time.	  Neutrophils	  in	  tanshinone	  IIA	  treated	  larvae	  appeared	  to	  move	  further	  over	  
time	  than	  those	  from	  DMSO	  control	  larvae.	  
	  




As	   an	   additional	   method	   to	   investigate	   the	   neutrophil	   migration	   dynamics,	   a	  
simulation	   based	   ABC	   SMC	   modelling	   method	   was	   used	   (Toni	   et	   al.,	   2009).	   This	  
approach	  can	  be	  applied	  to	  dynamic	  biological	  systems	  to	  compare	  the	  data	  to	  a	  set	  of	  
candidate	  models,	   in	  order	  to	  select	   the	  model	   that	  best	  represents	   the	  data.	   In	   this	  
case,	  models	  with	   varying	   degrees	   of	   diffusivity	   and	   drift	   were	   initially	   simulated	   at	  
random	   and	   compared	   to	   the	   experimental	   observations.	   Those	   that	   adequately	  
represented	  the	  data	  within	  a	  certain	  threshold	  were	  saved	  as	  a	  sample	  of	  all	  possible	  
models.	   At	   each	   subsequent	   iteration	   the	   parameters	   of	   plausible	   models	   were	  
adapted	   slightly	   to	   reduce	   the	   error	   threshold	   until	   only	   those	   close	   to	   the	  
experimental	  observations	  remained.	  In	  both	  DMSO	  and	  tanshinone	  IIA	  treated	  larvae	  
neutrophil	   reverse	  migration	  was	  best	  described	  by	   the	  pure-­‐diffusion	  model	   (model	  
1),	  indicative	  of	  undirected	  migration	  (Figure	  5.10	  A).	  	  
	  
Interestingly,	  the	  diffusivity	  was	  much	  higher	  in	  the	  presence	  of	  tanshinone	  IIA	  (Figure	  
5.10	  B).	  When	  comparing	  the	  combined	  distribution	  of	  drift	  and	  diffusivity	  in	  the	  drift-­‐
diffusion	  models,	  it	  was	  clear	  that	  there	  was	  no	  significant	  difference	  in	  drift	  between	  
tanshinone	  IIA	  and	  the	  controls	  (Figure	  5.10	  C,	  D).	  
	  
These	  analyses	  indicated	  that	  tanshinone	  IIA	  does	  not	  actively	  drive	  neutrophils	  away	  
from	   the	   wound,	   but	   rather	   they	   move	   away	   in	   a	   passive,	   diffusion-­‐like	   manner,	  
comparable	  to	  the	  neutrophils	   in	  the	  control	   larvae.	  These	  results	  suggested	  that	  the	  
increase	   in	   reverse	  migration	  was	  not	  due	   to	  a	   repelling	  gradient	   at	   the	  wound,	  but	  
rather	  an	   increase	   in	   random	  movement.	  This	  was	   reflected	  by	   the	  measurement	  of	  






















Figure	  5.10:	  Neutrophil	  migration	  dynamics	  are	  best	  described	  by	  the	  pure-­‐diffusion	  
model	  under	  control	  conditions	  and	  in	  the	  presence	  of	  tanshinone	  IIA.	  	  
Data	  analysis	  and	  generation	  of	  this	  figure	  was	  performed	  by	  Geoffrey	  Holmes	  (Automatic	  Control	  and	  
Systems	  Engineering,	  University	  of	  Sheffield),	  using	  simulation	  based	  ABC	  SMC	  modelling	  as	  described	  in	  
(Holmes,	   Anderson,	   et	   al.,	   2012).	   In	   brief,	   models	   with	   varying	   degrees	   of	   diffusivity	   and	   drift	   were	  
initially	   simulated	  at	   random,	   compared	   to	   the	  experimental	  observations,	   and	   those	   that	  adequately	  
represented	  the	  data	  within	  a	  certain	  threshold	  were	  saved	  as	  a	  sample	  of	  all	  possible	  models.	  At	  each	  
subsequent	   iteration,	  the	  parameters	  of	  plausible	  models	  were	  adapted	  to	  reduce	  the	  error	  threshold	  
until	  only	  those	  close	  to	  the	  experimental	  observations	  remained.	  (A)	  In	  both	  DMSO	  and	  tanshinone	  IIA	  
treated	  larvae,	  pure-­‐diffusion	  was	  the	  preferred	  model	  (model	  1).	  The	  element	  of	  diffusivity	  was	  higher	  
in	  tanshinone	  IIA	  treated	  larvae	  (B),	  but	  there	  was	  no	  significant	  difference	  in	  drift	  between	  these	  and	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5.5.3	   Tanshinone	   IIA	   does	   not	   increase	   neutrophil	   speed	   during	   inflammation	  
resolution	  
It	  was	  possible	  that	  the	   increase	   in	  neutrophil	  diffusivity	  observed	  in	  the	  presence	  of	  
tanshinone	  IIA	  could	  be	  a	  consequence	  of	  altered	  directional	  preference	  or	  enhanced	  
speed,	   which	   might	   result	   in	   the	   neutrophils	   moving	   away	   from	   the	   wound	   more	  
rapidly.	   To	   investigate	   this	   hypothesis,	   the	   individual	   tracks	   of	   the	   reverse	  migrating	  
neutrophils	   were	   analysed	   using	   Volocity®	   software.	   There	   was	   no	   difference	   in	  
neutrophil	   speed	   or	   meandering	   index	   between	   tanshinone	   IIA	   and	   DMSO	   treated	  
larvae	  (Figure	  5.11).	  	  
	  
These	  results	  suggested	  that	  a	  change	  in	  neutrophil	  speed	  was	  not	  responsible	  for	  the	  
increase	   in	   reverse	  migration,	   but	   that	   an	   alternative	  mechanism	  must	   be	   involved.	  
The	   pure-­‐diffusion	   model	   describes	   migration	   as	   a	   form	   of	   stochastic	   redistribution	  
without	  directional	  bias.	  As	  the	  neutrophils	  in	  tanshinone	  IIA	  treated	  larvae	  appeared	  
to	  move	   away	   from	   the	   wound	   in	   an	   undirected	  manner,	   it	   was	   hypothesised	   that	  
perhaps	   they	  were	  unable	   to	  detect	  and	   respond	   to	   the	  chemotactic	  gradient	  at	   the	  
wound.	  This	  would	  enable	  them	  to	  ‘diffuse’	  away	  more	  readily	  and	  perhaps	  gradually	  
move	   away	   from	   the	   wound	   rather	   than	   favouring	   migration	   along	   the	   injury	   site,	  











Figure	   5.11:	   Tanshinone	   IIA	   does	   not	   affect	   neutrophil	   speed	   or	  meandering	   index	  
during	  inflammation	  resolution.	  
Tail	   fin	   transection	   was	   performed	   on	  mpx/Kaede	   larvae	   at	   3	   dpf,	   and	   those	   that	   mounted	   a	   good	  
neutrophilic	   response	   were	   selected	   for	   treatment	   with	   25	   μM	   tanshinone	   IIA	   or	   the	   DMSO	   vehicle	  
control	   at	   4	   hpi.	   At	   6	   hpi,	   larvae	   were	   mounted	   and	   neutrophils	   at	   the	   site	   of	   injury	   were	  
photoconverted	   from	   green	   to	   red	   fluorescence	   on	   a	   confocal	   spinning	   disk	   system	   using	   an	  
UltraVIEWPhotoKinesisTM	   device,	   with	   the	   405	   nm	   laser	   line	   at	   40%	   laser	   energy.	   Larvae	   were	   time-­‐
lapsed	   on	   an	   inverted	   compound	   fluorescence	  microscope	   for	   3.5	   hours	   and	   red-­‐labelled	   cells	   were	  
tracked	   over	   the	   course	   of	   the	   time-­‐lapse	   using	   Volocity®.	   There	  was	   no	   difference	   in	   (A)	   neutrophil	  
speed	  or	  (B)	  meandering	  index	  in	  tanshinone	  IIA	  treated	  larvae	  compared	  to	  the	  DMSO	  vehicle	  controls	  
(Unpaired	   t-­‐test;	  P	  =	  0.8196	   for	   speed	   and	   P	  =	  0.7244	   for	  meandering	   index;	  n	  =	  18,	   performed	  as	   3	  
independent	  experiments).	  	  
	  




















































5.6	   Investigation	   into	   the	   effect	   of	   tanshinone	   IIA	   on	   chemokine	   receptor	  
surface	  expression	  
	  
Little	   is	   known	   about	   the	   mechanisms	   governing	   neutrophil	   retention	   at	   sites	   of	  
inflammation	  and	  what	  signals,	  or	  lack	  of,	  might	  regulate	  reverse	  migration.	  This	  may	  
be	   partly	   due	   to	   the	   technical	   difficulties	   associated	   with	   the	   investigation	   of	   this	  
process	   in	  mammalian	  models.	  Despite	   this,	   reverse	  migration	  has	  been	  observed	   in	  
vivo	   in	   a	   mouse	   model	   of	   ischemia-­‐reperfusion	   injury.	   Here,	   fluorescently-­‐labelled	  
neutrophils	   were	   reported	   to	   undergo	   reverse	   transendothelial	   migration	   more	  
frequently	   following	  genetic	  or	  pharmacological	   inhibition	  of	   the	   junctional	  adhesion	  
molecule	  JAM-­‐C	  (Woodfin	  et	  al.,	  2011).	  In	  this	  study,	  the	  reverse	  migrated	  neutrophils	  
displayed	  elevated	  cell	  surface	  expression	  of	  Intercellular	  Adhesion	  Molecule-­‐1	  (ICAM-­‐
1;	   also	   known	  as	  CD54).	   This	   is	   a	   cell	   surface	  glycoprotein	   that	   can	  be	  expressed	  on	  
both	   leukocytes	   and	  endothelial	   cells,	  which	  binds	   to	   integrin	  molecules	   to	   facilitate	  
cell	  migration	  (Zimmerman	  et	  al.,	  1992).	  Its	  up-­‐regulation	  was	  consistent	  with	  studies	  
in	  human	  neutrophils,	  which	  have	  revealed	  that	  reverse	  migrated	  neutrophils	  display	  a	  
unique	  cell-­‐surface	  receptor	  phenotype,	  with	  elevated	  expression	  of	  CD11b	  and	  ICAM-­‐
1	   and	   reduced	   expression	   of	   the	   key	   neutrophil	   chemokine	   receptors	   CXCR1	   and	  
CXCR2	  (Buckley	  et	  al.,	  2006).	  	  
	  
The	  modelling	   analysis	   performed	  on	   the	   reverse	  migration	   data	   suggested	   that	   the	  
neutrophils	   in	   tanshinone	   IIA	   treated	   larvae	  might	   be	  unable	   to	   detect	   a	   chemokine	  
gradient.	   Given	   the	   unique	   cell	   surface	   receptor	   expression	   reported	   in	   reverse	  
migrated	   neutrophils,	   it	   was	   hypothesised	   that	   tanshinone	   IIA	   might	   induce	   this	  
altered	   phenotype,	   for	   example	   by	   causing	   down-­‐regulation	   of	   CXCR1	   and	   CXCR2.	  
Down-­‐regulation	  of	   these	  chemokine	   receptors	  might	   result	   in	   the	  neutrophils	  being	  
unable	  to	  respond	  to	  a	  retention	  signal	  at	  the	  wound,	  causing	  them	  to	  diffuse	  away,	  
which	  would	   correlate	  with	   the	  modelling	   data.	   In	   support	   of	   this	   hypothesis,	   it	   has	  
recently	   been	   demonstrated	   that	   the	   putative	   zebrafish	   homologue	   of	   IL-­‐8,	   zCxcl8,	  
mediates	  neutrophil	  migration	  and	  retention	  in	  vivo	  (Sarris	  et	  al.,	  2012).	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5.6.1	   Investigation	   into	   the	   effect	   of	   tanshinone	   IIA	   on	   CXCR1	   and	   CXCR2	   surface	  
expression	  in	  unstimulated	  human	  neutrophils	  
To	  begin	  investigating	  the	  effect	  of	  tanshinone	  IIA	  on	  CXCR1	  and	  CXCR2,	  I	  first	  sought	  
to	   establish	   the	   basal	   surface	   expression	   levels	   of	   these	   chemokine	   receptors	   on	  
freshly	  isolated	  human	  neutrophils.	  Neutrophils	  were	  separated	  from	  peripheral	  whole	  
blood	   as	   described	   previously,	   followed	   by	   staining	   with	   either	   CXCR1-­‐fluorescein	  
isothiocyanate	   (CXCR1-­‐FITC)	   or	   CXCR2-­‐phycoerythrin	   (CXCR2-­‐PE)	   monoclonal	  
antibodies	   (MAbs),	  which	  were	  directly	   conjugated	   to	   the	   fluorochromes.	  Cells	  were	  
stained	   for	   30	   minutes	   at	   4oC,	   alongside	   the	   appropriate	   isotype	   controls,	   and	   cell	  
surface	  expression	  of	  CXCR1-­‐FITC	  and	  CXCR2-­‐PE	  was	  assessed	  using	  a	  FACSCalibur	  flow	  
cytometer.	  
	  
To	   isolate	   the	   neutrophil	   population	   from	   cell	   debris	   and	   other	   cell	   types	   that	  may	  
have	  been	  contaminating	  the	  neutrophil	  suspension,	  a	  neutrophil	  gate	  was	  applied	  to	  
an	  unstained	  control	  sample	  based	  on	  forward	  and	  side	  scatter,	  using	  FlowJo	  software	  
(Figure	  5.12	  A).	  The	  same	  gating	  was	  applied	  to	  all	  samples,	  ensuring	  that	  neutrophils	  
were	  not	   lost	   from	  the	  gate.	  Single-­‐parameter	  histograms	  were	  generated	   to	  display	  
the	  level	  of	  fluorescence	  in	  the	  FL-­‐1	  channel	  for	  CXCR1-­‐FITC	  (Figure	  5.12	  B)	  and	  the	  FL-­‐
2	   channel	   for	   CXCR2-­‐PE	   (Figure	   5.12	   C).	   The	   geometric	   mean	   (also	   known	   as	  mean	  
fluorescence	   intensity	  (MFI))	  was	  measured	  for	  each	  sample.	  Under	  basal	  conditions,	  
neutrophils	  expressed	  both	  CXCR1	  and	  CXCR2,	  with	  mean	   fluorescence	   intensities	  of	  
82.3	  and	  78.1,	  respectively.	  
	  
To	   investigate	   the	   effect	   of	   tanshinone	   IIA	   on	   CXCR1	   and	  CXCR2	   surface	   expression,	  
neutrophils	   were	   isolated	   as	   described,	   followed	   by	   treatment	   with	   either	   10	   μM	  
tanshinone	  IIA	  or	  DMSO	  as	  a	  vehicle	  control	  for	  2	  hours	  at	  37°C.	  Neutrophils	  were	  re-­‐
suspended	   for	   staining	  with	   either	  CXCR1-­‐FITC,	   CXCR2-­‐PE	  or	   the	   appropriate	   isotype	  
controls,	   for	   30	   minutes	   at	   4oC.	   Cell	   surface	   expression	   of	   CXCR1	   and	   CXCR2	   was	  
assessed	   by	   flow	   cytometry	   in	   the	   same	   manner	   as	   described	   for	   the	   previous	  
experiment.	  Based	  on	  the	  MFI	  values,	  there	  was	  no	  significant	  difference	  in	  CXCR1	  or	  
CXCR2	  neutrophil	   surface	   expression	   in	   the	  presence	  of	   tanshinone	   IIA	   compared	   to	  






Figure	  5.12:	  Human	  neutrophils	  express	  CXCR1	  and	  CXCR2	  under	  basal	  conditions.	  
Human	   neutrophils	   were	   isolated	   from	   whole	   blood,	   as	   described,	   and	   stained	   with	   either	   human	  
CXCR1-­‐FITC,	  human	  CXCR2-­‐PE,	  mouse	  IgG2A-­‐FITC	  or	  mouse	  IgG2A-­‐PE	  at	  a	  1:5	  dilution,	  for	  30	  minutes	  at	  
4oC.	  After	  washing	  and	   fixing,	   sample	   fluorescence	  was	  measured	  using	  a	  FACSCalibur	   flow	  cytometer	  
and	   the	   results	  were	   analysed	   using	   FlowJo.	   An	   unstained	   control	  was	   used	   to	   isolate	   the	   neutrophil	  
population	   (A),	   and	   this	   gating	   was	   applied	   to	   all	   subsequent	   samples.	   Single	   parameter	   histograms	  
were	  generated	  to	  measure	  the	  MFI	  of	  (B)	  CXCR1-­‐FITC	  in	  the	  FL-­‐1	  channel	  (82.3)	  and	  (C)	  CXCR2-­‐PE	  in	  the	  




























































Figure	  5.13:	  Tanshinone	   IIA	  does	  not	  affect	  neutrophil	   surface	  expression	  of	  CXCR1	  
or	  CXCR2.	  
Human	   neutrophils	   were	   isolated	   from	   whole	   blood,	   as	   described,	   and	   treated	   with	   either	   10	   μM	  
tanshinone	   IIA	   or	   DMSO	   as	   a	   vehicle	   control,	   for	   2	   hours	   at	   37	  oC.	   After	  washing	   and	   re-­‐suspending,	  
neutrophils	  were	  stained	  with	  either	  human	  CXCR1-­‐FITC,	  human	  CXCR2-­‐PE,	  mouse	  IgG2A-­‐FITC	  or	  mouse	  
IgG2A-­‐PE	   at	   a	   1:5	   dilution,	   for	   30	  minutes	   at	   4oC.	   After	  washing	   and	   fixing,	   sample	   fluorescence	  was	  
measured	  using	  a	  FACSCalibur	   flow	  cytometer	  and	  the	  results	  were	  analysed	  using	  FlowJo.	  Neutrophil	  
gating	  was	  applied	  as	  previously	  indicated	  (Figure	  5.12	  A).	  There	  was	  no	  significant	  difference	  in	  the	  MFI	  
of	   (A)	   CXCR1-­‐FITC	   or	   (C)	   CXCR2-­‐PE	   between	   tanshinone	   IIA	   and	   the	   DMSO	   vehicle	   control	   (One-­‐way	  
ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test	  to	  compare	  all	  columns;	  P	  =	  0.6443	  for	  CXCR1,	  





































































































5.6.2	   Investigation	   into	   the	   effect	   of	   tanshinone	   IIA	   on	   CXCR1	   and	   CXCR2	   surface	  
expression	  in	  human	  neutrophils	  following	  IL-­‐8	  stimulation	  
The	  results	  described	  above	  suggested	  that	  tanshinone	  IIA	  had	  no	  effect	  on	  CXCR1	  and	  
CXCR2	   surface	   expression.	   However,	   these	   experiments	   were	   performed	   on	  
unstimulated	  neutrophils	  and	  perhaps	  the	   lack	  of	  stimulus	  could	  explain	  the	  absence	  
of	   any	   effect.	   Upon	   stimulation	   with	   IL-­‐8	   (CXCL8),	   CXCR1	   and	   CXCR2	   are	   rapidly	  
internalised,	   IL-­‐8	   is	   degraded	   by	   lysosomal	   enzymes,	   and	   the	   receptors	   are	   recycled	  
back	   to	   the	   neutrophil	   surface	   membrane	   (Samanta	   et	   al.,	   1990).	   Based	   on	   the	  
hypothesis	   that	   tanshinone	   IIA	   could	   prevent	   neutrophils	   from	   detecting	   the	  
chemokine	  gradient,	  it	  was	  perhaps	  more	  likely	  that	  rather	  than	  affecting	  basal	  levels	  
of	  cell	  surface	  expression,	  tanshinone	  IIA	  might	  inhibit	  recycling	  of	  the	  receptors	  once	  
they	  had	  been	  internalised.	  	  
	  
To	   investigate	   the	   hypothesis	   that	   tanshinone	   IIA	   could	   reduce	   chemokine	   receptor	  
recycling,	  freshly	  isolated	  human	  neutrophils	  were	  stimulated	  with	  varying	  doses	  of	  IL-­‐
8,	  in	  combination	  with	  either	  10	  μM	  tanshinone	  IIA	  or	  DMSO	  as	  a	  vehicle	  control,	  for	  
30	  minutes	  at	  37°C.	  The	  concentrations	  of	  IL-­‐8	  required	  to	  stimulate	  CXCR1	  and	  CXCR2	  
internalisation	  were	  selected	  based	  on	  published	  data	  (Sabroe	  et	  al.,	  1997).	  Following	  
stimulation,	  neutrophils	  were	  transferred	  to	  ice	  and	  washed	  multiple	  times	  to	  remove	  
all	   traces	   of	   the	   chemokine.	   At	   this	   stage,	   some	   samples	   were	   used	   to	   measure	  
receptor	   internalisation,	   and	   were	   stained	   with	   either	   CXCR1-­‐FITC	   or	   CXCR2-­‐PE	   as	  
described	   above.	   To	   measure	   receptor	   recycling,	   the	   appropriate	   samples	   were	   re-­‐
suspended	  in	  the	  corresponding	  buffer	  containing	  either	  tanshinone	  IIA	  or	  DMSO	  and	  
were	   returned	   to	   37°C.	   At	   various	   time	   intervals,	   as	   indicated,	   the	   neutrophils	  were	  
transferred	   to	   ice,	  washed	  and	  re-­‐suspended,	   followed	  by	  staining	   for	  CXCR1-­‐FITC	  or	  
CXCR2-­‐PE.	  	  
	  
Flow	  cytometry	  and	  neutrophil	  gating	  were	  performed	  as	  previously	  described	  and	  the	  
mean	   fluorescence	   intensity	   in	   the	   appropriate	   channel	   was	   measured	   for	   each	  
sample.	  The	  data	  were	  expressed	  as	  a	  percentage	  of	   the	  basal	   fluorescence	  for	  each	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chemokine	   receptor,	  which	  was	  measured	   using	   an	   unstimulated,	   untreated	   control	  
sample.	  
	  
The	  results	   indicated	  that	  tanshinone	   IIA	  did	  not	  significantly	  affect	   internalisation	  of	  
either	   CXCR1	   (Figure	   5.14)	   or	   CXCR2	   (Figure	   5.15)	   in	   neutrophils	   compared	   to	   the	  
DMSO	   vehicle	   control.	   For	   each	   receptor,	   there	   was	   a	   clear	   dose	   response	   in	   the	  
presence	  of	  both	  tanshinone	  IIA	  and	  DMSO,	  with	  more	   internalisation	  occurring	  with	  
increasing	  concentration	  of	  IL-­‐8	  (illustrated	  in	  Figure	  5.14	  B,	  C	  and	  Figure	  5.15	  B,	  C).	  It	  
was	  also	  apparent	  that	  a	  higher	   ligand	  concentration	  was	  required	  for	   internalisation	  
of	   CXCR1	   than	   CXCR2,	  which	  was	   in	   keeping	  with	   published	   data	   (Richardson	   et	   al.,	  
1998;	  Rose	  et	  al.,	  2004).	  	  
	  
As	  described	  above,	  receptor	  recycling	  could	  be	  investigated	  in	  the	  same	  experiments,	  
such	  that	  the	  percentage	  of	  fluorescence	  measured	  following	  receptor	  internalisation	  
could	  be	  used	  as	  a	  baseline,	  or	  the	  0	  minute	  time	  point.	  Re-­‐expression	  of	  the	  receptors	  
could	  then	  be	  measured	  following	  removal	  of	  the	  IL-­‐8	  ligand	  and	  re-­‐incubation	  of	  the	  
neutrophils	   at	   37°C	   to	   allow	   the	   receptors	   to	   recycle	   back	   to	   the	   membrane.	   For	  
CXCR1,	   re-­‐expression	   was	   measured	   after	   30	   minutes	   and	   there	   was	   no	   significant	  
difference	   between	   the	   surface	  membrane	   levels	   of	   CXCR1	   between	   tanshinone	   IIA	  
and	  DMSO	  treated	  neutrophils,	  stimulated	  with	  either	  10	  or	  100	  nM	  IL-­‐8	  (Figure	  5.16).	  
At	  the	  10	  nM	  concentration,	  there	  actually	  appeared	  to	  be	  down-­‐regulation	  of	  CXCR1	  
surface	   expression	   in	   the	   DMSO	   treated	   neutrophils	   between	   0	   and	   30	   minutes,	  
although	  this	  was	  likely	  due	  to	  random	  noise	  and	  the	  fact	  that	  there	  was	  only	  a	  small	  
level	  of	  internalisation	  to	  begin	  with.	  	  	  
	  
For	  CXCR2,	  re-­‐expression	  was	  measured	  at	  both	  10	  and	  30	  minute	  intervals	  following	  
receptor	   internalisation	   and	   removal	   of	   IL-­‐8.	   Again,	   no	   significant	   differences	   in	   the	  
surface	   level	  expression	  of	  CXCR2	  were	  observed	  between	  tanshinone	   IIA	  and	  DMSO	  
treated	  neutrophils,	  stimulated	  with	  either	  dose	  of	  IL-­‐8,	  at	  either	  10	  or	  30	  minutes.	  In	  
comparison	  to	  CXCR1,	  the	  levels	  of	  CXCR2	  in	  neutrophils	  stimulated	  with	  100	  nM	  IL-­‐8	  
were	   lower	  at	  30	  minutes,	   suggesting	   that	   recycling	  of	  CXCR2	  occurred	  more	  slowly.	  





Figure	  5.14:	  Tanshinone	  IIA	  does	  not	  increase	  internalisation	  of	  CXCR1.	  
Human	  neutrophils	  were	  isolated	  from	  whole	  blood,	  as	  described,	  and	  stimulated	  with	  IL-­‐8	  at	  the	  dose	  
indicated,	  alongside	  either	  10	  μM	  tanshinone	  IIA	  or	  DMSO	  for	  30	  minutes	  at	  37	  oC.	  After	  washing	  and	  re-­‐
suspending,	   neutrophils	   were	   stained	   with	   either	   human	   CXCR1-­‐FITC	   or	   mouse	   IgG2A-­‐FITC	   at	   a	   1:5	  
dilution,	   for	   30	  minutes	   at	   4oC.	   After	  washing	   and	   fixing,	   sample	   fluorescence	  was	  measured	   using	   a	  
FACSCalibur	  flow	  cytometer	  and	  the	  results	  were	  analysed	  using	  FlowJo.	  Neutrophil	  gating	  was	  applied	  
as	   previously	   indicated	   (Figure	   5.12	   A).	   Data	   were	   expressed	   as	   a	   percentage	   of	   basal	   CXCR1-­‐FITC	  
fluorescence	   for	  each	  dose	  of	   IL-­‐8	   (A).	   There	  was	  no	   significant	  difference	   in	   internalisation	  of	  CXCR1	  
between	  tanshinone	  IIA	  and	  the	  DMSO	  vehicle	  control	  at	  any	  of	  the	  IL-­‐8	  doses	  tested	  (Two-­‐way	  ANOVA	  
with	   Bonferroni’s	   multiple	   comparison	   post-­‐test;	   P	   >	   0.05;	   n	   =	   1).	   Representative	   single-­‐parameter	  
histograms	  are	  shown	  for	  (B)	  DMSO	  and	  (C)	  tanshinone	  IIA.	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Figure	  5.15:	  Tanshinone	  IIA	  does	  not	  increase	  internalisation	  of	  CXCR2.	  
Human	  neutrophils	  were	  isolated	  from	  whole	  blood,	  as	  described,	  and	  stimulated	  with	  IL-­‐8	  at	  the	  dose	  
indicated,	  alongside	  either	  10	  μM	  tanshinone	  IIA	  or	  DMSO	  for	  30	  minutes	  at	  37	  oC.	  After	  washing	  and	  re-­‐
suspending,	  neutrophils	  were	  stained	  with	  either	  human	  CXCR2-­‐PE	  or	  mouse	  IgG2A-­‐PE	  at	  a	  1:5	  dilution,	  
for	  30	  minutes	  at	  4oC.	  After	  washing	  and	  fixing,	  sample	  fluorescence	  was	  measured	  using	  a	  FACSCalibur	  
flow	  cytometer	  and	  the	  results	  were	  analysed	  using	  FlowJo.	  Neutrophil	  gating	  was	  applied	  as	  previously	  
indicated	  (Figure	  5.12	  A).	  Data	  were	  expressed	  as	  a	  percentage	  of	  basal	  CXCR2-­‐PE	  fluorescence	  for	  each	  
dose	  of	  IL-­‐8	  (A).	  There	  was	  no	  significant	  difference	  in	  internalisation	  of	  CXCR2	  between	  tanshinone	  IIA	  
and	   the	   DMSO	   vehicle	   control	   at	   any	   of	   the	   IL-­‐8	   doses	   tested	   (Two-­‐way	   ANOVA	   with	   Bonferroni’s	  
multiple	  comparison	  post-­‐test;	  P	  >	  0.05;	  n	  =	  3).	  Representative	  single-­‐parameter	  histograms	  are	  shown	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Figure	  5.16:	  Tanshinone	  IIA	  does	  not	  reduce	  surface	  re-­‐expression	  of	  CXCR1.	  
Human	  neutrophils	  were	  isolated	  from	  whole	  blood,	  as	  described,	  and	  stimulated	  with	  IL-­‐8	  at	  the	  dose	  
indicated,	   alongside	   either	   10	   μM	   tanshinone	   IIA	   or	   DMSO	   for	   30	   minutes	   at	   37	   oC.	   After	   washing,	  
neutrophils	  were	  re-­‐suspended	  and	  incubated	  with	  either	  10	  μM	  tanshinone	  IIA	  or	  DMSO	  at	  37	  oC	  for	  30	  
minutes.	  Neutrophils	  were	   then	  washed	  and	   stained	  with	  either	  human	  CXCR1-­‐FITC	  or	  mouse	   IgG2A-­‐
FITC	   at	   a	   1:5	   dilution,	   for	   30	   minutes	   at	   4oC.	   After	   washing	   and	   fixing,	   sample	   fluorescence	   was	  
measured	  using	  a	  FACSCalibur	   flow	  cytometer	  and	  the	  results	  were	  analysed	  using	  FlowJo.	  Neutrophil	  
gating	  was	  applied	  and	  data	  were	  expressed	  as	  a	  percentage	  of	  basal	  CXCR1-­‐FITC	  fluorescence	  for	  each	  
dose	  of	  IL-­‐8.	  (A)	  Data	  are	  plotted	  alongside	  the	  percentage	  fluorescence	  obtained	  in	  the	  internalisation	  
assay	  (0	  minutes)	  to	  represent	  receptor	  recycling.	  There	  was	  no	  significant	  difference	  in	  re-­‐expression	  of	  
CXCR1	  between	  tanshinone	   IIA	  and	  the	  DMSO	  vehicle	  control	  at	  either	  of	   the	   IL-­‐8	  doses	   tested	   (Two-­‐
way	  ANOVA	  with	   Bonferroni’s	  multiple	   comparison	   post-­‐test;	  P	   >	   0.05;	  n	   =	   1).	   Representative	   single-­‐
parameter	  histograms	  are	  shown	  for	  re-­‐expression	  with	  (B)	  10	  nM	  IL-­‐8	  and	  (C)	  100	  nM	  IL-­‐8.	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Figure	  5.17:	  Tanshinone	  IIA	  does	  not	  reduce	  surface	  re-­‐expression	  of	  CXCR2.	  
Human	  neutrophils	  were	  isolated	  from	  whole	  blood,	  as	  described,	  and	  stimulated	  with	  IL-­‐8	  at	  the	  dose	  
indicated,	   alongside	   either	   10	   μM	   tanshinone	   IIA	   or	   DMSO	   for	   30	   minutes	   at	   37	   oC.	   After	   washing,	  
neutrophils	  were	  re-­‐suspended	  and	  incubated	  with	  either	  10	  μM	  tanshinone	  IIA	  or	  DMSO	  at	  37	  oC	  for	  30	  
minutes.	  Neutrophils	  were	  then	  washed	  and	  stained	  with	  either	  human	  CXCR2-­‐PE	  or	  mouse	  IgG2A-­‐PE	  at	  
a	   1:5	   dilution,	   for	   either	   10	   or	   30	  minutes	   at	   4oC.	   After	  washing	   and	   fixing,	   sample	   fluorescence	  was	  
measured	  using	  a	  FACSCalibur	   flow	  cytometer	  and	  the	  results	  were	  analysed	  using	  FlowJo.	  Neutrophil	  
gating	  was	  applied	  and	  data	  were	  expressed	  as	  a	  percentage	  of	  basal	  CXCR2-­‐PE	  fluorescence	  for	  each	  
dose	  of	  IL-­‐8.	  (A)	  Data	  are	  plotted	  alongside	  the	  percentage	  fluorescence	  obtained	  in	  the	  internalisation	  
assay	  (0	  minutes)	  to	  represent	  receptor	  recycling.	  There	  was	  no	  significant	  difference	  in	  re-­‐expression	  of	  
CXCR2	  between	   tanshinone	   IIA	   and	   the	  DMSO	  vehicle	   control	   at	   either	  of	   the	   IL-­‐8	  doses	   tested	  or	   at	  
either	  time	  point	  (Two-­‐way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test;	  P	  >	  0.05;	  n	  =	  3	  for	  0	  
and	  30	  minute	  time	  points,	  n	  =	  2	  for	  10	  minute	  time	  point).	  Representative	  single-­‐parameter	  histograms	  
are	  shown	  for	  re-­‐expression	  with	  (B)	  10	  nM	  IL-­‐8	  and	  (C)	  100	  nM	  IL-­‐8.	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5.6.3	  The	  CXCR2	  antagonist	  SB225002	  has	  no	  effect	  on	  neutrophil	  reverse	  migration	  
Although	  there	  did	  not	  appear	  to	  be	  any	  effect	  on	  CXCR2	  internalisation	  or	  recycling	  in	  
human	  neutrophils	  stimulated	  with	  IL-­‐8	  in	  the	  presence	  of	  tanshinone	  IIA	  in	  vitro,	  this	  
did	  not	  rule	  out	  an	  effect	  that	  might	  be	  occurring	  downstream	  of	  the	  receptor	  to	  cause	  
the	  neutrophil	  reverse	  migration	  observed	  in	  vivo.	  To	  determine	  whether	  the	  effect	  of	  
tanshinone	  IIA	  was	  likely	  to	  be	  downstream	  of	  CXCR2,	  reverse	  migration	  assays	  were	  
performed	  to	  test	  whether	  the	  effect	  could	  be	  recapitulated	  using	  a	  pharmacological	  
inhibitor	  of	  human	  CXCR2,	  SB225002.	  This	   is	  a	  selective,	  non-­‐peptide	  antagonist	   that	  
has	  ameliorative	  effects	  in	  mammalian	  models	  of	  inflammation,	  primarily	  by	  reducing	  
neutrophil	  influx	  (White	  et	  al.,	  1998;	  Bento	  et	  al.,	  2008).	  
	  
Initially,	  a	  preliminary	  experiment	  was	  performed	  to	  investigate	  the	  effect	  of	  SB225002	  
specifically	   on	   the	   resolution	   phase	   of	   inflammation.	   At	   3	   dpf,	  mpx:GFP	   larvae	  were	  
injured	   and	   those	   that	   mounted	   a	   good	   neutrophilic	   response	   were	   treated	   with	  
varying	  doses	  of	  SB225002	  at	  6	  hpi.	  Neutrophil	  numbers	  remaining	  at	  the	  site	  of	  injury	  
were	   recorded	   at	   12	   hpi.	   Although	   not	   significant,	   there	   was	   a	   clear	   reduction	   in	  
neutrophil	  number	  at	  the	  wound	  in	  larvae	  treated	  with	  3	  μM	  SB225002	  compared	  to	  
those	  treated	  with	  the	  DMSO	  vehicle	  control	  (Figure	  5.18	  A).	  It	  is	  likely	  that	  this	  result	  
would	  become	  significant	   if	   the	  assay	  was	  repeated,	  however	  the	  outcome	  from	  this	  
single	  experiment	  was	  sufficient	  to	  indicate	  an	  appropriate	  concentration	  of	  SB225002	  
to	  use	  to	  examine	  reverse	  migration.	  Toxicity	  was	  apparent	  at	  higher	  doses.	  
	  
Reverse	  migration	  assays	  were	  performed	  using	  3	  dpf	  mpx/Kaede	  larvae,	  as	  previously	  
described,	  and	  the	  numbers	  of	  neutrophils	  that	  migrated	  away	  from	  the	  wound	  were	  
quantified	  over	  time.	  There	  was	  no	  difference	  in	  reverse	  migration	  in	  the	  presence	  of	  
SB225002	   compared	   to	   the	   DMSO	   vehicle	   control	   (Figure	   5.18	   B).	   These	   data	  
suggested	   it	   was	   unlikely	   that	   tanshinone	   IIA	   was	   exerting	   its	   effect	   by	   blocking	   a	  
component	   of	   the	   signalling	   pathway	   downstream	   of	   Cxcr2.	   However,	   it	   is	   possible	  
that	  the	  dose	  of	  SB225002	  used	  in	  these	  experiments	  was	  not	  high	  enough	  to	  induce	  





Figure	   5.18:	   The	   human	   CXCR2	   inhibitor	   SB225002	   does	   not	   increase	   the	   reverse	  
migration	  of	  neutrophils	  in	  zebrafish	  larvae.	  
(A)	  As	  a	  preliminary	  experiment,	  tail	  transection	  was	  performed	  on	  mpx:GFP	  larvae	  at	  3	  dpf	  and	  those	  
that	   mounted	   a	   good	   neutrophilic	   response	   at	   6	   hpi	   were	   treated	   with	   varying	   doses	   of	   SB225002.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  12	  hpi	  and	  there	  appeared	  to	  be	  a	  reduction	  in	  
neutrophil	   number	   with	   3	   μM	   SB225002,	   though	   this	   was	   not	   significant	   (One-­‐way	   ANOVA	   with	  
Dunnett’s	  multiple	  comparison	  post-­‐test;	  n	  =	  6,	  performed	  as	  1	  experiment).	  Toxicity	  was	  observed	  at	  
higher	  concentrations.	  	  (B)	  Tail	  fin	  transection	  was	  performed	  on	  mpx/Kaede	  larvae	  at	  3	  dpf,	  and	  those	  
that	  mounted	  a	   good	  neutrophilic	   response	  were	   selected	   for	   treatment	  with	  3	   μM	  SB225002	  or	   the	  
DMSO	  vehicle	  control	  at	  4	  hpi.	  At	  6	  hpi,	  larvae	  were	  mounted	  and	  neutrophils	  at	  the	  site	  of	  injury	  were	  
photoconverted	   from	   green	   to	   red	   fluorescence	   on	   a	   confocal	   spinning	   disk	   system	   using	   an	  
UltraVIEWPhotoKinesisTM	   device,	   with	   the	   405	   nm	   laser	   line	   at	   40%	   laser	   energy.	   Larvae	   were	   time-­‐
lapsed	  on	   an	   inverted	   compound	   fluorescence	  microscope	   for	   4.5	   hours	   and	   the	   number	   of	   red	   cells	  
that	  migrated	  away	  from	  the	  site	  of	  injury	  into	  a	  region	  was	  quantified	  over	  the	  time-­‐course.	  There	  was	  
no	  difference	  in	  neutrophil	  reverse	  migration	  between	  SB225002	  treated	  larvae	  and	  the	  DMSO	  control	  
treated	  larvae	  (n	  =	  18,	  performed	  as	  3	  independent	  experiments,	  data	  expressed	  as	  mean	  ±	  SEM).	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5.6.4	  Preliminary	  investigation	  into	  the	  effect	  of	  tanshinone	  IIA	  on	  CXCR4	  
The	  results	  obtained	  in	  the	  previous	  experiments	  implied	  that	  the	  effect	  of	  tanshinone	  
IIA	   on	   neutrophil	   reverse	   migration	   was	   not	   mediated	   by	   changes	   in	   the	   surface	  
expression	   of	   CXCR1	   or	   CXCR2,	   or	   by	   an	   inhibition	   of	   the	   downstream	   signalling	  
pathways.	   I	  hypothesised	  that	  regulation	  of	  an	  alternative	  chemokine	  receptor	  might	  
be	  responsible	  for	  the	  activity,	  as	  although	  neutrophils	  predominantly	  express	  CXCR1	  
and	   CXCR2	   (Baggiolini,	   1993),	   there	   is	   some	   evidence	   to	   suggest	   that	   under	  
inflammatory	   conditions,	   neutrophils	  may	   alter	   their	   chemokine	   receptor	   expression	  
phenotype	  (Johnston	  et	  al.,	  1999;	  Yamashiro	  et	  al.,	  2001).	  	  
	  
Of	  particular	  interest	  was	  the	  finding	  that	  neutrophils	  from	  the	  bronchoalveolar	  lavage	  
fluid	  of	  chronic	  lung	  disease	  patients	  and	  the	  synovial	  fluid	  of	  arthritis	  sufferers	  express	  
high	  levels	  of	  CXCR4	  in	  comparison	  to	  peripheral	  blood	  neutrophils	  (Brühl	  et	  al.,	  2001;	  
Hartl	  et	  al.,	  2008).	  The	  association	  between	  CXCR4	  and	  its	  ligand,	  SDF-­‐1,	  is	  responsible	  
for	  the	  retention	  of	  neutrophils	  in	  the	  bone	  marrow	  and	  disruption	  of	  this	  interaction,	  
for	  example	  by	  CXCR4	  antagonists,	  induces	  neutrophil	  release	  (Devine	  et	  al.,	  2008).	  It	  
was	   hypothesised	   that	   a	   similar	   mechanism	   might	   retain	   neutrophils	   at	   sites	   of	  
inflammation.	   In	   support	   of	   this,	   evidence	   from	   both	   human	   patients	   and	   mouse	  
models	  of	  inflammatory	  disease	  indicates	  that	  SDF-­‐1	  expression	  is	  increased	  at	  sites	  of	  
inflammation	   and	   promotes	   neutrophil	   recruitment,	   as	   migration	   is	   abrogated	   by	  
antibody	  blocking	  of	  SDF-­‐1	  (Struyf	  et	  al.,	  2005;	  Petty	  et	  al.,	  2007).	  It	  is	  suggested	  that	  
SDF-­‐1	  mediated	  migration	   is	   secondary	   to	   the	   initial	   wave	   of	   leukocyte	   recruitment	  
regulated	  by	  other	  chemokines	  and	  that	  SDF-­‐1	  is	  released	  primarily	  by	  epithelial	  cells	  
to	  coordinate	  a	  sustained	  response	  (Petty	  et	  al.,	  2007).	  	  
	  
Zebrafish	  possess	   two	  Cxcr4	   receptors,	  Cxcr4a	  and	  Cxcr4b,	   the	   latter	  of	  which	   is	   the	  
predominantly	   expressed	   subtype	   on	   neutrophils	   (Walters	   et	   al.,	   2010).	   There	   also	  
exist	   two	  Sdf-­‐1	   ligands,	  of	  which	  Sdf-­‐1a	  appears	   to	  be	  highly	  expressed	   in	   regions	  of	  
neutrophil	  production	  such	  as	  the	  CHT	  (Walters	  et	  al.,	  2010).	   In	  zebrafish,	   the	  Cxcr4-­‐
Sdf-­‐1	   signalling	   axis	   is	   believed	   to	   function	   in	   a	   similar	  manner	   to	   that	   identified	   in	  
humans.	  Cxcr4-­‐Sdf-­‐1	  signalling	  retains	  neutrophils	  and	  a	  transgenic	  zebrafish	   line	  has	  
been	   generated	   to	   model	   WHIM	   syndrome	   (Walters	   et	   al.,	   2010).	   This	   expresses	   a	  
	  228	  
mutant	   form	   of	   Cxcr4	   with	   a	   truncated	   C-­‐terminal	   tail,	   which	   might	   prevent	  
internalisation	  of	  the	  receptor,	  causing	  sustained	  signalling	  and	  neutrophil	  retention	  in	  
the	  CHT.	  	  
	  
Based	  on	  the	  hypothesis	  that	  Cxcr4-­‐Sdf-­‐1	  binding	  might	  function	  as	  a	  retention	  signal	  
for	  neutrophils	  at	   sites	  of	   inflammation,	   I	   initially	   tested	   the	  human	  CXCR4	   inhibitor,	  
AMD3100,	   to	   investigate	   its	   effect	   during	   the	   resolution	   phase.	   Tail	   transection	  was	  
performed	  on	  3	  dpf	  mpx:GFP	  larvae	  and	  good	  responders	  were	  exposed	  to	  AMD3100	  
at	  6	  hpi.	  Neutrophils	  at	  the	  site	  of	  injury	  were	  counted	  at	  12	  hpi,	  which	  revealed	  that	  
there	   was	   no	   significant	   difference	   in	   neutrophil	   number	   in	   the	   AMD3100	   treated	  
larvae	  compared	  to	  the	  DMSO	  control	  treated	  larvae	  (Figure	  5.19	  A).	  SP600125,	  which	  
significantly	  reduced	  neutrophil	  numbers	  at	  the	  wound,	  was	  used	  as	  a	  positive	  control.	  
I	   also	   explored	   the	   effect	   of	   AMD3100	   on	   neutrophil	   recruitment,	   by	   treating	   3	   dpf	  
mpx:GFP	  larvae	  immediately	  following	  tail	  fin	  injury	  and	  counting	  neutrophil	  numbers	  
at	  the	  wound	  at	  6	  hpi.	  There	  was	  no	  significant	  difference	  between	  AMD3100	  and	  the	  
DMSO	   control	   groups,	   however	   there	   was	   a	   significant	   increase	   in	   neutrophil	  
recruitment	   between	   10	   and	   25	   μM	   AMD3100	   (Figure	   5.19	   B).	   This	   suggested	   that	  
inhibition	   of	   Cxcr4	   might	   increase	   neutrophil	   recruitment,	   potentially	   by	   promoting	  
release	  of	  neutrophils	  from	  the	  CHT.	  	  
	  
From	  these	  experiments,	  it	  seemed	  unlikely	  that	  antagonism	  of	  Cxcr4	  would	  replicate	  
the	   increase	   in	   reverse	   migration	   observed	   in	   the	   presence	   of	   tanshinone	   IIA.	  
However,	   it	   is	   possible	   that	  blocking	  Cxcr4	  with	  AMD3100	  would	   cause	  multiple	  off-­‐
target	   effects,	   particularly	   as	   it	   would	   inhibit	   both	   forms	   of	   Cxcr4	   in	   zebrafish,	  
therefore	  it	  could	  not	  be	  ruled	  out	  that	  Cxcr4	  signalling	  in	  neutrophils	  might	  mediate	  
retention	   at	   sites	   of	   inflammation.	   As	   an	   alternative	   approach	   to	   investigate	   my	  
hypothesis,	   I	   performed	  whole	  mount	   in	   situ	   hybridisation	   (WISH)	   to	   determine	   the	  
expression	  of	  sdf-­‐1a	  during	  the	  resolution	  phase	  of	   inflammation	   in	   injured	  mpx:GFP	  
zebrafish	  larvae	  exposed	  to	  either	  tanshinone	  IIA	  or	  DMSO	  alone.	  I	  hypothesised	  that	  
there	   might	   be	   an	   Sdf-­‐1	   gradient	   at	   the	   wound,	   which	   would	   be	   reduced	   in	   the	  








Figure	   5.19:	   The	   CXCR4	   antagonist	   AMD3100	   does	   not	   accelerate	   inflammation	  
resolution	  in	  zebrafish.	  
(A)	  To	  investigate	  the	  effect	  of	  AMD3100	  on	  inflammation	  resolution,	  tail	  transection	  was	  performed	  on	  
mpx:GFP	   larvae	  at	  3	  dpf	  and	   those	   that	  mounted	  a	  good	  neutrophilic	   response	  at	  6	  hpi	  were	   treated	  
with	  varying	  doses	  of	  AMD3100.	  Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  12	  hpi.	  There	  
was	  no	  difference	   in	  neutrophil	  number	   in	   the	  presence	  of	  AMD3100	  compared	   to	   the	  DMSO	  vehicle	  
control	   (One-­‐way	  ANOVA	  with	  Dunnett’s	  multiple	  comparison	  post-­‐test;	  where	  ***	  P	  <	  0.001;	  n	  =	  18,	  
performed	   as	   3	   independent	   experiments).	   (B)	   To	   investigate	   the	   effect	   of	   AMD3100	   on	   neutrophil	  
recruitment,	   3	   dpf	   mpx:GFP	   larvae	   were	   injured	   and	   treated	   immediately	   with	   varying	   doses	   of	  
AMD3100.	  Neutrophil	  numbers	  at	  the	  site	  of	   injury	  were	  counted	  at	  6	  hpi.	  There	  was	  no	  difference	   in	  
neutrophil	   number	   in	   the	   presence	   of	   AMD3100	   compared	   to	   the	   DMSO	   vehicle	   control,	   however	  
significantly	  more	  neutrophils	  were	  recruited	  with	  a	  dose	  of	  25	  μM	  AMD3100	  compared	  to	  10	  μM.	  (One-­‐
way	  ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test;	  where	  *	  P	  <	  0.05	  and	  ***	  P	  <	  0.001;	  n	  =	  
12,	  performed	  as	  2	  independent	  experiments).	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A	  resolution	  assay	  was	  carried	  out	  on	  mpx:GFP	  zebrafish	  larvae	  at	  3	  dpf	  following	  the	  
usual	   protocol,	   but	   rather	   than	   counting	   neutrophil	   number	   at	   12	   hpi,	   larvae	   were	  
fixed	   in	   4%	   PFA.	   WISH	   was	   performed,	   as	   described,	   using	   an	   in	   situ	   RNA	   probe	  
generated	   from	   a	   plasmid	   vector	   containing	   the	   zebrafish	   sdf-­‐1a	   coding	   sequence,	  
obtained	   as	   a	   kind	   gift	   from	   Dr	   Stone	   Elworthy	   (University	   of	   Sheffield).	   Strikingly,	  
there	   appeared	   to	   be	   an	   increase	   in	   sdf-­‐1a	   expression	   in	   the	   injured	   tail	   fins	   of	  
tanshinone	   IIA	   treated	   larvae	   compared	   to	   the	   DMSO	   control	   treated	   larvae	   (Figure	  
5.20).	  This	  was	  unexpected	  given	  that	  fewer	  neutrophils	  are	  retained	  at	  the	  wound	  in	  
the	   presence	   of	   tanshinone	   IIA.	   To	   date,	   this	   experiment	   has	   been	   performed	   once	  
only	  and	  repetition	  is	  required	  to	  confirm	  this	  preliminary,	  yet	  interesting,	  observation.	  	  	  
	  
Finally,	   I	   also	   carried	   out	   a	   preliminary	   experiment	   to	   investigate	   the	   effect	   of	  
tanshinone	  IIA	  on	  CXCR4	  surface	  expression	  in	  human	  neutrophils,	  in	  a	  similar	  manner	  
to	   the	   experiments	   performed	   on	   CXCR1	   and	   CXCR2.	   Freshly	   isolated	   human	  
neutrophils	   express	  only	   low	   levels	  of	  CXCR4,	  but	   this	   is	  up-­‐regulated	  with	  ageing,	   a	  
mechanism	   that	   is	   believed	   to	   mediate	   neutrophil	   clearance	   by	   the	   homing	   of	  
senescent	   neutrophils	   back	   to	   the	   bone	   marrow	   (Martin	   et	   al.,	   2003).	   In	   order	   to	  
measure	   the	   effect	   of	   tanshinone	   IIA	   on	   CXCR4,	   neutrophils	   were	   isolated	   from	  
peripheral	  blood,	   followed	  by	  culture	   in	  media	  at	  37°C	   for	  12	  hours.	  Flow	  cytometry	  
was	  performed	  as	  previously	  described,	  using	  a	  CXCR4-­‐FITC	  MAb.	  This	  revealed	  that	  12	  
hours	  was	  sufficient	  to	  observe	  an	  increase	  in	  CXCR4	  expression	  compared	  to	  a	  control	  
neutrophil	   sample,	   which	   was	   incubated	   at	   4°C	   immediately	   after	   the	   separation	  
process	   (Figure	   5.21).	   After	   12	   hours,	   neutrophils	   were	   incubated	   with	   either	  
tanshinone	  IIA	  or	  DMSO	  as	  a	  vehicle	  control	  for	  2	  hours,	  followed	  by	  stimulation	  with	  
varying	   concentrations	   of	   SDF-­‐1α	   ligand	   for	   30	   minutes.	   CXCR4	   internalisation	   was	  
assessed	  by	  flow	  cytometry	  as	  previously	  described,	  and	  the	  preliminary	  data	  obtained	  
suggested	  that	  there	  was	  a	  lack	  of	  CXCR4	  internalisation	  in	  the	  presence	  of	  tanshinone	  
IIA,	  at	  all	  doses	  of	  SDF-­‐1α	  tested	  (Figure	  5.22).	  The	  significance	  of	  this	  remains	  unclear,	  
and	   requires	   further	   experimentation	   in	   order	   to	   determine	   whether	   this	   is	   a	   real	  
effect.	  	  








Figure	  5.20:	  WISH	  reveals	  that	  tanshinone	  IIA	  up-­‐regulates	  sdf-­‐1a	  expression	  at	  the	  
site	  of	  injury	  in	  3	  dpf	  larvae.	  
Tail	  transection	  was	  performed	  on	  mpx:GFP	  larvae	  at	  3	  dpf	  and	  those	  that	  mounted	  a	  good	  neutrophilic	  
response	  at	  6	  hpi	  were	  treated	  with	  either	  25	  μM	  tanshinone	  IIA	  or	  DMSO.	  Larvae	  were	  fixed	  in	  4%	  PFA	  
at	  12	  hpi	  and	  WISH	  was	  performed,	  as	  described,	  to	  investigate	  sdf-­‐1a	  expression.	  Larvae	  were	  imaged	  
using	  a	  fluorescent	  dissecting	  microscope	  with	  a	  Leica	  DFC310	  camera,	  which	  suggested	  that	  there	  was	  
an	  up-­‐regulation	  of	  sdf-­‐1a	  at	  the	  site	  of	   injury	   in	  tanshinone	  IIA	  treated	   larvae.	   Increased	  staining	  was	  
also	  evident	  in	  the	  neuromasts	  (n	  ≥	  30,	  performed	  as	  1	  experiment).	  	  









Figure	  5.21:	  CXCR4	  expression	  in	  human	  neutrophils	  increases	  with	  senescence.	  
Human	  neutrophils	  were	   isolated	  from	  whole	  blood,	  as	  described,	  and	  cultured	   in	  media	  for	  12	  hours	  
prior	  to	  staining	  with	  either	  human	  CXCR4-­‐FITC	  or	  mouse	  IgG2A-­‐FITC	  at	  a	  1:10	  dilution,	  for	  30	  minutes	  
at	  4oC.	  After	  washing	  and	  fixing,	  sample	  fluorescence	  was	  measured	  using	  a	  FACSCalibur	  flow	  cytometer	  
and	  the	  results	  were	  analysed	  using	  FlowJo.	  The	  neutrophil	  population	  was	  gated	  as	   illustrated	   in	   (A),	  
and	  this	  gating	  was	  applied	  to	  all	  subsequent	  samples.	  A	  single	  parameter	  histogram	  was	  generated	  to	  
measure	  the	  mean	  fluorescence	  intensity	  in	  the	  FL-­‐1	  channel	  (B),	  which	  indicated	  that	  CXCR4	  expression	  










































Figure	   5.22:	   Preliminary	   evidence	   suggests	   that	   tanshinone	   IIA	   might	   prevent	  
internalisation	  of	  CXCR4	  in	  human	  neutrophils.	  
Human	  neutrophils	  were	  isolated	  from	  whole	  blood,	  as	  described,	  and	  cultured	  in	  media	  for	  12	  hours.	  
Neutrophils	  were	  then	   incubated	  with	  either	  10	  μM	  tanshinone	   IIA	  or	  DMSO	  for	  2	  hours,	   followed	  by	  
stimulation	  with	   varying	   doses	   of	   SDF-­‐1α,	   as	   indicated.	   After	  washing	   and	   re-­‐suspending,	   neutrophils	  
were	  stained	  with	  either	  human	  CXCR4-­‐FITC	  or	  mouse	  IgG2A-­‐FITC	  at	  a	  1:10	  dilution,	  for	  30	  minutes	  at	  
4oC.	  After	  washing	  and	   fixing,	   sample	   fluorescence	  was	  measured	  using	  a	  FACSCalibur	   flow	  cytometer	  
and	   the	   results	   were	   analysed	   using	   FlowJo.	   Neutrophil	   gating	   was	   applied	   and	   single	   parameter	  
histograms	  were	  generated	  to	  assess	  the	  levels	  of	  CXCR4-­‐FITC	  expression.	  Internalisation	  of	  CXCR4	  did	  
not	  appear	  to	  occur	  in	  the	  presence	  of	  tanshinone	  IIA,	  at	  all	  doses	  of	  SDF-­‐1α	  tested,	  judged	  by	  a	  lack	  of	  
left	  shift	  in	  the	  histograms	  (n	  =	  1).	  
Sample %
TAN CXCR4 100ng:ml SDF 85.6
DMSO CXCR4 100ng:ml SDF 82.1
CXCR4 100ng:ml SDF 90.1
Neutrophil Gate













TAN CXCR4 10ng:ml SDF 85.7
DMSO CXCR4 10ng:ml SDF 85.6
CXCR4 10ng:ml SDF 88.6
Neutrophil Gate













TAN CXCR4 1ng:ml SDF 84.7
DMSO CXCR4 1ng:ml SDF 84.9
CXCR4 1ng:ml SDF 89
Neutrophil Gate





















In	   this	   chapter	   I	   have	   investigated	   the	   pro-­‐resolution	   properties	   of	   tanshinone	   IIA,	  
which	  was	  one	  of	  the	  most	  potent	  accelerators	  of	  inflammation	  resolution	  identified	  in	  
the	   Spectrum	   Collection	   screen.	   Tanshinone	   IIA	   and	   the	   closely	   related	  
cryptotanshinone	  possess	  known	  anti-­‐inflammatory	  activity	  and	  their	  use	  in	  traditional	  
remedies	  to	  treat	  cardiovascular	  and	  inflammatory	  disorders	  provides	  some	  evidence	  
that	   they	   are	   functionally	   active	   and	   can	   be	   tolerated	   in	   humans.	   I	   found	   that	   both	  
compounds	  could	  induce	  neutrophil	  apoptosis	  in	  vitro	  and	  that	  tanshinone	  IIA	  blocked	  
the	   effects	   of	   pro-­‐survival	   stimuli.	   Tanshinone	   IIA	   also	   acted	   via	   an	   additional	  
mechanism	   in	   vivo;	   by	   promoting	   reverse	   migration	   of	   neutrophils	   away	   from	   the	  
wound.	   This	   is	   the	   first	   evidence	   to	   demonstrate	   that	   it	   is	   possible	   to	  
pharmacologically	   drive	   inflammation	   resolution	   in	   this	   manner	   and	   suggests	   a	  
potential	   strategy	   by	  which	   the	   neutrophil	   could	   be	   targeted	   in	   the	   development	   of	  
more	  effective	  inflammatory	  disease	  therapy.	  	  
5.7.1	  Tanshinone	  IIA	  does	  not	  affect	  neutrophil	  recruitment	  
Initially,	   the	   effects	   of	   tanshinone	   IIA	  on	  neutrophil	   recruitment	   to	   the	   site	   of	   injury	  
were	  examined	  in	  zebrafish	  larvae.	  No	  significant	  reduction	  in	  neutrophil	  number	  was	  
found	   in	   tanshinone	   IIA	   treated	   larvae	  compared	  to	  those	  treated	  with	  DMSO	  alone,	  
suggesting	   that	   this	   compound	   acted	   specifically	   on	   the	   resolution	   phase	   of	  
inflammation.	   These	   findings	   were	   slightly	   contradictory	   to	   those	   observed	   in	   the	  
secondary	   assays	   performed	   immediately	   following	   the	   Spectrum	   Collection	   screen	  
described	   in	   Chapter	   3,	   which	   indicated	   that	   there	   was	   a	   reduction	   in	   neutrophil	  
recruitment	   with	   tanshinone	   IIA	   at	   the	   highest	   dose	   tested.	   This	   discrepancy	   could	  
likely	  be	  attributed	  to	  the	  inherent	  variability	  between	  zebrafish	  larvae,	  along	  with	  the	  
nature	  of	  this	  assay.	   In	  contrast	  to	  the	  resolution	  assay	   in	  which	   larvae	  that	  mount	  a	  
good	   response	   to	   injury	   are	   selected	   for	   compound	   treatment,	   in	   the	   recruitment	  
assay	   larvae	   are	   treated	   immediately	   following	   injury,	   therefore	   it	   is	   not	   possible	   to	  
select	   those	   that	   should	   recruit	   the	  expected	  mean	  number	  of	  neutrophils	   by	  6	  hpi.	  
This	  is	  perhaps	  reflected	  in	  the	  higher	  standard	  deviation	  calculated	  in	  tanshinone	  IIA	  
treated	   larvae	   in	   the	  original	   recruitment	  assay	   (8.63	  compared	  to	  5.16	  calculated	   in	  




that	  in	  some	  zebrafish	  larvae,	  the	  inflammatory	  response	  was	  beginning	  to	  resolve	  at	  6	  
hpi	   and	   some	  of	   the	  neutrophils	   that	  were	   recruited	  early	   to	   the	   site	  of	   injury	  were	  
either	   undergoing	   apoptosis	   or	   had	  begun	   to	  migrate	   away.	  As	   an	  extra	  measure	   to	  
ensure	  that	  the	  data	  generated	  in	  the	  dose	  response	  experiment	  were	  valid,	  the	  assay	  
was	   repeated	   four	   times,	   still	   finding	   no	   significant	   difference	   in	   neutrophil	  
recruitment	   between	   the	   DMSO	   control	   treated	   larvae	   and	   those	   treated	   with	  
tanshinone	  IIA.	  
	  
These	   data	   were	   further	   supported	   by	   the	   lack	   of	   effect	   on	   neutrophil	   chemotactic	  
behaviour	   in	  the	  presence	  of	  tanshinone	   IIA.	  There	  were	  no	  significant	  differences	   in	  
neutrophil	   speed,	  meandering	   index	  or	  displacement	  between	  treatment	  groups	  and	  
analysis	   of	   neutrophil	   bearing	   indicated	   that	   neutrophils	   in	   tanshinone	   IIA	   treated	  
larvae	  migrated	  preferentially	  towards	  the	  wound.	  In	  the	  previous	  chapter,	  tanshinone	  
IIA	  was	  found	  to	  have	  no	  effect	  on	  PI-­‐3K	  activity	  during	  recruitment	  and	  the	  neutrophil	  
polarity	   index	   remained	   unchanged.	   This	   provides	   additional	   evidence	   that	   this	  
compound	  has	  no	  effect	  on	  neutrophil	  recruitment	  in	  the	  zebrafish	  model.	  The	  activity	  
of	   cryptotanshinone	   was	   not	   further	   tested	   in	   recruitment	   assays,	   although	  
interestingly	   it	   has	   been	   reported	   that	   macrophage	   migration	   is	   reduced	   in	   the	  
presence	   of	   cryptotanshinone	   and	   this	   is	   partly	   mediated	   by	   inhibition	   of	   PI-­‐3K	  
signalling	  (Don	  et	  al.,	  2007).	  	  Whether	  this	  is	  specific	  to	  macrophages	  is	  unknown,	  but	  
it	  would	  be	  possible	  to	  investigate	  the	  effect	  of	  cryptotanshinone	  on	  PI-­‐3K	  activation	  in	  
neutrophils	  using	  the	  PI-­‐3K	  assay	  described	  in	  Chapter	  4.	  
5.7.2	  Tanshinone	  IIA	  causes	  neutrophil	  apoptosis	  
Tanshinone	   IIA	   significantly	   accelerated	   inflammation	   resolution	   in	   zebrafish	   by	  
reducing	   neutrophil	   numbers	   at	   the	  wound	   in	   a	   dose-­‐dependent	  manner.	   Apoptosis	  
followed	  by	  phagocytic	  uptake	  by	  macrophages	  is	  the	  best	  described	  process	  by	  which	  
neutrophils	  are	  removed	  from	  sites	  of	  inflammation	  (Savill	  et	  al.,	  1989)	  and	  due	  to	  the	  
known	  apoptotic	  potential	  of	  tanshinone	  IIA	  in	  other	  cell	  types	  (Sung	  et	  al.,	  1999;	  Won	  
et	  al.,	  2010;	  Jiao	  et	  al.,	  2011;	  Chen	  et	  al.,	  2012;	  Wei	  et	  al.,	  2012),	  I	  hypothesised	  that	  
this	  mechanism	  might	   be	   responsible	   for	   its	   pro-­‐resolution	   activity.	   Both	   tanshinone	  
IIA	  and	  cryptotanshinone	  were	  found	  to	   increase	  constitutive	  neutrophil	  apoptosis	   in	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vitro,	  with	   the	   latter	  having	   the	  greatest	  effect.	   It	   is	  possible	   that	   the	  higher	   level	  of	  
apoptosis	  observed	   in	   the	  presence	  of	  cryptotanshinone	  might	  be	  due	   to	   toxicity,	  as	  
this	   compound	   caused	   some	   death	   in	   zebrafish	   larvae.	   Although,	   by	   simple	   visual	  
observation	   of	   the	   cytospins	   obtained	   from	   both	   the	   tanshinone	   IIA	   and	  
cryptotanshinone	  conditions,	  the	  neutrophils	  appeared	  apoptotic	  rather	  than	  necrotic	  
in	   morphology.	   To	   be	   certain,	   it	   would	   be	   informative	   to	   investigate	   whether	   this	  
effect	  is	  abrogated	  in	  the	  presence	  of	  a	  pan-­‐caspase	  inhibitor	  such	  as	  Q-­‐VD-­‐OPh.	  There	  
is	  currently	  no	  published	  evidence	  to	  describe	  a	  pro-­‐apoptotic	  role	  for	  the	  tanshinones	  
in	  neutrophils,	  although	  evidence	  does	   indicate	   that	  both	  compounds	  are	  associated	  
with	  caspase	  activation	  and	  down-­‐regulation	  of	  Mcl-­‐1	   in	  other	  cell	  types	  (Sung	  et	  al.,	  
1999;	   Won	   et	   al.,	   2010;	   Wei	   et	   al.,	   2012),	   which	   might	   explain	   their	   mechanistic	  
activity.	  	  
	  
One	   of	   the	   most	   interesting	   findings	   from	   these	   in	   vitro	   studies	   was	   that	   the	   pro-­‐
apoptotic	  effect	  of	  the	  tanshinones	  was	  not	  lost	  in	  the	  presence	  of	  GM-­‐CSF,	  a	  potent	  
neutrophil	  survival	  factor	  (Lee	  et	  al.,	  1993).	  Thus,	  it	   is	  possible	  that	  these	  compounds	  
are	  able	  to	  block	  the	   intracellular	  signalling	  downstream	  of	  GM-­‐CSF	  receptor	  binding	  
that	  delays	  apoptosis,	  such	  as	  the	  PI-­‐3K,	  MAPK	  or	  JAK/STAT	  pathways	  (Epling-­‐Burnette	  
et	  al.,	  2001).	  Intriguingly,	  tanshinone	  IIA	  and	  cryptotanshinone	  have	  been	  reported	  to	  
inhibit	   activity	   of	   STAT1	   and	   STAT3,	   respectively	   (Xu	   et	   al.,	   2008;	   Shin	   et	   al.,	   2009).	  
However,	   as	   these	   compounds	   also	   appeared	   to	   accelerate	   constitutive	   death,	   it	   is	  
perhaps	  more	  likely	  that	  they	  are	  acting	  further	  downstream,	  for	  example	  by	  inhibiting	  
anti-­‐apoptotic	  BCL-­‐2	  family	  proteins	  such	  as	  Mcl-­‐1.	  	  
	  
The	  apoptotic	  potential	  of	  tanshinone	  IIA	  was	  also	  investigated	   in	  vivo	  by	  TSA/TUNEL	  
staining,	  which	   revealed	  an	   increase	   in	  neutrophil	  apoptosis	  at	   the	  site	  of	   injury	   in	  3	  
dpf	   zebrafish	   larvae.	   The	   caveats	   associated	   with	   this	   assay	   have	   already	   been	  
discussed	  in	  the	  previous	  chapter;	  so	  will	  not	  be	  dwelled	  on	  further	  here.	  However,	  it	  
was	  clear	  that	  the	  effect	  on	  neutrophil	  apoptosis	  in	  the	  presence	  of	  tanshinone	  IIA	  was	  
only	  small	  (1.57%,	  compared	  to	  3.33%	  for	  isopimpinellin	  and	  6.90%	  for	  flavone),	  which	  
prompted	   the	   investigation	   into	   an	   additional	   mechanism	   to	   explain	   the	   significant	  




5.7.3	  Tanshinone	  IIA	  increases	  neutrophil	  reverse	  migration	  
Reverse	  migration	   is	   becoming	   increasingly	   accepted	   as	   a	  mechanism	   for	   neutrophil	  
clearance	   from	   sites	   of	   inflammation	   and	   resolution	   of	   the	   inflammatory	   response.	  
Numerous	   research	   groups	   have	   observed	   this	   phenomenon	   in	   zebrafish	   larvae	  
(Mathias	   et	   al.,	   2006;	  Hall	   et	   al.,	   2007;	   Elks	   et	   al.,	   2011;	   Yoo	  &	  Huttenlocher,	   2011).	  
Although	  more	  technically	  challenging	  to	  investigate,	  neutrophil	  reverse	  migration	  has	  
also	  been	  reported	  to	  occur	   in	  mammalian	  systems	  (Buckley	  et	  al.,	  2006;	  Woodfin	  et	  
al.,	  2011).	  As	  such,	  it	  is	  possible	  that	  targeting	  the	  mechanisms	  responsible	  for	  driving	  
neutrophil	   migration	   might	   provide	   some	   therapeutic	   benefit	   in	   the	   chronic	  
inflammatory	  disease	  state.	  
	  
Using	   zebrafish	   larvae	   expressing	   the	   photoconvertible	   protein	   Kaede	   specifically	   in	  
neutrophils,	  I	  was	  able	  to	  label	  the	  neutrophil	  population	  that	  had	  recruited	  to	  the	  tail	  
fin	  wound	  at	  6	  hpi	  and	  track	  their	  migration	  during	  the	  resolution	  phase.	  Interestingly,	  
I	   found	   that	   in	   larvae	   pre-­‐treated	   with	   tanshinone	   IIA,	   the	   reverse	   migration	   of	  
neutrophils	  away	  from	  the	  wound	  was	  enhanced	  compared	  to	  the	  controls.	  This	  is	  the	  
first	   evidence	   to	   demonstrate	   that	   it	   is	   possible	   to	   pharmacologically	   drive	   the	  
resolution	   of	   neutrophilic	   inflammation	   by	   promoting	   reverse	   migration.	   The	   most	  
rapid	   movement	   occurred	   during	   the	   first	   2	   hours	   following	   photoconversion	   and	  
neutrophils	   appeared	   to	   preferentially	   migrate	   through	   the	   tissues	   rather	   than	  
undergoing	   transendothelial	   reverse	   migration	   back	   into	   the	   vasculature.	   This	   is	   in	  
direct	  contrast	  to	  other	  reports,	  which	  suggest	  that	  a	   large	  proportion	  of	  neutrophils	  
migrate	   away	   from	   a	   wound	   via	   the	   bloodstream	   (Mathias	   et	   al.,	   2006;	   Yoo	   &	  
Huttenlocher,	  2011),	  however	  it	  is	  possible	  that	  these	  differences	  are	  due	  to	  both	  the	  
size	  and	  location	  of	  the	  wound.	  	  
	  
The	   data	   obtained	   here,	   along	   with	   other	   published	   evidence,	   suggest	   that	   during	  
inflammation	  resolution	  in	  the	  zebrafish,	  the	  majority	  of	  neutrophils	  undergo	  reverse	  
migration	  rather	  than	  detectable	  apoptosis	  (Mathias	  et	  al.,	  2006;	  Yoo	  &	  Huttenlocher,	  
2011).	   In	   a	   rat	   model	   of	   glomerulonephritis,	   it	   was	   demonstrated	   that	   neutrophils	  
were	   cleared	   from	   the	   inflamed	   glomeruli	   by	   reverse	   migration	   in	   preference	   to	  
apoptosis	  in	  situ	  (Hughes	  et	  al.,	  1997).	  However,	  this	  is	  contradictory	  to	  evidence	  from	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other	  mammalian	  systems,	  which	  suggest	  that	  the	  rate	  of	  neutrophil	  reverse	  migration	  
is	   much	   lower	   (Buckley	   et	   al.,	   2006;	  Woodfin	   et	   al.,	   2011).	   It	   is	   possible	   that	   these	  
differences	  are	  species	  specific,	  depend	  on	  the	  type	  of	  inflammatory	  stimulus	  involved,	  
or	  that	  reverse	  migration	  plays	  a	  more	   important	  role	   in	  zebrafish	  at	  the	   larval	  stage	  
than	  it	  does	  in	  adult	  animals.	  The	  relative	  contribution	  of	  reverse	  migration	  compared	  
to	   apoptosis	   towards	   neutrophil	   clearance	   and	   inflammation	   resolution	   remains	  
unclear.	  
	  
The	   precise	   mechanisms	   involved	   in	   neutrophil	   reverse	   migration	   are	   not	   well	  
understood,	   although	   it	   has	   been	   revealed	   that	   this	   process	   can	   be	   delayed	   in	  
zebrafish	  by	  activation	  of	  Hif-­‐1α,	  a	  component	  of	  the	  hypoxia	  signalling	  pathway	  (Elks	  
et	   al.,	   2011).	   As	   I	   had	   already	   shown	   that	   tanshinone	   IIA	   could	   override	   GM-­‐CSF	  
induced	   survival	   signalling	   in	   vitro,	   I	   wished	   to	   investigate	   whether	   this	   might	   be	  
reflected	  by	  an	  alternative	  survival	  factor	   in	  vivo.	  Using	  the	  techniques	  established	  in	  
(Elks	   et	   al.,	   2011),	   I	   performed	   reverse	   migration	   assays	   on	   larvae	   injected	   with	  
dominant-­‐active	   hif-­‐1αb	   RNA	   at	   the	   one-­‐cell	   stage	   and	   found	   that	   the	   reverse	  
migration	   effect	   of	   tanshinone	   IIA	   was	  maintained	   even	   in	   the	   presence	   of	   hypoxia	  
signalling.	  This	  was	  an	  important	  finding	  given	  that	  a	  prerequisite	  for	  novel	  therapies	  is	  
the	   ability	   to	   override	   host	   survival	   signals,	   in	   order	   to	   promote	   resolution	   of	  
inflammation	   in	   the	   chronic	   disease	   state.	   Recent	   data	   obtained	   in	   our	   laboratory	  
(Joseph	   Burgon	   and	   Dr	   Stephen	   Renshaw,	   personal	   communication)	   and	   in	  
collaboration	   with	   others	   (Joseph	   Wilson	   and	   Dr	   Sarah	   Walmsley,	   personal	  
communication)	   indicate	   that	   tanshinone	   IIA	   might	   also	   abrogate	   hypoxic	   survival	  
signalling	   in	   vitro	   to	   promote	   neutrophil	   apoptosis.	   It	   would	   be	   interesting	   to	  
determine	   the	   contribution	   of	   tanshinone	   IIA	   induced	   neutrophil	   apoptosis	   towards	  
the	  resolution	  of	  inflammation	  under	  hypoxic	  conditions	  in	  the	  zebrafish,	  compared	  to	  
its	  effect	  on	  reverse	  migration.	  	  	  
5.7.4	  Reverse	  migration	  is	  a	  passive	  rather	  than	  active	  process	  
Given	   that	   little	   is	   known	   about	   the	   mechanisms	   involved	   in	   neutrophil	   reverse	  
migration,	  it	  is	  difficult	  to	  speculate	  whether	  it	  functions	  as	  an	  active	  process	  to	  drive	  




redistribution-­‐like	  process,	  whereby	  neutrophils	  gradually	  diffuse	  away	  once	  they	  have	  
completed	  their	  anti-­‐inflammatory	  tasks.	  These	  ideas	  are	  subject	  to	  some	  controversy,	  
with	  some	  zebrafish	  research	  groups	  claiming	  that	   it	   is	  an	  active	  process	   (Mathias	  et	  
al.,	  2006;	  Starnes	  et	  al.,	  2012),	  whilst	  others	  are	  in	  dispute	  (Holmes,	  Dixon,	  et	  al.,	  2012;	  
Holmes,	   Anderson,	   et	   al.,	   2012).	   The	   latter	   evidence	   is	   based	   on	   mathematical	  
modelling	  of	   the	  whole	  neutrophil	  population	   involved	   in	  the	   inflammatory	  response	  
induced	   by	   tail	   fin	   injury.	   Analysis	   in	   this	   manner	   should	   avoid	   any	   possible	   bias	  
towards	   identification	  of	  an	  active	  component,	  particularly	  as	  neutrophils	  are	  known	  
to	   display	   some	   directionality	   over	   short	   distances	   due	   to	   their	   inherent	   behaviour	  
(Guyader	  et	  al.,	  2008).	   In	  addition,	  differences	   in	   the	  size	  and	   location	  of	   the	  wound	  
may	  dictate	  the	  nature	  of	  the	  neutrophil	  migration	  dynamics.	  	  
	  
In	   order	   to	   determine	   whether	   the	   neutrophil	   reverse	   migration	   occurring	   in	   the	  
presence	  of	  tanshinone	  IIA	  was	  characteristic	  of	  an	  active	  or	  passive	  process,	  the	  data	  
were	   analysed	   by	   Geoffrey	   Holmes	   from	   the	   Automatic	   Control	   and	   Systems	  
Engineering	   department	   at	   the	   University	   of	   Sheffield,	   using	   dynamic	   modelling	  
techniques	   previously	   described	   in	   (Holmes,	   Anderson,	   et	   al.,	   2012).	   This	   analysis	  
indicated	   that	   under	   both	   control	   and	   tanshinone	   IIA	   treated	   conditions,	   neutrophil	  
reverse	  migration	  during	  inflammation	  resolution	  was	  most	  accurately	  described	  by	  a	  
pure-­‐diffusion	  model,	  without	   the	   influence	   of	   an	   attractive	   or	   repulsive	   chemokine	  
gradient.	  Analysis	  of	   the	  mean	  squared	  distance	  from	  the	  wound	   indicated	  that	  over	  
time,	   neutrophils	  moved	   further	   away	   in	   tanshinone	   IIA	   treated	   larvae	   compared	   to	  
the	  controls,	  in	  support	  of	  the	  data	  obtained	  by	  quantification	  of	  neutrophil	  number	  in	  
the	   region	   away	   from	   the	   wound.	   This	   was	   reflected	   in	   the	   increased	   neutrophil	  
diffusivity	   measured	   in	   the	   presence	   of	   tanshinone	   IIA.	   Interestingly,	   the	   enhanced	  
reverse	  migration	  observed	  in	  tanshinone	  IIA	  treated	  larvae	  could	  not	  be	  explained	  by	  
an	   increase	   in	   neutrophil	   speed,	   suggesting	   that	   an	   alternative	   mechanism	   was	  
involved,	  such	  as	  a	  change	  in	  directional	  preference.	  	  
5.7.5	  How	  does	  tanshinone	  IIA	  promote	  neutrophil	  reverse	  migration?	  
Reverse	   migrated	   neutrophils	   are	   reported	   to	   have	   a	   unique	   cell	   surface	   receptor	  
phenotype,	   which	   includes	   down-­‐regulation	   of	   the	   key	   chemokine	   receptors	   CXCR1	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and	  CXCR2	  (Buckley	  et	  al.,	  2006).	  Based	  on	  this	  evidence,	  along	  with	  the	  observation	  
that	   tanshinone	   IIA	  caused	  an	   increase	   in	   the	  passive	  redistribution	  of	  neutrophils,	   it	  
was	  hypothesised	  that	  this	  compound	  might	  cause	  down-­‐regulation	  of	  these	  receptors	  
to	  limit	  the	  gradient	  sensing	  capacity	  of	  neutrophils.	  	  
	  
In	  the	  initial	  flow	  cytometry	  experiments,	  no	  effect	  on	  the	  basal	  surface	  expression	  of	  
CXCR1	  or	  CXCR2	  was	  found	  in	  freshly	  isolated	  neutrophils	  treated	  with	  tanshinone	  IIA.	  
Although	   it	  was	  possible	  that	  this	  was	  due	  to	   issues	  relating	  to	  dosing	  or	  duration	  of	  
treatment,	   it	   was	   more	   accurate	   to	   investigate	   the	   effect	   of	   the	   compound	   on	  
neutrophils	   stimulated	   with	   the	   CXCR	   ligand	   IL-­‐8,	   this	   being	   more	   relevant	   to	  
physiological	  conditions.	  However,	  even	  following	  IL-­‐8	  stimulation,	  no	  effect	  was	  seen	  
on	   either	   CXCR1	   or	   CXCR2	   internalisation,	   or	   receptor	   recycling,	   in	   the	   presence	   of	  
tanshinone	   IIA.	  There	  did	  appear	   to	  be	  a	  small	   shift	   towards	   lower	  expression	   in	   the	  
internalisation	  curve	  for	  CXCR1	  from	  neutrophils	  treated	  with	  tanshinone	  IIA,	  however	  
this	  was	  not	  significant	  and	  as	  there	  was	  no	  effect	  on	  receptor	  recycling,	  it	  was	  unlikely	  
that	  this	  was	  a	  real	  effect.	  	  
	  
The	   effect	   of	   tanshinone	   IIA	   on	   CXCR2	  was	   also	   investigated	   in	   vivo,	   as	   although	  no	  
effect	  was	  observed	  in	  vitro,	  it	  could	  not	  be	  determined	  from	  these	  assays	  whether	  the	  
compound	   was	   affecting	   intracellular	   signalling	   downstream	   of	   ligand-­‐receptor	  
binding.	   CXCR2	   was	   prioritised,	   as	   it	   is	   believed	   to	   play	   a	   more	   significant	   role	   in	  
neutrophil	   recruitment	   than	   CXCR1	   (Chuntharapai	   et	   al.,	   1995;	   Nasser	   et	   al.,	   2009).	  
Recently,	   a	   putative	   zebrafish	   homologue	   of	   IL-­‐8,	   zCxcl8,	   has	   been	   identified	   in	  
zebrafish	   and	   has	   been	   shown	   to	   mediate	   both	   neutrophil	   recruitment	   and,	   most	  
interestingly,	   neutrophil	   retention	   (Sarris	   et	   al.,	   2012).	   This	   study	   indicated	   that	   the	  
interaction	   of	   zCxcl8	   with	   extracellular	   heparan	   sulphate	   proteoglycans	   (HSPGs)	  
formed	  tissue	  localised	  chemokine	  gradients	  that	  restricted	  leukocyte	  motility	  at	  sites	  
of	   infection.	   This	   effect	   was	   lost	   when	   the	   interaction	   was	   impaired	   using	   either	   a	  
mutant	   zCxcl8	   that	   was	   unable	   to	   bind	   to	   HSPGs	   or	   by	   injection	   of	   heparinase	   to	  
degrade	   the	   extracellular	  matrix.	   A	   second	   zebrafish	  Cxcl8	   gene	   has	   been	   identified	  
and	  both	  ligands	  have	  been	  shown	  to	  be	  important	  for	  neutrophil	  recruitment	  to	  the	  




wound	   (de	  Oliveira	   et	   al.,	   2013).	  Using	   the	   human	  CXCR2	   antagonist	   SB225002,	   this	  
study	   also	   demonstrated	   that	   neutrophil	   recruitment	   to	   a	   wound	   was	  mediated	   by	  
zebrafish	   Cxcr2.	   If	   there	   were	   a	   high	   zCxcl8	   gradient	   at	   the	   site	   of	   inflammation,	  
promoting	   neutrophil	   retention,	   then	   this	   would	   fit	   with	   my	   hypothesis	   that	  
tanshinone	   IIA	   reduces	   the	   ability	   of	   neutrophils	   to	   respond	   to	   this	   gradient,	  
potentially	  via	  an	  inhibition	  of	  Cxcr2	  signalling.	  However,	  I	  was	  unable	  to	  replicate	  the	  
effect	   of	   tanshinone	   IIA	   using	   SB225002,	   suggesting	   that	   inhibition	   of	   Cxcl8-­‐Cxcr2	  
signalling	   was	   not	   sufficient	   to	   promote	   neutrophil	   reverse	   migration	   during	  
resolution.	  It	  could	  be	  that	  the	  concentration	  of	  SB225002	  used	  in	  these	  experiments	  
was	  too	  low	  to	  produce	  an	  effect	  and	  more	  thorough	  dosing	  to	  establish	  the	  optimum	  
concentration	   required	   for	   Cxcr2	   inhibition	   during	   both	   recruitment	   and	   resolution	  
might	  be	  valuable.	  Some	  toxicity	  was	  observed	  with	  this	  compound	  at	  higher	  doses,	  so	  
care	  must	  be	  taken	  to	  ensure	  that	  effects	  on	  neutrophil	  number	  are	  not	  simply	  due	  to	  
increased	  and	  non-­‐specific	  cell	  death.	  	  
	  
Although	   Cxcr2	   is	   believed	   to	   be	   the	   predominant	   receptor	   mediating	   neutrophil	  
recruitment	  in	  zebrafish	  (Sarris	  et	  al.,	  2012;	  Deng	  et	  al.,	  2013;	  de	  Oliveira	  et	  al.,	  2013),	  
in	   the	   presence	   of	   SB225002,	   signalling	   will	   still	   be	   occurring	   via	   the	   interaction	   of	  
Cxcl8	   with	   Cxcr1.	   The	   association	   between	   CXCR1	   and	   CXCR2	   is	   complex;	   receptor	  
cross-­‐talk	  exists	  and	  ligand-­‐binding	  to	  either	  receptor	  can	  influence	  the	  internalisation	  
of	   the	   other	   by	   heterologous	   desensitisation	   (Stillie	   et	   al.,	   2009).	   It	   has	   also	   been	  
proposed	   that	   the	   high	   level	   of	   IL-­‐8	   at	   sites	   of	   inflammation	   promotes	   global	  
inactivation	  and	  internalisation	  of	  CXCR1	  and	  CXCR2,	  which	  functions	  as	  a	  stop	  signal	  
for	  human	  neutrophils	  (Rose	  et	  al.,	  2004).	  It	  is	  possible	  that	  the	  downstream	  signalling	  
pathways	  mediated	  by	   IL-­‐8	  are	  differentially	   regulated	  during	  neutrophil	   recruitment	  
and	  retention.	  For	  example,	  perhaps	  PI-­‐3K	  signalling	  is	  predominantly	  activated	  during	  
neutrophil	   recruitment,	   but	   a	   different	   pathway	   is	   activated	   to	   promote	   neutrophil	  
retention.	   Under	   normal	   conditions	   in	   which	   the	   inflammatory	   response	   resolves,	  
there	   must	   be	   a	   switch	   in	   chemokine	   signalling	   or	   a	   gradual	   loss	   of	   the	   retention	  
gradient,	  permitting	  neutrophils	  to	  migrate	  away.	  Whether	  tanshinone	  IIA	  is	  acting	  on	  
a	  component	  of	  this	  signalling	  cascade	  in	  order	  to	  accelerate	  the	  process,	  or	  whether	  
an	  entirely	  different	  chemokine	  receptor	  pathway	   is	  being	  affected,	  remains	  unclear.	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Perhaps	  signalling	  downstream	  of	  end-­‐target	  chemoattractants	  such	  as	  fMLP	  and	  C5a	  
(Heit	  et	  al.,	  2002)	  is	  more	  likely	  to	  mediate	  neutrophil	  retention.	  
5.7.6	  Does	  preliminary	  evidence	  suggest	  that	  tanshinone	  IIA	  affects	  the	  CXCR4-­‐SDF-­‐1	  
signalling	  pathway?	  
It	   is	  believed	  that	  under	  certain	   inflammatory	  conditions,	  neutrophils	  may	  alter	   their	  
chemokine	   receptor	   expression	   phenotype	   (Johnston	   et	   al.,	   1999;	   Yamashiro	   et	   al.,	  
2001).	  In	  particular,	  up-­‐regulation	  of	  CXCR4	  has	  been	  reported	  in	  chronic	  inflammatory	  
disease	   patients	   (Brühl	   et	   al.,	   2001;	   Hartl	   et	   al.,	   2008).	   As	   the	   interaction	   between	  
CXCR4	  and	  its	  ligand,	  SDF-­‐1,	  functions	  as	  a	  retention	  signal	  for	  neutrophils	  in	  the	  bone	  
marrow	   (Devine	   et	   al.,	   2008),	   I	   hypothesised	   that	   a	   similar	   mechanism	   might	   be	  
important	   for	   neutrophil	   retention	   at	   sites	   of	   inflammation	   and	   that	   tanshinone	   IIA	  
might	  disrupt	  this	  signalling	  axis.	  	  
	  
I	   first	   explored	   the	   effect	   of	   Cxcr4	   inhibition	   in	   vivo	   using	   AMD3100,	   a	   mammalian	  
CXCR4	  antagonist	  that	  has	  been	  shown	  to	  induce	  neutrophil	  mobilisation	  in	  both	  mice	  
and	   humans	   (Liles	   et	   al.,	   2003;	   Broxmeyer	   et	   al.,	   2005).	   Data	   obtained	   from	   both	  
recruitment	   and	   resolution	   assays	   suggested	   that	   Cxcr4	   inhibition	   did	   not	   prevent	  
neutrophil	  retention	  at	  the	  wound.	  In	  fact,	  in	  both	  assays	  there	  appeared	  to	  be	  higher	  
numbers	  of	  neutrophils	  at	  the	  site	  of	  injury	  with	  increasing	  dose	  of	  AMD3100.	  Cxcr4-­‐
Sdf-­‐1	  signalling	  has	  been	  shown	  to	  retain	  neutrophils	  in	  the	  CHT	  in	  zebrafish	  (Walters	  
et	   al.,	   2010),	   thus	   inhibition	   of	   this	   retention	   signal	   to	   augment	   neutrophil	   release	  
might	   explain	   the	   increase	   in	   neutrophil	   number	   observed	   at	   the	   wound	   in	   the	  
presence	  of	  AMD3100.	  It	  could	  be	  that	  a	  Cxcr4-­‐Sdf-­‐1	  axis	  does	  exist	  at	  the	  wound,	  but	  
perhaps	   the	   dose	   of	   inhibitor	   used	   was	   not	   sufficient	   to	   overcome	   the	   excess	   of	  
neutrophil	   release	   from	   the	   CHT	   and	   cause	   a	   detectable	   effect	   on	   inflammation	  
resolution.	   Thorough	   dosing	   and	   reverse	  migration	   assays	   need	   to	   be	   performed	   to	  
establish	  whether	   or	   not	   there	   is	   any	   effect.	   Interestingly,	   Cxcl8-­‐Cxcr2	   signalling	   has	  
recently	   been	   shown	   to	   play	   an	   important	   role	   in	   neutrophil	   recruitment	   and	  
mobilisation	   from	   the	   CHT	   in	   response	   to	   infection	   (Deng	   et	   al.,	   2013).	   This	   may	  
indicate	  that	  Cxcr4	  and	  Cxcr2	  signal	   in	  an	  antagonistic	  manner	  to	  regulate	  neutrophil	  




In	  contrast	  to	  my	  hypothesis	  that	  tanshinone	  IIA	  might	  reduce	  an	  Sdf-­‐1	  gradient	  at	  the	  
wound,	  preliminary	  data	  obtained	  by	  WISH	  suggested	  that	  there	  were	  actually	  higher	  
levels	  of	  sdf-­‐1a	  expression	  at	  the	  site	  of	  injury	  in	  the	  presence	  of	  tanshinone	  IIA.	  This	  
assay	   needs	   to	   be	   repeated,	   with	   the	   appropriate	   sense	   probe	   control,	   in	   order	   to	  
confirm	  the	  observation.	  It	  would	  be	  useful	  to	  fully	  characterise	  the	  gradient	  of	  sdf-­‐1a	  
expression	  during	  both	  the	  recruitment	  and	  resolution	  phases	  of	  inflammation.	  Some	  
evidence	   suggests	   that	   neutrophils	   can	   be	   repelled	   by	   high	   levels	   of	   chemokines,	  
including	   IL-­‐8	   (Tharp	   et	   al.,	   2006).	   It	   could	   be	   hypothesised	   that	   tanshinone	   IIA	  
increases	   the	   level	   of	   Sdf-­‐1a	   and	   this	   acts	   as	   a	   chemorepellent	   to	   drive	   neutrophils	  
away	   from	   the	   wound,	   although	   this	   would	   not	   correlate	   with	   the	   mathematical	  
modelling	   data.	   Interestingly,	   high	   levels	   of	   SDF-­‐1	   have	   been	   shown	   to	   repel	   T	   cells	  
(Poznansky	  et	  al.,	  2000).	  WISH	  could	  also	  be	  performed	  to	  investigate	  the	  expression	  
of	   cxcr4b	   in	   injured	   zebrafish	   larvae,	   although	   the	   technique	   may	   not	   be	   sensitive	  
enough	  to	  detect	  changes	  in	  its	  expression	  specifically	  on	  neutrophils.	  	  
	  
Preliminary	   in	   vitro	   experiments	   performed	   on	   freshly	   isolated	   human	   neutrophils	  
revealed	   that	   tanshinone	   IIA	   might	   prevent	   internalisation	   of	   CXCR4	   in	   response	   to	  
SDF-­‐1α	  stimulation.	  However,	  care	  needs	  to	  be	  taken	  when	  interpreting	  these	  data,	  as	  
CXCR4	  is	  known	  to	  be	  up-­‐regulated	  in	  neutrophils	  when	  they	  become	  apoptotic	  (Hartl	  
et	  al.,	  2008;	  Rankin,	  2010).	  It	  is	  possible	  that	  the	  lack	  of	  CXCR4	  internalisation	  observed	  
here	   is	   simply	   due	   to	   a	   higher	   level	   of	   surface	   expression	   on	   tanshinone	   IIA	   treated	  
neutrophils	   compared	   to	   the	   controls,	   as	  my	   data	   indicate	   that	   tanshinone	   IIA	   does	  
cause	   an	   increase	   in	   neutrophil	   apoptosis.	   Repeating	   these	   experiments	   in	   the	  
presence	   of	   a	   caspase	   inhibitor	   might	   help	   to	   determine	   whether	   the	   reduced	  
internalisation	  of	  CXCR4	  is	  occurring	  independently	  of	  apoptosis.	  	  
5.7.7	  Conclusions	  
Tanshinone	   IIA	   was	   identified	   as	   a	   potent	   pro-­‐resolution	   compound	   and	   its	   effects	  
have	  been	  investigated	  in	  both	  zebrafish	  and	  isolated	  human	  neutrophils.	  It	  promotes	  
neutrophil	   apoptosis	   both	   in	   vitro	   and	   in	   vivo,	   but	   also	   drives	   resolution	   in	   vivo	   by	  
enhancing	   the	   reverse	   migration	   of	   neutrophils	   away	   from	   a	   site	   of	   inflammation.	  
Currently,	   no	   other	   pharmacological	   agents	   have	   been	   reported	   to	   function	   via	   this	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mechanism.	   Importantly,	   the	   effects	   of	   tanshinone	   IIA	   on	   both	   neutrophil	   apoptosis	  
and	  reverse	  migration	  appear	  to	  be	  maintained	  in	  the	  presence	  of	  survival	  factors	  that	  
are	  expressed	  at	  sites	  of	   inflammation.	  It	  has	  been	  established	  by	  dynamic	  modelling	  
techniques	  that	   in	  zebrafish,	  reverse	  migration	  occurs	  as	  a	  passive	  rather	  than	  active	  
process,	  to	  clear	  neutrophils	  from	  the	  wound.	  Tanshinone	  IIA	  accelerates	  this,	  which	  I	  
hypothesise	   is	   due	   to	   a	   reduction	   in	   the	   chemokine	   gradient	   sensing	   ability	   of	   the	  
neutrophils.	  This	  does	  not	  appear	  to	  be	  CXCR1-­‐	  or	  CXCR2-­‐dependent.	  	  
	  
Although	   the	   precise	   mechanistic	   activity	   of	   tanshinone	   IIA	   has	   not	   been	   fully	  
determined,	   the	   identification	   of	   this	   compound	   has	   provided	   some	   insight	   into	   the	  
nature	   of	   reverse	   migration	   in	   zebrafish,	   showing	   that	   it	   is	   possible	   to	  
pharmacologically	   manipulate	   this	   process	   to	   promote	   inflammation	   resolution.	  
Tanshinone	   IIA	   may	   provide	   a	   useful	   tool	   for	   further	   dissection	   of	   the	   molecular	  
pathways	   involved.	   The	   preliminary	   data	   suggest	   that	   tanshinone	   IIA	   may	   disrupt	  
CXCR4-­‐SDF-­‐1	  signalling,	  although	  further	  experimentation	   is	  needed	  to	   fully	  establish	  








Chapter	  6:	  Final	  Discussion	  and	  Future	  Work	  
	  
The	   resolution	  of	   inflammation	   is	  an	  active	  and	   regulated	  process,	  which	   is	  essential	  
for	   maintaining	   normal	   homeostasis.	   A	   prerequisite	   for	   successful	   inflammation	  
resolution	  is	  the	  clearance	  of	  extravasated	  neutrophils,	  key	  inflammatory	  granulocytes	  
that	   are	   equipped	   with	   an	   array	   of	   anti-­‐microbial	   mediators	   to	   eliminate	   infectious	  
agents	   at	   sites	   of	   inflammation.	   Neutrophils	   are	   highly	   specialised	   for	   host	   defence,	  
but	  their	  powerful	  effector	  functions	  are	  not	  specific	  to	  invading	  pathogens	  and	  have	  
the	   potential	   to	   cause	   extensive	   damage	   to	   host	   cells.	   If	   the	  mechanisms	   governing	  
inflammation	   resolution	   are	   not	   precisely	   regulated,	   persistent	   neutrophilic	  
inflammation	   may	   ensue	   and	   this	   can	   lead	   to	   extensive	   host	   tissue	   damage,	   which	  
contributes	   to	   the	   pathogenesis	   of	   many	   chronic	   inflammatory	   diseases.	   Current	  
treatments	  are	  unable	  to	  resolve	  existing	  inflammation.	  Therefore,	  there	  is	  a	  demand	  
for	  novel	   therapies	   that	   specifically	   target	  neutrophil	   clearance	  mechanisms	   to	  drive	  
inflammation	   resolution.	  High-­‐throughput	   screening	  of	  diverse	  compound	  collections	  
is	   an	   approach	   towards	   the	   discovery	   of	   new	   lead	   compounds	   that	   might	   provide	  
therapeutic	   benefit.	   The	   zebrafish	   model	   is	   ideal	   for	   research	   such	   as	   this,	   filling	   a	  
niche	  between	  in	  vitro	  cell	  based	  studies	  and	  mammalian	  disease	  models,	  which	  would	  
be	   inappropriate	   for	   the	   testing	  of	   large	  numbers	  of	   compounds.	   It	   is	   comparatively	  
simple	   to	   perform	   phenotypic-­‐based	   assays	   on	   zebrafish	   larvae,	   enabling	   the	   rapid,	  
straightforward	  and	  unbiased	   identification	  of	  potential	   lead	  compounds	   that	   induce	  
the	  desired	  effect.	  
6.1	  An	  in	  vivo	  screen	  for	  accelerators	  of	  inflammation	  resolution	  
Using	  a	  zebrafish	  model	  of	  acute	  resolving	  inflammation,	  I	  designed	  a	  screening	  assay	  
with	   the	  aim	  to	   identify	  compounds	   that	  could	  drive	   the	   resolution	  of	   inflammation.	  
This	  approach	  was	  based	  on	  the	  output	  of	  a	  preliminary	  screen,	  which	  illustrated	  the	  
potential	   of	   this	   model	   to	   discover	   novel	   candidate	   compounds	   for	   inflammatory	  
disease	  therapy	  (Loynes	  et	  al.,	  2009).	  To	  date,	  one	  other	  inflammation	  based	  zebrafish	  
drug	  screen	  has	  been	  published,	  the	  chemically-­‐induced	  inflammation	  assay,	  in	  which	  
copper	  sulphate	  is	  used	  to	  cause	  oxidative	  stress	  and	  selective	  damage	  to	  sensory	  hair	  
cells	  within	  neuromasts	  of	  the	  lateral	  line	  (d’Alençon	  et	  al.,	  2010).	  Although	  this	  model	  
has	   provided	   some	   promising	   results	   in	   terms	   of	   the	   identification	   of	   anti-­‐
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inflammatory	  compounds	  that	  may	  inhibit	  neutrophil	  recruitment,	  there	  remained	  the	  
need	   to	   perform	   a	  more	   focused	   drug	   screen	   in	   order	   to	   identify	   agents	   that	   acted	  
predominantly	  on	  the	  resolution	  phase	  of	  inflammation.	  	  
	  
The	   drug	   screen	   performed	   here	   was	   optimised	   according	   to	  multiple	   experimental	  
variables,	   including	  the	  method	  of	  embryo	  generation,	  age	  of	   larvae,	   temperature	  of	  
incubation	   and	   time	  point	   of	   final	   screening	   for	   positive	  hit	   identification.	   The	   assay	  
was	   partially	   automated	   using	   the	   Phenosight	   High-­‐Content	   plate	   reader,	   which	  
enabled	  rapid	  data	  collection	  and	  analysis	  by	  manual	  scoring	  of	  the	  images	  generated.	  
The	   screening	   assay	   may	   have	   benefited	   from	   the	   implementation	   of	   automated	  
analysis	  software	  to	  validate	  the	  results.	  However,	  the	  test	  screen	  performed	  using	  the	  
Merlion	   compound	   collection	   indicated	   that	   the	   manual	   scoring	   technique	   was	  
sufficient	   to	   identify	   positive	   hits,	   based	   on	   comparison	   with	   a	   trial	   version	   of	  
automated	   analysis	   software.	   Screening	   of	   the	   Spectrum	   Collection	   identified	   21	  
compounds	   that	   reproducibly	   promoted	   inflammation	   resolution	   in	   vivo	   and	   all	   of	  
those	  that	  were	  selected	  for	  further	  testing	  significantly	  reduced	  neutrophil	  numbers	  
in	   the	   resolution	   assay,	   supporting	   the	   robustness	   of	   the	   screening	   assay	   to	   identify	  
drivers	   of	   inflammation	   resolution.	   The	   functionality	   of	   the	   screen	   was	   illustrated	  
further	   by	   cluster	   analysis	   of	   the	   hit	   compounds	   with	   a	   collection	   of	   known	   anti-­‐
inflammatory	  compounds	  provided	  by	  a	  collaboration	  with	  GSK,	  based	  on	  their	  activity	  
in	   the	  secondary	  assays.	  This	   revealed	  that	   the	  majority	  of	   the	  hits	   formed	  a	  distinct	  
cluster	   separate	   to	   almost	   all	   of	   the	   known	   compounds,	   due	   to	   their	   primarily	   pro-­‐
resolution	  and	  minor	  anti-­‐recruitment	  activity;	  the	  desired	  effects	  for	  lead	  compounds	  
from	  which	  to	  design	  novel	  inflammatory	  disease	  therapies.	  Despite	  their	  effectiveness	  
in	  the	  zebrafish	  model	  however,	  it	  must	  be	  appreciated	  that	  this	  does	  not	  necessarily	  
directly	  translate	  to	  effectiveness	  in	  mammalian	  models	  and	  human	  disease,	  in	  which	  
different	   mechanisms	   may	   be	   important	   for	   regulating	   inflammation	   resolution.	  
Testing	   of	   the	   most	   promising	   compounds	   in	   mammalian	   models	   of	   inflammatory	  




6.2	  An	  in	  vivo	  assay	  to	  measure	  PI-­‐3K	  activity	  
From	   the	   hierarchical	   cluster	   analysis	   performed	   in	   Chapter	   3,	   I	   was	   able	   to	  
hypothesise	   that	   the	   hit	   compound	   isopimpinellin	   acted	   via	   an	   inhibition	   of	   PI-­‐3K	  
activity.	   This	   prompted	   the	   development	   of	   an	   in	   vivo	   assay	   to	   investigate	   PI-­‐3K	   in	  
neutrophils	  during	   the	  recruitment	  phase	  of	   inflammation.	  Using	  simple	   imaging	  and	  
analysis	   techniques,	   I	   designed	   a	   method	   to	   assess	   the	   polarity	   of	   migrating	  
neutrophils	  in	  lyz/PHAkt	  larvae,	  comparable	  to	  published	  techniques	  (Yoo	  et	  al.,	  2010).	  
Activation	  of	  PI-­‐3K	  triggers	  translocation	  of	  PHAkt-­‐EGFP	  to	  the	  plasma	  membrane	  and	  
formation	  of	   the	   leading	  edge	   to	  enable	   cell	   polarisation	  and	  directional	  movement,	  
which	   can	   be	   observed	   in	   vivo.	   My	   assay	   accurately	   identified	   a	   loss	   of	   neutrophil	  
polarity	   induced	   by	   the	   PI-­‐3K	   inhibitor,	   LY294002.	   This	   effect	   was	   replicated	   in	   the	  
presence	  of	  isopimpinellin,	  suggesting	  that	  the	  inhibitory	  activity	  of	  this	  compound	  on	  
neutrophil	   recruitment	   is	  at	   least	   in	  part	  due	   to	  blockade	  of	  PI-­‐3K	   signalling.	   Further	  
work	  would	  be	  required	  to	   investigate	  whether	   isopimpinellin	  acts	  specifically	  on	  the	  
PI-­‐3K	  pathway,	  or	  whether	  other	  key	  neutrophil	  recruitment	  pathways,	  such	  as	  MAPK	  
signalling,	  are	  also	  affected.	  	  
6.3	   Did	   the	   screen	   identify	   a	   common	   chemical	   structure	   that	   is	   responsible	   for	  
driving	  inflammation	  resolution?	  
Chemical	  structure	  comparison	  revealed	  that	  a	  number	  of	  the	  positive	  hits	  identified	  in	  
the	   screen	   contained	  a	  1,4-­‐benzopyrone	  group,	   commonly	   referred	   to	  as	   chromone.	  
To	  investigate	  the	  relevance	  of	  this,	  I	  tested	  chromone	  alone	  in	  each	  of	  the	  secondary	  
assays,	  which	   indicated	   that	   this	   structure	  might	   play	   a	   role	   in	   driving	   inflammation	  
resolution,	   without	   affecting	   neutrophil	   recruitment	   or	   total	   neutrophil	   number.	   A	  
series	   of	   chromone	   analogues	  were	   synthesised	   and	   tested,	  with	   varying	   degrees	   of	  
activity,	  however	  due	  to	  issues	  with	  the	  instability	  of	  these	  compounds,	  I	  was	  unsure	  
of	  their	  reliability	  and	  indeed	  usefulness	  in	  terms	  of	  drug	  development.	  The	  realisation	  
that	   a	   number	   of	   chromone-­‐derived	   drugs	   are	   used	   in	   clinical	   practice	   as	  mast	   cell	  
stabilisers	   prompted	   further	   investigation	   into	   the	   activity	   of	   these	   compounds,	   as	  
their	   anti-­‐inflammatory	   is	   only	   partially	   defined	   (Yazid,	   Leoni,	   et	   al.,	   2010).	  
Interestingly,	   I	  had	  discovered	  that	   isopimpinellin	  was	  a	  potent	   inducer	  of	  neutrophil	  
apoptosis	   in	   vivo	   and	   I	   hypothesised	   that	   this	  might	   be	   a	  mechanism	   to	   explain	   the	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anti-­‐inflammatory	   potential	   of	   the	   currently	   available	   cromones.	   In	   support	   of	   this	  
hypothesis,	   there	   is	  evidence	  to	  suggest	   that	   these	  drugs	  promote	  release	  of	  Anx-­‐A1	  
by	   directly	   inhibiting	   PP2A	   (Yazid,	   Leoni,	   et	   al.,	   2010),	   a	   phosphatase	   that	   has	   been	  
associated	  with	   the	  destabilisation	  of	  Mcl-­‐1	  and	  acceleration	  of	  neutrophil	  apoptosis	  
(Derouet	  et	  al.,	  2004).	  	  
	  
However,	   on	   testing	   of	   chromone	   derivatives	   including	   disodium	   cromoglycate,	  
nedocromil	   and	   isopimpinellin	   on	   human	   neutrophils	   in	   vitro,	   I	   found	   no	   effect	   on	  
either	   constitutive	   apoptosis	   or	   survival	   induced	   by	   GM-­‐CSF	   or	   dexamethasone.	  
Surprisingly,	   in	   contrast	   to	   my	   original	   hypothesis,	   I	   found	   that	   another	   chromone-­‐
derived	  hit	  compound,	  methylquercetin,	  appeared	  to	  promote	  neutrophil	  survival.	  This	  
disputes	   published	   evidence	   that	   reports	   an	   acceleration	   of	   neutrophil	   apoptosis	   by	  
similar	   flavones	   (Lucas	   et	   al.,	   2012).	   It	   is	   highly	   likely	   that	   the	   addition	   of	   different	  
structural	   groups	   onto	   the	   chromone	   backbone	   influences	   the	   function	   of	   each	  
compound,	   which	   may,	   perhaps	   in	   combination	   with	   variations	   in	   dosing	   or	  
experimental	  technique,	  explain	  the	  differences	  observed.	  	  
	  
The	  research	  presented	  here	  does	  not	  provide	  conclusive	  evidence	  that	  the	  presence	  
of	   the	   chromone	   group	   is	   responsible	   for	   the	   pro-­‐resolution	   activity	   of	   the	   hits	  
identified.	  It	  does	  however	  raise	  some	  interesting	  questions	  relating	  to	  the	  role	  of	  Anx-­‐
A1	   in	   neutrophil	   apoptosis.	   Although	   I	   did	   not	   observe	   an	   increase	   in	   neutrophil	  
apoptosis	   in	  vitro	   in	  the	  presence	  of	  the	  chromone	  derivatives	  tested,	  some	  of	  these	  
did	  appear	  to	  promote	  inflammation	  resolution	   in	  vivo.	  This	  might	  suggest	  that	  some	  
necessary	   stimulus	   or	   cell	   type	   was	   missing	   from	   the	   in	   vitro	   system.	   A	   potential	  
candidate	   is	   the	   macrophage,	   in	   which	   the	   release	   of	   Anx-­‐A1	   has	   been	   shown	   to	  
enhance	  the	  phagocytic	  uptake	  of	  apoptotic	  neutrophils	  (Scannell	  et	  al.,	  2007).	  Further	  
studies	  could	  be	  performed	  in	  zebrafish	  following	  macrophage	  ablation,	  to	  investigate	  
whether	  the	  pro-­‐resolution	  effects	  of	  chromone	  derivatives	  such	  as	  isopimpinellin	  and	  
disodium	  cromoglycate	  are	  maintained	  in	  the	  absence	  of	  this	  cell	  type.	  It	  might	  also	  be	  
interesting	   to	   further	   explore	   the	   interaction	   between	   these	   compounds	   and	  
glucocorticoids,	   as	   the	   results	   obtained	   here	   were	   inconclusive.	   This	   may	   help	   to	  




6.4	  Tanshinone	  IIA	  as	  a	  potent	  inducer	  of	  inflammation	  resolution	  
Perhaps	   the	   most	   interesting	   finding	   from	   this	   project	   is	   the	   identification	   of	   a	  
compound	   that	   can	   drive	   inflammation	   resolution	   in	   vivo	   by	   increasing	   the	   reverse	  
migration	  of	  neutrophils	  away	  from	  the	  wound.	  There	  are	  currently	  no	  other	  published	  
reports	   to	  describe	   the	  pharmacological	  acceleration	  of	   this	  process,	  highlighting	   the	  
potential	   impact	   of	   this	   finding	   for	   research	   into	   the	   mechanisms	   governing	  
inflammation	   resolution.	   Tanshinone	   IIA	   might	   provide	   a	   useful	   tool	   to	   dissect	   the	  
currently	  unknown	  mechanisms	  involved	  in	  mediating	  neutrophil	  reverse	  migration.	  As	  
this	  compound	  has	  already	  been	  tested	  in	  multiple	  mammalian	  models	  of	  disease	  and	  
has	  even	  been	  used	  clinically	  without	  any	  reports	  of	  adverse	  effects	  (Zhou	  et	  al.,	  2005),	  
it	  represents	  a	  good	  candidate	  for	  inflammatory	  disease	  therapy.	  	  	  	  	  
	  
The	  pro-­‐resolution	  effect	  of	  tanshinone	   IIA	   is	   two-­‐fold.	  Not	  only	  does	  this	  compound	  
promote	  reverse	  migration	  but	  it	  also	  appears	  to	  induce	  neutrophil	  apoptosis	  both	   in	  
vitro	   and	   in	   vivo.	   Further	   work	   is	   required	   to	   determine	   the	   signalling	   pathway	   or	  
pathways	  that	  are	  affected.	  A	  potential	   target	  might	  be	  MAPK,	  as	  tanshinone	   IIA	  has	  
been	  reported	  to	  induce	  apoptosis	  in	  other	  cell	  types	  by	  the	  inhibition	  of	  this	  pathway	  
(Jiao	   &	   Wen,	   2011;	   Pan	   &	   Wang,	   2012).	   One	   of	   the	   most	   important	   properties	   of	  
tanshinone	  IIA	  is	  its	  ability	  to	  induce	  neutrophil	  apoptosis	  even	  in	  the	  presence	  of	  pro-­‐
survival	  stimuli,	  including	  GM-­‐CSF	  and	  hypoxia.	  This	  is	  key	  for	  a	  potential	  therapeutic,	  
which	   must	   be	   able	   to	   predominate	   persistent	   host	   survival	   signalling	   at	   sites	   of	  
chronic	   inflammation.	   The	   potential	   of	   tanshinone	   IIA	   to	   override	   pro-­‐inflammatory	  
stimuli	  is	  also	  reflected	  in	  vivo.	  The	  reverse	  migration	  of	  neutrophils	  away	  from	  the	  site	  
of	   injury	   is	   not	   only	   increased	   by	   tanshinone	   IIA	   during	   resolution	   of	   the	   acute	  
inflammatory	   response,	  but	   this	  effect	   is	  also	  maintained	   in	   the	  presence	  of	  hypoxia	  
signalling,	   induced	   by	   the	   injection	   of	   dominant-­‐active	   hif-­‐1αb	   RNA.	   Further	   work	  
could	   be	   performed	   to	   confirm	   this	   effect	   by	   testing	   tanshinone	   IIA	   in	   a	   stable	  
transgenic	  line	  expressing	  dominant-­‐active	  Hif-­‐1αb	  specifically	  in	  neutrophils.	  
	  
Whether	  tanshinone	  IIA	  can	  affect	  other	  immune	  cells,	  such	  as	  macrophages,	  has	  not	  
yet	   been	   investigated	   in	   vivo.	   There	   are	   reports	   that	   describe	   inhibition	   of	   MAPK	  
signalling	   in	  LPS-­‐treated	  RAW264.7	  cells	  by	  tanshinone	   IIA	  (Jeon	  et	  al.,	  2008;	  Tang	  et	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al.,	  2011),	   thus	   it	   is	  possible	   there	  may	  be	  an	   indirect	  effect	  on	  neutrophils	  due	   to	  a	  
change	   in	   macrophage	   function.	   Performing	   experiments	   to	   assess	   macrophage	  
numbers	  during	  inflammation	  in	  the	  presence	  of	  tanshinone	  IIA	  might	  be	  informative,	  
along	   with	   investigating	   whether	   the	   effect	   on	   reverse	   migration	   and	   apoptosis	   is	  
maintained	  following	  macrophage	  ablation.	  	  
6.5	  What	  has	  this	  research	  revealed	  about	  neutrophil	  reverse	  migration?	  
The	  work	  presented	  here	  has	  provided	  some	  insight	  into	  neutrophil	  reverse	  migration	  
and	  has	  identified	  some	  potentially	  interesting	  candidates	  that	  may	  be	  involved	  in	  the	  
regulation	  of	   this	   process.	   In	   accordance	  with	   published	  data	   (Holmes,	  Anderson,	   et	  
al.,	   2012),	   the	   results	   from	   the	   modelling	   analyses	   provide	   further	   evidence	   that	  
neutrophil	  reverse	  migration	   is	  a	  passive	  redistribution-­‐like	  process,	   in	  contrast	  to	  an	  
active	   fugetaxis.	   Tanshinone	   IIA	   appeared	   to	   enhance	   this	   activity,	   without	   the	  
introduction	  of	  an	  active,	  or	   ‘drift’	  component.	  As	  there	  was	  no	  change	  in	  neutrophil	  
speed	  compared	  to	  the	  controls,	  yet	  there	  was	  an	  increase	  in	  diffusivity,	  this	  strongly	  
indicated	  that	  tanshinone	  IIA	  alters	  the	  directional	  preference	  of	  neutrophils.	  This	  may	  
be	   related	   to	   a	   change	   in	   neutrophil	   chemokine	   receptor	   expression	   or	   function,	   or	  
changes	  in	  the	  extracellular	  chemokine	  gradients.	  The	  latter	  seems	  unlikely	  given	  that	  
neutrophil-­‐specific	  overexpression	  of	  dominant-­‐active	  hif-­‐1αb	  delays	  reverse	  migration	  
(Elks	   et	   al.,	   2011),	   however,	   it	   is	   possible	   that	   something	   much	   more	   complex	   is	  
occurring.	  Data	  obtained	  from	  the	  preliminary	  WISH	  experiments	  suggested	  that	  there	  
might	  be	  an	  up-­‐regulation	  in	  Sdf-­‐1a	  expression	  at	  the	  site	  of	  injury	  in	  zebrafish	  larvae	  
treated	   with	   tanshinone	   IIA.	   Further	   work	   is	   required	   to	   determine	   the	   role	   of	   the	  
Cxcr4-­‐Sdf-­‐1	  signalling	  axis	  in	  zebrafish	  during	  inflammation	  and	  the	  potential	  impact	  of	  
tanshinone	  IIA	  on	  this	  pathway.	  
	  
The	   investigation	   into	   the	   effect	   of	   tanshinone	   IIA	   on	   CXCR1	   and	   CXCR2	   expression	  
both	   in	   vitro	   and	   in	   vivo	   provided	   reasonably	   conclusive	   evidence	   that	   a	   down-­‐
regulation	   in	   surface	   expression	   of	   these	   receptors	   does	   not	   contribute	   to	   the	  
enhanced	   neutrophil	   reverse	  migration	   observed	   in	   the	   presence	   of	   tanshinone	   IIA.	  
However,	  it	  cannot	  be	  ruled	  out	  that	  this	  compound	  may	  affect	  intracellular	  signalling,	  




play	  a	  role	  in	  neutrophil	  retention	  at	  sites	  of	  inflammation	  (Sarris	  et	  al.,	  2012),	  thus	  it	  is	  
logical	  that	  Cxcr1	  or	  Cxcr2	  may	  be	  important	  for	  transducing	  this	  signal,	  however	  this	  
requires	  further	  investigation.	  	  	  
6.6	  What	  are	  the	  consequences	  of	  neutrophil	  reverse	  migration?	  
The	   clearance	   of	   neutrophils	   from	   sites	   of	   inflammation	   is	   required	   for	   successful	  
inflammation	   resolution.	   In	   zebrafish,	   neutrophil	   removal	   has	   been	   shown	   to	  
contribute	  to	  rapid	  and	  efficient	  tissue	  repair	  (Li	  et	  al.,	  2012;	  de	  Oliveira	  et	  al.,	  2013).	  It	  
seems	  likely	  that	  reverse	  migration	  is	  a	  pro-­‐resolution	  process	  and	  there	  is	  only	  limited	  
evidence	   to	   suggest	   that	   reverse	   migrated	   neutrophils	   may	   contribute	   to	   the	  
dissemination	   of	   inflammation	   in	   a	   pathophysiological	  manner	   (Buckley	   et	   al.,	   2006;	  
Woodfin	   et	   al.,	   2011).	   Research	   carried	   out	   in	   the	   Renshaw	   lab	   and	   by	   others	   has	  
indicated	  that	  zebrafish	  neutrophils	  can	  survive	  for	  prolonged	  periods,	  with	  a	  potential	  
half-­‐life	  of	  up	   to	  5	  days,	   and	   they	  do	  not	   appear	   to	   localise	   to	   specific	   tissues,	   even	  
after	  leaving	  a	  wound	  (Yoo	  and	  Huttenlocher,	  2011;	  Dixon	  et	  al.,	  2012).	  Further	  work	  is	  
required	   in	   order	   to	   establish	   the	   role	   of	   reverse	   migrated	   neutrophils	   and	   their	  
function	   and	   viability.	   An	   interesting	   way	   to	   investigate	   this	   would	   be	   to	   adapt	   the	  
reverse	   migration	   assay	   by	   inducing	   a	   second	   injury	   in	   zebrafish	   larvae	   after	   peak	  
inflammation,	  perhaps	  at	  a	  site	  anterior	  to	  the	  tail	   fin	  wound,	  to	  determine	  whether	  
neutrophils	  were	   able	   to	   reverse	  migrate	   away	   from	   the	   original	  wound	   and	   detect	  
and	  respond	  to	  the	  chemokine	  gradient	  at	  the	  second	  wound.	  It	  would	  be	  particularly	  
useful	   to	   investigate	   the	   effect	   of	   tanshinone	   IIA	   in	   this	   assay,	  which	  might	   provide	  
further	  clues	  towards	  its	  mechanism	  of	  action.	  
	  
In	  the	  reverse	  migration	  data	  presented	  here,	  the	  majority	  of	  neutrophils	  appeared	  to	  
preferentially	   migrate	   away	   from	   the	   wound	   through	   the	   tissues	   rather	   than	  
undergoing	   transendothelial	   reverse	  migration	  back	   into	   the	  blood	  vessels.	   This	   is	   in	  
contrast	   to	  mammalian	   systems,	   in	  which	   neutrophils	   are	   reported	   to	   return	   to	   the	  
vasculature	  (Woodfin	  et	  al.,	  2011).	  Thus,	  it	  is	  possible	  that	  there	  are	  limitations	  in	  the	  
use	   of	   zebrafish	   for	   investigating	   neutrophil	   reverse	   migration,	   as	   the	   molecular	  
mechanisms	  regulating	  this	  process	  in	  zebrafish	  may	  be	  different	  to	  those	  in	  mammals.	  
Likewise,	  there	  may	  be	  a	  distinct	  set	  of	  signalling	  pathways	  that	  are	  active	  in	  zebrafish	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at	   the	   larval	   stage	   but	   the	   function	   of	   which	   are	   not	  maintained	   in	   adulthood.	   The	  
effect	   of	   tanshinone	   IIA	   must	   be	   explored	   in	   mammalian	   systems	   to	   determine	  
whether	  its	  ability	  to	  accelerate	  neutrophil	  reverse	  migration	  is	  zebrafish	  specific,	  or	  if	  
this	  mechanism	  may	  have	  translatable	  therapeutic	  potential	  to	  promote	  inflammation	  
resolution	   in	   mammalian	   inflammatory	   disease	   models.	   This	   research	   is	   currently	  
underway.	  
	  
Despite	   being	   originally	   considered	   as	   a	   cell	   of	   the	   innate	   immune	   system,	   it	   is	  
becoming	   increasing	  evident	   that	  neutrophils	  may	   interact	  with	  cells	  of	   the	  adaptive	  
immune	  system	  and	  have	  the	  capacity	  to	  alter	  their	  functional	  response.	  For	  example,	  
neutrophils	  can	  release	  a	  host	  of	  DAMPs	  during	  inflammation	  or	  infection,	  which	  can	  
induce	   the	   proliferation	   and	  maturation	   of	   T	   cells	   and	   dendritic	   cells	   (Kumar	   et	   al.,	  
2010).	   Neutrophils	   have	   also	   been	   reported	   to	   act	   as	   antigen-­‐presenting	   cells	   and	  
migrate	  to	  lymph	  nodes	  following	  infection	  (Chtanova	  et	  al.,	  2008),	  thus	  it	   is	  possible	  
that	  reverse	  migration	  may	  in	  fact	  be	  a	  pro-­‐inflammatory	  mechanism	  that	  functions	  to	  
activate	   adaptive	   immune	   responses.	   Investigating	   the	   effect	   of	   tanshinone	   IIA	   on	  
neutrophil	  migration	  in	  mammalian	  models	  of	  inflammation	  will	  help	  to	  elucidate	  the	  
mechanisms	  and	  consequences	  of	  its	  activity.	  
	  
6.7	  Thesis	  summary	  
To	   summarise,	   in	   this	   thesis	   I	   have	   described	   the	   design,	   optimisation	   and	  
implementation	   of	   an	   inflammation	   drug	   screen	   performed	   in	   transgenic	   zebrafish	  
larvae.	  I	  aimed	  to	  screen	  a	  diverse	  compound	  collection	  with	  the	  hypothesis	  that	  novel	  
compounds	  with	  the	  ability	  to	  drive	   inflammation	  resolution	  would	  be	   identified.	  My	  
approach	   successfully	   detected	   21	   active	   compounds,	   acting	   via	   distinct	   anti-­‐
inflammatory	   and	   pro-­‐resolution	   mechanisms,	   and	   the	   techniques	   that	   I	   developed	  
have	   since	   been	   employed	   to	   screen	   large	   numbers	   of	   compounds	   within	   our	  
laboratory,	   generating	   some	   promising	   results.	   Hierarchical	   cluster	   analysis	   of	   these	  
compounds	  with	  known	  anti-­‐inflammatories	  enabled	  me	  to	  accurately	  predict	  that	  the	  
hit	  compound	  isopimpinellin	  inhibits	  PI-­‐3K	  activity	  during	  neutrophil	  recruitment.	  I	  also	  




inflammation.	   The	   most	   interesting	   of	   these,	   tanshinone	   IIA,	   induces	   apoptosis	   of	  
neutrophils	  both	   in	   vivo	   and	   in	   vitro,	   even	   in	   the	  presence	  of	   survival	   signals.	   It	   also	  
drives	   inflammation	   resolution	   in	   vivo	   by	   promoting	   neutrophil	   clearance	   from	   the	  
wound	  by	  reverse	  migration	  and	  this	  effect	   is	  maintained	   in	   the	  presence	  of	  survival	  
signalling.	  	  
	  
Much	   work	   is	   required	   to	   determine	   the	   mechanisms	   governing	   neutrophil	   reverse	  
migration	  and	  its	  importance	  in	  driving	  the	  resolution	  of	  inflammation.	  The	  zebrafish	  is	  
an	   ideal	   model	   for	   the	   study	   of	   this	   complex	   process	   and	   tanshinone	   IIA	  may	   be	   a	  
particular	   useful	   tool	   to	   dissect	   the	   mechanisms	   involved.	   Further	   investigation	   is	  
required	  in	  order	  to	  establish	  the	  precise	  chemotactic	  signals,	  inflammatory	  mediators	  
and	   signalling	   proteins	   that	   are	   important	   throughout	   the	   different	   phases	   of	   the	  
inflammatory	  response.	  Expanding	  our	  knowledge	  in	  this	  area	  of	  research	  will	  enable	  
the	   appropriate	   targeting	   of	   key	   components	   in	   neutrophils	   and	   advance	   the	  
development	  of	  more	  effective	  treatments	  for	  chronic	  inflammatory	  diseases.	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1.	  E3	  medium	  
	  
To	  make	  1	  L	  of	  60x	  E3	  stock:	   	   5	  mM	  NaCl	  
0.17	  mM	  KCl	  
0.33	  mM	  CaCl2	  
0.33	  mM	  MgSO4	  
dH2O	  up	  to	  1	  L	  
	  
To	  make	  1	  L	  of	  1x	  E3	  stock:	   	   16.6	  ml	  60x	  E3	  stock	  
	   	   	   	   	   1%	  methylene	  blue	  
dH2O	  up	  to	  1	  L	  
	  
In	  all	  cases,	  the	  60x	  E3	  stock	  was	  autoclaved	  prior	  to	  dilution	  and	  use	  in	  in	  vivo	  
inflammation	  assays,	  to	  avoid	  contamination.	  	  
	  
2.	  20x	  Saline	  sodium	  citrate	  buffer	  (SSC)	  
	  
To	  make	  200	  ml:	   35.06	  g	  NaCl	  
	   	   	   17.64	  g	  NaCitrate	  
dH2O	  up	  to	  200	  ml	  
pH7	  using	  citric	  acid	  
	  
3.	  Hybridisation	  wash	  buffer	  (HybWash)	  
	  
To	  make	  50	  ml:	   25	  ml	  50%	  formamide	  
	   	   	   12.5	  ml	  20x	  SSC	  
	   	   	   460	  μl	  citric	  acid	  
	   	   	   50	  μl	  Tween	  20	  
	   	   	   	   	  
4.	  Pre-­‐hybridisation	  buffer	  (PreHyb)	  
	  
As	  HybWash,	  with:	   50	  μg/ml	  heparin	  
	   	   	   500	  μg/ml	  tRNA	  
	  
5.	  Probe-­‐hybridisation	  buffer	  (ProbeHyb)	  
	  
As	  PreHyb,	  with:	   1:200	  dilution	  of	  probe	  in	  formamide	  
	  
6.	  Blocking	  solution	  
	  
PBT,	  with:	   	   2%	  sheep	  serum	  






7.	  Staining	  wash	  
	  
To	  make	  50	  ml:	   5	  ml	  100	  mM	  trisHCl	  (pH	  9.5)	  
	   	   	   2.5	  ml	  50	  mM	  MgCl2	  
	   	   	   5	  ml	  100	  mM	  NaCl	  
dH2O	  up	  to	  50	  ml	  
	  
8.	  Staining	  solution	  
	  
As	  staining	  wash,	  with:	   100	  mg/ml	  NBT	  
	   	   	   	   50	  mg/ml	  BCIP	  
	  
9.	  Fluorescence-­‐activated	  cell	  sorting	  (FACS)	  buffer	  1	  
	  
To	  make	  50	  ml:	   0.5	  ml	  1	  M	  HEPES	  
	   	   	   0.125	  g	  BSA	  
	   	   	   PBS	  up	  to	  50	  ml	  
	  
FACS	  buffer	  1	  was	  kept	  at	  4°C	  at	  all	  times.	  	  
	  
10.	  Fluorescence-­‐activated	  cell	  sorting	  (FACS)	  buffer	  2	  
	  
To	  make	  50	  ml:	   0.5	  ml	  1	  M	  HEPES	  
	   	   	   0.125	  g	  BSA	  
	   	   	   HBSS	  up	  to	  50	  ml	  
	  
FACS	  buffer	  2	  was	  kept	  at	  4°C	  at	  all	  times.	  	  
	  
	  












Appendix	   2:	   Antibiotic	   activity	   alone	   is	   not	   sufficient	   to	   drive	   inflammation	  
resolution	  in	  vivo.	  
	  
At	  3	  dpf,	  mpx:GFP	  larvae	  were	  injured	  and	  good	  responders	  were	  treated	  at	  6	  hpi	  with	  either	  the	  DMSO	  
vehicle	  control,	  30	  μM	  SP600125,	  penicillin	  streptomycin	  at	  a	   final	  concentration	  of	  50	  U/ml	  penicillin	  
and	   50	   μg/ml	   streptomycin	   (P/S),	   10	   μM	   erythromycin	   estolate	   (EE)	   or	   P/S	   and	   EE	   in	   combination.	  
Neutrophil	  numbers	  at	  the	  site	  of	  injury	  were	  counted	  at	  12	  hpi.	  There	  was	  no	  difference	  in	  neutrophil	  
number	  in	  the	  presence	  of	  P/S	  compared	  to	  the	  DMSO	  vehicle	  control	  but	  there	  were	  significantly	  fewer	  
neutrophils	   at	   the	   site	   of	   injury	   in	   larvae	   treated	   with	   either	   EE	   or	   EE	   and	   P/S	   combined	   (One-­‐way	  
ANOVA	  with	  Bonferroni’s	  multiple	  comparison	  post-­‐test;	  where	  ***	  P	  <	  0.001;	  n	  =	  12,	  performed	  as	  2	  
independent	   experiments).	   These	   results	   indicated	   that	   antibiotic	   activity	   alone	  was	   not	   sufficient	   to	  
drive	   inflammation	   resolution	   and	   that	   there	  was	  no	   additive	   anti-­‐bacterial	   effect	   responsible	   for	   the	  
reduction	  in	  neutrophil	  number	  when	  larvae	  were	  exposed	  to	  both	  erythromycin	  estolate	  and	  penicillin-­‐
streptomycin	  in	  combination.	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